data_2fy9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fy9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.554 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 48.7 m . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.156 0.503 . . . . 1.09 111.289 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.772 HD13 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -86.02 -33.91 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.647 -0.872 . . . . 1.06 108.647 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.52 19.61 76.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.831 -1.077 . . . . 0.51 112.548 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 27.9 m -115.92 131.32 68.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.573 0.701 . . . . 1.07 111.177 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.8 p -114.63 141.73 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.512 -1.222 . . . . 1.07 109.36 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.74 165.11 13.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.977 0.418 . . . . 1.9 110.607 -176.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 33.4 mmtp -120.22 124.24 45.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.242 -1.021 . . . . 1.63 108.242 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.71 HG22 HG23 ' B' ' 28' ' ' ILE . 39.7 t -56.38 141.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.497 0.498 . . . . 1.06 109.912 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.85 -75.15 0.07 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.938 -0.574 . . . . 1.31 109.676 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.25 -46.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.842 -0.799 . . . . 1.23 108.842 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.624 HD13 ' H ' ' A' ' 13' ' ' LEU . 1.1 mp -77.78 -50.47 12.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.887 -1.051 . . . . 1.59 110.734 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.17 -5.49 0.05 OUTLIER Glycine 0 C--O 1.225 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.25 111.832 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.787 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 56.5 mtm180 -68.99 135.03 50.28 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 122.07 0.148 . . . . 3.66 110.868 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -141.12 179.99 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.906 -0.775 . . . . 0.97 108.906 174.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.7 p -107.38 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.171 0.51 . . . . 1.07 110.91 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.596 ' HB3' HD12 ' A' ' 22' ' ' LEU . 78.6 mmm -84.13 148.62 53.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.105 -0.702 . . . . 1.62 109.105 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.0 Cg_endo -80.41 157.65 22.45 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.93 1.753 . . . . 0.18 113.679 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.6 tp -52.68 -34.61 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.969 -1.014 . . . . 0.93 109.713 171.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.42 -25.67 66.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.344 -0.843 . . . . 1.08 110.982 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -78.39 -40.97 34.53 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.83 -0.804 . . . . 1.04 108.83 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.648 ' HD2' HG23 ' A' ' 28' ' ' ILE . 21.0 mtm180 -63.78 -30.88 71.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.41 -0.814 . . . . 1.59 109.837 176.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 77.8 mtp180 -83.82 -33.3 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.267 -0.879 . . . . 0.83 110.854 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.02 -46.88 73.14 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.806 0.813 . . . . 0.92 109.413 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD23 ' H ' ' A' ' 47' ' ' LYS . 82.8 mt -85.19 -101.52 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.291 -1.322 . . . . 1.11 110.372 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -179.36 50.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.632 -0.713 . . . . 1.72 109.4 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.648 HG23 ' HD2' ' A' ' 23' ' ' ARG . 2.4 mp -98.44 136.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.872 -1.058 . . . . 1.02 109.932 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.16 -51.59 2.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.802 -0.359 . . . . 0.91 111.629 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.869 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -145.31 -32.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.463 -0.335 . . . . 1.05 110.221 -177.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 20.3 mtpp -137.83 -50.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.813 -0.81 . . . . 2.18 108.813 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.47 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 35.91 -118.84 0.13 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.461 -1.245 . . . . 1.18 113.138 -176.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' HB3' HG21 ' B' ' 7' ' ' VAL . 21.1 m -163.32 138.65 6.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.362 0.528 . . . . 0.57 111.198 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 HG23 ' B' ' 10' ' ' VAL . 3.1 mp -139.6 110.23 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.759 -0.46 . . . . 1.1 109.759 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 41.3 tt0 -104.15 137.17 42.48 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.501 -0.555 . . . . 1.31 109.501 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.84 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -110.06 151.37 27.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.964 0.888 . . . . 2.28 112.601 -174.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 14.8 t80 -127.25 122.15 33.15 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.11 -1.404 . . . . 3.08 107.519 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -93.28 132.78 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 119.798 -0.761 . . . . 1.1 111.131 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -133.92 102.85 5.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.183 -0.917 . . . . 1.16 110.343 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.5 -88.44 0.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.815 -0.629 . . . . 0.38 112.04 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.67 -8.46 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.598 0.237 . . . . 2.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.68 168.75 9.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.141 0.496 . . . . 1.68 111.09 -168.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.724 HG13 HD13 ' B' ' 22' ' ' LEU . 15.5 mm -122.53 141.65 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.249 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 46.4 mt -121.96 111.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.694 0.283 . . . . 1.06 110.382 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.84 ' HG ' ' HD1' ' A' ' 36' ' ' PHE . 10.6 mp -101.13 132.28 46.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.538 -0.301 . . . . 1.09 111.809 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.71 157.34 37.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.139 0.495 . . . . 2.71 111.093 172.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.863 ' H ' HD23 ' A' ' 26' ' ' LEU . 3.2 tmtp? -63.15 153.47 34.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.732 . . . . 1.21 110.406 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.731 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 61.6 t80 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.496 -0.32 . . . . 2.09 111.245 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 54.2 m . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.145 0.498 . . . . 1.3 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.682 HD12 ' HB2' ' A' ' 36' ' ' PHE . 1.9 mt -84.34 -42.0 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.848 -1.167 . . . . 0.91 107.848 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.76 27.02 69.92 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.559 -1.201 . . . . 0.43 112.199 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.9 131.9 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.192 0.52 . . . . 0.56 110.345 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.5 p -111.54 141.27 27.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.333 -0.849 . . . . 0.98 109.323 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.7 ' HD2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -114.21 162.39 16.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.009 0.433 . . . . 1.62 110.354 -175.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.8 mmtp -118.18 121.57 40.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.449 -0.945 . . . . 1.77 108.449 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 34' ' ' ILE . 5.2 t -55.48 135.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.555 -0.535 . . . . 1.06 109.555 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.86 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.999 -0.546 . . . . 1.22 109.535 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.869 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.4 mt-10 -154.7 -34.42 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.302 -0.999 . . . . 1.22 108.302 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.81 -49.23 11.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.098 -1.41 . . . . 1.54 110.329 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.537 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 152.21 -6.24 0.5 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.724 -1.125 . . . . 0.19 110.711 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 43.0 mtm180 -63.45 131.06 46.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.72 -0.24 . . . . 3.42 110.451 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.635 HG23 ' HA ' ' B' ' 10' ' ' VAL . 0.8 OUTLIER -138.76 179.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.757 -0.831 . . . . 1.07 108.757 174.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -107.77 113.51 43.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.98 110.885 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.542 ' HB3' HD12 ' B' ' 22' ' ' LEU . 74.8 mmm -84.89 149.0 52.47 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.815 . . . . 1.08 108.801 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 39.5 Cg_endo -80.68 158.44 21.75 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.744 1.629 . . . . 0.23 113.63 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.49 -30.92 32.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.229 -0.896 . . . . 0.24 109.707 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -25.76 67.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.223 -0.444 . . . . 1.07 110.704 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.724 HD13 HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -78.08 -41.74 34.34 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.826 -0.805 . . . . 1.1 108.826 175.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.703 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 32.8 mtp180 -61.79 -33.65 74.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.849 -1.069 . . . . 1.98 110.68 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 55.2 mtp180 -79.66 -37.68 35.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.34 -0.845 . . . . 1.11 109.872 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.42 -50.52 71.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.429 -1.26 . . . . 0.28 110.161 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.856 HD22 ' H ' ' B' ' 47' ' ' LYS . 56.5 mt -92.93 -80.44 0.38 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.65 -1.159 . . . . 1.18 112.075 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 t0 177.4 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.089 -0.245 . . . . 1.54 111.619 -168.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.71 HG23 HG22 ' A' ' 10' ' ' VAL . 1.5 mp -88.87 124.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.335 0.588 . . . . 1.07 111.668 -163.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.43 -34.86 9.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.96 . . . . 0.62 112.786 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.65 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -166.05 -33.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.502 -0.555 . . . . 0.4 109.502 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.65 ' HG3' HG23 ' B' ' 30' ' ' ILE . 18.6 mtpp -136.58 -49.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.787 -0.82 . . . . 1.99 108.787 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 35.39 -111.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.467 -1.242 . . . . 1.17 113.766 -176.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 27.3 m -166.05 138.35 3.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.343 0.52 . . . . 0.55 110.891 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.67 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -142.19 107.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.729 -0.471 . . . . 1.09 109.729 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 44.7 tt0 -103.62 139.5 38.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.711 -0.477 . . . . 1.33 109.711 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.772 ' HB2' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.85 154.73 21.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.015 0.912 . . . . 2.21 112.637 -173.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.692 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 22.9 t80 -129.96 126.22 37.3 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 114.091 -1.413 . . . . 2.99 107.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.554 ' H ' ' HB2' ' A' ' 3' ' ' SER . 10.2 p -93.04 136.43 25.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.732 -0.787 . . . . 1.07 110.339 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 11.8 t70 -134.16 100.91 4.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 1.18 109.804 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.34 -90.47 0.19 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.852 -0.69 . . . . 0.48 111.721 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -118.31 -13.47 9.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.946 0.403 . . . . 1.91 110.704 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' B' ' 39' ' ' ASP . 2.8 ptpt -98.1 169.14 9.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.4 110.939 -168.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -124.56 140.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.373 -0.831 . . . . 0.87 109.206 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 35.9 mt -119.22 113.75 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.588 -0.278 . . . . 1.07 110.546 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.838 HD11 HD11 ' A' ' 45' ' ' LEU . 11.2 mp -101.13 128.46 47.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.808 0.337 . . . . 0.97 111.575 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.731 ' HB2' ' HZ3' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -152.19 153.53 34.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 2.47 110.476 175.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.856 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.6 tmtt? -65.03 166.01 10.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 1.09 109.757 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.038 0.447 . . . . 1.89 110.225 -174.114 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.547 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 121.415 0.626 . . . . 1.09 109.317 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.714 HD12 ' HB2' ' B' ' 36' ' ' PHE . 5.3 mt -103.57 -49.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.662 -0.699 . . . . 1.06 109.388 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.58 25.32 30.65 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.567 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.7 133.27 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.0 0.905 . . . . 1.07 110.991 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.633 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.3 p -112.99 141.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 113.651 -1.613 . . . . 1.07 108.727 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 1.2 mpt_? -112.06 156.7 21.78 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.923 0.392 . . . . 1.9 110.462 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -121.25 118.14 28.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.33 -0.989 . . . . 1.63 108.33 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.7 HG22 HG21 ' B' ' 28' ' ' ILE . 22.5 t -54.22 144.49 5.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 123.948 0.78 . . . . 1.06 111.87 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.88 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.95 -1.023 . . . . 1.31 110.059 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.607 ' HG2' HD11 ' B' ' 30' ' ' ILE . 40.5 mt-10 -154.3 -43.78 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.627 -1.249 . . . . 1.23 107.627 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.51 -34.96 65.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.259 -1.337 . . . . 1.59 111.263 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' CA ' HG11 ' A' ' 10' ' ' VAL . . . 137.24 -4.64 3.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.451 -0.795 . . . . 0.25 111.152 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 9.0 mtp180 -68.57 133.57 48.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.644 -0.278 . . . . 3.66 110.626 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.2 pt -138.79 -179.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.578 -0.527 . . . . 0.97 109.578 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -109.81 103.11 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.084 0.469 . . . . 1.07 110.802 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.484 ' SD ' HD12 ' A' ' 16' ' ' ILE . 83.3 mmm -78.7 149.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.989 -0.745 . . . . 1.62 108.989 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -81.48 155.77 18.81 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.871 1.714 . . . . 0.18 113.61 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.7 tp -51.7 -32.36 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.93 109.884 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.24 -29.68 68.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.334 -0.848 . . . . 1.08 111.487 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.725 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.63 35.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.242 -0.651 . . . . 1.04 109.242 177.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.657 ' HD3' HG13 ' B' ' 10' ' ' VAL . 33.3 mtm180 -63.98 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.66 -0.7 . . . . 1.59 109.658 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 68.3 mtp180 -83.67 -33.03 25.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.031 -0.986 . . . . 0.83 110.663 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.47 -37.85 77.45 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.92 110.117 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.67 -88.64 0.23 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.145 -0.934 . . . . 1.11 111.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.738 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 22.1 t70 177.27 23.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.024 0.44 . . . . 1.72 109.977 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.555 HG21 HG22 ' B' ' 10' ' ' VAL . 2.6 mp -83.5 129.9 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 O-C-N 122.184 -0.323 . . . . 1.02 110.963 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.0 -48.37 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.91 111.236 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.15 -30.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 1.05 110.113 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.571 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.4 mtpt -137.03 -51.9 0.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.296 -0.631 . . . . 2.18 109.296 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER 36.44 -117.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.517 -1.219 . . . . 1.18 113.994 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.528 ' HB3' HG21 ' B' ' 7' ' ' VAL . 13.3 m -162.51 135.51 5.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.274 0.488 . . . . 0.57 111.428 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.847 HD11 HG23 ' B' ' 10' ' ' VAL . 3.2 mp -137.38 107.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 1.1 109.775 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 46.2 tt0 -103.1 138.03 40.48 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.287 -0.634 . . . . 1.31 109.287 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.993 0.901 . . . . 2.28 112.866 -174.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' HD1' HD13 ' A' ' 44' ' ' ILE . 18.4 t80 -127.83 123.43 35.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.126 -1.397 . . . . 3.08 108.179 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.524 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.0 p -92.3 132.6 36.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 119.824 -0.75 . . . . 1.1 110.492 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -133.59 102.65 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.515 -1.22 . . . . 1.16 109.248 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.39 -97.17 0.59 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.706 -0.759 . . . . 0.38 111.269 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -117.83 -9.55 10.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.323 0.583 . . . . 2.0 109.697 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.4 ttpt -92.09 157.73 16.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.449 -0.796 . . . . 1.68 111.538 -169.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.843 HG13 HD12 ' B' ' 22' ' ' LEU . 20.2 mm -118.58 139.53 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 44.2 mt -121.99 109.81 25.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.629 -0.26 . . . . 1.06 110.676 -173.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.806 HD11 HD11 ' B' ' 45' ' ' LEU . 11.3 mp -96.44 136.15 37.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.003 0.43 . . . . 1.09 111.612 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -145.15 170.81 15.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.186 -0.915 . . . . 2.71 110.173 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.738 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 5.1 tmtt? -87.03 149.23 24.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.307 -0.86 . . . . 1.21 109.097 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.8 t80 . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 120.933 0.397 . . . . 2.09 110.936 -175.544 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.524 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 24.2 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.527 0.679 . . . . 1.3 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.66 -46.88 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.466 -0.788 . . . . 0.91 109.362 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.28 29.12 46.4 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.197 -0.911 . . . . 0.43 112.493 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.31 131.37 71.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.374 0.607 . . . . 0.56 110.681 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 33' ' ' SER . 15.0 p -107.91 142.89 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.225 -0.898 . . . . 0.98 109.189 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.2 mpt_? -111.56 161.03 16.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.31 -0.405 . . . . 1.62 110.535 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.38 116.09 22.71 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.85 . . . . 1.77 108.704 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.847 HG23 HD11 ' A' ' 34' ' ' ILE . 7.5 t -53.25 141.86 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.706 0.629 . . . . 1.06 111.196 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.12 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.042 -0.981 . . . . 1.22 109.946 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.636 ' HG2' HD12 ' A' ' 30' ' ' ILE . 35.7 mt-10 -149.83 -41.78 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.109 -1.071 . . . . 1.22 108.109 169.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.2 mt -72.88 -36.55 67.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.269 -1.332 . . . . 1.54 110.864 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.566 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 134.78 -1.46 3.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.19 111.069 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 47.3 mtp85 -64.45 131.27 46.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.685 -0.257 . . . . 3.42 110.694 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.535 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -138.7 179.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.241 -0.652 . . . . 1.07 109.241 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.735 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -108.89 106.28 20.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.185 0.517 . . . . 0.98 110.732 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.517 ' SD ' HD11 ' B' ' 16' ' ' ILE . 81.0 mmm -79.77 146.04 63.62 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.853 -0.795 . . . . 1.08 108.853 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.76 158.62 31.61 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.08 1.853 . . . . 0.23 113.316 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -56.81 -31.05 34.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.269 -0.878 . . . . 0.24 109.273 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -59.33 -26.84 65.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.07 111.26 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.843 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.36 -39.84 31.64 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.931 -0.766 . . . . 1.1 108.931 176.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' B' ' 20' ' ' ILE . 42.9 mtm180 -66.45 -26.98 67.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.027 -0.988 . . . . 1.98 110.577 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -83.45 -32.34 26.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.529 -0.76 . . . . 1.11 109.603 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.62 62.35 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.074 -0.966 . . . . 0.28 110.494 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 53.0 mt -85.26 -93.9 0.08 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.547 -1.206 . . . . 1.18 109.364 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.511 ' OD1' ' HG3' ' B' ' 47' ' ' LYS . 6.7 p30 177.76 40.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.367 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.7 HG21 HG22 ' A' ' 10' ' ' VAL . 1.3 mp -81.01 125.05 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.07 109.798 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.77 -43.57 10.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.928 -0.578 . . . . 0.62 111.138 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.607 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -160.4 -30.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 0.4 109.388 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.488 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.2 mtpt -133.89 -52.45 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 1.99 109.382 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.539 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.4 OUTLIER 39.45 -117.83 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.848 -1.069 . . . . 1.17 113.725 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 34.4 m -162.05 134.47 5.77 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.034 0.379 . . . . 0.55 111.639 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.646 HD11 HG23 ' A' ' 10' ' ' VAL . 3.7 mp -137.88 103.58 2.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.945 -0.391 . . . . 1.09 109.945 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 47.7 tt0 -97.79 137.7 36.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.692 -0.485 . . . . 1.33 109.692 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.723 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -113.31 154.65 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.088 0.947 . . . . 2.21 113.002 -174.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 27.1 t80 -130.51 123.12 28.93 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 114.031 -1.44 . . . . 2.99 108.169 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.547 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.5 p -93.11 133.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.566 -0.854 . . . . 1.07 110.756 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.502 ' HB2' ' HE1' ' B' ' 37' ' ' PHE . 17.3 t70 -132.41 103.78 6.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.3 -0.864 . . . . 1.18 109.974 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.53 -84.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.899 -0.591 . . . . 0.48 111.719 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.96 -22.49 4.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.7 -0.481 . . . . 1.91 109.7 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.406 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 3.2 ptpp? -91.17 167.96 11.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.569 . . . . 1.4 110.866 -168.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 22' ' ' LEU . 5.3 mm -125.46 139.39 51.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.623 -0.717 . . . . 0.87 109.224 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 15.6 mt -118.23 117.85 56.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.436 -0.347 . . . . 1.07 110.559 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 45' ' ' LEU . 11.1 mp -104.2 134.68 47.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.955 0.407 . . . . 0.97 111.761 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -147.1 167.96 22.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.284 -0.871 . . . . 2.47 109.558 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.511 ' HG3' ' OD1' ' B' ' 27' ' ' ASP . 1.7 tmtp? -89.11 149.33 23.24 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.539 -0.912 . . . . 1.09 108.539 174.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.507 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 64.8 t80 . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 120.678 0.275 . . . . 1.89 111.311 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.729 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.7 m . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.245 0.545 . . . . 1.09 110.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.596 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -88.33 -36.18 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 1.06 109.635 -178.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.66 78.18 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.387 -0.824 . . . . 0.51 112.284 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.596 HG22 ' HB ' ' A' ' 4' ' ' ILE . 29.5 m -119.15 132.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.689 0.757 . . . . 1.07 111.053 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.3 p -114.76 138.89 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.276 -1.329 . . . . 1.07 109.114 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.556 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.22 148.97 32.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.069 0.461 . . . . 1.9 110.294 -174.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -112.98 120.28 40.85 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.321 -0.854 . . . . 1.63 108.898 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.634 HG22 HG21 ' B' ' 28' ' ' ILE . 36.3 t -54.7 144.72 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.482 -0.781 . . . . 1.06 111.809 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -80.32 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.842 -1.072 . . . . 1.31 109.917 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HG2' HD11 ' B' ' 30' ' ' ILE . 41.0 mt-10 -153.82 -42.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.931 -1.137 . . . . 1.23 107.931 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.38 -19.01 36.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.462 -1.245 . . . . 1.59 111.472 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 123.89 -3.79 9.19 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.836 -0.697 . . . . 0.25 111.682 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.742 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 47.7 mtm180 -67.38 126.45 29.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.361 -0.237 . . . . 3.66 110.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.628 HD11 ' HE1' ' A' ' 18' ' ' MET . 1.0 OUTLIER -136.96 179.74 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.191 -0.67 . . . . 0.97 109.191 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.1 p -110.6 118.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.194 0.521 . . . . 1.07 111.094 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.758 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.7 mmt -86.15 151.3 53.99 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.876 -0.602 . . . . 1.62 109.698 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.4 Cg_endo -85.59 156.03 10.51 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.02 1.814 . . . . 0.18 113.157 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.702 HD13 HH21 ' A' ' 23' ' ' ARG . 3.9 tp -51.18 -33.67 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.06 -0.973 . . . . 0.93 109.792 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.55 -29.56 68.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.615 -0.72 . . . . 1.08 111.877 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.843 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.37 35.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.007 -0.738 . . . . 1.04 109.007 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.702 HH21 HD13 ' A' ' 20' ' ' ILE . 62.3 mtm180 -64.84 -29.66 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 1.59 109.812 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.6 mtp180 -84.64 -35.23 22.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.176 -0.92 . . . . 0.83 110.657 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.71 72.34 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.534 -0.757 . . . . 0.92 110.237 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.762 HD21 ' H ' ' A' ' 47' ' ' LYS . 97.2 mt -89.45 -89.61 0.15 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.8 -1.091 . . . . 1.11 111.421 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 36.7 t70 168.52 58.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.97 -1.122 . . . . 1.72 107.97 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.603 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.0 mp -115.29 134.34 58.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.913 -0.585 . . . . 1.02 110.485 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.13 -59.69 1.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.37 0.605 . . . . 0.91 111.166 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.62 -31.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.466 -0.788 . . . . 1.05 109.59 -176.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HG3' HG21 ' A' ' 30' ' ' ILE . 40.2 mtpt -134.63 -56.34 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.083 -0.71 . . . . 2.18 109.083 174.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' C ' ' HG ' ' A' ' 33' ' ' SER . 0.9 OUTLIER 38.9 -121.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 1.18 113.899 -176.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB3' HG21 ' B' ' 7' ' ' VAL . 15.6 m -161.4 135.28 6.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.458 0.572 . . . . 0.57 111.236 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.72 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -139.88 104.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.332 -0.618 . . . . 1.1 109.332 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.1 tt0 -102.86 135.05 45.24 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.571 -0.529 . . . . 1.31 109.571 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.767 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -112.49 154.33 26.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.02 0.914 . . . . 2.28 113.098 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.5 ' HD1' HD13 ' A' ' 44' ' ' ILE . 24.9 t80 -131.76 121.91 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.982 -1.463 . . . . 3.08 107.868 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.641 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -92.62 135.32 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.198 -0.601 . . . . 1.1 110.703 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -133.74 102.4 5.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.979 -1.01 . . . . 1.16 109.966 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.5 -82.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.38 112.037 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.75 -20.15 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.34 0.591 . . . . 2.0 109.901 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 5.6 ttpt -93.05 157.97 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.256 -0.884 . . . . 1.68 111.376 -166.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.908 HG13 HD13 ' B' ' 22' ' ' LEU . 16.9 mm -114.78 141.5 31.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.432 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 43.8 mt -122.36 107.2 19.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.607 0.242 . . . . 1.06 110.758 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.1 mp -94.46 131.29 40.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.442 -0.345 . . . . 1.09 111.265 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HA ' HD22 ' A' ' 26' ' ' LEU . 4.1 ptmt -149.91 148.7 29.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.908 -0.587 . . . . 2.71 111.136 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.762 ' H ' HD21 ' A' ' 26' ' ' LEU . 3.3 tmtp? -72.39 137.3 46.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.21 109.985 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.562 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 63.0 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.535 -0.757 . . . . 2.09 111.616 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.641 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.0 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.344 0.592 . . . . 1.3 110.252 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.767 HD12 ' HD2' ' A' ' 36' ' ' PHE . 1.3 mt -96.97 -32.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.91 109.882 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.2 28.61 73.81 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.583 -0.735 . . . . 0.43 112.888 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -124.52 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.158 0.504 . . . . 0.56 110.609 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -110.63 144.19 19.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.503 -0.771 . . . . 0.98 109.185 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.597 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mpt_? -114.56 155.11 27.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.035 0.445 . . . . 1.62 110.631 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 116.98 27.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.258 -1.016 . . . . 1.77 108.258 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.72 HG23 HD11 ' A' ' 34' ' ' ILE . 9.1 t -52.45 137.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 O-C-N 123.803 0.689 . . . . 1.06 111.226 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.19 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.227 -0.897 . . . . 1.22 110.212 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 30' ' ' ILE . 44.3 mt-10 -152.92 -38.11 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.408 -0.96 . . . . 1.22 108.408 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.57 -29.27 25.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.786 -1.097 . . . . 1.54 111.006 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.525 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 133.18 -3.2 4.8 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.663 -0.975 . . . . 0.19 110.663 -172.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.2 mtm180 -63.33 129.47 40.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.356 . . . . 3.42 110.701 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.546 HD11 ' HE3' ' B' ' 18' ' ' MET . 0.5 OUTLIER -139.24 179.51 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.901 -0.777 . . . . 1.07 108.901 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.742 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -109.26 117.29 54.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.178 0.513 . . . . 0.98 111.263 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.626 ' HA ' ' HE1' ' B' ' 18' ' ' MET . 23.8 mmt -81.61 154.6 71.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.235 -0.654 . . . . 1.08 109.235 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.0 Cg_endo -86.47 156.27 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.129 1.886 . . . . 0.23 113.342 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' B' ' 23' ' ' ARG . 4.0 tp -56.47 -30.39 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.832 . . . . 0.24 109.314 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -58.84 -28.95 66.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.87 . . . . 1.07 110.909 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.908 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.72 -40.22 34.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.987 -0.745 . . . . 1.1 108.987 177.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 57.0 mtm180 -64.2 -27.69 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.037 -0.983 . . . . 1.98 110.357 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -83.99 -35.19 24.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.165 -0.925 . . . . 1.11 110.018 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -51.33 67.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.849 -1.069 . . . . 0.28 110.878 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.739 HD21 ' H ' ' B' ' 47' ' ' LYS . 70.3 mt -90.83 -85.65 0.22 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.611 -1.177 . . . . 1.18 111.675 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.617 ' C ' HD11 ' B' ' 28' ' ' ILE . 24.3 t0 169.05 55.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.67 -0.863 . . . . 1.54 108.67 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.634 HG21 HG22 ' A' ' 10' ' ' VAL . 1.3 mp -116.23 139.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 1.07 109.908 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.45 -59.58 1.93 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.814 -0.63 . . . . 0.62 111.083 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.446 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -140.85 -33.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.177 -0.465 . . . . 0.4 110.072 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.476 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.0 mtpt -133.98 -52.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.913 -0.773 . . . . 1.99 108.913 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.558 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.8 OUTLIER 36.94 -118.96 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.686 -1.143 . . . . 1.17 114.063 -176.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 15.9 m -161.43 134.72 6.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.996 0.362 . . . . 0.55 111.337 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.637 HG22 HD21 ' B' ' 45' ' ' LEU . 3.8 mp -141.71 102.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.682 -0.488 . . . . 1.09 109.682 171.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 38.5 tt0 -99.29 136.87 38.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 1.33 109.576 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.723 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -110.43 158.12 18.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.283 1.039 . . . . 2.21 113.268 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 35.1 t80 -135.39 125.13 25.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.632 -1.622 . . . . 2.99 107.86 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.729 ' H ' ' HB2' ' A' ' 3' ' ' SER . 13.5 p -92.9 135.31 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.87 -0.732 . . . . 1.07 110.111 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -133.64 100.05 4.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.833 -0.621 . . . . 1.18 110.039 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 -80.42 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.48 111.917 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.69 -19.79 3.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.238 0.542 . . . . 1.91 110.008 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -91.82 167.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.489 -0.778 . . . . 1.4 110.796 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 22' ' ' LEU . 8.4 mm -121.72 139.98 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.554 -0.748 . . . . 0.87 109.149 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.2 mt -118.27 111.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.498 -0.319 . . . . 1.07 110.59 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.822 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -99.61 132.23 45.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.647 0.261 . . . . 0.97 111.478 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -153.76 145.33 23.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.012 -0.54 . . . . 2.47 111.328 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.739 ' H ' HD21 ' B' ' 26' ' ' LEU . 1.9 tmtp? -72.37 135.5 45.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 1.09 109.905 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 t80 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.354 -0.839 . . . . 1.89 112.207 -171.619 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.372 0.606 . . . . 1.09 111.38 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -84.82 -34.13 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.297 -1.001 . . . . 1.06 108.297 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.35 16.09 78.85 Favored Glycine 0 CA--C 1.504 -0.603 0 CA-C-N 114.88 -1.055 . . . . 0.51 112.736 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' C ' ' HG3' ' B' ' 35' ' ' GLU . 23.4 m -114.7 131.17 67.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.778 0.799 . . . . 1.07 111.475 -175.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.7 p -110.21 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.997 -1.456 . . . . 1.07 108.746 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' NE ' HG11 ' A' ' 17' ' ' VAL . 2.7 mpt_? -122.04 164.24 18.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.436 -0.347 . . . . 1.9 110.557 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 34.1 mmtm -115.06 127.59 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.592 -0.892 . . . . 1.63 108.592 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.83 HG21 HD11 ' B' ' 34' ' ' ILE . 18.3 t -58.55 136.64 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.57 -0.53 . . . . 1.06 109.57 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.71 -77.87 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.899 -0.591 . . . . 1.31 109.564 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.5 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.3 mt-10 -154.81 -45.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.747 -1.205 . . . . 1.23 107.747 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.13 -34.69 63.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.338 -1.301 . . . . 1.59 110.908 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' HG11 ' A' ' 10' ' ' VAL . . . 141.86 -9.62 2.56 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.21 -0.905 . . . . 0.25 111.12 -172.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.842 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 27.9 mtm180 -62.45 131.43 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.262 . . . . 3.66 111.165 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.704 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -141.46 179.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.096 -0.705 . . . . 0.97 109.096 174.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -107.91 107.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.346 0.593 . . . . 1.07 110.908 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.585 ' HB3' HD12 ' A' ' 22' ' ' LEU . 77.4 mmm -80.29 152.56 73.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.122 -0.695 . . . . 1.62 109.122 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 95.2 Cg_endo -84.66 157.22 12.12 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.767 1.645 . . . . 0.18 114.119 -171.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.1 tp -50.44 -37.81 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.816 -1.084 . . . . 0.93 110.224 170.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.71 -26.13 65.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 1.08 110.782 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -77.09 -39.21 50.49 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.947 -0.76 . . . . 1.04 108.947 177.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.612 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 17.3 mtm180 -64.02 -34.74 78.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.312 -0.858 . . . . 1.59 110.028 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.7 mtp180 -79.62 -35.6 39.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.175 -0.92 . . . . 0.83 110.083 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.43 -51.4 29.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.051 -0.977 . . . . 0.92 110.212 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 47' ' ' LYS . 86.5 mt -78.01 -89.87 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.173 -0.921 . . . . 1.11 111.492 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 11.2 t70 175.15 43.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.511 -0.922 . . . . 1.72 108.511 -169.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -115.44 138.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 1.02 111.317 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.94 -51.15 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.013 -0.539 . . . . 0.91 111.513 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.594 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -147.18 -29.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.032 -0.359 . . . . 1.05 110.032 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HG3' HG23 ' A' ' 30' ' ' ILE . 18.4 mtpp -138.98 -52.23 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.265 -0.642 . . . . 2.18 109.265 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 35.08 -110.24 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.49 -1.232 . . . . 1.18 113.946 -177.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 50.4 m -165.34 142.44 5.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.377 0.535 . . . . 0.57 111.168 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.978 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -141.13 108.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 110.26 -0.274 . . . . 1.1 110.26 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.4 tt0 -105.63 132.17 52.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.987 -0.375 . . . . 1.31 109.987 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.609 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.41 155.97 23.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.404 1.097 . . . . 2.28 113.017 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 40.9 t80 -125.22 153.38 43.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.331 -1.759 . . . . 3.08 106.454 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.9 p -122.16 133.09 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.788 -0.765 . . . . 1.1 110.175 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.56 96.9 4.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 1.16 110.033 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.89 -82.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.586 -0.733 . . . . 0.38 111.502 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HD22 ' B' ' 26' ' ' LEU . 14.6 m-20 -125.5 -17.7 5.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.724 -0.238 . . . . 2.0 110.99 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 166.27 12.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 1.68 110.72 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG13 HD11 ' B' ' 22' ' ' LEU . 15.3 mm -120.72 142.96 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 43.0 mt -124.65 111.24 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 1.06 110.613 -174.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.828 HD13 HD11 ' B' ' 45' ' ' LEU . 11.0 mp -94.64 135.78 35.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.24 0.543 . . . . 1.09 111.905 -174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 16.4 ttpp -149.68 134.56 17.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.852 -1.067 . . . . 2.71 109.421 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.656 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.7 tmtp? -63.86 155.32 30.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.637 -0.875 . . . . 1.21 108.637 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.614 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 25.1 t80 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.067 0.46 . . . . 2.09 111.004 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.405 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.1 m . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.248 0.546 . . . . 1.3 110.858 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.16 -35.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.528 -1.286 . . . . 0.91 107.528 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.66 73.82 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 114.382 -1.281 . . . . 0.43 112.375 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.66 132.21 69.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.219 0.533 . . . . 0.56 110.603 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -109.44 147.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.98 109.196 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.481 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mpt_? -120.12 167.01 12.65 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.144 -0.48 . . . . 1.62 110.377 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 40.6 mmtm -119.02 122.53 42.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.699 -0.852 . . . . 1.77 108.699 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.978 HG23 HD11 ' A' ' 34' ' ' ILE . 4.3 t -56.04 133.31 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.281 -0.637 . . . . 1.06 109.281 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -79.16 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.756 -0.656 . . . . 1.22 109.972 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.503 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.4 mt-10 -152.73 -40.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.085 -1.08 . . . . 1.22 108.085 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.655 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.3 OUTLIER -89.74 -15.2 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.067 -1.424 . . . . 1.54 110.493 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.712 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 124.21 -4.75 8.91 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.19 111.934 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 53.0 mtm180 -63.45 131.74 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.869 0.067 . . . . 3.42 110.839 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -142.15 179.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.904 -0.776 . . . . 1.07 108.904 174.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.842 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -107.95 109.14 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.007 0.432 . . . . 0.98 110.769 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.576 ' HB3' HD13 ' B' ' 22' ' ' LEU . 77.3 mmm -80.97 152.25 71.41 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.702 -0.851 . . . . 1.08 108.702 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 40.7 Cg_endo -83.16 158.1 15.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.559 1.506 . . . . 0.23 113.583 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.607 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.9 tp -58.62 -29.55 39.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.142 -0.935 . . . . 0.24 109.307 172.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.54 -27.82 67.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 1.07 110.823 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.736 HD11 HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -76.99 -41.42 42.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.723 -0.843 . . . . 1.1 108.723 176.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.717 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 65.1 mtp180 -62.81 -31.25 72.2 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.543 -1.208 . . . . 1.98 110.899 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -81.15 -33.99 32.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.361 -0.836 . . . . 1.11 109.652 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.59 19.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.729 -1.123 . . . . 0.28 111.419 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.702 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 74.2 mt -82.06 -81.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.862 -1.063 . . . . 1.18 111.091 -171.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.585 ' C ' HD11 ' B' ' 28' ' ' ILE . 37.6 t70 170.9 49.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 -173.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.717 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -115.8 133.93 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.1 0.476 . . . . 1.07 110.336 -173.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.79 -48.47 3.92 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.512 -0.767 . . . . 0.62 111.385 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.6 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -152.9 -29.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.008 0.432 . . . . 0.4 109.97 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.6 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.8 mtpp -138.55 -51.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.944 -0.761 . . . . 1.99 108.944 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.564 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 36.35 -108.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.518 -1.219 . . . . 1.17 114.136 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.629 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 21.0 m -167.93 141.27 3.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.884 0.311 . . . . 0.55 110.67 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 10' ' ' VAL . 4.2 mp -144.23 106.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 110.214 -0.291 . . . . 1.09 110.214 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 tt0 -98.6 142.17 30.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.852 -0.425 . . . . 1.33 109.852 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.583 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -114.45 155.4 26.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.067 0.936 . . . . 2.21 112.911 -175.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.807 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.4 t80 -127.31 151.17 49.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.754 -1.572 . . . . 2.99 106.754 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.48 ' H ' ' HB2' ' A' ' 3' ' ' SER . 4.6 p -118.99 134.62 62.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.665 -0.814 . . . . 1.07 110.604 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -129.44 95.81 4.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.222 -0.899 . . . . 1.18 109.827 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.59 -82.31 0.39 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.901 -0.666 . . . . 0.48 111.662 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.412 ' O ' HD22 ' A' ' 26' ' ' LEU . 26.6 m-20 -128.46 -13.26 4.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.516 0.198 . . . . 1.91 110.514 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 1.2 ptpp? -100.29 168.94 9.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.389 . . . . 1.4 110.55 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 23.4 mm -124.67 144.81 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.8 -0.637 . . . . 0.87 109.955 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.807 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 39.4 mt -125.93 115.08 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.27 -0.423 . . . . 1.07 110.951 -173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.828 HD11 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -101.47 134.27 44.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.081 0.467 . . . . 0.97 111.869 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.558 ' HA ' HD23 ' B' ' 26' ' ' LEU . 24.5 ttpp -147.99 137.6 22.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.191 -0.913 . . . . 2.47 109.257 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -64.68 150.28 47.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.395 -0.965 . . . . 1.09 108.395 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.625 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.77 0.319 . . . . 1.89 110.707 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.607 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 5.2 m . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 120.985 0.422 . . . . 1.09 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' B' ' 37' ' ' PHE . 3.9 mt -97.69 -37.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 1.06 109.701 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.64 40.54 31.7 Favored Glycine 0 CA--C 1.506 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.51 112.446 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 4' ' ' ILE . 8.1 m -138.12 133.57 44.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.486 0.66 . . . . 1.07 111.309 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -118.89 140.9 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.763 -1.108 . . . . 1.07 109.061 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.545 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -116.29 160.05 21.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.82 -0.437 . . . . 1.9 109.82 -174.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 26.3 mmtp -122.15 120.44 34.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.335 -0.987 . . . . 1.63 108.335 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.749 HG21 HD11 ' B' ' 34' ' ' ILE . 18.1 t -52.32 138.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.732 0.645 . . . . 1.06 110.767 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.84 -71.86 0.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.77 -0.65 . . . . 1.31 109.695 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -154.39 -51.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.938 -0.764 . . . . 1.23 108.938 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -82.56 -23.93 34.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.65 -1.159 . . . . 1.59 110.821 -177.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 139.75 -9.6 3.12 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.913 -0.661 . . . . 0.25 112.139 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 35.6 mtm180 -62.8 129.82 42.14 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.824 -0.221 . . . . 3.66 110.945 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.566 HD11 ' HE3' ' A' ' 18' ' ' MET . 0.5 OUTLIER -139.18 177.33 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.268 -0.641 . . . . 0.97 109.268 175.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -106.31 111.61 35.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.301 0.572 . . . . 1.07 111.096 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.566 ' HE3' HD11 ' A' ' 16' ' ' ILE . 2.8 mmt -83.01 155.58 67.47 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.022 -0.733 . . . . 1.62 109.022 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.2 Cg_endo -86.69 153.86 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.033 1.822 . . . . 0.18 113.573 -173.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.3 tp -52.59 -33.0 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.93 109.667 169.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -62.15 -26.53 68.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.514 -0.766 . . . . 1.08 110.873 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.766 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -78.91 -38.9 36.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.73 -0.841 . . . . 1.04 108.73 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.695 ' HD3' HG13 ' B' ' 10' ' ' VAL . 37.3 mtm180 -65.07 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.107 -0.951 . . . . 1.59 110.249 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.3 mtp180 -84.62 -37.52 20.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.164 -0.925 . . . . 0.83 110.529 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.2 -50.18 55.94 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.472 -0.785 . . . . 0.92 110.43 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.616 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -80.6 -86.33 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.789 -1.096 . . . . 1.11 111.13 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t0 166.6 61.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.6 -1.259 . . . . 1.72 107.6 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -123.95 134.27 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.02 110.406 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.33 -56.67 2.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.151 0.5 . . . . 0.91 110.825 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -141.48 -30.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.81 -0.632 . . . . 1.05 109.699 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 6.7 mtpp -136.17 -54.15 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.323 -0.621 . . . . 2.18 109.323 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.55 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.97 -116.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.423 -1.262 . . . . 1.18 113.706 -175.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 14.0 m -162.0 136.73 7.0 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.409 0.549 . . . . 0.57 111.125 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.853 HD11 HG21 ' B' ' 10' ' ' VAL . 3.8 mp -138.6 103.15 2.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.868 -0.419 . . . . 1.1 109.868 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.6 tt0 -97.95 137.73 36.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.254 -0.647 . . . . 1.31 109.254 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -121.68 151.04 40.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.426 1.108 . . . . 2.28 112.989 -175.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.661 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -113.5 165.87 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.311 -1.768 . . . . 3.08 107.034 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.493 ' H ' ' HB2' ' B' ' 3' ' ' SER . 2.9 p -133.19 125.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.49 0.662 . . . . 1.1 109.906 167.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -128.57 104.59 7.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.926 -1.034 . . . . 1.16 109.758 -173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.83 -92.08 0.53 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.156 -0.778 . . . . 0.38 111.156 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.592 ' O ' HD23 ' B' ' 26' ' ' LEU . 28.7 m-20 -126.9 4.57 6.57 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.993 -0.373 . . . . 2.0 109.993 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -109.97 157.24 19.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 1.68 111.437 -168.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.864 HG13 HD12 ' B' ' 22' ' ' LEU . 19.8 mm -113.84 142.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 mt -123.78 115.48 45.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.521 -0.309 . . . . 1.06 110.92 -173.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.768 HD11 HD11 ' B' ' 45' ' ' LEU . 10.5 mp -101.27 129.79 47.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.47 0.652 . . . . 1.09 112.429 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 13.4 ttpt -142.49 141.09 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.579 -1.191 . . . . 2.71 109.749 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 1.5 tmtp? -73.96 148.95 41.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.574 -0.898 . . . . 1.21 108.574 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.63 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 36.6 t80 . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.064 0.459 . . . . 2.09 111.235 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 19.9 m . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 121.441 0.638 . . . . 1.3 110.362 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.63 -46.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.481 -0.781 . . . . 0.91 109.398 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.63 35.02 37.59 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.267 -0.879 . . . . 0.43 112.512 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -129.09 132.4 67.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.042 0.448 . . . . 0.56 110.39 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.3 p -112.07 143.15 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.874 -0.787 . . . . 0.98 108.874 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.402 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mpt_? -114.81 162.9 16.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.237 -0.438 . . . . 1.62 110.602 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.59 121.3 38.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.523 -0.918 . . . . 1.77 108.523 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.853 HG21 HD11 ' A' ' 34' ' ' ILE . 2.9 t -56.32 132.87 20.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 O-C-N 123.358 0.411 . . . . 1.06 110.115 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.17 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.22 109.672 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 30' ' ' ILE . 40.8 mt-10 -155.13 -39.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 124.272 0.983 . . . . 1.22 108.445 171.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.662 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.2 OUTLIER -92.06 -18.01 24.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.458 -1.246 . . . . 1.54 110.472 -177.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 130.1 -7.49 6.04 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.639 -0.71 . . . . 0.19 112.106 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 39.2 mtm180 -61.45 129.99 43.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.819 -0.224 . . . . 3.42 110.789 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.546 HG21 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -140.8 176.01 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.298 -0.63 . . . . 1.07 109.298 175.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 1.5 p -105.3 108.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.295 0.569 . . . . 0.98 111.358 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.64 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.9 mmt -75.3 156.26 85.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.027 -0.731 . . . . 1.08 109.027 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.1 Cg_endo -87.84 155.58 7.36 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.988 1.792 . . . . 0.23 113.417 -176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.62 -0.718 . . . . 0.24 109.283 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -59.31 -30.03 68.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.401 -0.818 . . . . 1.07 110.804 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.864 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.33 -39.99 58.83 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.701 -0.851 . . . . 1.1 108.701 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.662 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 33.8 mtm180 -64.47 -30.09 71.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.862 -1.063 . . . . 1.98 110.318 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -84.64 -24.63 28.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.311 -0.859 . . . . 1.11 110.39 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.12 -53.2 8.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.218 -0.901 . . . . 0.28 110.941 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.764 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 16.2 mt -83.13 -81.39 0.16 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.056 -0.975 . . . . 1.18 110.212 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.624 ' C ' HD11 ' B' ' 28' ' ' ILE . 20.3 t70 165.19 61.24 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.965 -1.124 . . . . 1.54 107.965 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -116.63 133.73 62.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.845 -0.616 . . . . 1.07 109.653 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.58 -56.82 2.21 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.178 -0.464 . . . . 0.62 110.853 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.413 ' O ' HG11 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -143.03 -31.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.84 -0.618 . . . . 0.4 109.672 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -134.6 -51.88 0.8 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.354 -0.61 . . . . 1.99 109.354 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.636 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.4 OUTLIER 39.77 -113.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.677 -1.147 . . . . 1.17 113.818 -176.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.559 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 18.7 m -161.93 135.95 6.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.042 0.214 . . . . 0.55 111.235 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.749 HD11 HG21 ' A' ' 10' ' ' VAL . 4.2 mp -139.87 102.07 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 N-CA-C 109.677 -0.49 . . . . 1.09 109.677 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 45.6 tt0 -96.47 135.55 38.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.33 109.388 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.531 ' CE2' ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -121.07 151.29 40.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.603 0.716 . . . . 2.21 112.375 -176.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.563 ' HA ' HG13 ' A' ' 4' ' ' ILE . 2.8 p90 -143.34 139.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.962 -1.017 . . . . 2.99 110.307 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.607 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.2 p -92.9 141.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.383 0.611 . . . . 1.07 110.791 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.98 102.22 5.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.164 -0.926 . . . . 1.18 109.355 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.6 -88.18 0.53 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.104 -0.799 . . . . 0.48 111.104 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.07 -8.13 5.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.412 -0.218 . . . . 1.91 110.412 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -105.78 168.42 9.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 1.4 111.0 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.766 HG13 HD12 ' A' ' 22' ' ' LEU . 30.4 mm -119.65 142.5 34.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.861 -0.609 . . . . 0.87 109.491 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 11.8 mt -125.95 125.44 68.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.912 -0.315 . . . . 1.07 110.178 -175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.768 HD11 HD11 ' A' ' 45' ' ' LEU . 10.7 mp -107.48 128.87 54.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.203 0.525 . . . . 0.97 111.86 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 10.3 ttpt -142.47 138.68 31.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.831 -1.077 . . . . 2.47 110.158 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.764 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.6 tmtp? -70.01 146.67 50.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.822 -0.807 . . . . 1.09 108.822 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.572 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 40.5 t80 . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 1.89 111.419 -173.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 25.0 m . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.0 0.429 . . . . 1.09 111.998 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.1 mt -82.57 -35.59 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.037 -1.098 . . . . 1.06 108.037 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.53 13.74 74.49 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 114.738 -1.119 . . . . 0.51 112.798 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 29.1 m -105.17 132.44 51.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.502 0.667 . . . . 1.07 110.93 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.8 p -113.52 139.78 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.494 -1.23 . . . . 1.07 109.913 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -114.4 156.65 24.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.893 -0.594 . . . . 1.9 110.435 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -117.71 122.86 44.64 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.877 -0.786 . . . . 1.63 108.877 175.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.668 HG23 HG21 ' B' ' 28' ' ' ILE . 27.4 t -57.64 146.19 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 1.06 111.781 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -77.55 0.06 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.12 -0.945 . . . . 1.31 110.151 174.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -155.22 -43.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.729 -0.841 . . . . 1.23 108.729 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 -25.88 30.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.647 -1.16 . . . . 1.59 110.936 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 133.93 -6.76 4.79 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.295 -0.866 . . . . 0.25 110.984 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 48.2 mtm180 -62.79 128.18 34.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.423 0.154 . . . . 3.66 110.83 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.585 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -139.52 179.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.688 -0.856 . . . . 0.97 108.688 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -106.28 116.18 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.083 0.468 . . . . 1.07 110.907 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.68 ' HE2' HD23 ' B' ' 45' ' ' LEU . 13.9 mmt -83.56 150.84 60.77 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.34 -0.615 . . . . 1.62 109.34 174.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.56 154.48 18.22 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.777 1.651 . . . . 0.18 113.098 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.1 tp -53.41 -32.18 19.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.325 -0.852 . . . . 0.93 109.629 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.1 mm-40 -61.14 -27.78 68.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.08 111.111 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.829 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -40.7 41.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.625 -0.879 . . . . 1.04 108.625 176.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.579 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 42.3 mtm180 -63.66 -30.55 71.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.861 -1.063 . . . . 1.59 110.133 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.0 mtp180 -84.59 -32.12 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.37 -0.832 . . . . 0.83 110.73 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.19 76.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.528 -0.76 . . . . 0.92 109.803 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 47' ' ' LYS . 86.8 mt -96.66 -91.53 0.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.974 -1.012 . . . . 1.11 111.841 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 29.7 t70 172.31 55.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.742 -1.207 . . . . 1.72 107.742 -170.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.2 mp -116.23 130.38 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.81 -0.632 . . . . 1.02 109.813 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -58.07 2.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.241 0.543 . . . . 0.91 110.915 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.53 ' O ' HG13 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -143.42 -29.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.599 -0.728 . . . . 1.05 109.616 -177.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' HG23 ' A' ' 30' ' ' ILE . 34.9 mtpt -136.09 -54.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.665 . . . . 2.18 109.458 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 37.38 -124.4 0.21 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.814 1.042 . . . . 1.18 113.814 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' HB3' HG21 ' B' ' 7' ' ' VAL . 16.4 m -159.88 134.53 7.74 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.426 0.557 . . . . 0.57 111.318 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 45' ' ' LEU . 3.0 mp -139.58 108.42 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 110.155 -0.313 . . . . 1.1 110.155 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 66.9 tt0 -99.68 140.99 33.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.762 -0.458 . . . . 1.31 109.762 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -119.85 155.2 33.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.417 1.104 . . . . 2.28 113.502 -176.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.746 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 6.6 t80 -121.34 144.81 48.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.418 -1.719 . . . . 3.08 106.481 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' H ' ' HB2' ' B' ' 3' ' ' SER . 8.8 p -116.47 128.76 73.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.506 -0.878 . . . . 1.1 110.3 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -131.76 102.0 5.7 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.958 -1.019 . . . . 1.16 109.755 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.63 -92.92 0.45 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.334 -0.706 . . . . 0.38 111.334 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.54 -9.99 9.32 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.396 -0.594 . . . . 2.0 109.396 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -97.31 157.72 15.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.779 -0.646 . . . . 1.68 111.397 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.848 HG13 HD13 ' B' ' 22' ' ' LEU . 9.5 mm -116.38 144.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 47.3 mt -129.52 109.7 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 122.33 0.252 . . . . 1.06 110.782 -173.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.703 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -98.48 142.54 29.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.207 0.447 . . . . 1.09 112.207 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -150.36 158.52 44.25 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.635 -0.711 . . . . 2.71 109.241 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.8 tmtp? -70.85 149.24 47.0 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.455 -0.943 . . . . 1.21 108.455 174.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.568 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 91.7 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 2.09 110.853 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.4 m . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.171 0.51 . . . . 1.3 111.243 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.412 HD12 ' HD2' ' A' ' 36' ' ' PHE . 3.2 mt -83.19 -35.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.519 -1.289 . . . . 0.91 107.519 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 28.02 71.68 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.349 -1.296 . . . . 0.43 112.178 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.5 m -116.62 133.07 64.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.165 0.507 . . . . 0.56 110.272 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.1 p -113.46 140.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.98 109.861 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 6.6 mpt_? -114.4 157.35 22.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.993 -0.549 . . . . 1.62 110.667 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.13 119.02 33.47 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.472 -0.936 . . . . 1.77 108.472 177.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 34' ' ' ILE . 5.5 t -56.28 141.76 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 123.839 0.712 . . . . 1.06 111.719 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -60.7 -79.56 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.951 -1.022 . . . . 1.22 110.474 175.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 30' ' ' ILE . 39.9 mt-10 -156.22 -39.68 0.08 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.228 -1.027 . . . . 1.22 108.228 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.94 -25.03 32.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.686 -1.143 . . . . 1.54 110.457 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 127.66 -3.12 7.04 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.051 -0.977 . . . . 0.19 110.742 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.79 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 72.9 mtm180 -62.18 127.02 29.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.275 . . . . 3.42 110.613 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' B' ' 10' ' ' VAL . 1.0 OUTLIER -137.28 179.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 1.07 108.705 175.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.82 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -107.66 112.71 41.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.151 0.501 . . . . 0.98 111.034 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.651 ' HB3' HD22 ' B' ' 22' ' ' LEU . 29.2 mmt -76.3 154.35 84.19 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.11 -0.7 . . . . 1.08 109.11 173.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 51.5 Cg_endo -85.78 156.29 10.26 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 121.998 1.799 . . . . 0.23 112.707 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.621 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -57.67 -29.04 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.618 -0.719 . . . . 0.24 109.381 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.4 -28.48 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.718 -0.674 . . . . 1.07 110.691 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.848 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.77 -40.87 32.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.967 -0.753 . . . . 1.1 108.967 176.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.631 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 35.3 mtm180 -62.84 -30.09 71.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.892 -1.049 . . . . 1.98 110.245 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.37 -34.87 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.94 . . . . 1.11 109.973 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.75 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.013 -0.994 . . . . 0.28 109.964 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 47' ' ' LYS . 36.9 mt -94.44 -104.24 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.631 -1.168 . . . . 1.18 110.94 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.433 ' H ' HD11 ' B' ' 28' ' ' ILE . 11.2 m-20 -153.62 16.26 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.812 -0.176 . . . . 1.54 111.461 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.668 HG21 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -76.62 129.32 37.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.369 -0.533 . . . . 1.07 110.471 -164.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -57.59 2.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.67 -0.696 . . . . 0.62 110.387 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.532 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -142.48 -31.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.687 -0.688 . . . . 0.4 109.566 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.0 mtpt -134.54 -53.08 0.82 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.773 -0.648 . . . . 1.99 109.359 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.572 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.2 OUTLIER 41.05 -119.34 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.886 -1.052 . . . . 1.17 113.51 -177.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.504 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 46.5 m -165.43 132.35 2.85 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.475 -0.141 . . . . 0.55 110.866 -173.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 10' ' ' VAL . 3.8 mp -139.71 105.76 2.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.602 0.239 . . . . 1.09 110.609 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 57.9 tt0 -96.32 141.7 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.613 -0.514 . . . . 1.33 109.613 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.701 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.1 OUTLIER -113.83 159.8 19.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 122.121 0.963 . . . . 2.21 112.896 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.748 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 14.0 t80 -136.17 126.08 25.86 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 113.776 -1.556 . . . . 2.99 107.656 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.565 ' H ' ' HB2' ' A' ' 3' ' ' SER . 11.0 p -95.81 134.63 32.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.831 -0.748 . . . . 1.07 110.468 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -134.83 101.05 4.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.592 -0.731 . . . . 1.18 110.107 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.01 -93.63 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.005 -0.838 . . . . 0.48 111.005 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.54 -16.48 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.884 -0.413 . . . . 1.91 109.884 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' B' ' 42' ' ' LYS . 3.6 ptpp? -95.62 169.83 9.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.353 0.597 . . . . 1.4 111.109 -167.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.829 HG13 HD13 ' A' ' 22' ' ' LEU . 27.4 mm -125.38 142.34 42.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.172 -0.922 . . . . 0.87 109.447 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.748 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 25.3 mt -124.2 115.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 1.07 111.004 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.848 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -102.86 141.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.125 0.417 . . . . 0.97 112.125 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -151.11 158.73 44.39 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.796 -0.816 . . . . 2.47 108.796 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.63 ' H ' HD23 ' B' ' 26' ' ' LEU . 1.4 tmtp? -72.56 153.72 41.16 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.997 -1.112 . . . . 1.09 107.997 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.498 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 69.0 t80 . . . . . 0 C--N 1.322 -0.597 0 CA-C-O 120.821 0.344 . . . . 1.89 111.19 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.557 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 54.7 m . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 121.205 0.526 . . . . 1.09 111.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' B' ' 36' ' ' PHE . 2.3 mt -81.8 -32.26 11.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.243 -1.021 . . . . 1.06 108.243 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.29 13.12 76.85 Favored Glycine 0 CA--C 1.503 -0.689 0 CA-C-N 114.657 -1.156 . . . . 0.51 112.735 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' B' ' 36' ' ' PHE . 25.5 m -108.98 131.54 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.568 0.699 . . . . 1.07 111.056 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -109.34 140.74 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.553 -1.203 . . . . 1.07 109.284 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' NE ' HG11 ' A' ' 17' ' ' VAL . 3.0 mpt_? -114.45 159.71 20.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.166 -0.47 . . . . 1.9 110.344 -175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 30.6 mmtp -122.19 121.76 37.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.326 -0.99 . . . . 1.63 108.326 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG22 HG21 ' B' ' 28' ' ' ILE . 26.9 t -55.25 145.33 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.851 0.719 . . . . 1.06 110.953 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.43 -75.27 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.778 -0.647 . . . . 1.31 109.266 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' HD11 ' B' ' 30' ' ' ILE . 30.5 mt-10 -152.79 -39.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.38 -34.65 28.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.41 -1.268 . . . . 1.59 111.284 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.82 -11.09 2.63 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.942 -0.863 . . . . 0.25 110.942 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.713 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 49.7 mtt180 -62.88 131.68 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.517 -0.342 . . . . 3.66 110.869 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -139.85 176.04 6.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.071 -0.715 . . . . 0.97 109.071 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.3 p -104.64 112.77 39.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.209 0.528 . . . . 1.07 110.873 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 1.2 mmt -82.12 152.43 68.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.686 -0.857 . . . . 1.62 108.686 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 92.4 Cg_endo -83.91 156.54 13.48 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.664 1.576 . . . . 0.18 113.132 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.839 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.7 tp -54.65 -33.33 27.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.176 -0.92 . . . . 0.93 109.538 172.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.13 -26.88 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 1.08 111.01 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.82 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.69 -40.98 47.12 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.728 -0.842 . . . . 1.04 108.728 176.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 53.3 mtm180 -63.92 -30.18 71.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.097 -0.956 . . . . 1.59 110.165 176.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.839 ' HD2' HG13 ' A' ' 20' ' ' ILE . 37.6 mtp180 -85.15 -30.51 23.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.208 -0.906 . . . . 0.83 110.651 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.31 -45.67 65.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.555 0.693 . . . . 0.92 109.677 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 47' ' ' LYS . 90.1 mt -88.58 -93.72 0.1 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.862 -1.063 . . . . 1.11 111.508 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.0 t70 172.71 57.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.096 -1.075 . . . . 1.72 108.096 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 HG23 ' B' ' 10' ' ' VAL . 2.8 mp -113.88 131.27 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 1.02 110.461 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.31 -54.1 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.122 -0.49 . . . . 0.91 111.404 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.536 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.23 -33.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.905 -0.588 . . . . 1.05 109.982 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HG3' HG23 ' A' ' 30' ' ' ILE . 44.1 mtpt -136.88 -51.26 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.986 -0.746 . . . . 2.18 108.986 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.18 -119.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.513 -1.221 . . . . 1.18 113.378 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.443 ' HB3' HG21 ' B' ' 7' ' ' VAL . 17.1 m -163.21 135.29 5.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.482 0.583 . . . . 0.57 111.512 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.651 HG23 HD23 ' A' ' 45' ' ' LEU . 2.6 mp -141.88 105.93 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.96 -0.385 . . . . 1.1 109.96 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 72.0 tt0 -99.66 138.05 37.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.335 -0.617 . . . . 1.31 109.335 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.531 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -117.55 152.93 34.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.638 1.209 . . . . 2.28 114.136 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.927 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 32.1 t80 -114.43 157.78 22.43 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 112.98 -1.918 . . . . 3.08 107.134 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.526 ' H ' ' HB2' ' B' ' 3' ' ' SER . 5.5 p -127.55 130.7 70.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.116 -0.634 . . . . 1.1 110.033 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.516 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 19.3 t70 -130.63 97.24 4.31 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.471 -0.786 . . . . 1.16 109.744 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.19 -78.85 0.3 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.599 -0.728 . . . . 0.38 111.903 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.57 -30.5 4.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.471 0.653 . . . . 2.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.675 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -88.37 165.72 14.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.315 -0.857 . . . . 1.68 111.045 -163.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.831 HG13 HD11 ' B' ' 22' ' ' LEU . 15.4 mm -121.21 142.94 35.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.426 -0.807 . . . . 1.0 109.053 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.927 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 49.1 mt -128.55 108.45 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.511 -0.313 . . . . 1.06 110.851 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.656 HD11 HD11 ' B' ' 45' ' ' LEU . 9.7 mp -99.82 141.61 32.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.306 0.484 . . . . 1.09 112.306 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 156.97 41.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.45 -0.795 . . . . 2.71 110.682 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 3.8 tmtp? -73.32 149.16 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.315 -0.624 . . . . 1.21 109.315 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.636 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 69.7 t80 . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 2.09 111.738 -173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.526 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 67.0 m . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 121.205 0.526 . . . . 1.3 110.812 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 36' ' ' PHE . 4.0 mt -80.47 -33.18 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.553 -1.277 . . . . 0.91 107.553 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 20.12 66.65 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.135 -1.393 . . . . 0.43 112.596 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.8 132.02 59.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.56 110.196 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.7 p -106.5 141.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.597 -0.728 . . . . 0.98 109.041 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.1 mpt_? -113.03 157.4 21.59 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.289 0.566 . . . . 1.62 110.673 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 29.8 mmtp -119.14 119.24 33.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.909 -1.041 . . . . 1.77 108.566 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.626 HG21 HD12 ' A' ' 34' ' ' ILE . 7.4 t -57.25 139.82 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.642 0.589 . . . . 1.06 110.777 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.01 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.486 -0.779 . . . . 1.22 109.805 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -152.63 -42.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.392 -0.966 . . . . 1.22 108.392 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.5 -27.3 37.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.783 -1.098 . . . . 1.54 111.255 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 130.32 0.03 5.51 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.355 -0.698 . . . . 0.19 111.355 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 24.6 mtt-85 -66.93 130.84 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.121 -0.326 . . . . 3.42 110.121 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -139.53 175.69 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.413 -0.588 . . . . 1.07 109.413 176.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -105.32 108.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.964 0.412 . . . . 0.98 110.973 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.578 ' HB3' HD22 ' B' ' 22' ' ' LEU . 28.3 mmt -74.97 154.63 86.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.032 -0.729 . . . . 1.08 109.032 173.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 65.5 Cg_endo -86.85 155.49 8.69 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.999 1.799 . . . . 0.23 113.219 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -55.99 -30.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.24 109.431 171.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.3 -30.59 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 1.07 110.999 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.61 -40.35 56.57 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.78 -0.822 . . . . 1.1 108.78 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.536 ' HB2' HD11 ' B' ' 20' ' ' ILE . 34.4 mtm180 -66.13 -26.52 67.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 1.98 110.626 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -84.33 -35.37 23.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.577 -0.738 . . . . 1.11 109.734 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.67 -51.58 66.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.727 -1.124 . . . . 0.28 110.947 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.634 HD22 ' H ' ' B' ' 47' ' ' LYS . 71.0 mt -89.83 -85.6 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.732 -1.122 . . . . 1.18 111.139 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.604 ' C ' HD11 ' B' ' 28' ' ' ILE . 15.9 t0 166.46 61.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.797 -1.186 . . . . 1.54 107.797 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.629 HG21 HG22 ' A' ' 10' ' ' VAL . 1.3 mp -116.56 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.66 -0.7 . . . . 1.07 109.86 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.67 -51.59 2.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.721 -0.672 . . . . 0.62 111.652 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.446 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -144.16 -33.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 110.011 -0.366 . . . . 0.4 110.011 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.446 ' HG3' HG23 ' B' ' 30' ' ' ILE . 38.1 mtpt -136.29 -49.05 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.555 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.66 -115.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.384 -1.28 . . . . 1.17 113.832 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.551 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 14.2 m -164.08 135.37 4.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.994 0.361 . . . . 0.55 111.347 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.696 HG22 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -144.04 102.97 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 110.18 -0.304 . . . . 1.09 110.18 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 65.7 tt0 -96.03 139.32 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.541 -0.54 . . . . 1.33 109.541 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.89 155.62 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.524 1.154 . . . . 2.21 113.889 -175.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -120.14 157.26 29.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.1 -1.864 . . . . 2.99 107.073 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.557 ' H ' ' HB2' ' A' ' 3' ' ' SER . 8.5 p -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 120.093 -0.643 . . . . 1.07 109.955 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.798 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.7 t70 -132.3 95.8 3.73 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 1.18 109.917 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.1 -75.9 0.33 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.685 -0.689 . . . . 0.48 111.654 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.32 -29.04 3.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.484 0.659 . . . . 1.91 109.798 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.798 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.4 OUTLIER -85.81 158.36 20.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.112 -0.949 . . . . 1.4 111.778 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.82 HG13 HD12 ' A' ' 22' ' ' LEU . 17.7 mm -118.27 144.11 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.656 -0.702 . . . . 0.87 109.925 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.1 mt -128.66 114.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.07 110.956 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.719 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.1 mp -104.23 141.05 36.96 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.89 0.33 . . . . 0.97 111.89 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -151.71 151.55 31.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.946 -0.57 . . . . 2.47 110.345 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.634 ' H ' HD22 ' B' ' 26' ' ' LEU . 2.1 tmtp? -78.1 137.5 38.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.371 -0.603 . . . . 1.09 109.371 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.863 -0.608 . . . . 1.89 111.714 -169.574 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.714 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 75.2 m . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.276 0.56 . . . . 1.09 110.532 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.592 HD12 ' HB2' ' B' ' 36' ' ' PHE . 2.7 mt -100.04 -45.17 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.785 . . . . 1.06 109.304 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.13 24.03 60.23 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.493 -0.776 . . . . 0.51 112.222 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.22 133.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.648 0.737 . . . . 1.07 111.241 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -108.77 140.49 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 1.07 109.072 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.455 ' NE ' HG12 ' A' ' 17' ' ' VAL . 2.6 mpt_? -113.3 157.17 22.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.181 -0.463 . . . . 1.9 110.807 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.22 120.85 36.37 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.455 -0.793 . . . . 1.63 108.971 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.715 HG21 HG22 ' B' ' 28' ' ' ILE . 42.7 t -55.88 145.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 1.06 111.026 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -69.31 0.33 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.423 -0.584 . . . . 1.31 109.423 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -155.88 -54.16 0.09 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.126 -0.943 . . . . 1.23 108.734 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.654 HD13 ' H ' ' A' ' 13' ' ' LEU . 1.2 mp -77.81 -22.44 50.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.317 -1.311 . . . . 1.59 111.376 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.58 -11.33 4.02 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.821 -0.704 . . . . 0.25 111.886 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.76 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 39.6 mtt180 -60.25 134.51 57.13 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.906 -0.173 . . . . 3.66 110.751 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.43 175.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.515 -0.921 . . . . 0.97 108.515 172.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -106.37 100.69 11.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.347 0.594 . . . . 1.07 110.826 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 16' ' ' ILE . 81.1 mmm -74.94 148.61 84.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.818 -0.808 . . . . 1.62 108.818 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 82.0 Cg_endo -80.25 157.6 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.828 1.685 . . . . 0.18 113.247 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.612 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.1 tp -56.04 -31.79 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.333 -0.849 . . . . 0.93 109.405 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.3 mm-40 -61.19 -28.8 69.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 1.08 111.191 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.783 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.64 -39.33 57.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.488 -0.93 . . . . 1.04 108.488 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.598 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 50.6 mtm180 -66.04 -28.56 68.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.84 -1.073 . . . . 1.59 110.28 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HD2' HG13 ' A' ' 20' ' ' ILE . 72.4 mtp180 -84.99 -35.0 22.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.435 -0.802 . . . . 0.83 110.522 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.23 55.23 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.275 -0.875 . . . . 0.92 110.136 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -81.49 -88.84 0.08 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.86 -1.064 . . . . 1.11 110.577 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.1 t70 167.17 61.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.634 -1.247 . . . . 1.72 107.634 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.652 HG23 HG21 ' B' ' 10' ' ' VAL . 3.0 mp -113.26 132.23 62.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.657 -0.701 . . . . 1.02 110.102 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.28 -55.74 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 0.91 110.927 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.591 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -143.09 -32.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.778 -0.646 . . . . 1.05 109.91 -177.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 30' ' ' ILE . 31.7 mtpt -136.98 -50.3 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.358 0.599 . . . . 2.18 109.467 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER 36.86 -116.41 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.399 1.259 . . . . 1.18 114.399 -177.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HG ' ' C ' ' A' ' 32' ' ' ASP . 20.0 m -164.87 134.52 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.416 0.553 . . . . 0.57 111.424 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.74 HD11 HG22 ' B' ' 10' ' ' VAL . 2.8 mp -140.99 106.77 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.369 -0.234 . . . . 1.1 110.369 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 60.0 tt0 -98.76 142.08 30.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.744 -0.465 . . . . 1.31 109.744 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.1 155.03 35.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.231 1.015 . . . . 2.28 113.354 -175.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.531 ' HD1' HD13 ' A' ' 44' ' ' ILE . 34.7 t80 -134.47 126.73 30.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.714 -1.585 . . . . 3.08 108.122 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.679 ' H ' ' HB2' ' B' ' 3' ' ' SER . 6.3 p -92.9 129.14 43.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 119.498 -0.881 . . . . 1.1 110.705 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -127.08 109.04 11.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.011 -0.995 . . . . 1.16 108.942 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 -96.49 0.75 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.398 -1.081 . . . . 0.38 110.398 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.28 -8.12 8.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.565 0.221 . . . . 2.0 110.483 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -100.4 166.75 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.687 -0.233 . . . . 1.68 110.88 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.878 HG13 HD12 ' B' ' 22' ' ' LEU . 11.9 mm -116.25 143.42 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.055 -0.35 . . . . 1.0 110.055 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 49.1 mt -122.02 118.79 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.431 -0.349 . . . . 1.06 110.435 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.832 HD11 HD11 ' B' ' 45' ' ' LEU . 11.1 mp -103.37 133.5 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 1.09 111.63 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 11.4 ttpt -142.19 143.98 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.362 -0.835 . . . . 2.71 110.255 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.613 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -75.97 145.94 39.94 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.506 -0.924 . . . . 1.21 108.506 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.613 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 84.9 t80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.418 0.628 . . . . 2.09 110.918 -172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.679 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 75.2 m . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.063 0.459 . . . . 1.3 111.59 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' A' ' 36' ' ' PHE . 3.8 mt -105.72 -46.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.91 108.971 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.7 21.89 73.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.289 -0.868 . . . . 0.43 112.265 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' B' ' 4' ' ' ILE . 35.6 m -117.3 132.53 66.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.269 0.557 . . . . 0.56 110.825 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.5 p -105.0 143.13 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.024 -0.732 . . . . 0.98 109.024 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.484 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -113.17 158.89 19.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.1 0.476 . . . . 1.62 111.084 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.55 121.66 40.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.871 -1.059 . . . . 1.77 109.106 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 34' ' ' ILE . 14.5 t -57.66 141.39 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.304 -0.407 . . . . 1.06 110.29 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.16 -74.3 0.12 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 1.22 109.32 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -148.54 -55.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.485 0.66 . . . . 1.22 109.472 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.787 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.2 OUTLIER -76.96 -16.9 59.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.054 -0.976 . . . . 1.54 110.91 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 126.72 -0.85 7.37 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.991 -0.623 . . . . 0.19 111.672 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.674 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 6.3 mtm180 -67.01 126.56 29.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.188 -0.301 . . . . 3.42 110.188 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.506 HG21 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -132.81 172.36 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.811 -0.811 . . . . 1.07 108.811 176.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -104.67 101.58 12.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.301 0.572 . . . . 0.98 110.812 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.501 ' SD ' HD11 ' B' ' 16' ' ' ILE . 84.3 mmm -75.4 151.63 85.46 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.046 -0.724 . . . . 1.08 109.046 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 29.1 Cg_endo -83.36 156.8 14.58 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.628 1.552 . . . . 0.23 113.317 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -55.24 -30.72 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.24 109.909 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -62.68 -26.35 68.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.23 -0.441 . . . . 1.07 110.627 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.878 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.46 -40.61 49.92 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.901 -0.778 . . . . 1.1 108.901 175.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.633 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 53.0 mtm180 -65.19 -29.13 69.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.844 -1.071 . . . . 1.98 110.705 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 81.6 mtp180 -83.49 -30.55 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.354 -0.839 . . . . 1.11 109.821 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.83 -53.26 22.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.895 -1.048 . . . . 0.28 110.935 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 48.4 mt -85.16 -81.39 0.2 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.784 -1.098 . . . . 1.18 110.55 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.606 ' C ' HD11 ' B' ' 28' ' ' ILE . 20.1 t0 163.95 60.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.744 -1.206 . . . . 1.54 107.744 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.715 HG22 HG21 ' A' ' 10' ' ' VAL . 1.4 mp -116.84 132.89 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.104 -0.498 . . . . 1.07 109.67 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.69 -54.32 2.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.793 -0.64 . . . . 0.62 111.064 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -33.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.15 -0.477 . . . . 0.4 109.801 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 10' ' ' VAL . 21.1 mtpt -133.31 -52.38 0.89 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.328 -0.619 . . . . 1.99 109.328 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 36.25 -118.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.585 -1.189 . . . . 1.17 114.103 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 13.1 m -161.05 135.84 7.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.046 0.384 . . . . 0.55 111.979 -173.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.587 HG23 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -143.9 104.39 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 N-CA-C 110.289 -0.263 . . . . 1.09 110.289 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.705 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.4 tt0 -96.48 141.05 30.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.767 -0.457 . . . . 1.33 109.767 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.618 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -118.02 157.79 26.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.014 1.116 . . . . 2.21 114.014 -175.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.442 ' CD1' HD11 ' B' ' 44' ' ' ILE . 47.4 t80 -136.83 129.28 30.08 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 113.63 -1.623 . . . . 2.99 108.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.714 ' H ' ' HB2' ' A' ' 3' ' ' SER . 9.6 p -92.37 133.42 33.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 119.816 -0.753 . . . . 1.07 109.746 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -131.9 107.47 8.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.967 -0.753 . . . . 1.18 108.967 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.64 -91.01 0.66 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.051 -0.82 . . . . 0.48 111.051 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -128.77 -9.0 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.748 -0.464 . . . . 1.91 109.748 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' B' ' 42' ' ' LYS . 1.6 ptpp? -100.93 169.05 9.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 1.4 110.799 -168.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.783 HG13 HD13 ' A' ' 22' ' ' LEU . 23.0 mm -118.86 142.93 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 0.87 110.461 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 18.8 mt -119.75 124.89 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.322 -0.399 . . . . 1.07 110.109 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.832 HD11 HD11 ' A' ' 45' ' ' LEU . 11.0 mp -109.39 132.23 54.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.022 0.439 . . . . 0.97 111.64 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 13.9 ttpt -142.08 145.53 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 2.47 110.237 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -80.94 138.85 36.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.028 -0.731 . . . . 1.09 109.028 175.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.481 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 37.2 t80 . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.89 112.822 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.598 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 31.6 t . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 121.015 0.436 . . . . 1.09 111.9 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.7 mt -92.8 -34.0 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.051 -0.722 . . . . 1.06 109.051 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.38 6.18 79.61 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.027 -0.988 . . . . 0.51 112.733 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 31.8 m -102.41 133.38 46.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.605 0.717 . . . . 1.07 111.326 -176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 6.5 p -115.84 140.36 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.413 -1.267 . . . . 1.07 109.68 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.673 ' HG2' ' CZ ' ' B' ' 36' ' ' PHE . 11.6 mmt180 -110.54 165.08 12.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.978 -0.555 . . . . 1.9 110.857 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 28.4 mmtp -124.28 122.36 37.53 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.102 -1.073 . . . . 1.63 108.102 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.611 HG22 HD11 ' B' ' 34' ' ' ILE . 38.4 t -56.5 145.98 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 1.06 111.726 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.21 -78.04 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 1.31 109.699 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -153.45 -45.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.944 -0.761 . . . . 1.23 108.944 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 13' ' ' LEU . 1.3 mp -81.92 -27.59 33.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.952 -1.022 . . . . 1.59 110.808 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.16 -11.18 2.8 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.623 -0.717 . . . . 0.25 111.582 -174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 46.8 mtp180 -61.21 132.05 52.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.099 0.16 . . . . 3.66 111.0 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.607 HD11 ' HE1' ' A' ' 18' ' ' MET . 0.8 OUTLIER -139.07 178.57 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.684 -0.858 . . . . 0.97 108.684 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.798 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -107.41 109.21 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.488 0.661 . . . . 1.07 111.467 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.616 ' HB3' HD22 ' A' ' 22' ' ' LEU . 14.5 mmt -75.74 154.01 85.24 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.503 -0.771 . . . . 1.62 109.315 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.2 Cg_endo -83.26 154.39 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.68 1.587 . . . . 0.18 113.162 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 tp -54.74 -31.7 24.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.562 -0.744 . . . . 0.93 109.568 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.86 -28.21 68.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.45 -0.795 . . . . 1.08 110.768 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.8 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -39.6 44.67 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.787 -0.82 . . . . 1.04 108.787 176.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.1 mtm180 -64.73 -28.91 69.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.142 -0.936 . . . . 1.59 110.394 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -83.68 -38.58 21.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.163 -0.926 . . . . 0.83 110.227 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.67 85.37 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.289 -0.868 . . . . 0.92 110.525 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 47' ' ' LYS . 93.1 mt -87.8 -93.69 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.06 -0.973 . . . . 1.11 111.587 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -179.95 38.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.435 0.636 . . . . 1.72 109.307 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.593 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.1 mp -100.06 134.27 40.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.401 -0.363 . . . . 1.02 110.884 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -56.51 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.91 110.684 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.549 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.46 -29.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.954 -0.567 . . . . 1.05 109.724 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HG3' HG22 ' A' ' 30' ' ' ILE . 37.4 mtpt -136.11 -57.1 0.76 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.474 -0.785 . . . . 2.18 109.028 176.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.487 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 37.21 -128.13 0.17 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.097 -0.956 . . . . 1.18 113.036 -175.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 13.1 m -153.29 136.66 15.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.516 0.598 . . . . 0.57 111.589 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.705 HD11 HG21 ' B' ' 10' ' ' VAL . 4.2 mp -139.18 107.79 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.223 -0.288 . . . . 1.1 110.223 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.1 tt0 -105.28 140.67 38.07 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.022 -0.362 . . . . 1.31 110.022 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.753 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -123.04 153.62 39.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.533 0.938 . . . . 2.28 113.533 -174.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.623 ' HD1' HD12 ' A' ' 44' ' ' ILE . 33.8 t80 -125.12 124.31 41.58 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.078 -1.419 . . . . 3.08 108.742 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.1 p -93.65 134.58 30.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 C-N-CA 119.785 -0.766 . . . . 1.1 110.74 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -132.75 105.12 6.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.344 -0.844 . . . . 1.16 109.747 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.54 0.46 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.162 -0.775 . . . . 0.38 111.162 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -128.02 -8.03 5.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.369 0.604 . . . . 2.0 109.528 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.2 ttpt -93.16 156.96 16.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 1.68 111.329 -169.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.907 HG13 HD13 ' B' ' 22' ' ' LEU . 10.0 mm -116.93 142.92 28.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.623 HD12 ' HD1' ' A' ' 37' ' ' PHE . 47.0 mt -128.98 109.52 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.581 0.229 . . . . 1.06 110.907 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.855 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.4 mp -92.17 137.62 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.291 0.567 . . . . 1.09 112.184 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -145.97 141.59 27.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.794 -1.094 . . . . 2.71 109.527 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 33' ' ' SER . 7.1 tmtt? -76.58 146.32 38.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.098 -0.704 . . . . 1.21 109.098 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 t80 . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 120.762 -0.375 . . . . 2.09 111.808 -171.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 37.2 t . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.338 0.589 . . . . 1.3 109.985 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.753 HD12 ' HD2' ' A' ' 36' ' ' PHE . 2.9 mt -88.76 -40.12 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.561 -0.903 . . . . 0.91 108.561 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.28 77.73 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.026 -0.988 . . . . 0.43 112.49 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -114.23 132.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.041 0.448 . . . . 0.56 110.706 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.2 p -113.82 139.53 38.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.694 -0.685 . . . . 0.98 109.693 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.71 ' HG2' ' CE1' ' A' ' 36' ' ' PHE . 5.1 mmt180 -106.73 167.0 10.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.063 -0.517 . . . . 1.62 110.623 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' B' ' 8' ' ' ARG . 30.1 mmtp -125.9 119.03 26.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.113 -1.069 . . . . 1.77 108.113 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.705 HG21 HD11 ' A' ' 34' ' ' ILE . 8.5 t -56.55 142.04 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.43 0.633 . . . . 1.06 111.26 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.75 -76.38 0.06 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 1.22 110.058 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -152.44 -49.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.565 -0.902 . . . . 1.22 108.565 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.763 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.4 OUTLIER -79.93 -19.12 48.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.246 -1.343 . . . . 1.54 110.655 -176.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 128.02 -3.3 6.86 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.19 111.489 -176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.798 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 52.0 mtm180 -63.99 128.55 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.445 -0.206 . . . . 3.42 110.445 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.546 HG21 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -136.04 179.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.072 -0.714 . . . . 1.07 109.072 176.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -106.63 108.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.215 0.531 . . . . 0.98 111.04 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.69 ' HB3' HD22 ' B' ' 22' ' ' LEU . 30.4 mmt -74.66 152.95 87.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.65 -0.871 . . . . 1.08 108.65 172.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 43.3 Cg_endo -84.5 154.84 12.16 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.906 1.738 . . . . 0.23 112.943 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 4.1 tp -53.84 -32.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.24 109.571 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -61.12 -26.43 67.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.79 -0.641 . . . . 1.07 110.819 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.907 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.63 -40.94 32.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.926 -0.768 . . . . 1.1 108.926 176.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.536 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 38.8 mtm180 -65.65 -27.5 68.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 1.98 110.568 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 72.1 mtp180 -83.96 -30.75 25.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.257 -0.883 . . . . 1.11 110.047 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.99 -52.52 28.0 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.012 -0.994 . . . . 0.28 110.687 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 62.0 mt -85.6 -87.51 0.13 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.734 -1.121 . . . . 1.18 110.8 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.457 ' C ' HD11 ' B' ' 28' ' ' ILE . 38.9 t70 173.89 45.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.754 . . . . 1.54 109.005 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.616 HD11 ' N ' ' B' ' 28' ' ' ILE . 1.2 mp -108.0 129.11 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.066 0.46 . . . . 1.07 110.018 -174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.15 4.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.478 -0.783 . . . . 0.62 111.499 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.521 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -150.46 -33.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.742 -0.466 . . . . 0.4 109.742 177.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.521 ' HG3' HG23 ' B' ' 30' ' ' ILE . 44.1 mtpt -133.55 -50.92 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.316 0.579 . . . . 1.99 109.443 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.8 -113.56 0.1 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.22 1.192 . . . . 1.17 114.22 -177.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.6 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.5 m -164.38 137.39 5.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.189 0.45 . . . . 0.55 111.61 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 10' ' ' VAL . 4.3 mp -141.86 102.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 110.213 -0.292 . . . . 1.09 110.213 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 33.5 tt0 -95.18 142.53 27.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.4 -0.593 . . . . 1.33 109.4 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -118.99 158.52 25.6 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.183 0.992 . . . . 2.21 113.579 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 18.7 t80 -132.88 125.87 30.93 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 113.675 -1.602 . . . . 2.99 108.011 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.598 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.5 p -93.28 135.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.822 -0.751 . . . . 1.07 110.24 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.074 -0.713 . . . . 1.18 109.074 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.11 -95.17 0.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.977 -0.849 . . . . 0.48 110.977 -171.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.94 -13.58 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 1.91 110.169 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -92.82 167.78 11.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 1.4 110.834 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.855 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.7 mm -121.97 143.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.13 -0.486 . . . . 0.87 109.724 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 17.4 mt -124.5 113.85 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.504 -0.316 . . . . 1.07 110.798 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.819 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -98.02 139.52 33.73 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.265 0.555 . . . . 0.97 112.064 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -152.58 141.07 20.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.799 -1.091 . . . . 2.47 109.188 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tmtt? -72.74 153.4 41.16 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.842 -0.799 . . . . 1.09 108.842 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 75.9 t80 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.149 0.499 . . . . 1.89 111.358 -172.08 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.603 ' HB2' ' CD1' ' B' ' 37' ' ' PHE . 19.0 t . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.161 0.505 . . . . 1.09 109.681 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.43 -31.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.067 -0.716 . . . . 1.06 109.067 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.58 21.43 77.14 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.139 -0.937 . . . . 0.51 112.931 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.57 132.63 68.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.859 0.837 . . . . 1.07 111.748 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -111.1 140.86 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 113.935 -1.484 . . . . 1.07 108.578 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.462 ' NE ' HG12 ' A' ' 17' ' ' VAL . 3.7 mpt_? -114.78 155.0 27.53 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.017 0.437 . . . . 1.9 110.607 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 121.05 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.584 -0.895 . . . . 1.63 108.584 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.604 HG21 HD11 ' B' ' 34' ' ' ILE . 4.7 t -54.52 141.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.564 0.54 . . . . 1.06 110.312 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.36 -77.86 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.939 -0.763 . . . . 1.31 108.939 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' B' ' 30' ' ' ILE . 29.8 mt-10 -151.71 -36.2 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.623 -0.88 . . . . 1.23 108.623 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD11 ' HD2' ' A' ' 15' ' ' ARG . 11.2 mt -86.79 -19.09 29.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.14 -0.936 . . . . 1.59 111.7 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' CA ' HG12 ' A' ' 10' ' ' VAL . . . 124.19 -6.43 8.75 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 120.503 -0.856 . . . . 0.25 111.277 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.714 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.0 mtp180 -67.25 125.2 25.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.345 -0.242 . . . . 3.66 110.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.825 HD11 ' HE2' ' A' ' 18' ' ' MET . 0.6 OUTLIER -131.73 175.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.966 -0.753 . . . . 0.97 108.966 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -103.27 102.43 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.056 0.455 . . . . 1.07 110.938 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.825 ' HE2' HD11 ' A' ' 16' ' ' ILE . 13.2 mmt -74.54 149.99 86.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.4 -0.593 . . . . 1.62 109.4 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.4 Cg_endo -81.19 155.03 19.29 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.781 1.654 . . . . 0.18 113.383 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 4.7 tp -56.2 -31.81 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.178 -0.919 . . . . 0.93 109.059 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.87 -30.93 68.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.211 -0.904 . . . . 1.08 111.253 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.886 HD11 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.22 -41.12 58.33 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.457 -0.942 . . . . 1.04 108.457 177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.585 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 32.3 mtm180 -63.92 -29.57 70.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.782 -1.099 . . . . 1.59 110.224 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 73.5 mtp180 -85.26 -35.83 21.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.399 -0.819 . . . . 0.83 110.753 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.28 95.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.598 0.713 . . . . 0.92 109.874 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 77.2 mt -92.36 -104.83 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.678 -1.146 . . . . 1.11 110.255 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -174.72 49.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 1.72 109.422 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -93.18 131.68 39.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 1.02 109.513 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.58 -57.77 2.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.34 0.59 . . . . 0.91 110.587 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.709 HD12 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -146.68 -28.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.032 -0.986 . . . . 1.05 109.604 -175.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' HG23 ' A' ' 30' ' ' ILE . 21.2 mtpp -139.88 -52.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 2.18 109.141 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.498 ' HB2' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER 37.75 -115.27 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.094 1.146 . . . . 1.18 114.094 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' HB3' HG21 ' B' ' 7' ' ' VAL . 38.5 m -166.59 137.88 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.436 0.562 . . . . 0.57 111.065 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.742 HD13 HG21 ' B' ' 10' ' ' VAL . 3.7 mp -139.0 111.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.701 -0.481 . . . . 1.1 109.701 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 22.7 tt0 -107.92 130.2 55.04 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.31 0.244 . . . . 1.31 110.552 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.703 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -116.06 153.5 31.61 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.655 0.983 . . . . 2.28 113.655 -170.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.585 ' HD1' HD11 ' A' ' 44' ' ' ILE . 25.5 t80 -129.86 132.36 46.41 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 114.112 -1.404 . . . . 3.08 108.478 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.52 ' H ' ' HB3' ' B' ' 3' ' ' SER . 2.8 p -100.29 132.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 119.765 -0.774 . . . . 1.1 111.268 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.9 t70 -125.59 99.89 6.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.67 -1.15 . . . . 1.16 109.534 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.32 -84.31 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.583 -0.735 . . . . 0.38 111.365 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.01 -17.04 5.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.392 0.615 . . . . 2.0 109.64 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HD2' HG22 ' B' ' 44' ' ' ILE . 2.1 ttpt -92.47 158.07 16.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.345 -0.843 . . . . 1.68 111.325 -167.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.958 HG13 HD11 ' B' ' 22' ' ' LEU . 7.0 mm -118.12 139.46 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.585 HD11 ' HD1' ' A' ' 37' ' ' PHE . 43.6 mt -121.87 111.71 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.444 . . . . 1.06 110.508 -174.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.823 HD11 HD11 ' B' ' 45' ' ' LEU . 11.2 mp -102.87 138.19 40.08 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.815 0.302 . . . . 1.09 111.815 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 149.89 26.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 2.71 110.081 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -65.53 147.99 52.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.891 -0.595 . . . . 1.21 110.146 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.637 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 24.3 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 2.09 111.263 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.52 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 47.1 t . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.081 0.467 . . . . 1.3 110.723 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 mt -89.45 -40.73 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.923 -0.769 . . . . 0.91 108.923 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.88 39.65 59.0 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.43 112.538 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' A' ' 36' ' ' PHE . 15.3 m -131.97 132.21 61.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.023 0.439 . . . . 0.56 110.029 174.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.1 p -108.44 142.66 20.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.819 -0.808 . . . . 0.98 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.703 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 mpt_? -113.79 153.87 28.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.991 0.424 . . . . 1.62 110.764 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 121.45 44.64 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.565 -0.743 . . . . 1.77 109.054 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.742 HG21 HD13 ' A' ' 34' ' ' ILE . 3.8 t -53.62 137.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 123.837 0.711 . . . . 1.06 110.459 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -55.08 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.631 -0.713 . . . . 1.22 109.998 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.709 ' HG2' HD12 ' A' ' 30' ' ' ILE . 42.1 mt-10 -151.64 -32.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.499 -0.926 . . . . 1.22 108.499 173.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.33 -29.96 21.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.304 -1.317 . . . . 1.54 110.858 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 132.06 -8.37 5.42 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.768 -0.933 . . . . 0.19 110.768 -172.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 mtp180 -62.84 124.58 21.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.299 . . . . 3.42 110.508 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -129.58 174.77 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.649 -0.871 . . . . 1.07 108.649 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.9 p -104.15 104.06 16.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.326 0.584 . . . . 0.98 110.693 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 1.6 mmt -76.29 151.72 83.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 1.08 108.729 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.44 ' HD3' ' HE1' ' B' ' 18' ' ' MET . 44.4 Cg_endo -85.41 153.84 10.62 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.877 1.718 . . . . 0.23 113.321 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -53.85 -30.25 19.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.413 -0.812 . . . . 0.24 109.985 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.04 -25.67 67.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.206 -0.452 . . . . 1.07 110.88 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.958 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.62 -41.29 39.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.631 -0.877 . . . . 1.1 108.631 174.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.614 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 37.4 mtm180 -63.54 -29.83 71.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.887 -1.052 . . . . 1.98 110.683 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.527 ' HD2' HG13 ' B' ' 20' ' ' ILE . 62.0 mtp180 -84.36 -33.93 23.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.271 -0.877 . . . . 1.11 110.048 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -51.03 71.63 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.781 -1.1 . . . . 0.28 110.1 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 61.0 mt -92.4 -91.25 0.17 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.462 -1.245 . . . . 1.18 111.637 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.506 ' C ' HD11 ' B' ' 28' ' ' ILE . 16.7 t0 175.5 50.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.637 -0.875 . . . . 1.54 108.637 -170.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.634 HD11 ' N ' ' B' ' 28' ' ' ILE . 1.4 mp -109.34 132.92 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.966 -0.753 . . . . 1.07 108.966 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.36 -51.48 2.91 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.163 0.506 . . . . 0.62 111.852 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.622 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -146.94 -29.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.971 -0.559 . . . . 0.4 109.668 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.622 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.4 mtpp -140.06 -51.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.465 -0.568 . . . . 1.99 109.465 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 34.91 -115.44 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.802 1.038 . . . . 1.17 113.802 -176.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.0 m -163.4 136.99 5.74 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.155 -0.34 . . . . 0.55 111.37 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.653 HG21 HD23 ' B' ' 45' ' ' LEU . 4.3 mp -142.0 105.22 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.6 -0.519 . . . . 1.09 109.6 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.1 tt0 -102.73 134.45 46.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.318 -0.253 . . . . 1.33 110.318 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.504 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.79 158.67 23.52 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.214 1.19 . . . . 2.21 114.214 -173.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.678 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 66.4 t80 -126.07 152.71 45.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.199 -1.819 . . . . 2.99 107.177 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.562 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.9 p -117.87 137.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 120.057 -0.657 . . . . 1.07 110.041 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 31.5 t70 -133.65 95.6 3.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.928 -0.578 . . . . 1.18 110.111 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.03 -73.49 1.04 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.572 -0.74 . . . . 0.48 111.684 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -127.71 -30.5 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.462 0.649 . . . . 1.91 109.421 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -89.7 166.22 13.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.096 -0.956 . . . . 1.4 111.341 -163.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.886 HG13 HD11 ' A' ' 22' ' ' LEU . 25.4 mm -121.27 142.99 35.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.618 -0.719 . . . . 0.87 109.46 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.678 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 33.5 mt -124.06 109.74 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.409 -0.359 . . . . 1.07 110.69 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 45' ' ' LEU . 10.6 mp -101.69 134.66 44.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.331 0.493 . . . . 0.97 112.331 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.3 OUTLIER -149.08 148.75 30.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 2.47 109.667 172.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tttt -64.92 167.05 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.42 -0.585 . . . . 1.09 109.42 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.238 -0.585 . . . . 1.89 110.108 -171.494 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' H2 ' ' CD ' ' B' ' 35' ' ' GLU . 49.7 ttm . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.863 0.363 . . . . 5.41 110.066 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.817 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 32.3 mtmm -140.76 -160.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.812 -0.631 . . . . 3.01 109.92 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.554 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 48.7 m -48.56 -52.8 20.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.156 0.503 . . . . 1.09 111.289 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.772 HD13 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -86.02 -33.91 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.647 -0.872 . . . . 1.06 108.647 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.817 ' HA2' ' H ' ' A' ' 2' ' ' LYS . . . 70.52 19.61 76.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.831 -1.077 . . . . 0.51 112.548 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 27.9 m -115.92 131.32 68.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.573 0.701 . . . . 1.07 111.177 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.8 p -114.63 141.73 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.512 -1.222 . . . . 1.07 109.36 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.74 165.11 13.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.977 0.418 . . . . 1.9 110.607 -176.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 33.4 mmtp -120.22 124.24 45.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.242 -1.021 . . . . 1.63 108.242 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.71 HG22 HG23 ' B' ' 28' ' ' ILE . 39.7 t -56.38 141.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.497 0.498 . . . . 1.06 109.912 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.85 -75.15 0.07 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.938 -0.574 . . . . 1.31 109.676 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.25 -46.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.842 -0.799 . . . . 1.23 108.842 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.624 HD13 ' H ' ' A' ' 13' ' ' LEU . 1.1 mp -77.78 -50.47 12.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.887 -1.051 . . . . 1.59 110.734 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.17 -5.49 0.05 OUTLIER Glycine 0 C--O 1.225 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.25 111.832 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.787 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 56.5 mtm180 -68.99 135.03 50.28 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 122.07 0.148 . . . . 3.66 110.868 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -141.12 179.99 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.906 -0.775 . . . . 0.97 108.906 174.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.7 p -107.38 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.171 0.51 . . . . 1.07 110.91 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.596 ' HB3' HD12 ' A' ' 22' ' ' LEU . 78.6 mmm -84.13 148.62 53.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.105 -0.702 . . . . 1.62 109.105 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.0 Cg_endo -80.41 157.65 22.45 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.93 1.753 . . . . 0.18 113.679 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.6 tp -52.68 -34.61 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.969 -1.014 . . . . 0.93 109.713 171.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.42 -25.67 66.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.344 -0.843 . . . . 1.08 110.982 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -78.39 -40.97 34.53 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.83 -0.804 . . . . 1.04 108.83 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.648 ' HD2' HG23 ' A' ' 28' ' ' ILE . 21.0 mtm180 -63.78 -30.88 71.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.41 -0.814 . . . . 1.59 109.837 176.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 77.8 mtp180 -83.82 -33.3 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.267 -0.879 . . . . 0.83 110.854 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.02 -46.88 73.14 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.806 0.813 . . . . 0.92 109.413 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD23 ' H ' ' A' ' 47' ' ' LYS . 82.8 mt -85.19 -101.52 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.291 -1.322 . . . . 1.11 110.372 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -179.36 50.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.632 -0.713 . . . . 1.72 109.4 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.648 HG23 ' HD2' ' A' ' 23' ' ' ARG . 2.4 mp -98.44 136.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.872 -1.058 . . . . 1.02 109.932 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.16 -51.59 2.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.802 -0.359 . . . . 0.91 111.629 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.869 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -145.31 -32.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.463 -0.335 . . . . 1.05 110.221 -177.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 20.3 mtpp -137.83 -50.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.813 -0.81 . . . . 2.18 108.813 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.47 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 35.91 -118.84 0.13 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.461 -1.245 . . . . 1.18 113.138 -176.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' HB3' HG21 ' B' ' 7' ' ' VAL . 21.1 m -163.32 138.65 6.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.362 0.528 . . . . 0.57 111.198 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 HG23 ' B' ' 10' ' ' VAL . 3.1 mp -139.6 110.23 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.759 -0.46 . . . . 1.1 109.759 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 41.3 tt0 -104.15 137.17 42.48 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.501 -0.555 . . . . 1.31 109.501 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.84 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -110.06 151.37 27.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.964 0.888 . . . . 2.28 112.601 -174.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 14.8 t80 -127.25 122.15 33.15 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.11 -1.404 . . . . 3.08 107.519 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -93.28 132.78 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 119.798 -0.761 . . . . 1.1 111.131 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -133.92 102.85 5.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.183 -0.917 . . . . 1.16 110.343 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.5 -88.44 0.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.815 -0.629 . . . . 0.38 112.04 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.67 -8.46 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.598 0.237 . . . . 2.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.68 168.75 9.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.141 0.496 . . . . 1.68 111.09 -168.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.724 HG13 HD13 ' B' ' 22' ' ' LEU . 15.5 mm -122.53 141.65 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.249 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 46.4 mt -121.96 111.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.694 0.283 . . . . 1.06 110.382 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.84 ' HG ' ' HD1' ' A' ' 36' ' ' PHE . 10.6 mp -101.13 132.28 46.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.538 -0.301 . . . . 1.09 111.809 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.71 157.34 37.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.139 0.495 . . . . 2.71 111.093 172.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.863 ' H ' HD23 ' A' ' 26' ' ' LEU . 3.2 tmtp? -63.15 153.47 34.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.732 . . . . 1.21 110.406 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.731 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 61.6 t80 -71.28 -51.26 25.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.496 -0.32 . . . . 2.09 111.245 -175.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.833 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 24.1 ttmm -46.4 -59.73 4.6 Favored Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 123.85 0.719 . . . . 3.26 112.827 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 15.2 Cg_exo -68.95 108.97 2.04 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.742 1.628 . . . . 1.81 111.112 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -84.87 95.56 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 5.58 110.707 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.53 -153.79 30.0 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.827 -0.909 . . . . 3.79 110.827 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.35 137.18 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 3.89 110.709 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.723 -0.671 . . . . 3.44 109.607 -176.429 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.421 ' H2 ' ' CD ' ' A' ' 35' ' ' GLU . 51.3 ttm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.716 0.293 . . . . 5.36 110.489 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.788 ' H ' ' HA2' ' B' ' 5' ' ' GLY . 28.4 mttm -146.26 -162.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 2.83 110.293 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 54.2 m -52.11 -50.42 61.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.333 -0.849 . . . . 1.3 110.312 172.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.682 HD12 ' HB2' ' A' ' 36' ' ' PHE . 1.9 mt -84.34 -42.0 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.848 -1.167 . . . . 0.91 107.848 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.788 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 72.76 27.02 69.92 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.559 -1.201 . . . . 0.43 112.199 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.9 131.9 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.192 0.52 . . . . 0.56 110.345 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.5 p -111.54 141.27 27.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.333 -0.849 . . . . 0.98 109.323 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.7 ' HD2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -114.21 162.39 16.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.009 0.433 . . . . 1.62 110.354 -175.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.8 mmtp -118.18 121.57 40.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.449 -0.945 . . . . 1.77 108.449 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 34' ' ' ILE . 5.2 t -55.48 135.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.555 -0.535 . . . . 1.06 109.555 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.86 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.999 -0.546 . . . . 1.22 109.535 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.869 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.4 mt-10 -154.7 -34.42 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.302 -0.999 . . . . 1.22 108.302 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.81 -49.23 11.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.098 -1.41 . . . . 1.54 110.329 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.537 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 152.21 -6.24 0.5 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.724 -1.125 . . . . 0.19 110.711 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 43.0 mtm180 -63.45 131.06 46.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.72 -0.24 . . . . 3.42 110.451 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.635 HG23 ' HA ' ' B' ' 10' ' ' VAL . 0.8 OUTLIER -138.76 179.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.757 -0.831 . . . . 1.07 108.757 174.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -107.77 113.51 43.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.98 110.885 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.542 ' HB3' HD12 ' B' ' 22' ' ' LEU . 74.8 mmm -84.89 149.0 52.47 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.815 . . . . 1.08 108.801 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 39.5 Cg_endo -80.68 158.44 21.75 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.744 1.629 . . . . 0.23 113.63 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.49 -30.92 32.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.229 -0.896 . . . . 0.24 109.707 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -25.76 67.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.223 -0.444 . . . . 1.07 110.704 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.724 HD13 HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -78.08 -41.74 34.34 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.826 -0.805 . . . . 1.1 108.826 175.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.703 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 32.8 mtp180 -61.79 -33.65 74.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.849 -1.069 . . . . 1.98 110.68 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 55.2 mtp180 -79.66 -37.68 35.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.34 -0.845 . . . . 1.11 109.872 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.42 -50.52 71.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.429 -1.26 . . . . 0.28 110.161 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.856 HD22 ' H ' ' B' ' 47' ' ' LYS . 56.5 mt -92.93 -80.44 0.38 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.65 -1.159 . . . . 1.18 112.075 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 t0 177.4 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.089 -0.245 . . . . 1.54 111.619 -168.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.71 HG23 HG22 ' A' ' 10' ' ' VAL . 1.5 mp -88.87 124.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.335 0.588 . . . . 1.07 111.668 -163.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.43 -34.86 9.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.96 . . . . 0.62 112.786 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.65 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -166.05 -33.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.502 -0.555 . . . . 0.4 109.502 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.65 ' HG3' HG23 ' B' ' 30' ' ' ILE . 18.6 mtpp -136.58 -49.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.787 -0.82 . . . . 1.99 108.787 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 35.39 -111.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.467 -1.242 . . . . 1.17 113.766 -176.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 27.3 m -166.05 138.35 3.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.343 0.52 . . . . 0.55 110.891 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.67 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -142.19 107.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.729 -0.471 . . . . 1.09 109.729 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 44.7 tt0 -103.62 139.5 38.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.711 -0.477 . . . . 1.33 109.711 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.772 ' HB2' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.85 154.73 21.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.015 0.912 . . . . 2.21 112.637 -173.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.718 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 22.9 t80 -129.96 126.22 37.3 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 114.091 -1.413 . . . . 2.99 107.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.554 ' H ' ' HB2' ' A' ' 3' ' ' SER . 10.2 p -93.04 136.43 25.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.732 -0.787 . . . . 1.07 110.339 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 11.8 t70 -134.16 100.91 4.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 1.18 109.804 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.34 -90.47 0.19 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.852 -0.69 . . . . 0.48 111.721 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -118.31 -13.47 9.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.946 0.403 . . . . 1.91 110.704 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' B' ' 39' ' ' ASP . 2.8 ptpt -98.1 169.14 9.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.4 110.939 -168.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -124.56 140.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.373 -0.831 . . . . 0.87 109.206 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 35.9 mt -119.22 113.75 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.588 -0.278 . . . . 1.07 110.546 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.838 HD11 HD11 ' A' ' 45' ' ' LEU . 11.2 mp -101.13 128.46 47.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.808 0.337 . . . . 0.97 111.575 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.731 ' HB2' ' HZ3' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -152.19 153.53 34.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 2.47 110.476 175.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.856 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.6 tmtt? -65.03 166.01 10.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 1.09 109.757 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -86.87 -49.29 7.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.038 0.447 . . . . 1.89 110.225 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.772 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 24.2 ttmm -49.76 -56.38 17.49 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.926 -1.034 . . . . 3.35 112.577 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 13.2 Cg_exo -70.15 94.84 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.891 1.727 . . . . 1.57 111.642 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -63.73 114.85 4.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.099 -0.955 . . . . 5.57 111.021 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.1 -149.9 9.12 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.419 -1.072 . . . . 3.76 110.419 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.0 134.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.141 0.495 . . . . 4.32 110.286 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.243 0.758 0 CA-C-O 118.579 -0.724 . . . . 3.3 109.358 -175.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.173 -0.306 . . . . 5.41 110.173 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.825 ' HE3' ' HA ' ' B' ' 54' ' ' CYS . 1.9 mmpt? 55.0 -170.44 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.824 0.821 . . . . 3.01 113.173 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.547 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 22.8 t -80.01 -35.68 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.036 -0.984 . . . . 1.09 109.317 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.714 HD12 ' HB2' ' B' ' 36' ' ' PHE . 5.3 mt -103.57 -49.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.662 -0.699 . . . . 1.06 109.388 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.58 25.32 30.65 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.567 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.7 133.27 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.0 0.905 . . . . 1.07 110.991 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.633 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.3 p -112.99 141.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 113.651 -1.613 . . . . 1.07 108.727 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 1.2 mpt_? -112.06 156.7 21.78 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.923 0.392 . . . . 1.9 110.462 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -121.25 118.14 28.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.33 -0.989 . . . . 1.63 108.33 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.7 HG22 HG21 ' B' ' 28' ' ' ILE . 22.5 t -54.22 144.49 5.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 123.948 0.78 . . . . 1.06 111.87 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.88 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.95 -1.023 . . . . 1.31 110.059 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.607 ' HG2' HD11 ' B' ' 30' ' ' ILE . 40.5 mt-10 -154.3 -43.78 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.627 -1.249 . . . . 1.23 107.627 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.51 -34.96 65.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.259 -1.337 . . . . 1.59 111.263 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' CA ' HG11 ' A' ' 10' ' ' VAL . . . 137.24 -4.64 3.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.451 -0.795 . . . . 0.25 111.152 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 9.0 mtp180 -68.57 133.57 48.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.644 -0.278 . . . . 3.66 110.626 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.2 pt -138.79 -179.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.578 -0.527 . . . . 0.97 109.578 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -109.81 103.11 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.084 0.469 . . . . 1.07 110.802 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.484 ' SD ' HD12 ' A' ' 16' ' ' ILE . 83.3 mmm -78.7 149.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.989 -0.745 . . . . 1.62 108.989 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -81.48 155.77 18.81 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.871 1.714 . . . . 0.18 113.61 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.7 tp -51.7 -32.36 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.93 109.884 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.24 -29.68 68.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.334 -0.848 . . . . 1.08 111.487 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.725 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.63 35.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.242 -0.651 . . . . 1.04 109.242 177.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.657 ' HD3' HG13 ' B' ' 10' ' ' VAL . 33.3 mtm180 -63.98 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.66 -0.7 . . . . 1.59 109.658 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 68.3 mtp180 -83.67 -33.03 25.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.031 -0.986 . . . . 0.83 110.663 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.47 -37.85 77.45 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.92 110.117 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.67 -88.64 0.23 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.145 -0.934 . . . . 1.11 111.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.738 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 22.1 t70 177.27 23.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.024 0.44 . . . . 1.72 109.977 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.555 HG21 HG22 ' B' ' 10' ' ' VAL . 2.6 mp -83.5 129.9 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 O-C-N 122.184 -0.323 . . . . 1.02 110.963 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.0 -48.37 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.91 111.236 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.15 -30.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 1.05 110.113 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.571 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.4 mtpt -137.03 -51.9 0.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.296 -0.631 . . . . 2.18 109.296 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER 36.44 -117.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.517 -1.219 . . . . 1.18 113.994 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.528 ' HB3' HG21 ' B' ' 7' ' ' VAL . 13.3 m -162.51 135.51 5.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.274 0.488 . . . . 0.57 111.428 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.847 HD11 HG23 ' B' ' 10' ' ' VAL . 3.2 mp -137.38 107.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 1.1 109.775 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 46.2 tt0 -103.1 138.03 40.48 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.287 -0.634 . . . . 1.31 109.287 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.993 0.901 . . . . 2.28 112.866 -174.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.758 ' HD2' ' HE2' ' B' ' 2' ' ' LYS . 18.4 t80 -127.83 123.43 35.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.126 -1.397 . . . . 3.08 108.179 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.524 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.0 p -92.3 132.6 36.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 119.824 -0.75 . . . . 1.1 110.492 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -133.59 102.65 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.515 -1.22 . . . . 1.16 109.248 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.39 -97.17 0.59 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.706 -0.759 . . . . 0.38 111.269 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -117.83 -9.55 10.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.323 0.583 . . . . 2.0 109.697 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.4 ttpt -92.09 157.73 16.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.449 -0.796 . . . . 1.68 111.538 -169.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.843 HG13 HD12 ' B' ' 22' ' ' LEU . 20.2 mm -118.58 139.53 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 44.2 mt -121.99 109.81 25.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.629 -0.26 . . . . 1.06 110.676 -173.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.806 HD11 HD11 ' B' ' 45' ' ' LEU . 11.3 mp -96.44 136.15 37.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.003 0.43 . . . . 1.09 111.612 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 18.5 pttp -145.15 170.81 15.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.186 -0.915 . . . . 2.71 110.173 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.738 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 5.1 tmtt? -87.03 149.23 24.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.307 -0.86 . . . . 1.21 109.097 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -77.95 -56.19 4.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.933 0.397 . . . . 2.09 110.936 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.63 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 24.0 tptm -56.03 -60.77 7.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 113.92 1.081 . . . . 3.26 113.92 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 61.3 Cg_endo -73.39 -2.47 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.026 1.817 . . . . 1.81 113.89 -170.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -166.54 78.87 0.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 5.58 110.422 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.77 85.95 0.57 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.969 -0.634 . . . . 3.79 112.125 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.92 148.24 13.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.061 -0.348 . . . . 3.89 110.061 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 1.007 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 47.8 t . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.368 -0.825 . . . . 3.44 109.889 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.36 -0.237 . . . . 5.36 110.36 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 1.007 ' HE3' ' HA ' ' A' ' 54' ' ' CYS . 5.2 mmpt? 53.1 -161.81 0.11 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.686 0.624 . . . . 2.83 112.686 173.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.524 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 24.2 t -87.4 -36.78 17.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.37 -0.832 . . . . 1.3 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.66 -46.88 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.466 -0.788 . . . . 0.91 109.362 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.28 29.12 46.4 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.197 -0.911 . . . . 0.43 112.493 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.31 131.37 71.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.374 0.607 . . . . 0.56 110.681 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 33' ' ' SER . 15.0 p -107.91 142.89 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.225 -0.898 . . . . 0.98 109.189 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.2 mpt_? -111.56 161.03 16.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.31 -0.405 . . . . 1.62 110.535 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.38 116.09 22.71 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.85 . . . . 1.77 108.704 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.847 HG23 HD11 ' A' ' 34' ' ' ILE . 7.5 t -53.25 141.86 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.706 0.629 . . . . 1.06 111.196 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.12 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.042 -0.981 . . . . 1.22 109.946 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.636 ' HG2' HD12 ' A' ' 30' ' ' ILE . 35.7 mt-10 -149.83 -41.78 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.109 -1.071 . . . . 1.22 108.109 169.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.2 mt -72.88 -36.55 67.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.269 -1.332 . . . . 1.54 110.864 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.566 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 134.78 -1.46 3.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.19 111.069 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 47.3 mtp85 -64.45 131.27 46.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.685 -0.257 . . . . 3.42 110.694 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.535 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -138.7 179.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.241 -0.652 . . . . 1.07 109.241 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.735 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -108.89 106.28 20.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.185 0.517 . . . . 0.98 110.732 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.517 ' SD ' HD11 ' B' ' 16' ' ' ILE . 81.0 mmm -79.77 146.04 63.62 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.853 -0.795 . . . . 1.08 108.853 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.76 158.62 31.61 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.08 1.853 . . . . 0.23 113.316 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -56.81 -31.05 34.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.269 -0.878 . . . . 0.24 109.273 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -59.33 -26.84 65.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.07 111.26 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.843 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.36 -39.84 31.64 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.931 -0.766 . . . . 1.1 108.931 176.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' B' ' 20' ' ' ILE . 42.9 mtm180 -66.45 -26.98 67.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.027 -0.988 . . . . 1.98 110.577 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -83.45 -32.34 26.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.529 -0.76 . . . . 1.11 109.603 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.62 62.35 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.074 -0.966 . . . . 0.28 110.494 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 53.0 mt -85.26 -93.9 0.08 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.547 -1.206 . . . . 1.18 109.364 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.511 ' OD1' ' HG3' ' B' ' 47' ' ' LYS . 6.7 p30 177.76 40.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.367 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.7 HG21 HG22 ' A' ' 10' ' ' VAL . 1.3 mp -81.01 125.05 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.07 109.798 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.77 -43.57 10.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.928 -0.578 . . . . 0.62 111.138 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.607 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -160.4 -30.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 0.4 109.388 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.488 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.2 mtpt -133.89 -52.45 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 1.99 109.382 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.539 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.4 OUTLIER 39.45 -117.83 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.848 -1.069 . . . . 1.17 113.725 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 34.4 m -162.05 134.47 5.77 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.034 0.379 . . . . 0.55 111.639 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.646 HD11 HG23 ' A' ' 10' ' ' VAL . 3.7 mp -137.88 103.58 2.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.945 -0.391 . . . . 1.09 109.945 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 47.7 tt0 -97.79 137.7 36.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.692 -0.485 . . . . 1.33 109.692 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.723 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -113.31 154.65 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.088 0.947 . . . . 2.21 113.002 -174.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 27.1 t80 -130.51 123.12 28.93 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 114.031 -1.44 . . . . 2.99 108.169 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.547 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.5 p -93.11 133.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.566 -0.854 . . . . 1.07 110.756 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.502 ' HB2' ' HE1' ' B' ' 37' ' ' PHE . 17.3 t70 -132.41 103.78 6.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.3 -0.864 . . . . 1.18 109.974 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.53 -84.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.899 -0.591 . . . . 0.48 111.719 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.96 -22.49 4.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.7 -0.481 . . . . 1.91 109.7 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.406 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 3.2 ptpp? -91.17 167.96 11.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.569 . . . . 1.4 110.866 -168.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 22' ' ' LEU . 5.3 mm -125.46 139.39 51.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.623 -0.717 . . . . 0.87 109.224 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 15.6 mt -118.23 117.85 56.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.436 -0.347 . . . . 1.07 110.559 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 45' ' ' LEU . 11.1 mp -104.2 134.68 47.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.955 0.407 . . . . 0.97 111.761 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -147.1 167.96 22.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.284 -0.871 . . . . 2.47 109.558 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.752 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -89.11 149.33 23.24 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.539 -0.912 . . . . 1.09 108.539 174.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.507 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 64.8 t80 -72.78 -57.69 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.678 0.275 . . . . 1.89 111.311 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.718 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 22.9 tptm -50.6 -60.66 4.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 114.431 1.271 . . . . 3.35 114.431 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.752 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 34.3 Cg_exo -60.46 -42.67 39.01 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.97 1.78 . . . . 1.57 112.542 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -135.62 81.67 1.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.232 0.539 . . . . 5.57 110.197 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.13 86.05 0.6 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.743 -0.662 . . . . 3.76 111.963 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.83 150.62 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 110.173 -0.306 . . . . 4.32 110.173 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.825 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 53.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.735 -0.65 . . . . 3.3 109.649 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.87 -0.419 . . . . 5.41 109.87 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.898 ' HD3' ' HA ' ' B' ' 54' ' ' CYS . 32.5 mmtm -65.98 169.75 6.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 3.01 110.816 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.729 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.7 m -65.19 -49.17 70.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.316 -0.857 . . . . 1.09 110.502 176.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.596 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -88.33 -36.18 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 1.06 109.635 -178.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.66 78.18 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.387 -0.824 . . . . 0.51 112.284 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.596 HG22 ' HB ' ' A' ' 4' ' ' ILE . 29.5 m -119.15 132.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.689 0.757 . . . . 1.07 111.053 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.3 p -114.76 138.89 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.276 -1.329 . . . . 1.07 109.114 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.556 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.22 148.97 32.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.069 0.461 . . . . 1.9 110.294 -174.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -112.98 120.28 40.85 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.321 -0.854 . . . . 1.63 108.898 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.634 HG22 HG21 ' B' ' 28' ' ' ILE . 36.3 t -54.7 144.72 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.482 -0.781 . . . . 1.06 111.809 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -80.32 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.842 -1.072 . . . . 1.31 109.917 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HG2' HD11 ' B' ' 30' ' ' ILE . 41.0 mt-10 -153.82 -42.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.931 -1.137 . . . . 1.23 107.931 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.38 -19.01 36.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.462 -1.245 . . . . 1.59 111.472 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 123.89 -3.79 9.19 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.836 -0.697 . . . . 0.25 111.682 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.742 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 47.7 mtm180 -67.38 126.45 29.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.361 -0.237 . . . . 3.66 110.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.628 HD11 ' HE1' ' A' ' 18' ' ' MET . 1.0 OUTLIER -136.96 179.74 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.191 -0.67 . . . . 0.97 109.191 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.1 p -110.6 118.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.194 0.521 . . . . 1.07 111.094 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.758 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.7 mmt -86.15 151.3 53.99 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.876 -0.602 . . . . 1.62 109.698 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.4 Cg_endo -85.59 156.03 10.51 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.02 1.814 . . . . 0.18 113.157 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.702 HD13 HH21 ' A' ' 23' ' ' ARG . 3.9 tp -51.18 -33.67 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.06 -0.973 . . . . 0.93 109.792 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.55 -29.56 68.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.615 -0.72 . . . . 1.08 111.877 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.843 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.37 35.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.007 -0.738 . . . . 1.04 109.007 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.702 HH21 HD13 ' A' ' 20' ' ' ILE . 62.3 mtm180 -64.84 -29.66 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 1.59 109.812 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.6 mtp180 -84.64 -35.23 22.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.176 -0.92 . . . . 0.83 110.657 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.71 72.34 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.534 -0.757 . . . . 0.92 110.237 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.762 HD21 ' H ' ' A' ' 47' ' ' LYS . 97.2 mt -89.45 -89.61 0.15 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.8 -1.091 . . . . 1.11 111.421 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 36.7 t70 168.52 58.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.97 -1.122 . . . . 1.72 107.97 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.603 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.0 mp -115.29 134.34 58.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.913 -0.585 . . . . 1.02 110.485 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.13 -59.69 1.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.37 0.605 . . . . 0.91 111.166 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.62 -31.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.466 -0.788 . . . . 1.05 109.59 -176.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HG3' HG21 ' A' ' 30' ' ' ILE . 40.2 mtpt -134.63 -56.34 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.083 -0.71 . . . . 2.18 109.083 174.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' C ' ' HG ' ' A' ' 33' ' ' SER . 0.9 OUTLIER 38.9 -121.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 1.18 113.899 -176.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB3' HG21 ' B' ' 7' ' ' VAL . 15.6 m -161.4 135.28 6.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.458 0.572 . . . . 0.57 111.236 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.72 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -139.88 104.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.332 -0.618 . . . . 1.1 109.332 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 40.1 tt0 -102.86 135.05 45.24 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.571 -0.529 . . . . 1.31 109.571 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.767 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -112.49 154.33 26.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.02 0.914 . . . . 2.28 113.098 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.548 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 24.9 t80 -131.76 121.91 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.982 -1.463 . . . . 3.08 107.868 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.641 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -92.62 135.32 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.198 -0.601 . . . . 1.1 110.703 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -133.74 102.4 5.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.979 -1.01 . . . . 1.16 109.966 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.5 -82.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.38 112.037 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.75 -20.15 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.34 0.591 . . . . 2.0 109.901 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 5.6 ttpt -93.05 157.97 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.256 -0.884 . . . . 1.68 111.376 -166.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.908 HG13 HD13 ' B' ' 22' ' ' LEU . 16.9 mm -114.78 141.5 31.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.432 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 43.8 mt -122.36 107.2 19.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.607 0.242 . . . . 1.06 110.758 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.1 mp -94.46 131.29 40.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.442 -0.345 . . . . 1.09 111.265 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HA ' HD22 ' A' ' 26' ' ' LEU . 4.1 ptmt -149.91 148.7 29.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.908 -0.587 . . . . 2.71 111.136 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.762 ' H ' HD21 ' A' ' 26' ' ' LEU . 3.3 tmtp? -72.39 137.3 46.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.21 109.985 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.562 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 63.0 t80 -67.26 -50.06 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.535 -0.757 . . . . 2.09 111.616 -172.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.731 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 25.2 ttpp -47.41 -63.93 1.24 Allowed Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.104 0.779 . . . . 3.26 113.104 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.731 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 57.7 Cg_endo -73.89 -46.3 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.364 1.376 . . . . 1.81 112.552 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -117.0 76.76 1.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.344 0.592 . . . . 5.58 110.492 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.61 -53.56 8.36 Favored Glycine 0 CA--C 1.5 -0.851 0 CA-C-N 115.191 -0.913 . . . . 3.79 111.874 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -52.2 147.32 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.38 -0.91 . . . . 3.89 110.817 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.931 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.311 -0.852 . . . . 3.44 111.777 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.72 -0.474 . . . . 5.36 109.72 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.931 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 32.5 mmtm -61.3 169.53 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 2.83 111.643 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.641 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.0 m -68.91 -43.7 74.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.281 -0.872 . . . . 1.3 110.252 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.767 HD12 ' HD2' ' A' ' 36' ' ' PHE . 1.3 mt -96.97 -32.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.91 109.882 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.2 28.61 73.81 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.583 -0.735 . . . . 0.43 112.888 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -124.52 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.158 0.504 . . . . 0.56 110.609 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -110.63 144.19 19.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.503 -0.771 . . . . 0.98 109.185 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.597 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mpt_? -114.56 155.11 27.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.035 0.445 . . . . 1.62 110.631 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 116.98 27.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.258 -1.016 . . . . 1.77 108.258 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.72 HG23 HD11 ' A' ' 34' ' ' ILE . 9.1 t -52.45 137.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 O-C-N 123.803 0.689 . . . . 1.06 111.226 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.19 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.227 -0.897 . . . . 1.22 110.212 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 30' ' ' ILE . 44.3 mt-10 -152.92 -38.11 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.408 -0.96 . . . . 1.22 108.408 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.57 -29.27 25.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.786 -1.097 . . . . 1.54 111.006 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.525 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 133.18 -3.2 4.8 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.663 -0.975 . . . . 0.19 110.663 -172.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.2 mtm180 -63.33 129.47 40.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.356 . . . . 3.42 110.701 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.546 HD11 ' HE3' ' B' ' 18' ' ' MET . 0.5 OUTLIER -139.24 179.51 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.901 -0.777 . . . . 1.07 108.901 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.742 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -109.26 117.29 54.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.178 0.513 . . . . 0.98 111.263 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.626 ' HA ' ' HE1' ' B' ' 18' ' ' MET . 23.8 mmt -81.61 154.6 71.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.235 -0.654 . . . . 1.08 109.235 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.0 Cg_endo -86.47 156.27 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.129 1.886 . . . . 0.23 113.342 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' B' ' 23' ' ' ARG . 4.0 tp -56.47 -30.39 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.832 . . . . 0.24 109.314 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -58.84 -28.95 66.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.87 . . . . 1.07 110.909 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.908 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.72 -40.22 34.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.987 -0.745 . . . . 1.1 108.987 177.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 57.0 mtm180 -64.2 -27.69 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.037 -0.983 . . . . 1.98 110.357 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -83.99 -35.19 24.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.165 -0.925 . . . . 1.11 110.018 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -51.33 67.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.849 -1.069 . . . . 0.28 110.878 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.739 HD21 ' H ' ' B' ' 47' ' ' LYS . 70.3 mt -90.83 -85.65 0.22 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.611 -1.177 . . . . 1.18 111.675 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.617 ' C ' HD11 ' B' ' 28' ' ' ILE . 24.3 t0 169.05 55.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.67 -0.863 . . . . 1.54 108.67 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.634 HG21 HG22 ' A' ' 10' ' ' VAL . 1.3 mp -116.23 139.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 1.07 109.908 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.45 -59.58 1.93 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.814 -0.63 . . . . 0.62 111.083 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.446 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -140.85 -33.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.177 -0.465 . . . . 0.4 110.072 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.476 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.0 mtpt -133.98 -52.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.913 -0.773 . . . . 1.99 108.913 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.558 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.8 OUTLIER 36.94 -118.96 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.686 -1.143 . . . . 1.17 114.063 -176.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 15.9 m -161.43 134.72 6.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.996 0.362 . . . . 0.55 111.337 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.637 HG22 HD21 ' B' ' 45' ' ' LEU . 3.8 mp -141.71 102.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.682 -0.488 . . . . 1.09 109.682 171.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 38.5 tt0 -99.29 136.87 38.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 1.33 109.576 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.723 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -110.43 158.12 18.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.283 1.039 . . . . 2.21 113.268 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 35.1 t80 -135.39 125.13 25.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.632 -1.622 . . . . 2.99 107.86 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.729 ' H ' ' HB2' ' A' ' 3' ' ' SER . 13.5 p -92.9 135.31 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.87 -0.732 . . . . 1.07 110.111 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -133.64 100.05 4.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.833 -0.621 . . . . 1.18 110.039 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 -80.42 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.48 111.917 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.69 -19.79 3.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.238 0.542 . . . . 1.91 110.008 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -91.82 167.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.489 -0.778 . . . . 1.4 110.796 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 22' ' ' LEU . 8.4 mm -121.72 139.98 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.554 -0.748 . . . . 0.87 109.149 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.2 mt -118.27 111.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.498 -0.319 . . . . 1.07 110.59 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.822 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -99.61 132.23 45.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.647 0.261 . . . . 0.97 111.478 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.521 ' HE2' ' HE3' ' A' ' 2' ' ' LYS . 3.1 ptmt -153.76 145.33 23.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.012 -0.54 . . . . 2.47 111.328 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.739 ' H ' HD21 ' B' ' 26' ' ' LEU . 1.9 tmtp? -72.37 135.5 45.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 1.09 109.905 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -62.76 -53.65 51.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.354 -0.839 . . . . 1.89 112.207 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.763 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 26.2 ttpp -49.3 -59.47 6.49 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 113.361 0.874 . . . . 3.35 113.361 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 13.2 Cg_exo -70.93 -44.78 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.931 1.754 . . . . 1.57 112.308 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -122.17 75.67 1.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.212 0.529 . . . . 5.57 110.638 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.22 16.44 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.351 -0.84 . . . . 3.76 111.689 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.85 148.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.007 -1.097 . . . . 4.32 111.027 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.898 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 1.6 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.243 -0.884 . . . . 3.3 111.453 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ptp . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 122.15 0.976 . . . . 5.41 110.315 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.894 ' HG2' ' HB3' ' B' ' 54' ' ' CYS . 55.4 mtmt -75.19 -162.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.065 -1.425 . . . . 3.01 112.035 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 28.4 m -44.8 -54.59 6.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.244 -0.889 . . . . 1.09 111.38 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -84.82 -34.13 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.297 -1.001 . . . . 1.06 108.297 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.531 ' HA2' ' N ' ' A' ' 2' ' ' LYS . . . 73.35 16.09 78.85 Favored Glycine 0 CA--C 1.504 -0.603 0 CA-C-N 114.88 -1.055 . . . . 0.51 112.736 174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' C ' ' HG3' ' B' ' 35' ' ' GLU . 23.4 m -114.7 131.17 67.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.778 0.799 . . . . 1.07 111.475 -175.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.7 p -110.21 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.997 -1.456 . . . . 1.07 108.746 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' NE ' HG11 ' A' ' 17' ' ' VAL . 2.7 mpt_? -122.04 164.24 18.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.436 -0.347 . . . . 1.9 110.557 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 34.1 mmtm -115.06 127.59 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.592 -0.892 . . . . 1.63 108.592 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.83 HG21 HD11 ' B' ' 34' ' ' ILE . 18.3 t -58.55 136.64 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.57 -0.53 . . . . 1.06 109.57 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.71 -77.87 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.899 -0.591 . . . . 1.31 109.564 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.5 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.3 mt-10 -154.81 -45.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.747 -1.205 . . . . 1.23 107.747 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.13 -34.69 63.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.338 -1.301 . . . . 1.59 110.908 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' HG11 ' A' ' 10' ' ' VAL . . . 141.86 -9.62 2.56 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.21 -0.905 . . . . 0.25 111.12 -172.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.842 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 27.9 mtm180 -62.45 131.43 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.262 . . . . 3.66 111.165 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.704 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -141.46 179.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.096 -0.705 . . . . 0.97 109.096 174.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -107.91 107.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.346 0.593 . . . . 1.07 110.908 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.585 ' HB3' HD12 ' A' ' 22' ' ' LEU . 77.4 mmm -80.29 152.56 73.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.122 -0.695 . . . . 1.62 109.122 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 95.2 Cg_endo -84.66 157.22 12.12 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.767 1.645 . . . . 0.18 114.119 -171.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.1 tp -50.44 -37.81 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.816 -1.084 . . . . 0.93 110.224 170.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.71 -26.13 65.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 1.08 110.782 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -77.09 -39.21 50.49 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.947 -0.76 . . . . 1.04 108.947 177.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.612 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 17.3 mtm180 -64.02 -34.74 78.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.312 -0.858 . . . . 1.59 110.028 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.7 mtp180 -79.62 -35.6 39.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.175 -0.92 . . . . 0.83 110.083 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.43 -51.4 29.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.051 -0.977 . . . . 0.92 110.212 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 47' ' ' LYS . 86.5 mt -78.01 -89.87 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.173 -0.921 . . . . 1.11 111.492 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 11.2 t70 175.15 43.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.511 -0.922 . . . . 1.72 108.511 -169.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -115.44 138.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 1.02 111.317 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.94 -51.15 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.013 -0.539 . . . . 0.91 111.513 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.594 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -147.18 -29.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.032 -0.359 . . . . 1.05 110.032 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HG3' HG23 ' A' ' 30' ' ' ILE . 18.4 mtpp -138.98 -52.23 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.265 -0.642 . . . . 2.18 109.265 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 35.08 -110.24 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.49 -1.232 . . . . 1.18 113.946 -177.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 50.4 m -165.34 142.44 5.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.377 0.535 . . . . 0.57 111.168 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.978 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -141.13 108.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 110.26 -0.274 . . . . 1.1 110.26 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.594 ' HG2' ' HE3' ' B' ' 2' ' ' LYS . 40.4 tt0 -105.63 132.17 52.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.987 -0.375 . . . . 1.31 109.987 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.609 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.41 155.97 23.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.404 1.097 . . . . 2.28 113.017 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.936 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 40.9 t80 -125.22 153.38 43.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.331 -1.759 . . . . 3.08 106.454 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.9 p -122.16 133.09 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.788 -0.765 . . . . 1.1 110.175 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.56 96.9 4.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 1.16 110.033 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.89 -82.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.586 -0.733 . . . . 0.38 111.502 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HD22 ' B' ' 26' ' ' LEU . 14.6 m-20 -125.5 -17.7 5.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.724 -0.238 . . . . 2.0 110.99 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 166.27 12.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 1.68 110.72 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG13 HD11 ' B' ' 22' ' ' LEU . 15.3 mm -120.72 142.96 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 43.0 mt -124.65 111.24 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 1.06 110.613 -174.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.828 HD13 HD11 ' B' ' 45' ' ' LEU . 11.0 mp -94.64 135.78 35.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.24 0.543 . . . . 1.09 111.905 -174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HE3' ' HE2' ' B' ' 2' ' ' LYS . 16.4 ttpp -149.68 134.56 17.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.852 -1.067 . . . . 2.71 109.421 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.656 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.7 tmtp? -63.86 155.32 30.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.637 -0.875 . . . . 1.21 108.637 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.614 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 25.1 t80 -70.43 -49.33 49.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.067 0.46 . . . . 2.09 111.004 -173.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 40.4 ttmt -50.87 -55.07 30.34 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 113.807 1.04 . . . . 3.26 113.807 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 36.7 Cg_exo -38.21 136.06 0.6 Allowed 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.523 2.815 . . . . 1.81 113.72 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.76 152.8 40.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.593 -0.73 . . . . 5.58 111.074 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.71 73.93 0.59 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 109.531 -1.427 . . . . 3.79 109.531 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -52.35 137.66 11.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.641 0.734 . . . . 3.89 112.702 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.889 ' HB3' ' HG2' ' B' ' 2' ' ' LYS . 74.6 m . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 114.234 -1.348 . . . . 3.44 108.52 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.757 0.789 . . . . 5.36 110.6 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.936 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 14.5 mttt -75.75 -158.09 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.186 -0.915 . . . . 2.83 112.967 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.405 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.1 m -47.25 -58.2 4.36 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.682 -1.144 . . . . 1.3 110.858 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.16 -35.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.528 -1.286 . . . . 0.91 107.528 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.674 ' HA2' ' N ' ' B' ' 2' ' ' LYS . . . 67.11 28.66 73.82 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 114.382 -1.281 . . . . 0.43 112.375 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.66 132.21 69.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.219 0.533 . . . . 0.56 110.603 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -109.44 147.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.98 109.196 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.481 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mpt_? -120.12 167.01 12.65 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.144 -0.48 . . . . 1.62 110.377 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 40.6 mmtm -119.02 122.53 42.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.699 -0.852 . . . . 1.77 108.699 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.978 HG23 HD11 ' A' ' 34' ' ' ILE . 4.3 t -56.04 133.31 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.281 -0.637 . . . . 1.06 109.281 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -79.16 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.756 -0.656 . . . . 1.22 109.972 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.503 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.4 mt-10 -152.73 -40.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.085 -1.08 . . . . 1.22 108.085 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.655 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.3 OUTLIER -89.74 -15.2 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.067 -1.424 . . . . 1.54 110.493 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.712 ' HA2' HG11 ' B' ' 10' ' ' VAL . . . 124.21 -4.75 8.91 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.19 111.934 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 53.0 mtm180 -63.45 131.74 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.869 0.067 . . . . 3.42 110.839 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -142.15 179.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.904 -0.776 . . . . 1.07 108.904 174.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.842 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -107.95 109.14 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.007 0.432 . . . . 0.98 110.769 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.576 ' HB3' HD13 ' B' ' 22' ' ' LEU . 77.3 mmm -80.97 152.25 71.41 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.702 -0.851 . . . . 1.08 108.702 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 40.7 Cg_endo -83.16 158.1 15.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.559 1.506 . . . . 0.23 113.583 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.607 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.9 tp -58.62 -29.55 39.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.142 -0.935 . . . . 0.24 109.307 172.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.54 -27.82 67.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 1.07 110.823 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.736 HD11 HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -76.99 -41.42 42.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.723 -0.843 . . . . 1.1 108.723 176.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.717 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 65.1 mtp180 -62.81 -31.25 72.2 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.543 -1.208 . . . . 1.98 110.899 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -81.15 -33.99 32.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.361 -0.836 . . . . 1.11 109.652 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.59 19.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.729 -1.123 . . . . 0.28 111.419 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.702 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 74.2 mt -82.06 -81.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.862 -1.063 . . . . 1.18 111.091 -171.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.585 ' C ' HD11 ' B' ' 28' ' ' ILE . 37.6 t70 170.9 49.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 -173.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.717 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -115.8 133.93 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.1 0.476 . . . . 1.07 110.336 -173.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.79 -48.47 3.92 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.512 -0.767 . . . . 0.62 111.385 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.6 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -152.9 -29.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.008 0.432 . . . . 0.4 109.97 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.6 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.8 mtpp -138.55 -51.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.944 -0.761 . . . . 1.99 108.944 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.564 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 36.35 -108.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.518 -1.219 . . . . 1.17 114.136 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.629 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 21.0 m -167.93 141.27 3.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.884 0.311 . . . . 0.55 110.67 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 10' ' ' VAL . 4.2 mp -144.23 106.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 110.214 -0.291 . . . . 1.09 110.214 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 tt0 -98.6 142.17 30.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.852 -0.425 . . . . 1.33 109.852 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.583 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -114.45 155.4 26.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.067 0.936 . . . . 2.21 112.911 -175.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.807 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.4 t80 -127.31 151.17 49.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.754 -1.572 . . . . 2.99 106.754 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.48 ' H ' ' HB2' ' A' ' 3' ' ' SER . 4.6 p -118.99 134.62 62.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.665 -0.814 . . . . 1.07 110.604 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -129.44 95.81 4.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.222 -0.899 . . . . 1.18 109.827 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.59 -82.31 0.39 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.901 -0.666 . . . . 0.48 111.662 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.412 ' O ' HD22 ' A' ' 26' ' ' LEU . 26.6 m-20 -128.46 -13.26 4.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.516 0.198 . . . . 1.91 110.514 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 1.2 ptpp? -100.29 168.94 9.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.389 . . . . 1.4 110.55 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 23.4 mm -124.67 144.81 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.8 -0.637 . . . . 0.87 109.955 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.807 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 39.4 mt -125.93 115.08 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.27 -0.423 . . . . 1.07 110.951 -173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.828 HD11 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -101.47 134.27 44.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.081 0.467 . . . . 0.97 111.869 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.558 ' HA ' HD23 ' B' ' 26' ' ' LEU . 24.5 ttpp -147.99 137.6 22.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.191 -0.913 . . . . 2.47 109.257 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -64.68 150.28 47.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.395 -0.965 . . . . 1.09 108.395 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.625 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 0.8 OUTLIER -65.56 -51.93 56.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.77 0.319 . . . . 1.89 110.707 -172.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.666 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 31.6 ttmt -48.81 -57.69 10.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.729 1.011 . . . . 3.35 113.729 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 39.1 Cg_exo -38.99 125.53 1.08 Allowed 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.249 2.633 . . . . 1.57 113.577 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -61.13 154.59 22.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.904 -1.044 . . . . 5.57 111.826 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.3 76.22 0.82 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.693 -1.363 . . . . 3.76 109.693 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.93 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.635 0.731 . . . . 4.32 112.36 -171.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.894 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 73.9 m . . . . . 0 C--O 1.244 0.792 0 CA-C-N 114.487 -1.233 . . . . 3.3 108.159 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.507 -0.183 . . . . 5.41 110.507 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 58.27 -175.33 0.08 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.629 0.728 . . . . 3.01 112.749 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.607 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 5.2 m -76.9 -48.37 18.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.024 -0.989 . . . . 1.09 110.244 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' B' ' 37' ' ' PHE . 3.9 mt -97.69 -37.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 1.06 109.701 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.64 40.54 31.7 Favored Glycine 0 CA--C 1.506 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.51 112.446 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 4' ' ' ILE . 8.1 m -138.12 133.57 44.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.486 0.66 . . . . 1.07 111.309 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -118.89 140.9 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.763 -1.108 . . . . 1.07 109.061 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.545 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -116.29 160.05 21.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.82 -0.437 . . . . 1.9 109.82 -174.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 26.3 mmtp -122.15 120.44 34.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.335 -0.987 . . . . 1.63 108.335 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.749 HG21 HD11 ' B' ' 34' ' ' ILE . 18.1 t -52.32 138.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.732 0.645 . . . . 1.06 110.767 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.84 -71.86 0.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.77 -0.65 . . . . 1.31 109.695 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -154.39 -51.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.938 -0.764 . . . . 1.23 108.938 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -82.56 -23.93 34.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.65 -1.159 . . . . 1.59 110.821 -177.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 139.75 -9.6 3.12 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.913 -0.661 . . . . 0.25 112.139 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 35.6 mtm180 -62.8 129.82 42.14 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.824 -0.221 . . . . 3.66 110.945 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.566 HD11 ' HE3' ' A' ' 18' ' ' MET . 0.5 OUTLIER -139.18 177.33 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.268 -0.641 . . . . 0.97 109.268 175.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -106.31 111.61 35.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.301 0.572 . . . . 1.07 111.096 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.566 ' HE3' HD11 ' A' ' 16' ' ' ILE . 2.8 mmt -83.01 155.58 67.47 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.022 -0.733 . . . . 1.62 109.022 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.2 Cg_endo -86.69 153.86 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.033 1.822 . . . . 0.18 113.573 -173.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.3 tp -52.59 -33.0 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.93 109.667 169.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -62.15 -26.53 68.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.514 -0.766 . . . . 1.08 110.873 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.766 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -78.91 -38.9 36.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.73 -0.841 . . . . 1.04 108.73 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.695 ' HD3' HG13 ' B' ' 10' ' ' VAL . 37.3 mtm180 -65.07 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.107 -0.951 . . . . 1.59 110.249 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.3 mtp180 -84.62 -37.52 20.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.164 -0.925 . . . . 0.83 110.529 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.2 -50.18 55.94 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.472 -0.785 . . . . 0.92 110.43 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.616 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -80.6 -86.33 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.789 -1.096 . . . . 1.11 111.13 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t0 166.6 61.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.6 -1.259 . . . . 1.72 107.6 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -123.95 134.27 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.02 110.406 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.33 -56.67 2.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.151 0.5 . . . . 0.91 110.825 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -141.48 -30.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.81 -0.632 . . . . 1.05 109.699 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 6.7 mtpp -136.17 -54.15 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.323 -0.621 . . . . 2.18 109.323 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.55 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.97 -116.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.423 -1.262 . . . . 1.18 113.706 -175.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 14.0 m -162.0 136.73 7.0 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.409 0.549 . . . . 0.57 111.125 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.853 HD11 HG21 ' B' ' 10' ' ' VAL . 3.8 mp -138.6 103.15 2.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.868 -0.419 . . . . 1.1 109.868 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.6 tt0 -97.95 137.73 36.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.254 -0.647 . . . . 1.31 109.254 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -121.68 151.04 40.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.426 1.108 . . . . 2.28 112.989 -175.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.661 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -113.5 165.87 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.311 -1.768 . . . . 3.08 107.034 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' H ' ' HB2' ' B' ' 3' ' ' SER . 2.9 p -133.19 125.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.49 0.662 . . . . 1.1 109.906 167.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -128.57 104.59 7.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.926 -1.034 . . . . 1.16 109.758 -173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.83 -92.08 0.53 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.156 -0.778 . . . . 0.38 111.156 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.592 ' O ' HD23 ' B' ' 26' ' ' LEU . 28.7 m-20 -126.9 4.57 6.57 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.993 -0.373 . . . . 2.0 109.993 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -109.97 157.24 19.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 1.68 111.437 -168.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.864 HG13 HD12 ' B' ' 22' ' ' LEU . 19.8 mm -113.84 142.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 mt -123.78 115.48 45.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.521 -0.309 . . . . 1.06 110.92 -173.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.768 HD11 HD11 ' B' ' 45' ' ' LEU . 10.5 mp -101.27 129.79 47.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.47 0.652 . . . . 1.09 112.429 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 13.4 ttpt -142.49 141.09 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.579 -1.191 . . . . 2.71 109.749 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 1.5 tmtp? -73.96 148.95 41.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.574 -0.898 . . . . 1.21 108.574 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.63 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 36.6 t80 -66.78 -47.73 71.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.064 0.459 . . . . 2.09 111.235 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.703 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.6 tmtp? -48.56 -56.24 15.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.025 -0.989 . . . . 3.26 113.168 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_exo -52.86 108.36 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.244 1.963 . . . . 1.81 111.948 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -79.07 79.12 5.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.995 -0.548 . . . . 5.58 111.289 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.35 -85.48 1.44 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.336 -1.106 . . . . 3.79 110.336 170.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.1 p -157.85 145.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.857 0.36 . . . . 3.89 110.14 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.412 ' OXT' ' HE3' ' B' ' 2' ' ' LYS . 11.1 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 119.042 -0.504 . . . . 3.44 110.383 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.735 -0.469 . . . . 5.36 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.93 ' HE2' ' HA ' ' B' ' 2' ' ' LYS . 4.3 mmpt? 56.96 179.72 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.918 1.081 . . . . 2.83 113.918 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 19.9 m -68.67 -48.92 62.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.349 -1.296 . . . . 1.3 110.362 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.63 -46.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.481 -0.781 . . . . 0.91 109.398 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.63 35.02 37.59 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.267 -0.879 . . . . 0.43 112.512 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -129.09 132.4 67.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.042 0.448 . . . . 0.56 110.39 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.3 p -112.07 143.15 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.874 -0.787 . . . . 0.98 108.874 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.402 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mpt_? -114.81 162.9 16.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.237 -0.438 . . . . 1.62 110.602 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.59 121.3 38.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.523 -0.918 . . . . 1.77 108.523 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.853 HG21 HD11 ' A' ' 34' ' ' ILE . 2.9 t -56.32 132.87 20.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 O-C-N 123.358 0.411 . . . . 1.06 110.115 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.17 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.22 109.672 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 30' ' ' ILE . 40.8 mt-10 -155.13 -39.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 124.272 0.983 . . . . 1.22 108.445 171.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.662 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.2 OUTLIER -92.06 -18.01 24.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.458 -1.246 . . . . 1.54 110.472 -177.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 130.1 -7.49 6.04 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.639 -0.71 . . . . 0.19 112.106 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 39.2 mtm180 -61.45 129.99 43.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.819 -0.224 . . . . 3.42 110.789 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.546 HG21 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -140.8 176.01 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.298 -0.63 . . . . 1.07 109.298 175.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 1.5 p -105.3 108.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.295 0.569 . . . . 0.98 111.358 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.64 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.9 mmt -75.3 156.26 85.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.027 -0.731 . . . . 1.08 109.027 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.1 Cg_endo -87.84 155.58 7.36 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.988 1.792 . . . . 0.23 113.417 -176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.62 -0.718 . . . . 0.24 109.283 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -59.31 -30.03 68.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.401 -0.818 . . . . 1.07 110.804 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.864 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.33 -39.99 58.83 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.701 -0.851 . . . . 1.1 108.701 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.662 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 33.8 mtm180 -64.47 -30.09 71.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.862 -1.063 . . . . 1.98 110.318 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -84.64 -24.63 28.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.311 -0.859 . . . . 1.11 110.39 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.12 -53.2 8.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.218 -0.901 . . . . 0.28 110.941 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.764 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 16.2 mt -83.13 -81.39 0.16 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.056 -0.975 . . . . 1.18 110.212 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.624 ' C ' HD11 ' B' ' 28' ' ' ILE . 20.3 t70 165.19 61.24 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.965 -1.124 . . . . 1.54 107.965 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -116.63 133.73 62.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.845 -0.616 . . . . 1.07 109.653 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.58 -56.82 2.21 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.178 -0.464 . . . . 0.62 110.853 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.413 ' O ' HG11 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -143.03 -31.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.84 -0.618 . . . . 0.4 109.672 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -134.6 -51.88 0.8 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.354 -0.61 . . . . 1.99 109.354 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.636 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.4 OUTLIER 39.77 -113.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.677 -1.147 . . . . 1.17 113.818 -176.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.559 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 18.7 m -161.93 135.95 6.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.042 0.214 . . . . 0.55 111.235 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.749 HD11 HG21 ' A' ' 10' ' ' VAL . 4.2 mp -139.87 102.07 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 N-CA-C 109.677 -0.49 . . . . 1.09 109.677 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 45.6 tt0 -96.47 135.55 38.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.33 109.388 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.531 ' CE2' ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -121.07 151.29 40.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.603 0.716 . . . . 2.21 112.375 -176.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.563 ' HA ' HG13 ' A' ' 4' ' ' ILE . 2.8 p90 -143.34 139.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.962 -1.017 . . . . 2.99 110.307 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.607 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.2 p -92.9 141.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.383 0.611 . . . . 1.07 110.791 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.98 102.22 5.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.164 -0.926 . . . . 1.18 109.355 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.6 -88.18 0.53 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.104 -0.799 . . . . 0.48 111.104 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.07 -8.13 5.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.412 -0.218 . . . . 1.91 110.412 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -105.78 168.42 9.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 1.4 111.0 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.766 HG13 HD12 ' A' ' 22' ' ' LEU . 30.4 mm -119.65 142.5 34.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.861 -0.609 . . . . 0.87 109.491 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 11.8 mt -125.95 125.44 68.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.912 -0.315 . . . . 1.07 110.178 -175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.768 HD11 HD11 ' A' ' 45' ' ' LEU . 10.7 mp -107.48 128.87 54.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.203 0.525 . . . . 0.97 111.86 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 10.3 ttpt -142.47 138.68 31.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.831 -1.077 . . . . 2.47 110.158 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.764 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.6 tmtp? -70.01 146.67 50.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.822 -0.807 . . . . 1.09 108.822 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.572 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 40.5 t80 -64.89 -50.35 66.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 1.89 111.419 -173.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.703 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -47.96 -57.87 9.2 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.36 -0.836 . . . . 3.35 113.033 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 87.0 Cg_exo -48.69 110.75 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 122.266 1.978 . . . . 1.57 112.149 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -79.17 87.71 4.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.646 -0.706 . . . . 5.57 111.27 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.21 -87.09 1.97 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.311 -1.116 . . . . 3.76 110.311 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.4 142.76 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 4.32 109.907 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 C--O 1.245 0.831 0 CA-C-O 119.28 -0.391 . . . . 3.3 110.313 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.713 0.292 . . . . 5.41 110.874 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.783 ' HD2' ' HB2' ' B' ' 37' ' ' PHE . 54.0 mtmt -89.96 -172.58 3.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.075 0.398 . . . . 3.01 112.075 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 25.0 m -44.94 -57.6 3.69 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.46 0.704 . . . . 1.09 111.998 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.1 mt -82.57 -35.59 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.037 -1.098 . . . . 1.06 108.037 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.53 13.74 74.49 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 114.738 -1.119 . . . . 0.51 112.798 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 29.1 m -105.17 132.44 51.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.502 0.667 . . . . 1.07 110.93 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.8 p -113.52 139.78 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.494 -1.23 . . . . 1.07 109.913 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -114.4 156.65 24.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.893 -0.594 . . . . 1.9 110.435 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -117.71 122.86 44.64 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.877 -0.786 . . . . 1.63 108.877 175.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.668 HG23 HG21 ' B' ' 28' ' ' ILE . 27.4 t -57.64 146.19 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 1.06 111.781 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -77.55 0.06 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.12 -0.945 . . . . 1.31 110.151 174.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -155.22 -43.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.729 -0.841 . . . . 1.23 108.729 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 -25.88 30.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.647 -1.16 . . . . 1.59 110.936 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 133.93 -6.76 4.79 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.295 -0.866 . . . . 0.25 110.984 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 48.2 mtm180 -62.79 128.18 34.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.423 0.154 . . . . 3.66 110.83 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.585 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -139.52 179.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.688 -0.856 . . . . 0.97 108.688 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -106.28 116.18 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.083 0.468 . . . . 1.07 110.907 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.68 ' HE2' HD23 ' B' ' 45' ' ' LEU . 13.9 mmt -83.56 150.84 60.77 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.34 -0.615 . . . . 1.62 109.34 174.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.56 154.48 18.22 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.777 1.651 . . . . 0.18 113.098 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.1 tp -53.41 -32.18 19.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.325 -0.852 . . . . 0.93 109.629 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.1 mm-40 -61.14 -27.78 68.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.08 111.111 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.829 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -40.7 41.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.625 -0.879 . . . . 1.04 108.625 176.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.579 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 42.3 mtm180 -63.66 -30.55 71.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.861 -1.063 . . . . 1.59 110.133 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.0 mtp180 -84.59 -32.12 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.37 -0.832 . . . . 0.83 110.73 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.19 76.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.528 -0.76 . . . . 0.92 109.803 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 47' ' ' LYS . 86.8 mt -96.66 -91.53 0.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.974 -1.012 . . . . 1.11 111.841 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 29.7 t70 172.31 55.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.742 -1.207 . . . . 1.72 107.742 -170.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.2 mp -116.23 130.38 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.81 -0.632 . . . . 1.02 109.813 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -58.07 2.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.241 0.543 . . . . 0.91 110.915 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.53 ' O ' HG13 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -143.42 -29.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.599 -0.728 . . . . 1.05 109.616 -177.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' HG23 ' A' ' 30' ' ' ILE . 34.9 mtpt -136.09 -54.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.665 . . . . 2.18 109.458 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 37.38 -124.4 0.21 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.814 1.042 . . . . 1.18 113.814 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' HB3' HG21 ' B' ' 7' ' ' VAL . 16.4 m -159.88 134.53 7.74 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.426 0.557 . . . . 0.57 111.318 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 45' ' ' LEU . 3.0 mp -139.58 108.42 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 110.155 -0.313 . . . . 1.1 110.155 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 66.9 tt0 -99.68 140.99 33.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.762 -0.458 . . . . 1.31 109.762 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -119.85 155.2 33.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.417 1.104 . . . . 2.28 113.502 -176.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.901 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 6.6 t80 -121.34 144.81 48.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.418 -1.719 . . . . 3.08 106.481 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' H ' ' HB2' ' B' ' 3' ' ' SER . 8.8 p -116.47 128.76 73.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.506 -0.878 . . . . 1.1 110.3 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -131.76 102.0 5.7 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.958 -1.019 . . . . 1.16 109.755 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.63 -92.92 0.45 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.334 -0.706 . . . . 0.38 111.334 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.54 -9.99 9.32 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.396 -0.594 . . . . 2.0 109.396 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -97.31 157.72 15.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.779 -0.646 . . . . 1.68 111.397 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.848 HG13 HD13 ' B' ' 22' ' ' LEU . 9.5 mm -116.38 144.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 47.3 mt -129.52 109.7 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 122.33 0.252 . . . . 1.06 110.782 -173.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.703 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -98.48 142.54 29.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.207 0.447 . . . . 1.09 112.207 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -150.36 158.52 44.25 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.635 -0.711 . . . . 2.71 109.241 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.8 tmtp? -70.85 149.24 47.0 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.455 -0.943 . . . . 1.21 108.455 174.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.568 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 91.7 t80 -66.75 -54.34 23.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 2.09 110.853 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.846 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 23.5 tptm -45.84 -59.84 4.19 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.028 -0.987 . . . . 3.26 113.333 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.846 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 52.1 Cg_exo -56.09 122.89 12.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.178 1.919 . . . . 1.81 112.459 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -82.67 99.37 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.575 -0.738 . . . . 5.58 109.96 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.88 -120.06 4.45 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.668 -0.777 . . . . 3.79 111.489 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.16 137.46 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.233 0.539 . . . . 3.89 110.474 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.579 -0.737 . . . . 3.44 109.696 -177.075 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.788 0.328 . . . . 5.36 110.749 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.901 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 11.0 mtmt -86.46 -174.66 5.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.659 0.614 . . . . 2.83 112.659 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.4 m -49.01 -53.75 18.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.06 -0.973 . . . . 1.3 111.243 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.412 HD12 ' HD2' ' A' ' 36' ' ' PHE . 3.2 mt -83.19 -35.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.519 -1.289 . . . . 0.91 107.519 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.428 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 63.38 28.02 71.68 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.349 -1.296 . . . . 0.43 112.178 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.5 m -116.62 133.07 64.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.165 0.507 . . . . 0.56 110.272 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.1 p -113.46 140.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.98 109.861 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 6.6 mpt_? -114.4 157.35 22.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.993 -0.549 . . . . 1.62 110.667 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.13 119.02 33.47 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.472 -0.936 . . . . 1.77 108.472 177.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 34' ' ' ILE . 5.5 t -56.28 141.76 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 123.839 0.712 . . . . 1.06 111.719 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -60.7 -79.56 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.951 -1.022 . . . . 1.22 110.474 175.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 30' ' ' ILE . 39.9 mt-10 -156.22 -39.68 0.08 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.228 -1.027 . . . . 1.22 108.228 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.94 -25.03 32.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.686 -1.143 . . . . 1.54 110.457 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 127.66 -3.12 7.04 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.051 -0.977 . . . . 0.19 110.742 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.79 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 72.9 mtm180 -62.18 127.02 29.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.275 . . . . 3.42 110.613 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' B' ' 10' ' ' VAL . 1.0 OUTLIER -137.28 179.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 1.07 108.705 175.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.82 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -107.66 112.71 41.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.151 0.501 . . . . 0.98 111.034 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.651 ' HB3' HD22 ' B' ' 22' ' ' LEU . 29.2 mmt -76.3 154.35 84.19 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.11 -0.7 . . . . 1.08 109.11 173.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 51.5 Cg_endo -85.78 156.29 10.26 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 121.998 1.799 . . . . 0.23 112.707 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.621 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -57.67 -29.04 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.618 -0.719 . . . . 0.24 109.381 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.4 -28.48 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.718 -0.674 . . . . 1.07 110.691 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.848 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.77 -40.87 32.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.967 -0.753 . . . . 1.1 108.967 176.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.631 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 35.3 mtm180 -62.84 -30.09 71.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.892 -1.049 . . . . 1.98 110.245 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.37 -34.87 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.94 . . . . 1.11 109.973 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.75 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.013 -0.994 . . . . 0.28 109.964 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 47' ' ' LYS . 36.9 mt -94.44 -104.24 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.631 -1.168 . . . . 1.18 110.94 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.433 ' H ' HD11 ' B' ' 28' ' ' ILE . 11.2 m-20 -153.62 16.26 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.812 -0.176 . . . . 1.54 111.461 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.668 HG21 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -76.62 129.32 37.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.369 -0.533 . . . . 1.07 110.471 -164.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -57.59 2.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.67 -0.696 . . . . 0.62 110.387 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.532 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -142.48 -31.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.687 -0.688 . . . . 0.4 109.566 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.0 mtpt -134.54 -53.08 0.82 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.773 -0.648 . . . . 1.99 109.359 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.572 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.2 OUTLIER 41.05 -119.34 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.886 -1.052 . . . . 1.17 113.51 -177.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.504 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 46.5 m -165.43 132.35 2.85 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.475 -0.141 . . . . 0.55 110.866 -173.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 10' ' ' VAL . 3.8 mp -139.71 105.76 2.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.602 0.239 . . . . 1.09 110.609 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 57.9 tt0 -96.32 141.7 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.613 -0.514 . . . . 1.33 109.613 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.701 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.1 OUTLIER -113.83 159.8 19.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 122.121 0.963 . . . . 2.21 112.896 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 14.0 t80 -136.17 126.08 25.86 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 113.776 -1.556 . . . . 2.99 107.656 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.565 ' H ' ' HB2' ' A' ' 3' ' ' SER . 11.0 p -95.81 134.63 32.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.831 -0.748 . . . . 1.07 110.468 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -134.83 101.05 4.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.592 -0.731 . . . . 1.18 110.107 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.01 -93.63 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.005 -0.838 . . . . 0.48 111.005 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.54 -16.48 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.884 -0.413 . . . . 1.91 109.884 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' B' ' 42' ' ' LYS . 3.6 ptpp? -95.62 169.83 9.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.353 0.597 . . . . 1.4 111.109 -167.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.829 HG13 HD13 ' A' ' 22' ' ' LEU . 27.4 mm -125.38 142.34 42.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.172 -0.922 . . . . 0.87 109.447 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.748 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 25.3 mt -124.2 115.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 1.07 111.004 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.848 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -102.86 141.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.125 0.417 . . . . 0.97 112.125 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.481 ' HG2' ' HZ1' ' A' ' 2' ' ' LYS . 18.4 pttp -151.11 158.73 44.39 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.796 -0.816 . . . . 2.47 108.796 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.63 ' H ' HD23 ' B' ' 26' ' ' LEU . 1.4 tmtp? -72.56 153.72 41.16 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.997 -1.112 . . . . 1.09 107.997 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.498 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 69.0 t80 -66.44 -55.49 15.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.821 0.344 . . . . 1.89 111.19 -173.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.625 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 17.7 tptm -56.77 -52.4 74.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.487 0.921 . . . . 3.35 113.487 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 73.1 Cg_exo -53.38 115.27 2.19 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.062 1.841 . . . . 1.57 112.002 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.37 87.4 6.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.652 -0.704 . . . . 5.57 110.636 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.54 -144.48 16.92 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.257 -0.737 . . . . 3.76 111.257 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 143.78 10.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 4.32 110.504 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.249 1.066 0 CA-C-N 115.961 -0.563 . . . . 3.3 109.842 179.152 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HE2' ' CZ ' ' B' ' 48' ' ' TYR . 17.5 ptp . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.529 0.204 . . . . 5.41 111.072 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.999 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 25.9 mtpp -74.55 -178.5 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.285 -0.166 . . . . 3.01 110.741 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.557 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 54.7 m -48.73 -53.08 20.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.205 0.526 . . . . 1.09 111.888 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' B' ' 36' ' ' PHE . 2.3 mt -81.8 -32.26 11.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.243 -1.021 . . . . 1.06 108.243 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.29 13.12 76.85 Favored Glycine 0 CA--C 1.503 -0.689 0 CA-C-N 114.657 -1.156 . . . . 0.51 112.735 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' B' ' 36' ' ' PHE . 25.5 m -108.98 131.54 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.568 0.699 . . . . 1.07 111.056 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -109.34 140.74 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.553 -1.203 . . . . 1.07 109.284 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' NE ' HG11 ' A' ' 17' ' ' VAL . 3.0 mpt_? -114.45 159.71 20.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.166 -0.47 . . . . 1.9 110.344 -175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 30.6 mmtp -122.19 121.76 37.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.326 -0.99 . . . . 1.63 108.326 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG22 HG21 ' B' ' 28' ' ' ILE . 26.9 t -55.25 145.33 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.851 0.719 . . . . 1.06 110.953 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.43 -75.27 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.778 -0.647 . . . . 1.31 109.266 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' HD11 ' B' ' 30' ' ' ILE . 30.5 mt-10 -152.79 -39.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.38 -34.65 28.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.41 -1.268 . . . . 1.59 111.284 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.82 -11.09 2.63 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.942 -0.863 . . . . 0.25 110.942 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.713 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 49.7 mtt180 -62.88 131.68 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.517 -0.342 . . . . 3.66 110.869 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -139.85 176.04 6.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.071 -0.715 . . . . 0.97 109.071 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.3 p -104.64 112.77 39.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.209 0.528 . . . . 1.07 110.873 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 1.2 mmt -82.12 152.43 68.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.686 -0.857 . . . . 1.62 108.686 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 92.4 Cg_endo -83.91 156.54 13.48 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.664 1.576 . . . . 0.18 113.132 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.839 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.7 tp -54.65 -33.33 27.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.176 -0.92 . . . . 0.93 109.538 172.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.13 -26.88 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 1.08 111.01 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.82 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.69 -40.98 47.12 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.728 -0.842 . . . . 1.04 108.728 176.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 53.3 mtm180 -63.92 -30.18 71.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.097 -0.956 . . . . 1.59 110.165 176.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.839 ' HD2' HG13 ' A' ' 20' ' ' ILE . 37.6 mtp180 -85.15 -30.51 23.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.208 -0.906 . . . . 0.83 110.651 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.31 -45.67 65.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.555 0.693 . . . . 0.92 109.677 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 47' ' ' LYS . 90.1 mt -88.58 -93.72 0.1 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.862 -1.063 . . . . 1.11 111.508 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.0 t70 172.71 57.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.096 -1.075 . . . . 1.72 108.096 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 HG23 ' B' ' 10' ' ' VAL . 2.8 mp -113.88 131.27 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 1.02 110.461 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.31 -54.1 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.122 -0.49 . . . . 0.91 111.404 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.536 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.23 -33.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.905 -0.588 . . . . 1.05 109.982 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HG3' HG23 ' A' ' 30' ' ' ILE . 44.1 mtpt -136.88 -51.26 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.986 -0.746 . . . . 2.18 108.986 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.18 -119.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.513 -1.221 . . . . 1.18 113.378 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.443 ' HB3' HG21 ' B' ' 7' ' ' VAL . 17.1 m -163.21 135.29 5.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.482 0.583 . . . . 0.57 111.512 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.651 HG23 HD23 ' A' ' 45' ' ' LEU . 2.6 mp -141.88 105.93 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.96 -0.385 . . . . 1.1 109.96 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 72.0 tt0 -99.66 138.05 37.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.335 -0.617 . . . . 1.31 109.335 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -117.55 152.93 34.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.638 1.209 . . . . 2.28 114.136 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 1.045 ' HB2' ' HE3' ' B' ' 2' ' ' LYS . 32.1 t80 -114.43 157.78 22.43 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 112.98 -1.918 . . . . 3.08 107.134 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.526 ' H ' ' HB2' ' B' ' 3' ' ' SER . 5.5 p -127.55 130.7 70.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.116 -0.634 . . . . 1.1 110.033 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.516 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 19.3 t70 -130.63 97.24 4.31 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.471 -0.786 . . . . 1.16 109.744 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.19 -78.85 0.3 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.599 -0.728 . . . . 0.38 111.903 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.57 -30.5 4.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.471 0.653 . . . . 2.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.675 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -88.37 165.72 14.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.315 -0.857 . . . . 1.68 111.045 -163.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.831 HG13 HD11 ' B' ' 22' ' ' LEU . 15.4 mm -121.21 142.94 35.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.426 -0.807 . . . . 1.0 109.053 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.927 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 49.1 mt -128.55 108.45 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.511 -0.313 . . . . 1.06 110.851 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.656 HD11 HD11 ' B' ' 45' ' ' LEU . 9.7 mp -99.82 141.61 32.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.306 0.484 . . . . 1.09 112.306 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.874 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -151.94 156.97 41.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.45 -0.795 . . . . 2.71 110.682 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 3.8 tmtp? -73.32 149.16 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.315 -0.624 . . . . 1.21 109.315 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.636 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 69.7 t80 -74.78 -57.96 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 2.09 111.738 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 41.1 tptt -63.8 -56.71 23.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.256 1.206 . . . . 3.26 114.256 -167.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 80.3 Cg_exo -46.84 -63.5 0.32 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.841 2.361 . . . . 1.81 114.263 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.48 ' HB3' HG13 ' A' ' 53' ' ' VAL . 20.6 m-70 -79.22 -44.82 21.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.914 0.338 . . . . 5.58 111.914 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.84 62.29 6.53 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 120.943 -0.646 . . . . 3.79 112.059 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 51' ' ' HIS . 13.8 p -153.64 153.77 8.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.191 -0.505 . . . . 3.89 109.722 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.501 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 55.8 m . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.25 -0.881 . . . . 3.44 110.617 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.385 0.136 . . . . 5.36 111.171 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 1.045 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 26.2 mtpp -78.73 -173.21 3.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.409 0.147 . . . . 2.83 111.108 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.526 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 67.0 m -53.85 -54.75 34.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.205 0.526 . . . . 1.3 110.812 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 36' ' ' PHE . 4.0 mt -80.47 -33.18 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.553 -1.277 . . . . 0.91 107.553 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 20.12 66.65 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.135 -1.393 . . . . 0.43 112.596 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.8 132.02 59.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.56 110.196 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.7 p -106.5 141.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.597 -0.728 . . . . 0.98 109.041 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.1 mpt_? -113.03 157.4 21.59 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.289 0.566 . . . . 1.62 110.673 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 29.8 mmtp -119.14 119.24 33.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.909 -1.041 . . . . 1.77 108.566 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.626 HG21 HD12 ' A' ' 34' ' ' ILE . 7.4 t -57.25 139.82 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.642 0.589 . . . . 1.06 110.777 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.01 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.486 -0.779 . . . . 1.22 109.805 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -152.63 -42.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.392 -0.966 . . . . 1.22 108.392 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.5 -27.3 37.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.783 -1.098 . . . . 1.54 111.255 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 130.32 0.03 5.51 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.355 -0.698 . . . . 0.19 111.355 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 24.6 mtt-85 -66.93 130.84 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.121 -0.326 . . . . 3.42 110.121 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -139.53 175.69 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.413 -0.588 . . . . 1.07 109.413 176.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -105.32 108.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.964 0.412 . . . . 0.98 110.973 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.578 ' HB3' HD22 ' B' ' 22' ' ' LEU . 28.3 mmt -74.97 154.63 86.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.032 -0.729 . . . . 1.08 109.032 173.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 65.5 Cg_endo -86.85 155.49 8.69 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.999 1.799 . . . . 0.23 113.219 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -55.99 -30.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.24 109.431 171.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.3 -30.59 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 1.07 110.999 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.61 -40.35 56.57 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.78 -0.822 . . . . 1.1 108.78 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.536 ' HB2' HD11 ' B' ' 20' ' ' ILE . 34.4 mtm180 -66.13 -26.52 67.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 1.98 110.626 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -84.33 -35.37 23.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.577 -0.738 . . . . 1.11 109.734 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.67 -51.58 66.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.727 -1.124 . . . . 0.28 110.947 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.634 HD22 ' H ' ' B' ' 47' ' ' LYS . 71.0 mt -89.83 -85.6 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.732 -1.122 . . . . 1.18 111.139 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.604 ' C ' HD11 ' B' ' 28' ' ' ILE . 15.9 t0 166.46 61.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.797 -1.186 . . . . 1.54 107.797 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.629 HG21 HG22 ' A' ' 10' ' ' VAL . 1.3 mp -116.56 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.66 -0.7 . . . . 1.07 109.86 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.67 -51.59 2.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.721 -0.672 . . . . 0.62 111.652 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.446 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -144.16 -33.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 110.011 -0.366 . . . . 0.4 110.011 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.446 ' HG3' HG23 ' B' ' 30' ' ' ILE . 38.1 mtpt -136.29 -49.05 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.555 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.66 -115.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.384 -1.28 . . . . 1.17 113.832 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.551 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 14.2 m -164.08 135.37 4.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.994 0.361 . . . . 0.55 111.347 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.696 HG22 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -144.04 102.97 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 110.18 -0.304 . . . . 1.09 110.18 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 65.7 tt0 -96.03 139.32 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.541 -0.54 . . . . 1.33 109.541 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.89 155.62 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.524 1.154 . . . . 2.21 113.889 -175.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.999 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 38.8 t80 -120.14 157.26 29.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.1 -1.864 . . . . 2.99 107.073 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.557 ' H ' ' HB2' ' A' ' 3' ' ' SER . 8.5 p -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 120.093 -0.643 . . . . 1.07 109.955 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.798 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.7 t70 -132.3 95.8 3.73 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 1.18 109.917 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.1 -75.9 0.33 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.685 -0.689 . . . . 0.48 111.654 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.32 -29.04 3.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.484 0.659 . . . . 1.91 109.798 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.798 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.4 OUTLIER -85.81 158.36 20.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.112 -0.949 . . . . 1.4 111.778 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.82 HG13 HD12 ' A' ' 22' ' ' LEU . 17.7 mm -118.27 144.11 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.656 -0.702 . . . . 0.87 109.925 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.1 mt -128.66 114.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.07 110.956 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.719 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.1 mp -104.23 141.05 36.96 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.89 0.33 . . . . 0.97 111.89 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.689 ' HZ1' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -151.71 151.55 31.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.946 -0.57 . . . . 2.47 110.345 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.781 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 2.1 tmtp? -78.1 137.5 38.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.371 -0.603 . . . . 1.09 109.371 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 1' ' ' MET . 17.9 t80 -65.76 -58.71 5.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.863 -0.608 . . . . 1.89 111.714 -169.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.505 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 14.6 tppt? -60.05 -56.29 36.97 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.016 1.487 . . . . 3.35 115.016 -168.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.781 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 11.6 Cg_exo -71.88 15.46 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.704 2.27 . . . . 1.57 114.335 -169.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.12 -53.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.148 -0.316 . . . . 5.57 110.148 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.69 67.63 2.12 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.078 -0.582 . . . . 3.76 112.218 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.31 148.05 3.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.122 -0.539 . . . . 4.32 109.784 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.625 ' OXT' ' HG2' ' A' ' 2' ' ' LYS . 34.2 m . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.854 -0.593 . . . . 3.3 110.442 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HA ' ' HB2' ' B' ' 54' ' ' CYS . 91.9 mtp . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.681 0.277 . . . . 5.41 110.649 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.723 ' HE2' ' HD2' ' B' ' 37' ' ' PHE . 4.4 mmpt? -65.27 172.01 3.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.243 -0.435 . . . . 3.01 109.834 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.714 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 75.2 m -58.47 -40.77 83.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.276 0.56 . . . . 1.09 110.532 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.592 HD12 ' HB2' ' B' ' 36' ' ' PHE . 2.7 mt -100.04 -45.17 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.785 . . . . 1.06 109.304 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.13 24.03 60.23 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.493 -0.776 . . . . 0.51 112.222 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.22 133.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.648 0.737 . . . . 1.07 111.241 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -108.77 140.49 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 1.07 109.072 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.455 ' NE ' HG12 ' A' ' 17' ' ' VAL . 2.6 mpt_? -113.3 157.17 22.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.181 -0.463 . . . . 1.9 110.807 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.22 120.85 36.37 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.455 -0.793 . . . . 1.63 108.971 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.715 HG21 HG22 ' B' ' 28' ' ' ILE . 42.7 t -55.88 145.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 1.06 111.026 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -69.31 0.33 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.423 -0.584 . . . . 1.31 109.423 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -155.88 -54.16 0.09 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.126 -0.943 . . . . 1.23 108.734 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.654 HD13 ' H ' ' A' ' 13' ' ' LEU . 1.2 mp -77.81 -22.44 50.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.317 -1.311 . . . . 1.59 111.376 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.58 -11.33 4.02 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.821 -0.704 . . . . 0.25 111.886 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.76 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 39.6 mtt180 -60.25 134.51 57.13 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.906 -0.173 . . . . 3.66 110.751 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.43 175.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.515 -0.921 . . . . 0.97 108.515 172.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -106.37 100.69 11.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.347 0.594 . . . . 1.07 110.826 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 16' ' ' ILE . 81.1 mmm -74.94 148.61 84.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.818 -0.808 . . . . 1.62 108.818 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 82.0 Cg_endo -80.25 157.6 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.828 1.685 . . . . 0.18 113.247 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.612 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.1 tp -56.04 -31.79 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.333 -0.849 . . . . 0.93 109.405 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.3 mm-40 -61.19 -28.8 69.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 1.08 111.191 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.783 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.64 -39.33 57.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.488 -0.93 . . . . 1.04 108.488 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.598 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 50.6 mtm180 -66.04 -28.56 68.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.84 -1.073 . . . . 1.59 110.28 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HD2' HG13 ' A' ' 20' ' ' ILE . 72.4 mtp180 -84.99 -35.0 22.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.435 -0.802 . . . . 0.83 110.522 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.23 55.23 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.275 -0.875 . . . . 0.92 110.136 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -81.49 -88.84 0.08 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.86 -1.064 . . . . 1.11 110.577 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.1 t70 167.17 61.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.634 -1.247 . . . . 1.72 107.634 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.652 HG23 HG21 ' B' ' 10' ' ' VAL . 3.0 mp -113.26 132.23 62.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.657 -0.701 . . . . 1.02 110.102 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.28 -55.74 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 0.91 110.927 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.591 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -143.09 -32.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.778 -0.646 . . . . 1.05 109.91 -177.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 30' ' ' ILE . 31.7 mtpt -136.98 -50.3 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.358 0.599 . . . . 2.18 109.467 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER 36.86 -116.41 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.399 1.259 . . . . 1.18 114.399 -177.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HG ' ' C ' ' A' ' 32' ' ' ASP . 20.0 m -164.87 134.52 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.416 0.553 . . . . 0.57 111.424 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.74 HD11 HG22 ' B' ' 10' ' ' VAL . 2.8 mp -140.99 106.77 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.369 -0.234 . . . . 1.1 110.369 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 60.0 tt0 -98.76 142.08 30.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.744 -0.465 . . . . 1.31 109.744 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.1 155.03 35.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.231 1.015 . . . . 2.28 113.354 -175.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.763 ' HB2' ' HE3' ' B' ' 2' ' ' LYS . 34.7 t80 -134.47 126.73 30.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.714 -1.585 . . . . 3.08 108.122 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.679 ' H ' ' HB2' ' B' ' 3' ' ' SER . 6.3 p -92.9 129.14 43.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 119.498 -0.881 . . . . 1.1 110.705 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -127.08 109.04 11.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.011 -0.995 . . . . 1.16 108.942 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 -96.49 0.75 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.398 -1.081 . . . . 0.38 110.398 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.28 -8.12 8.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.565 0.221 . . . . 2.0 110.483 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -100.4 166.75 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.687 -0.233 . . . . 1.68 110.88 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.878 HG13 HD12 ' B' ' 22' ' ' LEU . 11.9 mm -116.25 143.42 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.055 -0.35 . . . . 1.0 110.055 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 49.1 mt -122.02 118.79 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.431 -0.349 . . . . 1.06 110.435 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.832 HD11 HD11 ' B' ' 45' ' ' LEU . 11.1 mp -103.37 133.5 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 1.09 111.63 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 11.4 ttpt -142.19 143.98 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.362 -0.835 . . . . 2.71 110.255 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.613 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -75.97 145.94 39.94 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.506 -0.924 . . . . 1.21 108.506 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.613 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 84.9 t80 -70.15 -53.55 16.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.418 0.628 . . . . 2.09 110.918 -172.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 16.3 tptp -53.33 -54.78 41.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 114.244 -1.344 . . . . 3.26 114.469 -173.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 36.6 Cg_exo -36.83 -62.96 0.24 Allowed 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.838 3.026 . . . . 1.81 114.633 -174.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -135.68 93.76 2.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.312 -0.996 . . . . 5.58 108.312 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.61 90.3 0.3 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.346 -0.843 . . . . 3.79 113.337 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.8 144.92 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.508 -0.553 . . . . 3.89 109.508 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.609 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 73.5 m . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.375 -0.821 . . . . 3.44 110.404 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.609 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 80.0 mtp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.063 -0.347 . . . . 5.36 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.763 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 9.6 mtpp -72.47 171.58 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.236 -0.653 . . . . 2.83 109.236 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.679 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 75.2 m -57.9 -33.83 69.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.829 -0.623 . . . . 1.3 111.59 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' A' ' 36' ' ' PHE . 3.8 mt -105.72 -46.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.91 108.971 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.7 21.89 73.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.289 -0.868 . . . . 0.43 112.265 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' B' ' 4' ' ' ILE . 35.6 m -117.3 132.53 66.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.269 0.557 . . . . 0.56 110.825 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.5 p -105.0 143.13 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.024 -0.732 . . . . 0.98 109.024 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.484 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -113.17 158.89 19.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.1 0.476 . . . . 1.62 111.084 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.55 121.66 40.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.871 -1.059 . . . . 1.77 109.106 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 34' ' ' ILE . 14.5 t -57.66 141.39 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.304 -0.407 . . . . 1.06 110.29 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.16 -74.3 0.12 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 1.22 109.32 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -148.54 -55.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.485 0.66 . . . . 1.22 109.472 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.787 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.2 OUTLIER -76.96 -16.9 59.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.054 -0.976 . . . . 1.54 110.91 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 126.72 -0.85 7.37 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.991 -0.623 . . . . 0.19 111.672 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.674 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 6.3 mtm180 -67.01 126.56 29.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.188 -0.301 . . . . 3.42 110.188 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.506 HG21 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -132.81 172.36 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.811 -0.811 . . . . 1.07 108.811 176.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -104.67 101.58 12.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.301 0.572 . . . . 0.98 110.812 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.501 ' SD ' HD11 ' B' ' 16' ' ' ILE . 84.3 mmm -75.4 151.63 85.46 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.046 -0.724 . . . . 1.08 109.046 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 29.1 Cg_endo -83.36 156.8 14.58 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.628 1.552 . . . . 0.23 113.317 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -55.24 -30.72 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.24 109.909 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -62.68 -26.35 68.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.23 -0.441 . . . . 1.07 110.627 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.878 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.46 -40.61 49.92 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.901 -0.778 . . . . 1.1 108.901 175.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.633 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 53.0 mtm180 -65.19 -29.13 69.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.844 -1.071 . . . . 1.98 110.705 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 81.6 mtp180 -83.49 -30.55 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.354 -0.839 . . . . 1.11 109.821 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.83 -53.26 22.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.895 -1.048 . . . . 0.28 110.935 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 48.4 mt -85.16 -81.39 0.2 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.784 -1.098 . . . . 1.18 110.55 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.606 ' C ' HD11 ' B' ' 28' ' ' ILE . 20.1 t0 163.95 60.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.744 -1.206 . . . . 1.54 107.744 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.715 HG22 HG21 ' A' ' 10' ' ' VAL . 1.4 mp -116.84 132.89 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.104 -0.498 . . . . 1.07 109.67 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.69 -54.32 2.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.793 -0.64 . . . . 0.62 111.064 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -33.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.15 -0.477 . . . . 0.4 109.801 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 10' ' ' VAL . 21.1 mtpt -133.31 -52.38 0.89 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.328 -0.619 . . . . 1.99 109.328 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 36.25 -118.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.585 -1.189 . . . . 1.17 114.103 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 13.1 m -161.05 135.84 7.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.046 0.384 . . . . 0.55 111.979 -173.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.587 HG23 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -143.9 104.39 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 N-CA-C 110.289 -0.263 . . . . 1.09 110.289 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.705 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.4 tt0 -96.48 141.05 30.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.767 -0.457 . . . . 1.33 109.767 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.618 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -118.02 157.79 26.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.014 1.116 . . . . 2.21 114.014 -175.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.723 ' HD2' ' HE2' ' A' ' 2' ' ' LYS . 47.4 t80 -136.83 129.28 30.08 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 113.63 -1.623 . . . . 2.99 108.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.714 ' H ' ' HB2' ' A' ' 3' ' ' SER . 9.6 p -92.37 133.42 33.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 119.816 -0.753 . . . . 1.07 109.746 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -131.9 107.47 8.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.967 -0.753 . . . . 1.18 108.967 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.64 -91.01 0.66 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.051 -0.82 . . . . 0.48 111.051 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -128.77 -9.0 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.748 -0.464 . . . . 1.91 109.748 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' B' ' 42' ' ' LYS . 1.6 ptpp? -100.93 169.05 9.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 1.4 110.799 -168.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.783 HG13 HD13 ' A' ' 22' ' ' LEU . 23.0 mm -118.86 142.93 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 0.87 110.461 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 18.8 mt -119.75 124.89 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.322 -0.399 . . . . 1.07 110.109 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.832 HD11 HD11 ' A' ' 45' ' ' LEU . 11.0 mp -109.39 132.23 54.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.022 0.439 . . . . 0.97 111.64 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 13.9 ttpt -142.08 145.53 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 2.47 110.237 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -80.94 138.85 36.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.028 -0.731 . . . . 1.09 109.028 175.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.481 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 37.2 t80 -61.17 -51.22 69.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.89 112.822 -171.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' B' ' 50' ' ' PRO . 4.8 mptp? -53.42 -61.78 4.54 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.702 1.001 . . . . 3.35 113.702 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.613 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 22.5 Cg_exo -64.81 110.18 1.42 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.745 1.63 . . . . 1.57 111.581 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 66.11 80.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.575 -0.739 . . . . 5.57 109.983 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.17 82.95 1.42 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.27 -0.877 . . . . 3.76 112.816 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.15 142.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 120.964 0.411 . . . . 4.32 110.583 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.668 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 37.6 m . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.51 -0.757 . . . . 3.3 109.35 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.911 0.386 . . . . 5.41 110.387 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' B' ' 54' ' ' CYS . 48.6 mtmt -103.53 -175.97 2.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.807 -0.357 . . . . 3.01 110.25 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.598 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 31.6 t -49.13 -43.52 41.7 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.675 0.609 . . . . 1.09 111.9 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.7 mt -92.8 -34.0 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.051 -0.722 . . . . 1.06 109.051 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.38 6.18 79.61 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.027 -0.988 . . . . 0.51 112.733 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 31.8 m -102.41 133.38 46.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.605 0.717 . . . . 1.07 111.326 -176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 6.5 p -115.84 140.36 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.413 -1.267 . . . . 1.07 109.68 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.673 ' HG2' ' CZ ' ' B' ' 36' ' ' PHE . 11.6 mmt180 -110.54 165.08 12.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.978 -0.555 . . . . 1.9 110.857 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 28.4 mmtp -124.28 122.36 37.53 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.102 -1.073 . . . . 1.63 108.102 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.611 HG22 HD11 ' B' ' 34' ' ' ILE . 38.4 t -56.5 145.98 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 1.06 111.726 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.21 -78.04 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 1.31 109.699 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -153.45 -45.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.944 -0.761 . . . . 1.23 108.944 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 13' ' ' LEU . 1.3 mp -81.92 -27.59 33.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.952 -1.022 . . . . 1.59 110.808 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.16 -11.18 2.8 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.623 -0.717 . . . . 0.25 111.582 -174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 46.8 mtp180 -61.21 132.05 52.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.099 0.16 . . . . 3.66 111.0 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.607 HD11 ' HE1' ' A' ' 18' ' ' MET . 0.8 OUTLIER -139.07 178.57 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.684 -0.858 . . . . 0.97 108.684 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.798 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -107.41 109.21 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.488 0.661 . . . . 1.07 111.467 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.616 ' HB3' HD22 ' A' ' 22' ' ' LEU . 14.5 mmt -75.74 154.01 85.24 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.503 -0.771 . . . . 1.62 109.315 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.2 Cg_endo -83.26 154.39 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.68 1.587 . . . . 0.18 113.162 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 tp -54.74 -31.7 24.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.562 -0.744 . . . . 0.93 109.568 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.86 -28.21 68.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.45 -0.795 . . . . 1.08 110.768 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.8 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -39.6 44.67 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.787 -0.82 . . . . 1.04 108.787 176.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.1 mtm180 -64.73 -28.91 69.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.142 -0.936 . . . . 1.59 110.394 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -83.68 -38.58 21.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.163 -0.926 . . . . 0.83 110.227 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.67 85.37 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.289 -0.868 . . . . 0.92 110.525 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 47' ' ' LYS . 93.1 mt -87.8 -93.69 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.06 -0.973 . . . . 1.11 111.587 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -179.95 38.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.435 0.636 . . . . 1.72 109.307 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.593 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.1 mp -100.06 134.27 40.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.401 -0.363 . . . . 1.02 110.884 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -56.51 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.91 110.684 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.549 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.46 -29.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.954 -0.567 . . . . 1.05 109.724 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HG3' HG22 ' A' ' 30' ' ' ILE . 37.4 mtpt -136.11 -57.1 0.76 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.474 -0.785 . . . . 2.18 109.028 176.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.487 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 37.21 -128.13 0.17 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.097 -0.956 . . . . 1.18 113.036 -175.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 13.1 m -153.29 136.66 15.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.516 0.598 . . . . 0.57 111.589 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.705 HD11 HG21 ' B' ' 10' ' ' VAL . 4.2 mp -139.18 107.79 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.223 -0.288 . . . . 1.1 110.223 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.1 tt0 -105.28 140.67 38.07 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.022 -0.362 . . . . 1.31 110.022 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.753 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -123.04 153.62 39.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.533 0.938 . . . . 2.28 113.533 -174.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 1.083 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 33.8 t80 -125.12 124.31 41.58 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.078 -1.419 . . . . 3.08 108.742 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.1 p -93.65 134.58 30.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 C-N-CA 119.785 -0.766 . . . . 1.1 110.74 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -132.75 105.12 6.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.344 -0.844 . . . . 1.16 109.747 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.54 0.46 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.162 -0.775 . . . . 0.38 111.162 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -128.02 -8.03 5.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.369 0.604 . . . . 2.0 109.528 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.2 ttpt -93.16 156.96 16.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 1.68 111.329 -169.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.907 HG13 HD13 ' B' ' 22' ' ' LEU . 10.0 mm -116.93 142.92 28.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.623 HD12 ' HD1' ' A' ' 37' ' ' PHE . 47.0 mt -128.98 109.52 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.581 0.229 . . . . 1.06 110.907 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.855 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.4 mp -92.17 137.62 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.291 0.567 . . . . 1.09 112.184 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -145.97 141.59 27.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.794 -1.094 . . . . 2.71 109.527 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 33' ' ' SER . 7.1 tmtt? -76.58 146.32 38.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.098 -0.704 . . . . 1.21 109.098 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -76.47 -51.0 12.62 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.762 -0.375 . . . . 2.09 111.808 -171.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.795 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 87.4 tttt -46.34 -55.67 13.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.832 -0.622 . . . . 3.26 112.616 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 21.6 Cg_exo -67.1 143.48 65.46 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.038 1.825 . . . . 1.81 111.621 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -93.01 152.01 19.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 5.58 109.715 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.68 -142.51 6.81 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.391 -0.909 . . . . 3.79 111.93 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.0 134.41 27.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.493 0.664 . . . . 3.89 111.943 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 1' ' ' MET . 84.7 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.726 -1.131 . . . . 3.44 108.556 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.5 mtt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.029 0.443 . . . . 5.36 110.054 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 1.083 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 48.7 mmtt -88.25 179.22 6.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.781 -0.645 . . . . 2.83 111.067 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 37.2 t -57.83 -42.82 85.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.751 . . . . 1.3 109.985 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.753 HD12 ' HD2' ' A' ' 36' ' ' PHE . 2.9 mt -88.76 -40.12 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.561 -0.903 . . . . 0.91 108.561 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.28 77.73 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.026 -0.988 . . . . 0.43 112.49 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -114.23 132.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.041 0.448 . . . . 0.56 110.706 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.2 p -113.82 139.53 38.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.694 -0.685 . . . . 0.98 109.693 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.71 ' HG2' ' CE1' ' A' ' 36' ' ' PHE . 5.1 mmt180 -106.73 167.0 10.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.063 -0.517 . . . . 1.62 110.623 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' B' ' 8' ' ' ARG . 30.1 mmtp -125.9 119.03 26.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.113 -1.069 . . . . 1.77 108.113 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.705 HG21 HD11 ' A' ' 34' ' ' ILE . 8.5 t -56.55 142.04 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.43 0.633 . . . . 1.06 111.26 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.75 -76.38 0.06 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 1.22 110.058 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -152.44 -49.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.565 -0.902 . . . . 1.22 108.565 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.763 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.4 OUTLIER -79.93 -19.12 48.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.246 -1.343 . . . . 1.54 110.655 -176.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 128.02 -3.3 6.86 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.19 111.489 -176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.798 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 52.0 mtm180 -63.99 128.55 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.445 -0.206 . . . . 3.42 110.445 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.546 HG21 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -136.04 179.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.072 -0.714 . . . . 1.07 109.072 176.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -106.63 108.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.215 0.531 . . . . 0.98 111.04 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.69 ' HB3' HD22 ' B' ' 22' ' ' LEU . 30.4 mmt -74.66 152.95 87.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.65 -0.871 . . . . 1.08 108.65 172.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 43.3 Cg_endo -84.5 154.84 12.16 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.906 1.738 . . . . 0.23 112.943 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 4.1 tp -53.84 -32.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.24 109.571 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -61.12 -26.43 67.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.79 -0.641 . . . . 1.07 110.819 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.907 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.63 -40.94 32.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.926 -0.768 . . . . 1.1 108.926 176.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.536 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 38.8 mtm180 -65.65 -27.5 68.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 1.98 110.568 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 72.1 mtp180 -83.96 -30.75 25.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.257 -0.883 . . . . 1.11 110.047 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.99 -52.52 28.0 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.012 -0.994 . . . . 0.28 110.687 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 62.0 mt -85.6 -87.51 0.13 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.734 -1.121 . . . . 1.18 110.8 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.457 ' C ' HD11 ' B' ' 28' ' ' ILE . 38.9 t70 173.89 45.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.754 . . . . 1.54 109.005 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.616 HD11 ' N ' ' B' ' 28' ' ' ILE . 1.2 mp -108.0 129.11 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.066 0.46 . . . . 1.07 110.018 -174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.15 4.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.478 -0.783 . . . . 0.62 111.499 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.521 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -150.46 -33.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.742 -0.466 . . . . 0.4 109.742 177.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.521 ' HG3' HG23 ' B' ' 30' ' ' ILE . 44.1 mtpt -133.55 -50.92 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.316 0.579 . . . . 1.99 109.443 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.8 -113.56 0.1 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.22 1.192 . . . . 1.17 114.22 -177.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.6 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.5 m -164.38 137.39 5.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.189 0.45 . . . . 0.55 111.61 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 10' ' ' VAL . 4.3 mp -141.86 102.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 110.213 -0.292 . . . . 1.09 110.213 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 33.5 tt0 -95.18 142.53 27.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.4 -0.593 . . . . 1.33 109.4 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -118.99 158.52 25.6 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.183 0.992 . . . . 2.21 113.579 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 18.7 t80 -132.88 125.87 30.93 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 113.675 -1.602 . . . . 2.99 108.011 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.598 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.5 p -93.28 135.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.822 -0.751 . . . . 1.07 110.24 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.074 -0.713 . . . . 1.18 109.074 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.11 -95.17 0.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.977 -0.849 . . . . 0.48 110.977 -171.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.94 -13.58 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 1.91 110.169 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -92.82 167.78 11.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 1.4 110.834 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.855 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.7 mm -121.97 143.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.13 -0.486 . . . . 0.87 109.724 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 17.4 mt -124.5 113.85 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.504 -0.316 . . . . 1.07 110.798 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.819 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -98.02 139.52 33.73 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.265 0.555 . . . . 0.97 112.064 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 2' ' ' LYS . 21.3 ttpt -152.58 141.07 20.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.799 -1.091 . . . . 2.47 109.188 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tmtt? -72.74 153.4 41.16 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.842 -0.799 . . . . 1.09 108.842 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -77.17 -52.83 8.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.149 0.499 . . . . 1.89 111.358 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 54.2 tttm -53.65 -46.58 98.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.003 -0.999 . . . . 3.35 113.203 -174.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 16.4 Cg_exo -69.49 130.46 19.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.956 1.77 . . . . 1.57 111.366 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.67 124.3 37.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.57 110.899 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.82 -126.49 1.1 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.657 -0.702 . . . . 3.76 111.848 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -78.81 144.93 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.02 0.438 . . . . 4.32 110.854 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.508 -0.758 . . . . 3.3 110.005 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 111.552 0.204 . . . . 5.41 111.552 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.675 ' HE2' ' HE2' ' B' ' 46' ' ' LYS . 38.3 mmtt 63.21 -175.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.63 0.729 . . . . 3.01 112.45 175.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.603 ' HB2' ' CD1' ' B' ' 37' ' ' PHE . 19.0 t -90.9 -46.2 8.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 1.09 109.681 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.43 -31.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.067 -0.716 . . . . 1.06 109.067 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 75.58 21.43 77.14 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.139 -0.937 . . . . 0.51 112.931 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.57 132.63 68.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.859 0.837 . . . . 1.07 111.748 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -111.1 140.86 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 113.935 -1.484 . . . . 1.07 108.578 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' NE ' HG12 ' A' ' 17' ' ' VAL . 3.7 mpt_? -114.78 155.0 27.53 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.017 0.437 . . . . 1.9 110.607 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 121.05 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.584 -0.895 . . . . 1.63 108.584 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.604 HG21 HD11 ' B' ' 34' ' ' ILE . 4.7 t -54.52 141.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.564 0.54 . . . . 1.06 110.312 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.36 -77.86 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.939 -0.763 . . . . 1.31 108.939 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' B' ' 30' ' ' ILE . 29.8 mt-10 -151.71 -36.2 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.623 -0.88 . . . . 1.23 108.623 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD11 ' HD2' ' A' ' 15' ' ' ARG . 11.2 mt -86.79 -19.09 29.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.14 -0.936 . . . . 1.59 111.7 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' CA ' HG12 ' A' ' 10' ' ' VAL . . . 124.19 -6.43 8.75 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 120.503 -0.856 . . . . 0.25 111.277 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.714 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.0 mtp180 -67.25 125.2 25.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.345 -0.242 . . . . 3.66 110.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.825 HD11 ' HE2' ' A' ' 18' ' ' MET . 0.6 OUTLIER -131.73 175.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.966 -0.753 . . . . 0.97 108.966 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -103.27 102.43 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.056 0.455 . . . . 1.07 110.938 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.825 ' HE2' HD11 ' A' ' 16' ' ' ILE . 13.2 mmt -74.54 149.99 86.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.4 -0.593 . . . . 1.62 109.4 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.4 Cg_endo -81.19 155.03 19.29 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.781 1.654 . . . . 0.18 113.383 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 4.7 tp -56.2 -31.81 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.178 -0.919 . . . . 0.93 109.059 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.87 -30.93 68.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.211 -0.904 . . . . 1.08 111.253 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.886 HD11 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.22 -41.12 58.33 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.457 -0.942 . . . . 1.04 108.457 177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.585 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 32.3 mtm180 -63.92 -29.57 70.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.782 -1.099 . . . . 1.59 110.224 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 73.5 mtp180 -85.26 -35.83 21.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.399 -0.819 . . . . 0.83 110.753 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.28 95.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.598 0.713 . . . . 0.92 109.874 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 77.2 mt -92.36 -104.83 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.678 -1.146 . . . . 1.11 110.255 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -174.72 49.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 1.72 109.422 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -93.18 131.68 39.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 1.02 109.513 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.58 -57.77 2.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.34 0.59 . . . . 0.91 110.587 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.709 HD12 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -146.68 -28.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.032 -0.986 . . . . 1.05 109.604 -175.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' HG23 ' A' ' 30' ' ' ILE . 21.2 mtpp -139.88 -52.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 2.18 109.141 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.498 ' HB2' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER 37.75 -115.27 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.094 1.146 . . . . 1.18 114.094 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' HB3' HG21 ' B' ' 7' ' ' VAL . 38.5 m -166.59 137.88 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.436 0.562 . . . . 0.57 111.065 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.742 HD13 HG21 ' B' ' 10' ' ' VAL . 3.7 mp -139.0 111.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.701 -0.481 . . . . 1.1 109.701 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 22.7 tt0 -107.92 130.2 55.04 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.31 0.244 . . . . 1.31 110.552 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.703 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -116.06 153.5 31.61 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.655 0.983 . . . . 2.28 113.655 -170.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.585 ' HD1' HD11 ' A' ' 44' ' ' ILE . 25.5 t80 -129.86 132.36 46.41 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 114.112 -1.404 . . . . 3.08 108.478 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.52 ' H ' ' HB3' ' B' ' 3' ' ' SER . 2.8 p -100.29 132.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 119.765 -0.774 . . . . 1.1 111.268 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.9 t70 -125.59 99.89 6.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.67 -1.15 . . . . 1.16 109.534 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.32 -84.31 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.583 -0.735 . . . . 0.38 111.365 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.01 -17.04 5.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.392 0.615 . . . . 2.0 109.64 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HD2' HG22 ' B' ' 44' ' ' ILE . 2.1 ttpt -92.47 158.07 16.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.345 -0.843 . . . . 1.68 111.325 -167.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.958 HG13 HD11 ' B' ' 22' ' ' LEU . 7.0 mm -118.12 139.46 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.585 HD11 ' HD1' ' A' ' 37' ' ' PHE . 43.6 mt -121.87 111.71 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.444 . . . . 1.06 110.508 -174.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.823 HD11 HD11 ' B' ' 45' ' ' LEU . 11.2 mp -102.87 138.19 40.08 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.815 0.302 . . . . 1.09 111.815 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 149.89 26.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 2.71 110.081 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 2.9 tmtp? -65.53 147.99 52.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.891 -0.595 . . . . 1.21 110.146 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.637 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 24.3 t80 -60.0 -52.02 67.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 2.09 111.263 -173.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.87 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 36.1 ttmt -55.07 -59.44 10.82 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.464 -0.789 . . . . 3.26 112.485 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.87 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 65.3 Cg_exo -53.98 125.52 19.0 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.277 1.985 . . . . 1.81 112.86 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -83.6 92.09 7.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.881 0.848 . . . . 5.58 110.476 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.3 -118.81 4.51 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.509 -1.036 . . . . 3.79 110.509 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.13 144.59 20.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 110.011 -0.366 . . . . 3.89 110.011 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 1.116 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 88.5 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.226 -0.892 . . . . 3.44 110.379 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 111.319 0.118 . . . . 5.36 111.319 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 1.116 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 6.5 mmmm 65.48 165.94 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.92 0.867 . . . . 2.83 112.854 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.52 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 47.1 t -70.48 -45.99 64.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 1.3 110.723 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 mt -89.45 -40.73 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.923 -0.769 . . . . 0.91 108.923 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.88 39.65 59.0 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.43 112.538 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' A' ' 36' ' ' PHE . 15.3 m -131.97 132.21 61.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.023 0.439 . . . . 0.56 110.029 174.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.1 p -108.44 142.66 20.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.819 -0.808 . . . . 0.98 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.703 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 mpt_? -113.79 153.87 28.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.991 0.424 . . . . 1.62 110.764 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 121.45 44.64 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.565 -0.743 . . . . 1.77 109.054 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.742 HG21 HD13 ' A' ' 34' ' ' ILE . 3.8 t -53.62 137.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 123.837 0.711 . . . . 1.06 110.459 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -55.08 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.631 -0.713 . . . . 1.22 109.998 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.709 ' HG2' HD12 ' A' ' 30' ' ' ILE . 42.1 mt-10 -151.64 -32.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.499 -0.926 . . . . 1.22 108.499 173.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.33 -29.96 21.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.304 -1.317 . . . . 1.54 110.858 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 132.06 -8.37 5.42 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.768 -0.933 . . . . 0.19 110.768 -172.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 mtp180 -62.84 124.58 21.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.299 . . . . 3.42 110.508 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -129.58 174.77 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.649 -0.871 . . . . 1.07 108.649 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.9 p -104.15 104.06 16.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.326 0.584 . . . . 0.98 110.693 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 1.6 mmt -76.29 151.72 83.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 1.08 108.729 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.44 ' HD3' ' HE1' ' B' ' 18' ' ' MET . 44.4 Cg_endo -85.41 153.84 10.62 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.877 1.718 . . . . 0.23 113.321 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -53.85 -30.25 19.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.413 -0.812 . . . . 0.24 109.985 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.04 -25.67 67.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.206 -0.452 . . . . 1.07 110.88 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.958 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.62 -41.29 39.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.631 -0.877 . . . . 1.1 108.631 174.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.614 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 37.4 mtm180 -63.54 -29.83 71.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.887 -1.052 . . . . 1.98 110.683 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.527 ' HD2' HG13 ' B' ' 20' ' ' ILE . 62.0 mtp180 -84.36 -33.93 23.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.271 -0.877 . . . . 1.11 110.048 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -51.03 71.63 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.781 -1.1 . . . . 0.28 110.1 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 61.0 mt -92.4 -91.25 0.17 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.462 -1.245 . . . . 1.18 111.637 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.506 ' C ' HD11 ' B' ' 28' ' ' ILE . 16.7 t0 175.5 50.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.637 -0.875 . . . . 1.54 108.637 -170.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.634 HD11 ' N ' ' B' ' 28' ' ' ILE . 1.4 mp -109.34 132.92 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.966 -0.753 . . . . 1.07 108.966 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.36 -51.48 2.91 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.163 0.506 . . . . 0.62 111.852 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.622 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -146.94 -29.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.971 -0.559 . . . . 0.4 109.668 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.622 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.4 mtpp -140.06 -51.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.465 -0.568 . . . . 1.99 109.465 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 34.91 -115.44 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.802 1.038 . . . . 1.17 113.802 -176.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.0 m -163.4 136.99 5.74 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.155 -0.34 . . . . 0.55 111.37 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.653 HG21 HD23 ' B' ' 45' ' ' LEU . 4.3 mp -142.0 105.22 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.6 -0.519 . . . . 1.09 109.6 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.1 tt0 -102.73 134.45 46.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.318 -0.253 . . . . 1.33 110.318 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.504 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.79 158.67 23.52 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.214 1.19 . . . . 2.21 114.214 -173.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.678 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 66.4 t80 -126.07 152.71 45.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.199 -1.819 . . . . 2.99 107.177 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.562 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.9 p -117.87 137.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 120.057 -0.657 . . . . 1.07 110.041 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 31.5 t70 -133.65 95.6 3.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.928 -0.578 . . . . 1.18 110.111 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.03 -73.49 1.04 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.572 -0.74 . . . . 0.48 111.684 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -127.71 -30.5 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.462 0.649 . . . . 1.91 109.421 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -89.7 166.22 13.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.096 -0.956 . . . . 1.4 111.341 -163.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.886 HG13 HD11 ' A' ' 22' ' ' LEU . 25.4 mm -121.27 142.99 35.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.618 -0.719 . . . . 0.87 109.46 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.678 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 33.5 mt -124.06 109.74 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.409 -0.359 . . . . 1.07 110.69 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 45' ' ' LEU . 10.6 mp -101.69 134.66 44.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.331 0.493 . . . . 0.97 112.331 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.675 ' HE2' ' HE2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -149.08 148.75 30.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 2.47 109.667 172.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.725 ' HB3' ' HD2' ' B' ' 50' ' ' PRO . 7.1 tttt -64.92 167.05 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.42 -0.585 . . . . 1.09 109.42 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -78.04 -49.66 13.57 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.238 -0.585 . . . . 1.89 110.108 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.772 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 39.9 ttmt -59.45 -58.31 20.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.29 -0.868 . . . . 3.35 112.644 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 50.2 Cg_exo -55.08 125.29 18.69 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.372 2.048 . . . . 1.57 112.695 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.49 81.64 7.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.793 0.806 . . . . 5.57 110.396 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.06 -88.29 1.31 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.562 -0.827 . . . . 3.76 111.506 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.33 143.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 4.32 109.66 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 92.0 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.704 -1.141 . . . . 3.3 109.302 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 48.7 m . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.156 0.503 . . . . 1.0 111.289 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -86.02 -33.91 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.647 -0.872 . . . . 0.34 108.647 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.52 19.61 76.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.831 -1.077 . . . . 0.51 112.548 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 27.9 m -115.92 131.32 68.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.573 0.701 . . . . 0.23 111.177 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.8 p -114.63 141.73 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.512 -1.222 . . . . 0.17 109.36 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.465 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.74 165.11 13.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.977 0.418 . . . . 1.21 110.607 -176.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 33.4 mmtp -120.22 124.24 45.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.242 -1.021 . . . . 1.13 108.242 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.709 HG21 HG21 ' B' ' 28' ' ' ILE . 39.7 t -56.38 141.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.497 0.498 . . . . 0.24 109.912 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.85 -75.15 0.07 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.938 -0.574 . . . . 1.31 109.676 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.25 -46.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.842 -0.799 . . . . 1.23 108.842 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -77.78 -50.47 12.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.887 -1.051 . . . . 0.85 110.734 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.17 -5.49 0.05 OUTLIER Glycine 0 C--O 1.225 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.17 111.832 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 56.5 mtm180 -68.99 135.03 50.28 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 122.07 0.148 . . . . 3.03 110.868 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -141.12 179.99 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.906 -0.775 . . . . 0.13 108.906 174.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.7 p -107.38 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.171 0.51 . . . . 0.19 110.91 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.653 ' HE1' HD11 ' B' ' 45' ' ' LEU . 78.6 mmm -84.13 148.62 53.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.105 -0.702 . . . . 0.84 109.105 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.0 Cg_endo -80.41 157.65 22.45 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.93 1.753 . . . . 0.16 113.679 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.6 tp -52.68 -34.61 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.969 -1.014 . . . . 0.26 109.713 171.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.42 -25.67 66.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.344 -0.843 . . . . 1.08 110.982 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -78.39 -40.97 34.53 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.83 -0.804 . . . . 0.2 108.83 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.65 ' HD2' HG22 ' A' ' 28' ' ' ILE . 21.0 mtm180 -63.78 -30.88 71.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.41 -0.814 . . . . 1.05 109.837 176.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 77.8 mtp180 -83.82 -33.3 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.267 -0.879 . . . . 0.71 110.854 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.02 -46.88 73.14 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.806 0.813 . . . . 0.26 109.413 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.874 HD22 ' H ' ' A' ' 47' ' ' LYS . 82.8 mt -85.19 -101.52 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.291 -1.322 . . . . 0.52 110.372 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' H ' HD12 ' A' ' 28' ' ' ILE . 4.7 p-10 -179.36 50.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.632 -0.713 . . . . 1.72 109.4 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG22 ' HD2' ' A' ' 23' ' ' ARG . 2.4 mp -98.44 136.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.872 -1.058 . . . . 0.28 109.932 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.16 -51.59 2.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.802 -0.359 . . . . 0.3 111.629 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.881 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -145.31 -32.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.463 -0.335 . . . . 0.33 110.221 -177.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 20.3 mtpp -137.83 -50.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.813 -0.81 . . . . 1.46 108.813 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 35.91 -118.84 0.13 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.461 -1.245 . . . . 1.18 113.138 -176.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB3' HG21 ' B' ' 7' ' ' VAL . 21.1 m -163.32 138.65 6.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.362 0.528 . . . . 0.21 111.198 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.824 HD11 HG23 ' B' ' 10' ' ' VAL . 3.1 mp -139.6 110.23 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.759 -0.46 . . . . 0.28 109.759 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 41.3 tt0 -104.15 137.17 42.48 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.501 -0.555 . . . . 1.31 109.501 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -110.06 151.37 27.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.964 0.888 . . . . 1.33 112.601 -174.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 14.8 t80 -127.25 122.15 33.15 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.11 -1.404 . . . . 2.22 107.519 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.464 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -93.28 132.78 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 119.798 -0.761 . . . . 0.27 111.131 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -133.92 102.85 5.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.183 -0.917 . . . . 1.16 110.343 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.5 -88.44 0.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.815 -0.629 . . . . 0.32 112.04 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.67 -8.46 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.598 0.237 . . . . 2.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.68 168.75 9.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.141 0.496 . . . . 1.05 111.09 -168.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.735 HG13 HD12 ' B' ' 22' ' ' LEU . 15.5 mm -122.53 141.65 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.324 -0.853 . . . . 0.18 109.249 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 46.4 mt -121.96 111.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.694 0.283 . . . . 0.28 110.382 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' B' ' 45' ' ' LEU . 10.6 mp -101.13 132.28 46.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.538 -0.301 . . . . 0.32 111.809 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.71 157.34 37.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.139 0.495 . . . . 2.16 111.093 172.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.874 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.2 tmtp? -63.15 153.47 34.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.732 . . . . 0.52 110.406 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.744 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 61.6 t80 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.496 -0.32 . . . . 1.25 111.245 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 54.2 m . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.145 0.498 . . . . 1.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 36' ' ' PHE . 1.9 mt -84.34 -42.0 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.848 -1.167 . . . . 0.32 107.848 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.76 27.02 69.92 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.559 -1.201 . . . . 0.43 112.199 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.9 131.9 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.192 0.52 . . . . 0.25 110.345 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.5 p -111.54 141.27 27.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.333 -0.849 . . . . 0.16 109.323 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.717 ' HD2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -114.21 162.39 16.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.009 0.433 . . . . 1.09 110.354 -175.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.8 mmtp -118.18 121.57 40.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.449 -0.945 . . . . 1.16 108.449 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 34' ' ' ILE . 5.2 t -55.48 135.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.555 -0.535 . . . . 0.25 109.555 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.86 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.999 -0.546 . . . . 1.22 109.535 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.881 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.4 mt-10 -154.7 -34.42 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.302 -0.999 . . . . 1.22 108.302 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.81 -49.23 11.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.098 -1.41 . . . . 0.9 110.329 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.511 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 152.21 -6.24 0.5 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.724 -1.125 . . . . 0.15 110.711 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 43.0 mtm180 -63.45 131.06 46.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.72 -0.24 . . . . 2.91 110.451 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.639 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.8 OUTLIER -138.76 179.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.757 -0.831 . . . . 0.16 108.757 174.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -107.77 113.51 43.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.19 110.885 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.564 ' HB3' HD13 ' B' ' 22' ' ' LEU . 74.8 mmm -84.89 149.0 52.47 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.815 . . . . 0.94 108.801 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 39.5 Cg_endo -80.68 158.44 21.75 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.744 1.629 . . . . 0.19 113.63 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.49 -30.92 32.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.229 -0.896 . . . . 0.22 109.707 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -25.76 67.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.223 -0.444 . . . . 1.07 110.704 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.735 HD12 HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -78.08 -41.74 34.34 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.826 -0.805 . . . . 0.24 108.826 175.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.737 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 32.8 mtp180 -61.79 -33.65 74.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.849 -1.069 . . . . 1.3 110.68 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 55.2 mtp180 -79.66 -37.68 35.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.34 -0.845 . . . . 0.87 109.872 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.42 -50.52 71.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.429 -1.26 . . . . 0.28 110.161 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.859 HD22 ' H ' ' B' ' 47' ' ' LYS . 56.5 mt -92.93 -80.44 0.38 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.65 -1.159 . . . . 0.57 112.075 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 t0 177.4 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.089 -0.245 . . . . 1.54 111.619 -168.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.737 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.5 mp -88.87 124.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.335 0.588 . . . . 0.31 111.668 -163.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.43 -34.86 9.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.96 . . . . 0.41 112.786 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.677 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -166.05 -33.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.502 -0.555 . . . . 0.34 109.502 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.677 ' HG3' HG23 ' B' ' 30' ' ' ILE . 18.6 mtpp -136.58 -49.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.787 -0.82 . . . . 1.38 108.787 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 35.39 -111.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.467 -1.242 . . . . 1.17 113.766 -176.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 27.3 m -166.05 138.35 3.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.343 0.52 . . . . 0.24 110.891 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -142.19 107.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.729 -0.471 . . . . 0.2 109.729 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 44.7 tt0 -103.62 139.5 38.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.711 -0.477 . . . . 1.33 109.711 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.78 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.85 154.73 21.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.015 0.912 . . . . 1.27 112.637 -173.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 22.9 t80 -129.96 126.22 37.3 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 114.091 -1.413 . . . . 2.1 107.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 10.2 p -93.04 136.43 25.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.732 -0.787 . . . . 0.3 110.339 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 11.8 t70 -134.16 100.91 4.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 1.18 109.804 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.34 -90.47 0.19 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.852 -0.69 . . . . 0.42 111.721 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -118.31 -13.47 9.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.946 0.403 . . . . 1.91 110.704 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' B' ' 39' ' ' ASP . 2.8 ptpt -98.1 169.14 9.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 0.78 110.939 -168.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -124.56 140.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.373 -0.831 . . . . 0.22 109.206 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 35.9 mt -119.22 113.75 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.588 -0.278 . . . . 0.3 110.546 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 45' ' ' LEU . 11.2 mp -101.13 128.46 47.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.808 0.337 . . . . 0.25 111.575 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.587 ' HA ' HD21 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -152.19 153.53 34.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 1.85 110.476 175.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.859 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.6 tmtt? -65.03 166.01 10.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.51 109.757 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.038 0.447 . . . . 1.17 110.225 -174.114 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 121.415 0.626 . . . . 1.0 109.317 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' B' ' 36' ' ' PHE . 5.3 mt -103.57 -49.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.662 -0.699 . . . . 0.34 109.388 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.58 25.32 30.65 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.567 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.7 133.27 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.0 0.905 . . . . 0.23 110.991 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.3 p -112.99 141.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 113.651 -1.613 . . . . 0.17 108.727 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 1.2 mpt_? -112.06 156.7 21.78 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.923 0.392 . . . . 1.21 110.462 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -121.25 118.14 28.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.33 -0.989 . . . . 1.13 108.33 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG23 HD11 ' B' ' 34' ' ' ILE . 22.5 t -54.22 144.49 5.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 123.948 0.78 . . . . 0.24 111.87 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.88 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.95 -1.023 . . . . 1.31 110.059 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.606 ' HG2' HD11 ' B' ' 30' ' ' ILE . 40.5 mt-10 -154.3 -43.78 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.627 -1.249 . . . . 1.23 107.627 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.51 -34.96 65.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.259 -1.337 . . . . 0.85 111.263 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' B' ' 23' ' ' ARG . . . 137.24 -4.64 3.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.451 -0.795 . . . . 0.17 111.152 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.743 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 9.0 mtp180 -68.57 133.57 48.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.644 -0.278 . . . . 3.03 110.626 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.2 pt -138.79 -179.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.578 -0.527 . . . . 0.13 109.578 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -109.81 103.11 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.084 0.469 . . . . 0.19 110.802 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 16' ' ' ILE . 83.3 mmm -78.7 149.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.989 -0.745 . . . . 0.84 108.989 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -81.48 155.77 18.81 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.871 1.714 . . . . 0.16 113.61 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.7 tp -51.7 -32.36 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.26 109.884 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.24 -29.68 68.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.334 -0.848 . . . . 1.08 111.487 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.63 35.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.242 -0.651 . . . . 0.2 109.242 177.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.679 ' HD3' HG11 ' B' ' 10' ' ' VAL . 33.3 mtm180 -63.98 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.66 -0.7 . . . . 1.05 109.658 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 68.3 mtp180 -83.67 -33.03 25.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.031 -0.986 . . . . 0.71 110.663 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.47 -37.85 77.45 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.26 110.117 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.67 -88.64 0.23 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.145 -0.934 . . . . 0.52 111.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.749 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 22.1 t70 177.27 23.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.024 0.44 . . . . 1.72 109.977 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.6 mp -83.5 129.9 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 O-C-N 122.184 -0.323 . . . . 0.28 110.963 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.0 -48.37 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.3 111.236 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.653 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.15 -30.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 0.33 110.113 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.4 mtpt -137.03 -51.9 0.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.296 -0.631 . . . . 1.46 109.296 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER 36.44 -117.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.517 -1.219 . . . . 1.18 113.994 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HG21 ' B' ' 7' ' ' VAL . 13.3 m -162.51 135.51 5.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.274 0.488 . . . . 0.21 111.428 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.877 HD11 HG23 ' B' ' 10' ' ' VAL . 3.2 mp -137.38 107.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.28 109.775 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 46.2 tt0 -103.1 138.03 40.48 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.287 -0.634 . . . . 1.31 109.287 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.993 0.901 . . . . 1.33 112.866 -174.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' HD1' HD12 ' A' ' 44' ' ' ILE . 18.4 t80 -127.83 123.43 35.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.126 -1.397 . . . . 2.22 108.179 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.516 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.0 p -92.3 132.6 36.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 119.824 -0.75 . . . . 0.27 110.492 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -133.59 102.65 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.515 -1.22 . . . . 1.16 109.248 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.39 -97.17 0.59 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.706 -0.759 . . . . 0.32 111.269 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -117.83 -9.55 10.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.323 0.583 . . . . 2.0 109.697 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.4 ttpt -92.09 157.73 16.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.449 -0.796 . . . . 1.05 111.538 -169.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.878 HG13 HD12 ' B' ' 22' ' ' LEU . 20.2 mm -118.58 139.53 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.179 -0.674 . . . . 0.18 109.179 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 44.2 mt -121.99 109.81 25.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.629 -0.26 . . . . 0.28 110.676 -173.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' B' ' 45' ' ' LEU . 11.3 mp -96.44 136.15 37.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.003 0.43 . . . . 0.32 111.612 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -145.15 170.81 15.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.186 -0.915 . . . . 2.16 110.173 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 5.1 tmtt? -87.03 149.23 24.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.307 -0.86 . . . . 0.52 109.097 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.8 t80 . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 120.933 0.397 . . . . 1.25 110.936 -175.544 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 24.2 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.527 0.679 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.66 -46.88 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.466 -0.788 . . . . 0.32 109.362 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.28 29.12 46.4 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.197 -0.911 . . . . 0.43 112.493 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.451 HG23 ' CE2' ' A' ' 36' ' ' PHE . 19.5 m -126.31 131.37 71.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.374 0.607 . . . . 0.25 110.681 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 33' ' ' SER . 15.0 p -107.91 142.89 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.225 -0.898 . . . . 0.16 109.189 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.2 mpt_? -111.56 161.03 16.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.31 -0.405 . . . . 1.09 110.535 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.38 116.09 22.71 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.85 . . . . 1.16 108.704 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.877 HG23 HD11 ' A' ' 34' ' ' ILE . 7.5 t -53.25 141.86 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.706 0.629 . . . . 0.25 111.196 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.12 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.042 -0.981 . . . . 1.22 109.946 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.653 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.7 mt-10 -149.83 -41.78 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.109 -1.071 . . . . 1.22 108.109 169.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.2 mt -72.88 -36.55 67.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.269 -1.332 . . . . 0.9 110.864 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.545 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 134.78 -1.46 3.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.15 111.069 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 47.3 mtp85 -64.45 131.27 46.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.685 -0.257 . . . . 2.91 110.694 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -138.7 179.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.241 -0.652 . . . . 0.16 109.241 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -108.89 106.28 20.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.185 0.517 . . . . 0.19 110.732 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.509 ' SD ' HD11 ' B' ' 16' ' ' ILE . 81.0 mmm -79.77 146.04 63.62 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.853 -0.795 . . . . 0.94 108.853 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.76 158.62 31.61 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.08 1.853 . . . . 0.19 113.316 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -56.81 -31.05 34.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.273 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -59.33 -26.84 65.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.07 111.26 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.878 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.36 -39.84 31.64 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.931 -0.766 . . . . 0.24 108.931 176.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.581 ' HB2' HD12 ' B' ' 20' ' ' ILE . 42.9 mtm180 -66.45 -26.98 67.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.027 -0.988 . . . . 1.3 110.577 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -83.45 -32.34 26.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.529 -0.76 . . . . 0.87 109.603 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.62 62.35 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.074 -0.966 . . . . 0.28 110.494 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 53.0 mt -85.26 -93.9 0.08 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.547 -1.206 . . . . 0.57 109.364 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.516 ' OD1' ' HG3' ' B' ' 47' ' ' LYS . 6.7 p30 177.76 40.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.367 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -81.01 125.05 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.31 109.798 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.77 -43.57 10.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.928 -0.578 . . . . 0.41 111.138 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -160.4 -30.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 0.34 109.388 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.518 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.2 mtpt -133.89 -52.45 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 1.38 109.382 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.55 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.4 OUTLIER 39.45 -117.83 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.848 -1.069 . . . . 1.17 113.725 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 34.4 m -162.05 134.47 5.77 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.034 0.379 . . . . 0.24 111.639 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.689 HD11 HG23 ' A' ' 10' ' ' VAL . 3.7 mp -137.88 103.58 2.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.945 -0.391 . . . . 0.2 109.945 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 47.7 tt0 -97.79 137.7 36.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.692 -0.485 . . . . 1.33 109.692 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.736 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.31 154.65 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.088 0.947 . . . . 1.27 113.002 -174.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.63 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 27.1 t80 -130.51 123.12 28.93 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 114.031 -1.44 . . . . 2.1 108.169 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.5 p -93.11 133.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.566 -0.854 . . . . 0.3 110.756 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' B' ' 37' ' ' PHE . 17.3 t70 -132.41 103.78 6.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.3 -0.864 . . . . 1.18 109.974 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.53 -84.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.899 -0.591 . . . . 0.42 111.719 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.96 -22.49 4.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.7 -0.481 . . . . 1.91 109.7 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -91.17 167.96 11.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.569 . . . . 0.78 110.866 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 5.3 mm -125.46 139.39 51.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.623 -0.717 . . . . 0.22 109.224 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 15.6 mt -118.23 117.85 56.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.436 -0.347 . . . . 0.3 110.559 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' A' ' 45' ' ' LEU . 11.1 mp -104.2 134.68 47.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.955 0.407 . . . . 0.25 111.761 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -147.1 167.96 22.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.284 -0.871 . . . . 1.85 109.558 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.7 tmtp? -89.11 149.33 23.24 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.539 -0.912 . . . . 0.51 108.539 174.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.518 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 64.8 t80 . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 120.678 0.275 . . . . 1.17 111.311 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.751 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.7 m . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.245 0.545 . . . . 1.0 110.502 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.603 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -88.33 -36.18 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.34 109.635 -178.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.66 78.18 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.387 -0.824 . . . . 0.51 112.284 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.603 HG22 ' HB ' ' A' ' 4' ' ' ILE . 29.5 m -119.15 132.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.689 0.757 . . . . 0.23 111.053 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.3 p -114.76 138.89 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.276 -1.329 . . . . 0.17 109.114 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.22 148.97 32.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.069 0.461 . . . . 1.21 110.294 -174.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -112.98 120.28 40.85 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.321 -0.854 . . . . 1.13 108.898 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.636 HG21 HG21 ' B' ' 28' ' ' ILE . 36.3 t -54.7 144.72 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.482 -0.781 . . . . 0.24 111.809 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -80.32 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.842 -1.072 . . . . 1.31 109.917 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' HD11 ' B' ' 30' ' ' ILE . 41.0 mt-10 -153.82 -42.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.931 -1.137 . . . . 1.23 107.931 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.38 -19.01 36.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.462 -1.245 . . . . 0.85 111.472 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 123.89 -3.79 9.19 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.836 -0.697 . . . . 0.17 111.682 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 47.7 mtm180 -67.38 126.45 29.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.361 -0.237 . . . . 3.03 110.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -136.96 179.74 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.191 -0.67 . . . . 0.13 109.191 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.1 p -110.6 118.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.194 0.521 . . . . 0.19 111.094 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.796 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.7 mmt -86.15 151.3 53.99 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.876 -0.602 . . . . 0.84 109.698 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.4 Cg_endo -85.59 156.03 10.51 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.02 1.814 . . . . 0.16 113.157 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.718 HD13 HH21 ' A' ' 23' ' ' ARG . 3.9 tp -51.18 -33.67 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.06 -0.973 . . . . 0.26 109.792 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.55 -29.56 68.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.615 -0.72 . . . . 1.08 111.877 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -80.47 -34.37 35.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.007 -0.738 . . . . 0.2 109.007 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.718 HH21 HD13 ' A' ' 20' ' ' ILE . 62.3 mtm180 -64.84 -29.66 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 1.05 109.812 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.6 mtp180 -84.64 -35.23 22.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.176 -0.92 . . . . 0.71 110.657 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.71 72.34 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.534 -0.757 . . . . 0.26 110.237 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.813 HD22 ' H ' ' A' ' 47' ' ' LYS . 97.2 mt -89.45 -89.61 0.15 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.8 -1.091 . . . . 0.52 111.421 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 36.7 t70 168.52 58.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.97 -1.122 . . . . 1.72 107.97 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.0 mp -115.29 134.34 58.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.913 -0.585 . . . . 0.28 110.485 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.13 -59.69 1.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.37 0.605 . . . . 0.3 111.166 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.62 -31.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.466 -0.788 . . . . 0.33 109.59 -176.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.2 mtpt -134.63 -56.34 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.083 -0.71 . . . . 1.46 109.083 174.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.9 -121.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 1.18 113.899 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.42 ' HB3' HG21 ' B' ' 7' ' ' VAL . 15.6 m -161.4 135.28 6.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.458 0.572 . . . . 0.21 111.236 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -139.88 104.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.28 109.332 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.1 tt0 -102.86 135.05 45.24 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.571 -0.529 . . . . 1.31 109.571 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -112.49 154.33 26.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.02 0.914 . . . . 1.33 113.098 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.511 ' HD1' HD12 ' A' ' 44' ' ' ILE . 24.9 t80 -131.76 121.91 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.982 -1.463 . . . . 2.22 107.868 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.663 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -92.62 135.32 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.198 -0.601 . . . . 0.27 110.703 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -133.74 102.4 5.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.979 -1.01 . . . . 1.16 109.966 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.5 -82.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.32 112.037 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.75 -20.15 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.34 0.591 . . . . 2.0 109.901 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 5.6 ttpt -93.05 157.97 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.256 -0.884 . . . . 1.05 111.376 -166.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.923 HG13 HD12 ' B' ' 22' ' ' LEU . 16.9 mm -114.78 141.5 31.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.904 -0.589 . . . . 0.18 109.432 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 43.8 mt -122.36 107.2 19.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.607 0.242 . . . . 0.28 110.758 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.772 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.1 mp -94.46 131.29 40.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.442 -0.345 . . . . 0.32 111.265 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HA ' HD21 ' A' ' 26' ' ' LEU . 4.1 ptmt -149.91 148.7 29.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.908 -0.587 . . . . 2.16 111.136 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.813 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.3 tmtp? -72.39 137.3 46.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.52 109.985 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.573 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 63.0 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.535 -0.757 . . . . 1.25 111.616 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.663 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.0 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.344 0.592 . . . . 1.0 110.252 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.819 HD12 ' HD2' ' A' ' 36' ' ' PHE . 1.3 mt -96.97 -32.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.32 109.882 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.2 28.61 73.81 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.583 -0.735 . . . . 0.43 112.888 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.474 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -124.52 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.158 0.504 . . . . 0.25 110.609 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -110.63 144.19 19.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.503 -0.771 . . . . 0.16 109.185 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mpt_? -114.56 155.11 27.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.035 0.445 . . . . 1.09 110.631 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 116.98 27.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.258 -1.016 . . . . 1.16 108.258 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 34' ' ' ILE . 9.1 t -52.45 137.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 O-C-N 123.803 0.689 . . . . 0.25 111.226 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.3 t70 -57.19 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.227 -0.897 . . . . 1.22 110.212 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 30' ' ' ILE . 44.3 mt-10 -152.92 -38.11 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.408 -0.96 . . . . 1.22 108.408 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.57 -29.27 25.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.786 -1.097 . . . . 0.9 111.006 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.518 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 133.18 -3.2 4.8 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.663 -0.975 . . . . 0.15 110.663 -172.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.2 mtm180 -63.33 129.47 40.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.356 . . . . 2.91 110.701 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.5 OUTLIER -139.24 179.51 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.901 -0.777 . . . . 0.16 108.901 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -109.26 117.29 54.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.178 0.513 . . . . 0.19 111.263 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 23.8 mmt -81.61 154.6 71.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.235 -0.654 . . . . 0.94 109.235 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.0 Cg_endo -86.47 156.27 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.129 1.886 . . . . 0.19 113.342 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' B' ' 23' ' ' ARG . 4.0 tp -56.47 -30.39 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.832 . . . . 0.22 109.314 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 3.4 mm-40 -58.84 -28.95 66.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.87 . . . . 1.07 110.909 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.923 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.72 -40.22 34.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.987 -0.745 . . . . 0.24 108.987 177.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.635 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 57.0 mtm180 -64.2 -27.69 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.037 -0.983 . . . . 1.3 110.357 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -83.99 -35.19 24.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.165 -0.925 . . . . 0.87 110.018 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -51.33 67.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.849 -1.069 . . . . 0.28 110.878 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.781 HD22 ' H ' ' B' ' 47' ' ' LYS . 70.3 mt -90.83 -85.65 0.22 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.611 -1.177 . . . . 0.57 111.675 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.59 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.3 t0 169.05 55.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.67 -0.863 . . . . 1.54 108.67 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.23 139.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.31 109.908 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.45 -59.58 1.93 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.814 -0.63 . . . . 0.41 111.083 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.47 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -140.85 -33.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.177 -0.465 . . . . 0.34 110.072 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 40.0 mtpt -133.98 -52.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.913 -0.773 . . . . 1.38 108.913 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.8 OUTLIER 36.94 -118.96 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.686 -1.143 . . . . 1.17 114.063 -176.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.572 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 15.9 m -161.43 134.72 6.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.996 0.362 . . . . 0.24 111.337 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.653 HG21 HD23 ' B' ' 45' ' ' LEU . 3.8 mp -141.71 102.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.682 -0.488 . . . . 0.2 109.682 171.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 38.5 tt0 -99.29 136.87 38.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 1.33 109.576 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.731 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -110.43 158.12 18.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.283 1.039 . . . . 1.27 113.268 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.656 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 35.1 t80 -135.39 125.13 25.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.632 -1.622 . . . . 2.1 107.86 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.751 ' H ' ' HB2' ' A' ' 3' ' ' SER . 13.5 p -92.9 135.31 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.87 -0.732 . . . . 0.3 110.111 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -133.64 100.05 4.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.833 -0.621 . . . . 1.18 110.039 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 -80.42 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.42 111.917 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.69 -19.79 3.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.238 0.542 . . . . 1.91 110.008 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -91.82 167.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.489 -0.778 . . . . 0.78 110.796 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 8.4 mm -121.72 139.98 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.554 -0.748 . . . . 0.22 109.149 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.2 mt -118.27 111.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.498 -0.319 . . . . 0.3 110.59 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.85 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -99.61 132.23 45.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.647 0.261 . . . . 0.25 111.478 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -153.76 145.33 23.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.012 -0.54 . . . . 1.85 111.328 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.781 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.9 tmtp? -72.37 135.5 45.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 0.51 109.905 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 t80 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.354 -0.839 . . . . 1.17 112.207 -171.619 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.505 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.372 0.606 . . . . 1.0 111.38 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -84.82 -34.13 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.297 -1.001 . . . . 0.34 108.297 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.35 16.09 78.85 Favored Glycine 0 CA--C 1.504 -0.603 0 CA-C-N 114.88 -1.055 . . . . 0.51 112.736 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 23.4 m -114.7 131.17 67.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.778 0.799 . . . . 0.23 111.475 -175.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.7 p -110.21 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.997 -1.456 . . . . 0.17 108.746 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.7 mpt_? -122.04 164.24 18.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.436 -0.347 . . . . 1.21 110.557 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 34.1 mmtm -115.06 127.59 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.592 -0.892 . . . . 1.13 108.592 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.851 HG23 HD11 ' B' ' 34' ' ' ILE . 18.3 t -58.55 136.64 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.57 -0.53 . . . . 0.24 109.57 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.71 -77.87 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.899 -0.591 . . . . 1.31 109.564 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.3 mt-10 -154.81 -45.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.747 -1.205 . . . . 1.23 107.747 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.13 -34.69 63.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.338 -1.301 . . . . 0.85 110.908 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 141.86 -9.62 2.56 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.21 -0.905 . . . . 0.17 111.12 -172.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 27.9 mtm180 -62.45 131.43 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.262 . . . . 3.03 111.165 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -141.46 179.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.096 -0.705 . . . . 0.13 109.096 174.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -107.91 107.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.346 0.593 . . . . 0.19 110.908 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.62 ' HB3' HD13 ' A' ' 22' ' ' LEU . 77.4 mmm -80.29 152.56 73.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.122 -0.695 . . . . 0.84 109.122 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 95.2 Cg_endo -84.66 157.22 12.12 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.767 1.645 . . . . 0.16 114.119 -171.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.511 HG13 ' HD2' ' A' ' 24' ' ' ARG . 3.1 tp -50.44 -37.81 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.816 -1.084 . . . . 0.26 110.224 170.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.4 mm-40 -59.71 -26.13 65.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 1.08 110.782 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -77.09 -39.21 50.49 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.947 -0.76 . . . . 0.2 108.947 177.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 17.3 mtm180 -64.02 -34.74 78.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.312 -0.858 . . . . 1.05 110.028 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.7 mtp180 -79.62 -35.6 39.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.175 -0.92 . . . . 0.71 110.083 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.43 -51.4 29.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.051 -0.977 . . . . 0.26 110.212 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.5 mt -78.01 -89.87 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.173 -0.921 . . . . 0.52 111.492 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 11.2 t70 175.15 43.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.511 -0.922 . . . . 1.72 108.511 -169.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -115.44 138.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 0.28 111.317 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.94 -51.15 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.013 -0.539 . . . . 0.3 111.513 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -147.18 -29.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.032 -0.359 . . . . 0.33 110.032 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 30' ' ' ILE . 18.4 mtpp -138.98 -52.23 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.265 -0.642 . . . . 1.46 109.265 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 35.08 -110.24 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.49 -1.232 . . . . 1.18 113.946 -177.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 50.4 m -165.34 142.44 5.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.377 0.535 . . . . 0.21 111.168 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.001 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -141.13 108.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 110.26 -0.274 . . . . 0.28 110.26 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.4 tt0 -105.63 132.17 52.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.987 -0.375 . . . . 1.31 109.987 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.614 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.41 155.97 23.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.404 1.097 . . . . 1.33 113.017 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 40.9 t80 -125.22 153.38 43.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.331 -1.759 . . . . 2.22 106.454 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.9 p -122.16 133.09 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.788 -0.765 . . . . 0.27 110.175 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.56 96.9 4.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 1.16 110.033 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.89 -82.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.586 -0.733 . . . . 0.32 111.502 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' HD23 ' B' ' 26' ' ' LEU . 14.6 m-20 -125.5 -17.7 5.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.724 -0.238 . . . . 2.0 110.99 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 166.27 12.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 1.05 110.72 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG13 HD12 ' B' ' 22' ' ' LEU . 15.3 mm -120.72 142.96 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.631 -0.507 . . . . 0.18 109.631 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 43.0 mt -124.65 111.24 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.28 110.613 -174.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -94.64 135.78 35.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.24 0.543 . . . . 0.32 111.905 -174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 16.4 ttpp -149.68 134.56 17.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.852 -1.067 . . . . 2.16 109.421 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.662 ' H ' HD22 ' A' ' 26' ' ' LEU . 1.7 tmtp? -63.86 155.32 30.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.637 -0.875 . . . . 0.52 108.637 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.619 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 25.1 t80 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.067 0.46 . . . . 1.25 111.004 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.1 m . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.248 0.546 . . . . 1.0 110.858 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.16 -35.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.528 -1.286 . . . . 0.32 107.528 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.66 73.82 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 114.382 -1.281 . . . . 0.43 112.375 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.8 m -118.66 132.21 69.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.219 0.533 . . . . 0.25 110.603 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -109.44 147.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.16 109.196 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.472 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mpt_? -120.12 167.01 12.65 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.144 -0.48 . . . . 1.09 110.377 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 40.6 mmtm -119.02 122.53 42.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.699 -0.852 . . . . 1.16 108.699 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 1.001 HG23 HD11 ' A' ' 34' ' ' ILE . 4.3 t -56.04 133.31 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.281 -0.637 . . . . 0.25 109.281 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -79.16 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.756 -0.656 . . . . 1.22 109.972 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.521 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.4 mt-10 -152.73 -40.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.085 -1.08 . . . . 1.22 108.085 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.3 OUTLIER -89.74 -15.2 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.067 -1.424 . . . . 0.9 110.493 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 124.21 -4.75 8.91 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.15 111.934 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 53.0 mtm180 -63.45 131.74 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.869 0.067 . . . . 2.91 110.839 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.694 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -142.15 179.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.904 -0.776 . . . . 0.16 108.904 174.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -107.95 109.14 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.007 0.432 . . . . 0.19 110.769 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.6 ' HB3' HD13 ' B' ' 22' ' ' LEU . 77.3 mmm -80.97 152.25 71.41 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.702 -0.851 . . . . 0.94 108.702 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 40.7 Cg_endo -83.16 158.1 15.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.559 1.506 . . . . 0.19 113.583 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.624 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.9 tp -58.62 -29.55 39.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.142 -0.935 . . . . 0.22 109.307 172.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.54 -27.82 67.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 1.07 110.823 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.736 HD12 HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -76.99 -41.42 42.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.723 -0.843 . . . . 0.24 108.723 176.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.765 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 65.1 mtp180 -62.81 -31.25 72.2 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.543 -1.208 . . . . 1.3 110.899 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -81.15 -33.99 32.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.361 -0.836 . . . . 0.87 109.652 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.59 19.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.729 -1.123 . . . . 0.28 111.419 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 74.2 mt -82.06 -81.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.862 -1.063 . . . . 0.57 111.091 -171.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.571 ' C ' HD12 ' B' ' 28' ' ' ILE . 37.6 t70 170.9 49.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 -173.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -115.8 133.93 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.1 0.476 . . . . 0.31 110.336 -173.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.79 -48.47 3.92 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.512 -0.767 . . . . 0.41 111.385 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.662 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -152.9 -29.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.008 0.432 . . . . 0.34 109.97 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.662 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.8 mtpp -138.55 -51.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.944 -0.761 . . . . 1.38 108.944 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.587 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 36.35 -108.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.518 -1.219 . . . . 1.17 114.136 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 21.0 m -167.93 141.27 3.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.884 0.311 . . . . 0.24 110.67 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.851 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -144.23 106.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 110.214 -0.291 . . . . 0.2 110.214 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 tt0 -98.6 142.17 30.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.852 -0.425 . . . . 1.33 109.852 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.589 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -114.45 155.4 26.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.067 0.936 . . . . 1.27 112.911 -175.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.821 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.4 t80 -127.31 151.17 49.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.754 -1.572 . . . . 2.1 106.754 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.505 ' H ' ' HB2' ' A' ' 3' ' ' SER . 4.6 p -118.99 134.62 62.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.665 -0.814 . . . . 0.3 110.604 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 19.8 t70 -129.44 95.81 4.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.222 -0.899 . . . . 1.18 109.827 -175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.59 -82.31 0.39 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.901 -0.666 . . . . 0.42 111.662 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.421 ' O ' HD23 ' A' ' 26' ' ' LEU . 26.6 m-20 -128.46 -13.26 4.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.516 0.198 . . . . 1.91 110.514 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 1.2 ptpp? -100.29 168.94 9.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.389 . . . . 0.78 110.55 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 23.4 mm -124.67 144.81 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.8 -0.637 . . . . 0.22 109.955 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.821 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 39.4 mt -125.93 115.08 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.27 -0.423 . . . . 0.3 110.951 -173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -101.47 134.27 44.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.081 0.467 . . . . 0.25 111.869 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HA ' HD22 ' B' ' 26' ' ' LEU . 24.5 ttpp -147.99 137.6 22.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.191 -0.913 . . . . 1.85 109.257 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -64.68 150.28 47.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.395 -0.965 . . . . 0.51 108.395 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.634 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.77 0.319 . . . . 1.17 110.707 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 5.2 m . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 120.985 0.422 . . . . 1.0 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' B' ' 37' ' ' PHE . 3.9 mt -97.69 -37.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.34 109.701 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.64 40.54 31.7 Favored Glycine 0 CA--C 1.506 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.51 112.446 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 4' ' ' ILE . 8.1 m -138.12 133.57 44.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.486 0.66 . . . . 0.23 111.309 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -118.89 140.9 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.763 -1.108 . . . . 0.17 109.061 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -116.29 160.05 21.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.82 -0.437 . . . . 1.21 109.82 -174.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 26.3 mmtp -122.15 120.44 34.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.335 -0.987 . . . . 1.13 108.335 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.794 HG23 HD11 ' B' ' 34' ' ' ILE . 18.1 t -52.32 138.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.732 0.645 . . . . 0.24 110.767 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.84 -71.86 0.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.77 -0.65 . . . . 1.31 109.695 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -154.39 -51.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.938 -0.764 . . . . 1.23 108.938 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -82.56 -23.93 34.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.65 -1.159 . . . . 0.85 110.821 -177.136 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 139.75 -9.6 3.12 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.913 -0.661 . . . . 0.17 112.139 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 35.6 mtm180 -62.8 129.82 42.14 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.824 -0.221 . . . . 3.03 110.945 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.18 177.33 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.268 -0.641 . . . . 0.13 109.268 175.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.733 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -106.31 111.61 35.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.301 0.572 . . . . 0.19 111.096 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 2.8 mmt -83.01 155.58 67.47 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.022 -0.733 . . . . 0.84 109.022 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.2 Cg_endo -86.69 153.86 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.033 1.822 . . . . 0.16 113.573 -173.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.3 tp -52.59 -33.0 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.26 109.667 169.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 2.3 mm-40 -62.15 -26.53 68.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.514 -0.766 . . . . 1.08 110.873 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -78.91 -38.9 36.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.73 -0.841 . . . . 0.2 108.73 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.72 ' HD3' HG11 ' B' ' 10' ' ' VAL . 37.3 mtm180 -65.07 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.107 -0.951 . . . . 1.05 110.249 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.3 mtp180 -84.62 -37.52 20.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.164 -0.925 . . . . 0.71 110.529 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.2 -50.18 55.94 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.43 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -80.6 -86.33 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.789 -1.096 . . . . 0.52 111.13 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' H ' HD12 ' A' ' 28' ' ' ILE . 18.4 t0 166.6 61.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.6 -1.259 . . . . 1.72 107.6 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.707 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -123.95 134.27 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.406 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.33 -56.67 2.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.151 0.5 . . . . 0.3 110.825 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -141.48 -30.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.81 -0.632 . . . . 0.33 109.699 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 6.7 mtpp -136.17 -54.15 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.323 -0.621 . . . . 1.46 109.323 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.97 -116.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.423 -1.262 . . . . 1.18 113.706 -175.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 14.0 m -162.0 136.73 7.0 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.409 0.549 . . . . 0.21 111.125 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' B' ' 10' ' ' VAL . 3.8 mp -138.6 103.15 2.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.868 -0.419 . . . . 0.28 109.868 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.6 tt0 -97.95 137.73 36.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.254 -0.647 . . . . 1.31 109.254 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -121.68 151.04 40.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.426 1.108 . . . . 1.33 112.989 -175.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -113.5 165.87 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.311 -1.768 . . . . 2.22 107.034 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' B' ' 3' ' ' SER . 2.9 p -133.19 125.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.49 0.662 . . . . 0.27 109.906 167.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -128.57 104.59 7.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.926 -1.034 . . . . 1.16 109.758 -173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.83 -92.08 0.53 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.156 -0.778 . . . . 0.32 111.156 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD23 ' B' ' 26' ' ' LEU . 28.7 m-20 -126.9 4.57 6.57 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.993 -0.373 . . . . 2.0 109.993 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -109.97 157.24 19.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 1.05 111.437 -168.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HD12 ' B' ' 22' ' ' LEU . 19.8 mm -113.84 142.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.837 -0.431 . . . . 0.18 109.837 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 mt -123.78 115.48 45.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.521 -0.309 . . . . 0.28 110.92 -173.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' B' ' 45' ' ' LEU . 10.5 mp -101.27 129.79 47.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.47 0.652 . . . . 0.32 112.429 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 13.4 ttpt -142.49 141.09 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.579 -1.191 . . . . 2.16 109.749 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 1.5 tmtp? -73.96 148.95 41.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.574 -0.898 . . . . 0.52 108.574 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.636 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 36.6 t80 . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.064 0.459 . . . . 1.25 111.235 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 19.9 m . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 121.441 0.638 . . . . 1.0 110.362 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.63 -46.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.481 -0.781 . . . . 0.32 109.398 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.63 35.02 37.59 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.267 -0.879 . . . . 0.43 112.512 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -129.09 132.4 67.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.042 0.448 . . . . 0.25 110.39 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.3 p -112.07 143.15 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.874 -0.787 . . . . 0.16 108.874 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.402 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.4 mpt_? -114.81 162.9 16.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.237 -0.438 . . . . 1.09 110.602 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.59 121.3 38.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.523 -0.918 . . . . 1.16 108.523 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 34' ' ' ILE . 2.9 t -56.32 132.87 20.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 O-C-N 123.358 0.411 . . . . 0.25 110.115 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.17 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.22 109.672 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.55 ' HG2' HD11 ' A' ' 30' ' ' ILE . 40.8 mt-10 -155.13 -39.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 124.272 0.983 . . . . 1.22 108.445 171.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.754 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -92.06 -18.01 24.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.458 -1.246 . . . . 0.9 110.472 -177.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 130.1 -7.49 6.04 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.639 -0.71 . . . . 0.15 112.106 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 39.2 mtm180 -61.45 129.99 43.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.819 -0.224 . . . . 2.91 110.789 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -140.8 176.01 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.298 -0.63 . . . . 0.16 109.298 175.302 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 1.5 p -105.3 108.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.295 0.569 . . . . 0.19 111.358 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.9 mmt -75.3 156.26 85.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.027 -0.731 . . . . 0.94 109.027 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.1 Cg_endo -87.84 155.58 7.36 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.988 1.792 . . . . 0.19 113.417 -176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.283 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -59.31 -30.03 68.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.401 -0.818 . . . . 1.07 110.804 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.881 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.33 -39.99 58.83 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.24 108.701 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.718 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 33.8 mtm180 -64.47 -30.09 71.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.862 -1.063 . . . . 1.3 110.318 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.414 ' HD2' HG13 ' B' ' 20' ' ' ILE . 74.8 mtp180 -84.64 -24.63 28.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.311 -0.859 . . . . 0.87 110.39 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.12 -53.2 8.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.218 -0.901 . . . . 0.28 110.941 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.785 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 16.2 mt -83.13 -81.39 0.16 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.056 -0.975 . . . . 0.57 110.212 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.593 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.3 t70 165.19 61.24 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.965 -1.124 . . . . 1.54 107.965 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -116.63 133.73 62.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.845 -0.616 . . . . 0.31 109.653 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.58 -56.82 2.21 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.178 -0.464 . . . . 0.41 110.853 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -143.03 -31.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.84 -0.618 . . . . 0.34 109.672 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -134.6 -51.88 0.8 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.354 -0.61 . . . . 1.38 109.354 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.4 OUTLIER 39.77 -113.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.677 -1.147 . . . . 1.17 113.818 -176.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 18.7 m -161.93 135.95 6.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.042 0.214 . . . . 0.24 111.235 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.794 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -139.87 102.07 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 N-CA-C 109.677 -0.49 . . . . 0.2 109.677 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 45.6 tt0 -96.47 135.55 38.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.33 109.388 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.527 ' CE2' ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -121.07 151.29 40.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.603 0.716 . . . . 1.27 112.375 -176.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.563 ' HA ' HG13 ' A' ' 4' ' ' ILE . 2.8 p90 -143.34 139.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.962 -1.017 . . . . 2.1 110.307 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.624 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.2 p -92.9 141.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.383 0.611 . . . . 0.3 110.791 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.98 102.22 5.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.164 -0.926 . . . . 1.18 109.355 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.6 -88.18 0.53 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.104 -0.799 . . . . 0.42 111.104 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.07 -8.13 5.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.412 -0.218 . . . . 1.91 110.412 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -105.78 168.42 9.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.78 111.0 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 22' ' ' LEU . 30.4 mm -119.65 142.5 34.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.861 -0.609 . . . . 0.22 109.491 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 11.8 mt -125.95 125.44 68.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.912 -0.315 . . . . 0.3 110.178 -175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -107.48 128.87 54.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.203 0.525 . . . . 0.25 111.86 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.509 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 10.3 ttpt -142.47 138.68 31.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.831 -1.077 . . . . 1.85 110.158 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.6 tmtp? -70.01 146.67 50.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.822 -0.807 . . . . 0.51 108.822 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.581 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 40.5 t80 . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 1.17 111.419 -173.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 25.0 m . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.0 0.429 . . . . 1.0 111.998 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.1 mt -82.57 -35.59 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.037 -1.098 . . . . 0.34 108.037 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.53 13.74 74.49 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 114.738 -1.119 . . . . 0.51 112.798 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 29.1 m -105.17 132.44 51.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.502 0.667 . . . . 0.23 110.93 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.8 p -113.52 139.78 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.494 -1.23 . . . . 0.17 109.913 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -114.4 156.65 24.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.893 -0.594 . . . . 1.21 110.435 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -117.71 122.86 44.64 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.877 -0.786 . . . . 1.13 108.877 175.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 28' ' ' ILE . 27.4 t -57.64 146.19 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.24 111.781 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -64.97 -77.55 0.06 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.12 -0.945 . . . . 1.31 110.151 174.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -155.22 -43.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.729 -0.841 . . . . 1.23 108.729 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 -25.88 30.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.647 -1.16 . . . . 0.85 110.936 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 133.93 -6.76 4.79 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.295 -0.866 . . . . 0.17 110.984 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 48.2 mtm180 -62.79 128.18 34.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.423 0.154 . . . . 3.03 110.83 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -139.52 179.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.688 -0.856 . . . . 0.13 108.688 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -106.28 116.18 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.083 0.468 . . . . 0.19 110.907 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.636 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.9 mmt -83.56 150.84 60.77 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.34 -0.615 . . . . 0.84 109.34 174.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.56 154.48 18.22 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.777 1.651 . . . . 0.16 113.098 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.536 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.1 tp -53.41 -32.18 19.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.325 -0.852 . . . . 0.26 109.629 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.1 mm-40 -61.14 -27.78 68.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.08 111.111 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.851 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -40.7 41.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.625 -0.879 . . . . 0.2 108.625 176.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.623 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 42.3 mtm180 -63.66 -30.55 71.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.861 -1.063 . . . . 1.05 110.133 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.0 mtp180 -84.59 -32.12 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.37 -0.832 . . . . 0.71 110.73 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.19 76.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.528 -0.76 . . . . 0.26 109.803 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.773 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.8 mt -96.66 -91.53 0.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.974 -1.012 . . . . 0.52 111.841 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 29.7 t70 172.31 55.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.742 -1.207 . . . . 1.72 107.742 -170.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.623 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.2 mp -116.23 130.38 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.81 -0.632 . . . . 0.28 109.813 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -58.07 2.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.241 0.543 . . . . 0.3 110.915 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.542 ' O ' HG12 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -143.42 -29.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.599 -0.728 . . . . 0.33 109.616 -177.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 30' ' ' ILE . 34.9 mtpt -136.09 -54.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.665 . . . . 1.46 109.458 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 37.38 -124.4 0.21 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.814 1.042 . . . . 1.18 113.814 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 16.4 m -159.88 134.53 7.74 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.426 0.557 . . . . 0.21 111.318 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -139.58 108.42 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 110.155 -0.313 . . . . 0.28 110.155 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 66.9 tt0 -99.68 140.99 33.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.762 -0.458 . . . . 1.31 109.762 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.455 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -119.85 155.2 33.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.417 1.104 . . . . 1.33 113.502 -176.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.766 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 6.6 t80 -121.34 144.81 48.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.418 -1.719 . . . . 2.22 106.481 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' HB2' ' B' ' 3' ' ' SER . 8.8 p -116.47 128.76 73.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.506 -0.878 . . . . 0.27 110.3 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -131.76 102.0 5.7 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.958 -1.019 . . . . 1.16 109.755 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.63 -92.92 0.45 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.334 -0.706 . . . . 0.32 111.334 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.54 -9.99 9.32 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.396 -0.594 . . . . 2.0 109.396 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -97.31 157.72 15.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.779 -0.646 . . . . 1.05 111.397 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.87 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 9.5 mm -116.38 144.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.261 -0.644 . . . . 0.18 109.261 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 47.3 mt -129.52 109.7 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 122.33 0.252 . . . . 0.28 110.782 -173.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.723 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -98.48 142.54 29.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.207 0.447 . . . . 0.32 112.207 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -150.36 158.52 44.25 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.635 -0.711 . . . . 2.16 109.241 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.773 ' H ' HD22 ' A' ' 26' ' ' LEU . 2.8 tmtp? -70.85 149.24 47.0 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.455 -0.943 . . . . 0.52 108.455 174.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.58 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 91.7 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 1.25 110.853 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.4 m . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.171 0.51 . . . . 1.0 111.243 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.416 HD12 ' HD2' ' A' ' 36' ' ' PHE . 3.2 mt -83.19 -35.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.519 -1.289 . . . . 0.32 107.519 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 28.02 71.68 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.349 -1.296 . . . . 0.43 112.178 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.5 m -116.62 133.07 64.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.165 0.507 . . . . 0.25 110.272 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.1 p -113.46 140.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.16 109.861 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.462 ' NH1' ' HB ' ' B' ' 6' ' ' VAL . 6.6 mpt_? -114.4 157.35 22.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.993 -0.549 . . . . 1.09 110.667 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.13 119.02 33.47 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.472 -0.936 . . . . 1.16 108.472 177.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.653 HG23 HD11 ' A' ' 34' ' ' ILE . 5.5 t -56.28 141.76 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 123.839 0.712 . . . . 0.25 111.719 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -60.7 -79.56 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.951 -1.022 . . . . 1.22 110.474 175.147 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 30' ' ' ILE . 39.9 mt-10 -156.22 -39.68 0.08 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.228 -1.027 . . . . 1.22 108.228 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.94 -25.03 32.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.686 -1.143 . . . . 0.9 110.457 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 127.66 -3.12 7.04 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.051 -0.977 . . . . 0.15 110.742 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 72.9 mtm180 -62.18 127.02 29.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.275 . . . . 2.91 110.613 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.0 OUTLIER -137.28 179.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.16 108.705 175.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.833 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -107.66 112.71 41.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.151 0.501 . . . . 0.19 111.034 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.666 ' HB3' HD22 ' B' ' 22' ' ' LEU . 29.2 mmt -76.3 154.35 84.19 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.11 -0.7 . . . . 0.94 109.11 173.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 51.5 Cg_endo -85.78 156.29 10.26 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 121.998 1.799 . . . . 0.19 112.707 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -57.67 -29.04 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.381 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.4 -28.48 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.718 -0.674 . . . . 1.07 110.691 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.857 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.77 -40.87 32.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.967 -0.753 . . . . 0.24 108.967 176.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 35.3 mtm180 -62.84 -30.09 71.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.892 -1.049 . . . . 1.3 110.245 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.37 -34.87 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.94 . . . . 0.87 109.973 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.75 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.013 -0.994 . . . . 0.28 109.964 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.654 HD22 ' H ' ' B' ' 47' ' ' LYS . 36.9 mt -94.44 -104.24 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.631 -1.168 . . . . 0.57 110.94 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.495 ' H ' HD12 ' B' ' 28' ' ' ILE . 11.2 m-20 -153.62 16.26 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.812 -0.176 . . . . 1.54 111.461 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.694 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -76.62 129.32 37.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.369 -0.533 . . . . 0.31 110.471 -164.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -57.59 2.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.67 -0.696 . . . . 0.41 110.387 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.573 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -142.48 -31.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.687 -0.688 . . . . 0.34 109.566 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.0 mtpt -134.54 -53.08 0.82 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.773 -0.648 . . . . 1.38 109.359 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.2 OUTLIER 41.05 -119.34 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.886 -1.052 . . . . 1.17 113.51 -177.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 46.5 m -165.43 132.35 2.85 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.475 -0.141 . . . . 0.24 110.866 -173.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -139.71 105.76 2.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.602 0.239 . . . . 0.2 110.609 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 57.9 tt0 -96.32 141.7 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.613 -0.514 . . . . 1.33 109.613 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.712 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.1 OUTLIER -113.83 159.8 19.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 122.121 0.963 . . . . 1.27 112.896 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.764 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 14.0 t80 -136.17 126.08 25.86 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 113.776 -1.556 . . . . 2.1 107.656 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 11.0 p -95.81 134.63 32.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.831 -0.748 . . . . 0.3 110.468 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -134.83 101.05 4.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.592 -0.731 . . . . 1.18 110.107 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.01 -93.63 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.005 -0.838 . . . . 0.42 111.005 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.54 -16.48 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.884 -0.413 . . . . 1.91 109.884 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' B' ' 42' ' ' LYS . 3.6 ptpp? -95.62 169.83 9.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.353 0.597 . . . . 0.78 111.109 -167.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.851 HG13 HD12 ' A' ' 22' ' ' LEU . 27.4 mm -125.38 142.34 42.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.172 -0.922 . . . . 0.22 109.447 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.764 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 25.3 mt -124.2 115.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 0.3 111.004 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.87 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -102.86 141.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.125 0.417 . . . . 0.25 112.125 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -151.11 158.73 44.39 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.796 -0.816 . . . . 1.85 108.796 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.654 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.4 tmtp? -72.56 153.72 41.16 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.997 -1.112 . . . . 0.51 107.997 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.508 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 69.0 t80 . . . . . 0 C--N 1.322 -0.597 0 CA-C-O 120.821 0.344 . . . . 1.17 111.19 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.572 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 54.7 m . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 121.205 0.526 . . . . 1.0 111.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' B' ' 36' ' ' PHE . 2.3 mt -81.8 -32.26 11.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.243 -1.021 . . . . 0.34 108.243 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.29 13.12 76.85 Favored Glycine 0 CA--C 1.503 -0.689 0 CA-C-N 114.657 -1.156 . . . . 0.51 112.735 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' B' ' 36' ' ' PHE . 25.5 m -108.98 131.54 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.568 0.699 . . . . 0.23 111.056 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -109.34 140.74 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.553 -1.203 . . . . 0.17 109.284 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.0 mpt_? -114.45 159.71 20.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.166 -0.47 . . . . 1.21 110.344 -175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 30.6 mmtp -122.19 121.76 37.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.326 -0.99 . . . . 1.13 108.326 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HG21 ' B' ' 28' ' ' ILE . 26.9 t -55.25 145.33 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.851 0.719 . . . . 0.24 110.953 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.43 -75.27 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.778 -0.647 . . . . 1.31 109.266 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' HD11 ' B' ' 30' ' ' ILE . 30.5 mt-10 -152.79 -39.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.38 -34.65 28.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.41 -1.268 . . . . 0.85 111.284 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.82 -11.09 2.63 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.942 -0.863 . . . . 0.17 110.942 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 49.7 mtt180 -62.88 131.68 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.517 -0.342 . . . . 3.03 110.869 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -139.85 176.04 6.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.071 -0.715 . . . . 0.13 109.071 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.707 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.3 p -104.64 112.77 39.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.209 0.528 . . . . 0.19 110.873 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 1.2 mmt -82.12 152.43 68.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.686 -0.857 . . . . 0.84 108.686 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 92.4 Cg_endo -83.91 156.54 13.48 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.664 1.576 . . . . 0.16 113.132 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.86 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.7 tp -54.65 -33.33 27.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.176 -0.92 . . . . 0.26 109.538 172.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.13 -26.88 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 1.08 111.01 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.69 -40.98 47.12 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.728 -0.842 . . . . 0.2 108.728 176.447 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 53.3 mtm180 -63.92 -30.18 71.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.097 -0.956 . . . . 1.05 110.165 176.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.86 ' HD2' HG13 ' A' ' 20' ' ' ILE . 37.6 mtp180 -85.15 -30.51 23.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.208 -0.906 . . . . 0.71 110.651 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.31 -45.67 65.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.555 0.693 . . . . 0.26 109.677 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 90.1 mt -88.58 -93.72 0.1 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.862 -1.063 . . . . 0.52 111.508 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 28' ' ' ILE . 37.0 t70 172.71 57.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.096 -1.075 . . . . 1.72 108.096 -172.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.561 HG21 HG21 ' B' ' 10' ' ' VAL . 2.8 mp -113.88 131.27 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.28 110.461 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.31 -54.1 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.122 -0.49 . . . . 0.3 111.404 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.23 -33.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.905 -0.588 . . . . 0.33 109.982 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 30' ' ' ILE . 44.1 mtpt -136.88 -51.26 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.986 -0.746 . . . . 1.46 108.986 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 38.18 -119.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.513 -1.221 . . . . 1.18 113.378 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.404 ' HB3' HG21 ' B' ' 7' ' ' VAL . 17.1 m -163.21 135.29 5.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.482 0.583 . . . . 0.21 111.512 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.662 HD11 HG23 ' B' ' 10' ' ' VAL . 2.6 mp -141.88 105.93 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.96 -0.385 . . . . 0.28 109.96 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 72.0 tt0 -99.66 138.05 37.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.335 -0.617 . . . . 1.31 109.335 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -117.55 152.93 34.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.638 1.209 . . . . 1.33 114.136 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.95 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 32.1 t80 -114.43 157.78 22.43 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 112.98 -1.918 . . . . 2.22 107.134 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' H ' ' HB2' ' B' ' 3' ' ' SER . 5.5 p -127.55 130.7 70.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.116 -0.634 . . . . 0.27 110.033 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 19.3 t70 -130.63 97.24 4.31 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.471 -0.786 . . . . 1.16 109.744 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.19 -78.85 0.3 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.599 -0.728 . . . . 0.32 111.903 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.57 -30.5 4.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.471 0.653 . . . . 2.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -88.37 165.72 14.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.045 -163.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 22' ' ' LEU . 15.4 mm -121.21 142.94 35.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.426 -0.807 . . . . 0.18 109.053 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.95 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 49.1 mt -128.55 108.45 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.511 -0.313 . . . . 0.28 110.851 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.7 mp -99.82 141.61 32.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.306 0.484 . . . . 0.32 112.306 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 156.97 41.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.45 -0.795 . . . . 2.16 110.682 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 3.8 tmtp? -73.32 149.16 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.315 -0.624 . . . . 0.52 109.315 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.64 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 69.7 t80 . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 1.25 111.738 -173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 67.0 m . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 121.205 0.526 . . . . 1.0 110.812 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.536 HD12 ' HD2' ' A' ' 36' ' ' PHE . 4.0 mt -80.47 -33.18 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.553 -1.277 . . . . 0.32 107.553 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 20.12 66.65 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.135 -1.393 . . . . 0.43 112.596 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.8 132.02 59.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.25 110.196 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.7 p -106.5 141.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.597 -0.728 . . . . 0.16 109.041 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.1 mpt_? -113.03 157.4 21.59 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.289 0.566 . . . . 1.09 110.673 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 29.8 mmtp -119.14 119.24 33.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.909 -1.041 . . . . 1.16 108.566 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.662 HG23 HD11 ' A' ' 34' ' ' ILE . 7.4 t -57.25 139.82 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.642 0.589 . . . . 0.25 110.777 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.01 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.486 -0.779 . . . . 1.22 109.805 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -152.63 -42.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.392 -0.966 . . . . 1.22 108.392 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.5 -27.3 37.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.783 -1.098 . . . . 0.9 111.255 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.447 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 130.32 0.03 5.51 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.355 -0.698 . . . . 0.15 111.355 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.707 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 24.6 mtt-85 -66.93 130.84 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.121 -0.326 . . . . 2.91 110.121 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -139.53 175.69 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.413 -0.588 . . . . 0.16 109.413 176.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -105.32 108.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.964 0.412 . . . . 0.19 110.973 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.3 mmt -74.97 154.63 86.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.032 -0.729 . . . . 0.94 109.032 173.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 65.5 Cg_endo -86.85 155.49 8.69 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.999 1.799 . . . . 0.19 113.219 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -55.99 -30.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.22 109.431 171.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.3 -30.59 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 1.07 110.999 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.61 -40.35 56.57 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.78 -0.822 . . . . 0.24 108.78 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 34.4 mtm180 -66.13 -26.52 67.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 1.3 110.626 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' HG13 ' B' ' 20' ' ' ILE . 68.9 mtp180 -84.33 -35.37 23.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.577 -0.738 . . . . 0.87 109.734 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.67 -51.58 66.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.727 -1.124 . . . . 0.28 110.947 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.653 HD22 ' H ' ' B' ' 47' ' ' LYS . 71.0 mt -89.83 -85.6 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.732 -1.122 . . . . 0.57 111.139 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.579 ' C ' HD12 ' B' ' 28' ' ' ILE . 15.9 t0 166.46 61.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.797 -1.186 . . . . 1.54 107.797 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.726 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.56 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.66 -0.7 . . . . 0.31 109.86 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.67 -51.59 2.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.721 -0.672 . . . . 0.41 111.652 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -144.16 -33.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 110.011 -0.366 . . . . 0.34 110.011 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 38.1 mtpt -136.29 -49.05 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 1.38 109.051 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.66 -115.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.384 -1.28 . . . . 1.17 113.832 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 14.2 m -164.08 135.37 4.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.994 0.361 . . . . 0.24 111.347 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.708 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -144.04 102.97 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 110.18 -0.304 . . . . 0.2 110.18 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 65.7 tt0 -96.03 139.32 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.541 -0.54 . . . . 1.33 109.541 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.89 155.62 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.524 1.154 . . . . 1.27 113.889 -175.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.894 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -120.14 157.26 29.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.1 -1.864 . . . . 2.1 107.073 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.572 ' H ' ' HB2' ' A' ' 3' ' ' SER . 8.5 p -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 120.093 -0.643 . . . . 0.3 109.955 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.822 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.7 t70 -132.3 95.8 3.73 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 1.18 109.917 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.1 -75.9 0.33 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.685 -0.689 . . . . 0.42 111.654 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.32 -29.04 3.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.484 0.659 . . . . 1.91 109.798 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.822 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.4 OUTLIER -85.81 158.36 20.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.112 -0.949 . . . . 0.78 111.778 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.837 HG13 HD12 ' A' ' 22' ' ' LEU . 17.7 mm -118.27 144.11 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.656 -0.702 . . . . 0.22 109.925 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.894 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.1 mt -128.66 114.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 0.3 110.956 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.1 mp -104.23 141.05 36.96 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.89 0.33 . . . . 0.25 111.89 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -151.71 151.55 31.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.946 -0.57 . . . . 1.85 110.345 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.653 ' H ' HD22 ' B' ' 26' ' ' LEU . 2.1 tmtp? -78.1 137.5 38.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.371 -0.603 . . . . 0.51 109.371 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.863 -0.608 . . . . 1.17 111.714 -169.574 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.735 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 75.2 m . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.276 0.56 . . . . 1.0 110.532 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.607 HD12 ' HB2' ' B' ' 36' ' ' PHE . 2.7 mt -100.04 -45.17 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.785 . . . . 0.34 109.304 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.13 24.03 60.23 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.493 -0.776 . . . . 0.51 112.222 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.4 m -121.22 133.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.648 0.737 . . . . 0.23 111.241 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -108.77 140.49 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.17 109.072 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.6 mpt_? -113.3 157.17 22.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.181 -0.463 . . . . 1.21 110.807 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.22 120.85 36.37 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.455 -0.793 . . . . 1.13 108.971 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG21 ' B' ' 28' ' ' ILE . 42.7 t -55.88 145.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.24 111.026 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -69.31 0.33 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.423 -0.584 . . . . 1.31 109.423 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -155.88 -54.16 0.09 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.126 -0.943 . . . . 1.23 108.734 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.2 mp -77.81 -22.44 50.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.317 -1.311 . . . . 0.85 111.376 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.58 -11.33 4.02 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.821 -0.704 . . . . 0.17 111.886 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.796 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 39.6 mtt180 -60.25 134.51 57.13 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.906 -0.173 . . . . 3.03 110.751 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.43 175.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.515 -0.921 . . . . 0.13 108.515 172.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -106.37 100.69 11.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.347 0.594 . . . . 0.19 110.826 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 16' ' ' ILE . 81.1 mmm -74.94 148.61 84.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.818 -0.808 . . . . 0.84 108.818 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 82.0 Cg_endo -80.25 157.6 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.828 1.685 . . . . 0.16 113.247 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.1 tp -56.04 -31.79 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.333 -0.849 . . . . 0.26 109.405 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.3 mm-40 -61.19 -28.8 69.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 1.08 111.191 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.8 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.64 -39.33 57.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.488 -0.93 . . . . 0.2 108.488 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.642 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 50.6 mtm180 -66.04 -28.56 68.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.84 -1.073 . . . . 1.05 110.28 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.642 ' HD2' HG13 ' A' ' 20' ' ' ILE . 72.4 mtp180 -84.99 -35.0 22.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.435 -0.802 . . . . 0.71 110.522 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.23 55.23 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.275 -0.875 . . . . 0.26 110.136 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.56 HD22 ' H ' ' A' ' 47' ' ' LYS . 87.0 mt -81.49 -88.84 0.08 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.86 -1.064 . . . . 0.52 110.577 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.1 t70 167.17 61.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.634 -1.247 . . . . 1.72 107.634 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.645 HG21 HG21 ' B' ' 10' ' ' VAL . 3.0 mp -113.26 132.23 62.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.657 -0.701 . . . . 0.28 110.102 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.28 -55.74 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 0.3 110.927 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -143.09 -32.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.778 -0.646 . . . . 0.33 109.91 -177.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.62 ' HG3' HG23 ' A' ' 30' ' ' ILE . 31.7 mtpt -136.98 -50.3 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.358 0.599 . . . . 1.46 109.467 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER 36.86 -116.41 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.399 1.259 . . . . 1.18 114.399 -177.407 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 20.0 m -164.87 134.52 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.416 0.553 . . . . 0.21 111.424 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.768 HD11 HG23 ' B' ' 10' ' ' VAL . 2.8 mp -140.99 106.77 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.369 -0.234 . . . . 0.28 110.369 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 60.0 tt0 -98.76 142.08 30.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.744 -0.465 . . . . 1.31 109.744 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.1 155.03 35.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.231 1.015 . . . . 1.33 113.354 -175.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' A' ' 44' ' ' ILE . 34.7 t80 -134.47 126.73 30.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.714 -1.585 . . . . 2.22 108.122 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.706 ' H ' ' HB2' ' B' ' 3' ' ' SER . 6.3 p -92.9 129.14 43.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 119.498 -0.881 . . . . 0.27 110.705 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -127.08 109.04 11.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.011 -0.995 . . . . 1.16 108.942 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 -96.49 0.75 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.398 -1.081 . . . . 0.32 110.398 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.28 -8.12 8.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.565 0.221 . . . . 2.0 110.483 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -100.4 166.75 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.687 -0.233 . . . . 1.05 110.88 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.896 HG13 HD12 ' B' ' 22' ' ' LEU . 11.9 mm -116.25 143.42 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.055 -0.35 . . . . 0.18 110.055 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 49.1 mt -122.02 118.79 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.431 -0.349 . . . . 0.28 110.435 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' B' ' 45' ' ' LEU . 11.1 mp -103.37 133.5 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.32 111.63 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 11.4 ttpt -142.19 143.98 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.362 -0.835 . . . . 2.16 110.255 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -75.97 145.94 39.94 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.506 -0.924 . . . . 0.52 108.506 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 84.9 t80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.418 0.628 . . . . 1.25 110.918 -172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.706 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 75.2 m . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.063 0.459 . . . . 1.0 111.59 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.8 mt -105.72 -46.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.32 108.971 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.7 21.89 73.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.289 -0.868 . . . . 0.43 112.265 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.3 132.53 66.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.269 0.557 . . . . 0.25 110.825 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.5 p -105.0 143.13 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.024 -0.732 . . . . 0.16 109.024 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.478 ' NE ' HG13 ' B' ' 17' ' ' VAL . 2.5 mpt_? -113.17 158.89 19.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.1 0.476 . . . . 1.09 111.084 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.6 mmtp -118.55 121.66 40.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.871 -1.059 . . . . 1.16 109.106 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.768 HG23 HD11 ' A' ' 34' ' ' ILE . 14.5 t -57.66 141.39 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.304 -0.407 . . . . 0.25 110.29 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.16 -74.3 0.12 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 1.22 109.32 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -148.54 -55.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.485 0.66 . . . . 1.22 109.472 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.874 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -76.96 -16.9 59.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.054 -0.976 . . . . 0.9 110.91 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 126.72 -0.85 7.37 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.991 -0.623 . . . . 0.15 111.672 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 6.3 mtm180 -67.01 126.56 29.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.188 -0.301 . . . . 2.91 110.188 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -132.81 172.36 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.811 -0.811 . . . . 0.16 108.811 176.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -104.67 101.58 12.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.301 0.572 . . . . 0.19 110.812 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.51 ' SD ' HD11 ' B' ' 16' ' ' ILE . 84.3 mmm -75.4 151.63 85.46 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.046 -0.724 . . . . 0.94 109.046 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 29.1 Cg_endo -83.36 156.8 14.58 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.628 1.552 . . . . 0.19 113.317 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -55.24 -30.72 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.909 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -62.68 -26.35 68.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.23 -0.441 . . . . 1.07 110.627 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.896 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.46 -40.61 49.92 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.901 -0.778 . . . . 0.24 108.901 175.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.682 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 53.0 mtm180 -65.19 -29.13 69.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.844 -1.071 . . . . 1.3 110.705 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 81.6 mtp180 -83.49 -30.55 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.354 -0.839 . . . . 0.87 109.821 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.83 -53.26 22.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.895 -1.048 . . . . 0.28 110.935 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.791 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 48.4 mt -85.16 -81.39 0.2 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.784 -1.098 . . . . 0.57 110.55 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.575 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.1 t0 163.95 60.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.744 -1.206 . . . . 1.54 107.744 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 10' ' ' VAL . 1.4 mp -116.84 132.89 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.104 -0.498 . . . . 0.31 109.67 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.69 -54.32 2.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.793 -0.64 . . . . 0.41 111.064 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -33.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.15 -0.477 . . . . 0.34 109.801 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 10' ' ' VAL . 21.1 mtpt -133.31 -52.38 0.89 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.328 -0.619 . . . . 1.38 109.328 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 36.25 -118.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.585 -1.189 . . . . 1.17 114.103 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 13.1 m -161.05 135.84 7.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.046 0.384 . . . . 0.24 111.979 -173.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.6 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -143.9 104.39 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 N-CA-C 110.289 -0.263 . . . . 0.2 110.289 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.4 tt0 -96.48 141.05 30.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.767 -0.457 . . . . 1.33 109.767 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.607 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.02 157.79 26.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.014 1.116 . . . . 1.27 114.014 -175.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.454 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 47.4 t80 -136.83 129.28 30.08 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 113.63 -1.623 . . . . 2.1 108.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.735 ' H ' ' HB2' ' A' ' 3' ' ' SER . 9.6 p -92.37 133.42 33.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 119.816 -0.753 . . . . 0.3 109.746 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -131.9 107.47 8.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.967 -0.753 . . . . 1.18 108.967 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.64 -91.01 0.66 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.051 -0.82 . . . . 0.42 111.051 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -128.77 -9.0 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.748 -0.464 . . . . 1.91 109.748 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -100.93 169.05 9.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.78 110.799 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 22' ' ' LEU . 23.0 mm -118.86 142.93 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 0.22 110.461 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 18.8 mt -119.75 124.89 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.322 -0.399 . . . . 0.3 110.109 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -109.39 132.23 54.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.022 0.439 . . . . 0.25 111.64 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 13.9 ttpt -142.08 145.53 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.85 110.237 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.791 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -80.94 138.85 36.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.028 -0.731 . . . . 0.51 109.028 175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.486 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 37.2 t80 . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.17 112.822 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.598 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 31.6 t . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 121.015 0.436 . . . . 1.0 111.9 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.7 mt -92.8 -34.0 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.051 -0.722 . . . . 0.34 109.051 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.38 6.18 79.61 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.027 -0.988 . . . . 0.51 112.733 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 31.8 m -102.41 133.38 46.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.605 0.717 . . . . 0.23 111.326 -176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 6.5 p -115.84 140.36 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.413 -1.267 . . . . 0.17 109.68 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.697 ' HG2' ' CZ ' ' B' ' 36' ' ' PHE . 11.6 mmt180 -110.54 165.08 12.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.857 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 28.4 mmtp -124.28 122.36 37.53 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.102 -1.073 . . . . 1.13 108.102 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.665 HG23 HD11 ' B' ' 34' ' ' ILE . 38.4 t -56.5 145.98 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.24 111.726 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.21 -78.04 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 1.31 109.699 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -153.45 -45.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.944 -0.761 . . . . 1.23 108.944 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -81.92 -27.59 33.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.952 -1.022 . . . . 0.85 110.808 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.16 -11.18 2.8 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.623 -0.717 . . . . 0.17 111.582 -174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 46.8 mtp180 -61.21 132.05 52.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.099 0.16 . . . . 3.03 111.0 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -139.07 178.57 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.684 -0.858 . . . . 0.13 108.684 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.82 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -107.41 109.21 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.488 0.661 . . . . 0.19 111.467 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.633 ' HB3' HD22 ' A' ' 22' ' ' LEU . 14.5 mmt -75.74 154.01 85.24 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.503 -0.771 . . . . 0.84 109.315 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.2 Cg_endo -83.26 154.39 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.68 1.587 . . . . 0.16 113.162 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 tp -54.74 -31.7 24.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.562 -0.744 . . . . 0.26 109.568 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.86 -28.21 68.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.45 -0.795 . . . . 1.08 110.768 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.816 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -39.6 44.67 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.787 -0.82 . . . . 0.2 108.787 176.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.1 mtm180 -64.73 -28.91 69.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.142 -0.936 . . . . 1.05 110.394 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -83.68 -38.58 21.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.163 -0.926 . . . . 0.71 110.227 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.67 85.37 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.289 -0.868 . . . . 0.26 110.525 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.555 HD22 ' HB2' ' A' ' 47' ' ' LYS . 93.1 mt -87.8 -93.69 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.06 -0.973 . . . . 0.52 111.587 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 33.0 t70 -179.95 38.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.435 0.636 . . . . 1.72 109.307 -172.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.1 mp -100.06 134.27 40.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.401 -0.363 . . . . 0.28 110.884 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -56.51 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.3 110.684 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.586 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.46 -29.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.954 -0.567 . . . . 0.33 109.724 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 30' ' ' ILE . 37.4 mtpt -136.11 -57.1 0.76 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.474 -0.785 . . . . 1.46 109.028 176.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 37.21 -128.13 0.17 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.097 -0.956 . . . . 1.18 113.036 -175.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 13.1 m -153.29 136.66 15.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.516 0.598 . . . . 0.21 111.589 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.725 HD11 HG23 ' B' ' 10' ' ' VAL . 4.2 mp -139.18 107.79 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.223 -0.288 . . . . 0.28 110.223 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.1 tt0 -105.28 140.67 38.07 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.022 -0.362 . . . . 1.31 110.022 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -123.04 153.62 39.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.533 0.938 . . . . 1.33 113.533 -174.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' HD1' HD12 ' A' ' 44' ' ' ILE . 33.8 t80 -125.12 124.31 41.58 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.078 -1.419 . . . . 2.22 108.742 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.1 p -93.65 134.58 30.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 C-N-CA 119.785 -0.766 . . . . 0.27 110.74 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -132.75 105.12 6.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.344 -0.844 . . . . 1.16 109.747 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.54 0.46 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.162 -0.775 . . . . 0.32 111.162 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -128.02 -8.03 5.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.369 0.604 . . . . 2.0 109.528 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.2 ttpt -93.16 156.96 16.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 1.05 111.329 -169.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.93 HG13 HD12 ' B' ' 22' ' ' LEU . 10.0 mm -116.93 142.92 28.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.484 -0.561 . . . . 0.18 109.484 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.622 HD12 ' HD1' ' A' ' 37' ' ' PHE . 47.0 mt -128.98 109.52 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.581 0.229 . . . . 0.28 110.907 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.88 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.4 mp -92.17 137.62 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.291 0.567 . . . . 0.32 112.184 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 12.6 ttpt -145.97 141.59 27.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.794 -1.094 . . . . 2.16 109.527 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 33' ' ' SER . 7.1 tmtt? -76.58 146.32 38.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.098 -0.704 . . . . 0.52 109.098 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 t80 . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 120.762 -0.375 . . . . 1.25 111.808 -171.778 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.525 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 37.2 t . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.338 0.589 . . . . 1.0 109.985 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.795 HD12 ' HD2' ' A' ' 36' ' ' PHE . 2.9 mt -88.76 -40.12 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.561 -0.903 . . . . 0.32 108.561 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.28 77.73 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.026 -0.988 . . . . 0.43 112.49 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -114.23 132.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.041 0.448 . . . . 0.25 110.706 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -113.82 139.53 38.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.694 -0.685 . . . . 0.16 109.693 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.726 ' HG2' ' CE1' ' A' ' 36' ' ' PHE . 5.1 mmt180 -106.73 167.0 10.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.063 -0.517 . . . . 1.09 110.623 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HD3' ' O ' ' B' ' 8' ' ' ARG . 30.1 mmtp -125.9 119.03 26.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.113 -1.069 . . . . 1.16 108.113 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.725 HG23 HD11 ' A' ' 34' ' ' ILE . 8.5 t -56.55 142.04 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.43 0.633 . . . . 0.25 111.26 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.75 -76.38 0.06 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 1.22 110.058 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -152.44 -49.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.565 -0.902 . . . . 1.22 108.565 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.83 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.4 OUTLIER -79.93 -19.12 48.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.246 -1.343 . . . . 0.9 110.655 -176.482 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 128.02 -3.3 6.86 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.15 111.489 -176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 52.0 mtm180 -63.99 128.55 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.445 -0.206 . . . . 2.91 110.445 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -136.04 179.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.072 -0.714 . . . . 0.16 109.072 176.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -106.63 108.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.215 0.531 . . . . 0.19 111.04 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.693 ' HB3' HD22 ' B' ' 22' ' ' LEU . 30.4 mmt -74.66 152.95 87.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.65 -0.871 . . . . 0.94 108.65 172.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 43.3 Cg_endo -84.5 154.84 12.16 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.906 1.738 . . . . 0.19 112.943 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 4.1 tp -53.84 -32.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.22 109.571 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -61.12 -26.43 67.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.79 -0.641 . . . . 1.07 110.819 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.93 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.63 -40.94 32.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.926 -0.768 . . . . 0.24 108.926 176.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 38.8 mtm180 -65.65 -27.5 68.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.568 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 72.1 mtp180 -83.96 -30.75 25.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.257 -0.883 . . . . 0.87 110.047 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.99 -52.52 28.0 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.012 -0.994 . . . . 0.28 110.687 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 62.0 mt -85.6 -87.51 0.13 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.734 -1.121 . . . . 0.57 110.8 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.435 ' C ' HD12 ' B' ' 28' ' ' ILE . 38.9 t70 173.89 45.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.754 . . . . 1.54 109.005 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 10' ' ' VAL . 1.2 mp -108.0 129.11 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.31 110.018 -174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.15 4.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.478 -0.783 . . . . 0.41 111.499 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.556 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -150.46 -33.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.742 -0.466 . . . . 0.34 109.742 177.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' B' ' 30' ' ' ILE . 44.1 mtpt -133.55 -50.92 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.316 0.579 . . . . 1.38 109.443 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.536 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.8 -113.56 0.1 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.22 1.192 . . . . 1.17 114.22 -177.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.5 m -164.38 137.39 5.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.189 0.45 . . . . 0.24 111.61 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -141.86 102.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 110.213 -0.292 . . . . 0.2 110.213 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 33.5 tt0 -95.18 142.53 27.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.4 -0.593 . . . . 1.33 109.4 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.697 ' CZ ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -118.99 158.52 25.6 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.183 0.992 . . . . 1.27 113.579 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 18.7 t80 -132.88 125.87 30.93 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 113.675 -1.602 . . . . 2.1 108.011 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.598 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.5 p -93.28 135.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.822 -0.751 . . . . 0.3 110.24 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.074 -0.713 . . . . 1.18 109.074 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.11 -95.17 0.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.977 -0.849 . . . . 0.42 110.977 -171.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.94 -13.58 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 1.91 110.169 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -92.82 167.78 11.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.78 110.834 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.7 mm -121.97 143.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.13 -0.486 . . . . 0.22 109.724 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 17.4 mt -124.5 113.85 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.504 -0.316 . . . . 0.3 110.798 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.836 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -98.02 139.52 33.73 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.265 0.555 . . . . 0.25 112.064 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -152.58 141.07 20.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.799 -1.091 . . . . 1.85 109.188 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tmtt? -72.74 153.4 41.16 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.842 -0.799 . . . . 0.51 108.842 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 75.9 t80 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.149 0.499 . . . . 1.17 111.358 -172.08 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.626 ' HB2' ' CD1' ' B' ' 37' ' ' PHE . 19.0 t . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.161 0.505 . . . . 1.0 109.681 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.43 -31.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.067 -0.716 . . . . 0.34 109.067 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.58 21.43 77.14 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.139 -0.937 . . . . 0.51 112.931 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.57 132.63 68.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.859 0.837 . . . . 0.23 111.748 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -111.1 140.86 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 113.935 -1.484 . . . . 0.17 108.578 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.7 mpt_? -114.78 155.0 27.53 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.017 0.437 . . . . 1.21 110.607 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 121.05 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.584 -0.895 . . . . 1.13 108.584 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.638 HG23 HD11 ' B' ' 34' ' ' ILE . 4.7 t -54.52 141.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.564 0.54 . . . . 0.24 110.312 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.36 -77.86 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.939 -0.763 . . . . 1.31 108.939 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.48 ' HG2' HD11 ' B' ' 30' ' ' ILE . 29.8 mt-10 -151.71 -36.2 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.623 -0.88 . . . . 1.23 108.623 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD12 ' HD2' ' A' ' 15' ' ' ARG . 11.2 mt -86.79 -19.09 29.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.14 -0.936 . . . . 0.85 111.7 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 124.19 -6.43 8.75 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 120.503 -0.856 . . . . 0.17 111.277 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.0 mtp180 -67.25 125.2 25.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.345 -0.242 . . . . 3.03 110.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -131.73 175.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.966 -0.753 . . . . 0.13 108.966 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.7 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -103.27 102.43 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.056 0.455 . . . . 0.19 110.938 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.625 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.2 mmt -74.54 149.99 86.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.4 -0.593 . . . . 0.84 109.4 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.4 Cg_endo -81.19 155.03 19.29 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.781 1.654 . . . . 0.16 113.383 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 4.7 tp -56.2 -31.81 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.178 -0.919 . . . . 0.26 109.059 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 13.0 mm-40 -58.87 -30.93 68.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.211 -0.904 . . . . 1.08 111.253 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.905 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.22 -41.12 58.33 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.457 -0.942 . . . . 0.2 108.457 177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.629 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 32.3 mtm180 -63.92 -29.57 70.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.782 -1.099 . . . . 1.05 110.224 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 73.5 mtp180 -85.26 -35.83 21.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.399 -0.819 . . . . 0.71 110.753 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.28 95.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.598 0.713 . . . . 0.26 109.874 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.565 HD22 ' H ' ' A' ' 47' ' ' LYS . 77.2 mt -92.36 -104.83 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.678 -1.146 . . . . 0.52 110.255 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -174.72 49.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 1.72 109.422 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.629 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -93.18 131.68 39.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.28 109.513 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.58 -57.77 2.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.34 0.59 . . . . 0.3 110.587 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -146.68 -28.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.032 -0.986 . . . . 0.33 109.604 -175.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HG3' HG23 ' A' ' 30' ' ' ILE . 21.2 mtpp -139.88 -52.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 1.46 109.141 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' HB2' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER 37.75 -115.27 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.094 1.146 . . . . 1.18 114.094 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 38.5 m -166.59 137.88 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.436 0.562 . . . . 0.21 111.065 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.751 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -139.0 111.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.701 -0.481 . . . . 0.28 109.701 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 22.7 tt0 -107.92 130.2 55.04 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.31 0.244 . . . . 1.31 110.552 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.701 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -116.06 153.5 31.61 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.655 0.983 . . . . 1.33 113.655 -170.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' HD1' HD12 ' A' ' 44' ' ' ILE . 25.5 t80 -129.86 132.36 46.41 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 114.112 -1.404 . . . . 2.22 108.478 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.532 ' H ' ' HB3' ' B' ' 3' ' ' SER . 2.8 p -100.29 132.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 119.765 -0.774 . . . . 0.27 111.268 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.9 t70 -125.59 99.89 6.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.67 -1.15 . . . . 1.16 109.534 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.32 -84.31 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.583 -0.735 . . . . 0.32 111.365 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.01 -17.04 5.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.392 0.615 . . . . 2.0 109.64 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' B' ' 44' ' ' ILE . 2.1 ttpt -92.47 158.07 16.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.345 -0.843 . . . . 1.05 111.325 -167.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.968 HG13 HD12 ' B' ' 22' ' ' LEU . 7.0 mm -118.12 139.46 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.887 -0.412 . . . . 0.18 109.887 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.591 HD12 ' HD1' ' A' ' 37' ' ' PHE . 43.6 mt -121.87 111.71 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.444 . . . . 0.28 110.508 -174.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -102.87 138.19 40.08 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.815 0.302 . . . . 0.32 111.815 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 149.89 26.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 2.16 110.081 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -65.53 147.99 52.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.891 -0.595 . . . . 0.52 110.146 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.634 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 24.3 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 1.25 111.263 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 47.1 t . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.081 0.467 . . . . 1.0 110.723 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HD2' ' A' ' 36' ' ' PHE . 10.5 mt -89.45 -40.73 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.923 -0.769 . . . . 0.32 108.923 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.88 39.65 59.0 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.43 112.538 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 36' ' ' PHE . 15.3 m -131.97 132.21 61.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.023 0.439 . . . . 0.25 110.029 174.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.1 p -108.44 142.66 20.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.819 -0.808 . . . . 0.16 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.701 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 mpt_? -113.79 153.87 28.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.991 0.424 . . . . 1.09 110.764 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 121.45 44.64 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.565 -0.743 . . . . 1.16 109.054 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 34' ' ' ILE . 3.8 t -53.62 137.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 123.837 0.711 . . . . 0.25 110.459 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -55.08 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.631 -0.713 . . . . 1.22 109.998 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.711 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.1 mt-10 -151.64 -32.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.499 -0.926 . . . . 1.22 108.499 173.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.33 -29.96 21.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.304 -1.317 . . . . 0.9 110.858 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 132.06 -8.37 5.42 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.768 -0.933 . . . . 0.15 110.768 -172.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 mtp180 -62.84 124.58 21.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.299 . . . . 2.91 110.508 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -129.58 174.77 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.649 -0.871 . . . . 0.16 108.649 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.723 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.9 p -104.15 104.06 16.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.326 0.584 . . . . 0.19 110.693 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 1.6 mmt -76.29 151.72 83.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 0.94 108.729 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.41 153.84 10.62 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.877 1.718 . . . . 0.19 113.321 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -53.85 -30.25 19.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.413 -0.812 . . . . 0.22 109.985 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.04 -25.67 67.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.206 -0.452 . . . . 1.07 110.88 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.968 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.62 -41.29 39.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.631 -0.877 . . . . 0.24 108.631 174.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 37.4 mtm180 -63.54 -29.83 71.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.887 -1.052 . . . . 1.3 110.683 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.563 ' HD2' HG13 ' B' ' 20' ' ' ILE . 62.0 mtp180 -84.36 -33.93 23.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.271 -0.877 . . . . 0.87 110.048 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -51.03 71.63 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.781 -1.1 . . . . 0.28 110.1 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.575 HD22 ' H ' ' B' ' 47' ' ' LYS . 61.0 mt -92.4 -91.25 0.17 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.462 -1.245 . . . . 0.57 111.637 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.476 ' C ' HD12 ' B' ' 28' ' ' ILE . 16.7 t0 175.5 50.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.637 -0.875 . . . . 1.54 108.637 -170.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -109.34 132.92 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.966 -0.753 . . . . 0.31 108.966 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.36 -51.48 2.91 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.163 0.506 . . . . 0.41 111.852 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.669 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -146.94 -29.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.971 -0.559 . . . . 0.34 109.668 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.669 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.4 mtpp -140.06 -51.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.465 -0.568 . . . . 1.38 109.465 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.452 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.7 OUTLIER 34.91 -115.44 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.802 1.038 . . . . 1.17 113.802 -176.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.0 m -163.4 136.99 5.74 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.155 -0.34 . . . . 0.24 111.37 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.668 HG21 HD23 ' B' ' 45' ' ' LEU . 4.3 mp -142.0 105.22 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.6 -0.519 . . . . 0.2 109.6 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.1 tt0 -102.73 134.45 46.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.318 -0.253 . . . . 1.33 110.318 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.509 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.79 158.67 23.52 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.214 1.19 . . . . 1.27 114.214 -173.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.692 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 66.4 t80 -126.07 152.71 45.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.199 -1.819 . . . . 2.1 107.177 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.608 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.9 p -117.87 137.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 120.057 -0.657 . . . . 0.3 110.041 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 31.5 t70 -133.65 95.6 3.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.928 -0.578 . . . . 1.18 110.111 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.03 -73.49 1.04 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.572 -0.74 . . . . 0.42 111.684 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -127.71 -30.5 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.462 0.649 . . . . 1.91 109.421 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -89.7 166.22 13.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.096 -0.956 . . . . 0.78 111.341 -163.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.905 HG13 HD12 ' A' ' 22' ' ' LEU . 25.4 mm -121.27 142.99 35.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.46 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 33.5 mt -124.06 109.74 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.409 -0.359 . . . . 0.3 110.69 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 45' ' ' LEU . 10.6 mp -101.69 134.66 44.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.331 0.493 . . . . 0.25 112.331 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.3 OUTLIER -149.08 148.75 30.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.85 109.667 172.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.575 ' H ' HD22 ' B' ' 26' ' ' LEU . 7.1 tttt -64.92 167.05 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.42 -0.585 . . . . 0.51 109.42 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.238 -0.585 . . . . 1.17 110.108 -171.494 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.863 0.363 . . . . 4.8 110.066 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.857 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 32.3 mtmm -140.76 -160.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.812 -0.631 . . . . 2.48 109.92 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 48.7 m -48.56 -52.8 20.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.156 0.503 . . . . 1.0 111.289 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -86.02 -33.91 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.647 -0.872 . . . . 0.34 108.647 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.857 ' HA2' ' H ' ' A' ' 2' ' ' LYS . . . 70.52 19.61 76.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.831 -1.077 . . . . 0.51 112.548 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 27.9 m -115.92 131.32 68.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.573 0.701 . . . . 0.23 111.177 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.8 p -114.63 141.73 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.512 -1.222 . . . . 0.17 109.36 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.465 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.74 165.11 13.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.977 0.418 . . . . 1.21 110.607 -176.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 33.4 mmtp -120.22 124.24 45.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.242 -1.021 . . . . 1.13 108.242 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.709 HG21 HG21 ' B' ' 28' ' ' ILE . 39.7 t -56.38 141.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.497 0.498 . . . . 0.24 109.912 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.85 -75.15 0.07 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.938 -0.574 . . . . 1.31 109.676 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.25 -46.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.842 -0.799 . . . . 1.23 108.842 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -77.78 -50.47 12.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.887 -1.051 . . . . 0.85 110.734 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.17 -5.49 0.05 OUTLIER Glycine 0 C--O 1.225 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.17 111.832 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 56.5 mtm180 -68.99 135.03 50.28 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 122.07 0.148 . . . . 3.03 110.868 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -141.12 179.99 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.906 -0.775 . . . . 0.13 108.906 174.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.7 p -107.38 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.171 0.51 . . . . 0.19 110.91 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.653 ' HE1' HD11 ' B' ' 45' ' ' LEU . 78.6 mmm -84.13 148.62 53.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.105 -0.702 . . . . 0.84 109.105 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.0 Cg_endo -80.41 157.65 22.45 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.93 1.753 . . . . 0.16 113.679 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.6 tp -52.68 -34.61 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.969 -1.014 . . . . 0.26 109.713 171.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.42 -25.67 66.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.344 -0.843 . . . . 1.08 110.982 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -78.39 -40.97 34.53 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.83 -0.804 . . . . 0.2 108.83 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.65 ' HD2' HG22 ' A' ' 28' ' ' ILE . 21.0 mtm180 -63.78 -30.88 71.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.41 -0.814 . . . . 1.05 109.837 176.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 77.8 mtp180 -83.82 -33.3 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.267 -0.879 . . . . 0.71 110.854 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.02 -46.88 73.14 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.806 0.813 . . . . 0.26 109.413 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.874 HD22 ' H ' ' A' ' 47' ' ' LYS . 82.8 mt -85.19 -101.52 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.291 -1.322 . . . . 0.52 110.372 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' H ' HD12 ' A' ' 28' ' ' ILE . 4.7 p-10 -179.36 50.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.632 -0.713 . . . . 1.72 109.4 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG22 ' HD2' ' A' ' 23' ' ' ARG . 2.4 mp -98.44 136.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.872 -1.058 . . . . 0.28 109.932 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.16 -51.59 2.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.802 -0.359 . . . . 0.3 111.629 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.881 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -145.31 -32.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.463 -0.335 . . . . 0.33 110.221 -177.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 20.3 mtpp -137.83 -50.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.813 -0.81 . . . . 1.46 108.813 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 35.91 -118.84 0.13 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.461 -1.245 . . . . 1.18 113.138 -176.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB3' HG21 ' B' ' 7' ' ' VAL . 21.1 m -163.32 138.65 6.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.362 0.528 . . . . 0.21 111.198 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD11 HG23 ' B' ' 10' ' ' VAL . 3.1 mp -139.6 110.23 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.759 -0.46 . . . . 0.28 109.759 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 41.3 tt0 -104.15 137.17 42.48 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.501 -0.555 . . . . 1.31 109.501 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -110.06 151.37 27.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.964 0.888 . . . . 1.33 112.601 -174.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 14.8 t80 -127.25 122.15 33.15 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.11 -1.404 . . . . 2.22 107.519 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.464 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -93.28 132.78 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 119.798 -0.761 . . . . 0.27 111.131 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -133.92 102.85 5.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.183 -0.917 . . . . 1.16 110.343 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.5 -88.44 0.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.815 -0.629 . . . . 0.32 112.04 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.67 -8.46 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.598 0.237 . . . . 2.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.68 168.75 9.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.141 0.496 . . . . 1.05 111.09 -168.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.735 HG13 HD12 ' B' ' 22' ' ' LEU . 15.5 mm -122.53 141.65 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.324 -0.853 . . . . 0.18 109.249 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 46.4 mt -121.96 111.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.694 0.283 . . . . 0.28 110.382 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' B' ' 45' ' ' LEU . 10.6 mp -101.13 132.28 46.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.538 -0.301 . . . . 0.32 111.809 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.71 157.34 37.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.139 0.495 . . . . 2.16 111.093 172.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.874 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.2 tmtp? -63.15 153.47 34.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.732 . . . . 0.52 110.406 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.744 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 61.6 t80 -71.28 -51.26 25.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.496 -0.32 . . . . 1.25 111.245 -175.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 24.1 ttmm -46.4 -59.73 4.6 Favored Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 123.85 0.719 . . . . 2.86 112.827 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 15.2 Cg_exo -68.95 108.97 2.04 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.742 1.628 . . . . 1.81 111.112 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -84.87 95.56 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 4.69 110.707 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.53 -153.79 30.0 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.827 -0.909 . . . . 3.14 110.827 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.35 137.18 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 3.58 110.709 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.723 -0.671 . . . . 2.87 109.607 -176.429 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.716 0.293 . . . . 4.74 110.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.818 ' H ' ' HA2' ' B' ' 5' ' ' GLY . 28.4 mttm -146.26 -162.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 2.31 110.293 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 54.2 m -52.11 -50.42 61.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.312 172.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 36' ' ' PHE . 1.9 mt -84.34 -42.0 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.848 -1.167 . . . . 0.32 107.848 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.818 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 72.76 27.02 69.92 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.559 -1.201 . . . . 0.43 112.199 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.9 131.9 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.192 0.52 . . . . 0.25 110.345 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.5 p -111.54 141.27 27.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.333 -0.849 . . . . 0.16 109.323 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.717 ' HD2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -114.21 162.39 16.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.009 0.433 . . . . 1.09 110.354 -175.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.8 mmtp -118.18 121.57 40.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.449 -0.945 . . . . 1.16 108.449 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 34' ' ' ILE . 5.2 t -55.48 135.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.555 -0.535 . . . . 0.25 109.555 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.86 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.999 -0.546 . . . . 1.22 109.535 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.881 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.4 mt-10 -154.7 -34.42 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.302 -0.999 . . . . 1.22 108.302 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.81 -49.23 11.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.098 -1.41 . . . . 0.9 110.329 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.511 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 152.21 -6.24 0.5 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.724 -1.125 . . . . 0.15 110.711 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 43.0 mtm180 -63.45 131.06 46.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.72 -0.24 . . . . 2.91 110.451 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.639 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.8 OUTLIER -138.76 179.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.757 -0.831 . . . . 0.16 108.757 174.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -107.77 113.51 43.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.19 110.885 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.564 ' HB3' HD13 ' B' ' 22' ' ' LEU . 74.8 mmm -84.89 149.0 52.47 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.815 . . . . 0.94 108.801 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 39.5 Cg_endo -80.68 158.44 21.75 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.744 1.629 . . . . 0.19 113.63 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.49 -30.92 32.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.229 -0.896 . . . . 0.22 109.707 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -25.76 67.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.223 -0.444 . . . . 1.07 110.704 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.735 HD12 HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -78.08 -41.74 34.34 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.826 -0.805 . . . . 0.24 108.826 175.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.737 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 32.8 mtp180 -61.79 -33.65 74.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.849 -1.069 . . . . 1.3 110.68 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 55.2 mtp180 -79.66 -37.68 35.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.34 -0.845 . . . . 0.87 109.872 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.42 -50.52 71.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.429 -1.26 . . . . 0.28 110.161 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.859 HD22 ' H ' ' B' ' 47' ' ' LYS . 56.5 mt -92.93 -80.44 0.38 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.65 -1.159 . . . . 0.57 112.075 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 t0 177.4 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.089 -0.245 . . . . 1.54 111.619 -168.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.737 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.5 mp -88.87 124.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.335 0.588 . . . . 0.31 111.668 -163.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.43 -34.86 9.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.96 . . . . 0.41 112.786 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.677 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -166.05 -33.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.502 -0.555 . . . . 0.34 109.502 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.677 ' HG3' HG23 ' B' ' 30' ' ' ILE . 18.6 mtpp -136.58 -49.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.787 -0.82 . . . . 1.38 108.787 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 35.39 -111.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.467 -1.242 . . . . 1.17 113.766 -176.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 27.3 m -166.05 138.35 3.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.343 0.52 . . . . 0.24 110.891 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -142.19 107.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.729 -0.471 . . . . 0.2 109.729 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 44.7 tt0 -103.62 139.5 38.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.711 -0.477 . . . . 1.33 109.711 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.78 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.85 154.73 21.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.015 0.912 . . . . 1.27 112.637 -173.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.725 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 22.9 t80 -129.96 126.22 37.3 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 114.091 -1.413 . . . . 2.1 107.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 10.2 p -93.04 136.43 25.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.732 -0.787 . . . . 0.3 110.339 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 11.8 t70 -134.16 100.91 4.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 1.18 109.804 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.34 -90.47 0.19 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.852 -0.69 . . . . 0.42 111.721 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -118.31 -13.47 9.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.946 0.403 . . . . 1.91 110.704 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' B' ' 39' ' ' ASP . 2.8 ptpt -98.1 169.14 9.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 0.78 110.939 -168.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -124.56 140.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.373 -0.831 . . . . 0.22 109.206 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 35.9 mt -119.22 113.75 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.588 -0.278 . . . . 0.3 110.546 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 45' ' ' LEU . 11.2 mp -101.13 128.46 47.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.808 0.337 . . . . 0.25 111.575 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.587 ' HA ' HD21 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -152.19 153.53 34.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 1.85 110.476 175.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.859 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.6 tmtt? -65.03 166.01 10.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.51 109.757 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -86.87 -49.29 7.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.038 0.447 . . . . 1.17 110.225 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.777 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 24.2 ttmm -49.76 -56.38 17.49 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.926 -1.034 . . . . 2.92 112.577 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 13.2 Cg_exo -70.15 94.84 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.891 1.727 . . . . 1.57 111.642 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -63.73 114.85 4.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.099 -0.955 . . . . 4.68 111.021 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.1 -149.9 9.12 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.419 -1.072 . . . . 3.12 110.419 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.0 134.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.141 0.495 . . . . 3.62 110.286 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.243 0.758 0 CA-C-O 118.579 -0.724 . . . . 2.82 109.358 -175.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.173 -0.306 . . . . 4.8 110.173 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.842 ' HE3' ' HA ' ' B' ' 54' ' ' CYS . 1.9 mmpt? 55.0 -170.44 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.824 0.821 . . . . 2.48 113.173 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 22.8 t -80.01 -35.68 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.036 -0.984 . . . . 1.0 109.317 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' B' ' 36' ' ' PHE . 5.3 mt -103.57 -49.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.662 -0.699 . . . . 0.34 109.388 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.58 25.32 30.65 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.567 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.7 133.27 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.0 0.905 . . . . 0.23 110.991 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.3 p -112.99 141.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 113.651 -1.613 . . . . 0.17 108.727 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 1.2 mpt_? -112.06 156.7 21.78 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.923 0.392 . . . . 1.21 110.462 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -121.25 118.14 28.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.33 -0.989 . . . . 1.13 108.33 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG23 HD11 ' B' ' 34' ' ' ILE . 22.5 t -54.22 144.49 5.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 123.948 0.78 . . . . 0.24 111.87 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.88 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.95 -1.023 . . . . 1.31 110.059 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.606 ' HG2' HD11 ' B' ' 30' ' ' ILE . 40.5 mt-10 -154.3 -43.78 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.627 -1.249 . . . . 1.23 107.627 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.51 -34.96 65.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.259 -1.337 . . . . 0.85 111.263 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' B' ' 23' ' ' ARG . . . 137.24 -4.64 3.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.451 -0.795 . . . . 0.17 111.152 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.743 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 9.0 mtp180 -68.57 133.57 48.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.644 -0.278 . . . . 3.03 110.626 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.2 pt -138.79 -179.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.578 -0.527 . . . . 0.13 109.578 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -109.81 103.11 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.084 0.469 . . . . 0.19 110.802 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 16' ' ' ILE . 83.3 mmm -78.7 149.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.989 -0.745 . . . . 0.84 108.989 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -81.48 155.77 18.81 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.871 1.714 . . . . 0.16 113.61 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.7 tp -51.7 -32.36 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.26 109.884 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.24 -29.68 68.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.334 -0.848 . . . . 1.08 111.487 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.63 35.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.242 -0.651 . . . . 0.2 109.242 177.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.679 ' HD3' HG11 ' B' ' 10' ' ' VAL . 33.3 mtm180 -63.98 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.66 -0.7 . . . . 1.05 109.658 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 68.3 mtp180 -83.67 -33.03 25.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.031 -0.986 . . . . 0.71 110.663 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.47 -37.85 77.45 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.26 110.117 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.67 -88.64 0.23 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.145 -0.934 . . . . 0.52 111.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.749 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 22.1 t70 177.27 23.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.024 0.44 . . . . 1.72 109.977 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.6 mp -83.5 129.9 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 O-C-N 122.184 -0.323 . . . . 0.28 110.963 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.0 -48.37 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.3 111.236 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.653 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.15 -30.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 0.33 110.113 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.4 mtpt -137.03 -51.9 0.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.296 -0.631 . . . . 1.46 109.296 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER 36.44 -117.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.517 -1.219 . . . . 1.18 113.994 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HG21 ' B' ' 7' ' ' VAL . 13.3 m -162.51 135.51 5.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.274 0.488 . . . . 0.21 111.428 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.877 HD11 HG23 ' B' ' 10' ' ' VAL . 3.2 mp -137.38 107.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.28 109.775 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 46.2 tt0 -103.1 138.03 40.48 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.287 -0.634 . . . . 1.31 109.287 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.993 0.901 . . . . 1.33 112.866 -174.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.753 ' HD2' ' HE2' ' B' ' 2' ' ' LYS . 18.4 t80 -127.83 123.43 35.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.126 -1.397 . . . . 2.22 108.179 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.0 p -92.3 132.6 36.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 119.824 -0.75 . . . . 0.27 110.492 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -133.59 102.65 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.515 -1.22 . . . . 1.16 109.248 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.39 -97.17 0.59 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.706 -0.759 . . . . 0.32 111.269 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -117.83 -9.55 10.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.323 0.583 . . . . 2.0 109.697 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.4 ttpt -92.09 157.73 16.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.449 -0.796 . . . . 1.05 111.538 -169.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.878 HG13 HD12 ' B' ' 22' ' ' LEU . 20.2 mm -118.58 139.53 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.179 -0.674 . . . . 0.18 109.179 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 44.2 mt -121.99 109.81 25.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.629 -0.26 . . . . 0.28 110.676 -173.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' B' ' 45' ' ' LEU . 11.3 mp -96.44 136.15 37.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.003 0.43 . . . . 0.32 111.612 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 18.5 pttp -145.15 170.81 15.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.186 -0.915 . . . . 2.16 110.173 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 5.1 tmtt? -87.03 149.23 24.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.307 -0.86 . . . . 0.52 109.097 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -77.95 -56.19 4.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.933 0.397 . . . . 1.25 110.936 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.642 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 24.0 tptm -56.03 -60.77 7.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 113.92 1.081 . . . . 2.86 113.92 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 61.3 Cg_endo -73.39 -2.47 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.026 1.817 . . . . 1.81 113.89 -170.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -166.54 78.87 0.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 4.69 110.422 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.77 85.95 0.57 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.969 -0.634 . . . . 3.14 112.125 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.92 148.24 13.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.061 -0.348 . . . . 3.58 110.061 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.021 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 47.8 t . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.368 -0.825 . . . . 2.87 109.889 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.36 -0.237 . . . . 4.74 110.36 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 1.021 ' HE3' ' HA ' ' A' ' 54' ' ' CYS . 5.2 mmpt? 53.1 -161.81 0.11 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.686 0.624 . . . . 2.31 112.686 173.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 24.2 t -87.4 -36.78 17.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.66 -46.88 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.466 -0.788 . . . . 0.32 109.362 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.28 29.12 46.4 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.197 -0.911 . . . . 0.43 112.493 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.451 HG23 ' CE2' ' A' ' 36' ' ' PHE . 19.5 m -126.31 131.37 71.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.374 0.607 . . . . 0.25 110.681 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 33' ' ' SER . 15.0 p -107.91 142.89 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.225 -0.898 . . . . 0.16 109.189 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.2 mpt_? -111.56 161.03 16.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.31 -0.405 . . . . 1.09 110.535 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.38 116.09 22.71 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.85 . . . . 1.16 108.704 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.877 HG23 HD11 ' A' ' 34' ' ' ILE . 7.5 t -53.25 141.86 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.706 0.629 . . . . 0.25 111.196 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.12 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.042 -0.981 . . . . 1.22 109.946 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.653 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.7 mt-10 -149.83 -41.78 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.109 -1.071 . . . . 1.22 108.109 169.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.2 mt -72.88 -36.55 67.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.269 -1.332 . . . . 0.9 110.864 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.545 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 134.78 -1.46 3.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.15 111.069 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 47.3 mtp85 -64.45 131.27 46.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.685 -0.257 . . . . 2.91 110.694 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -138.7 179.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.241 -0.652 . . . . 0.16 109.241 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -108.89 106.28 20.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.185 0.517 . . . . 0.19 110.732 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.509 ' SD ' HD11 ' B' ' 16' ' ' ILE . 81.0 mmm -79.77 146.04 63.62 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.853 -0.795 . . . . 0.94 108.853 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.76 158.62 31.61 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.08 1.853 . . . . 0.19 113.316 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -56.81 -31.05 34.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.273 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -59.33 -26.84 65.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.07 111.26 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.878 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.36 -39.84 31.64 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.931 -0.766 . . . . 0.24 108.931 176.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.581 ' HB2' HD12 ' B' ' 20' ' ' ILE . 42.9 mtm180 -66.45 -26.98 67.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.027 -0.988 . . . . 1.3 110.577 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -83.45 -32.34 26.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.529 -0.76 . . . . 0.87 109.603 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.62 62.35 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.074 -0.966 . . . . 0.28 110.494 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 53.0 mt -85.26 -93.9 0.08 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.547 -1.206 . . . . 0.57 109.364 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.516 ' OD1' ' HG3' ' B' ' 47' ' ' LYS . 6.7 p30 177.76 40.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.367 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -81.01 125.05 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.31 109.798 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.77 -43.57 10.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.928 -0.578 . . . . 0.41 111.138 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -160.4 -30.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 0.34 109.388 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.518 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.2 mtpt -133.89 -52.45 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 1.38 109.382 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.55 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.4 OUTLIER 39.45 -117.83 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.848 -1.069 . . . . 1.17 113.725 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 34.4 m -162.05 134.47 5.77 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.034 0.379 . . . . 0.24 111.639 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.689 HD11 HG23 ' A' ' 10' ' ' VAL . 3.7 mp -137.88 103.58 2.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.945 -0.391 . . . . 0.2 109.945 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 47.7 tt0 -97.79 137.7 36.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.692 -0.485 . . . . 1.33 109.692 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.736 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.31 154.65 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.088 0.947 . . . . 1.27 113.002 -174.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.63 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 27.1 t80 -130.51 123.12 28.93 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 114.031 -1.44 . . . . 2.1 108.169 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.5 p -93.11 133.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.566 -0.854 . . . . 0.3 110.756 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' B' ' 37' ' ' PHE . 17.3 t70 -132.41 103.78 6.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.3 -0.864 . . . . 1.18 109.974 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.53 -84.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.899 -0.591 . . . . 0.42 111.719 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.96 -22.49 4.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.7 -0.481 . . . . 1.91 109.7 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -91.17 167.96 11.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.569 . . . . 0.78 110.866 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 5.3 mm -125.46 139.39 51.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.623 -0.717 . . . . 0.22 109.224 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 15.6 mt -118.23 117.85 56.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.436 -0.347 . . . . 0.3 110.559 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' A' ' 45' ' ' LEU . 11.1 mp -104.2 134.68 47.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.955 0.407 . . . . 0.25 111.761 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.443 ' HE3' ' HD2' ' A' ' 2' ' ' LYS . 19.2 pttp -147.1 167.96 22.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.284 -0.871 . . . . 1.85 109.558 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.799 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -89.11 149.33 23.24 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.539 -0.912 . . . . 0.51 108.539 174.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.518 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 64.8 t80 -72.78 -57.69 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.678 0.275 . . . . 1.17 111.311 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.714 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 22.9 tptm -50.6 -60.66 4.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 114.431 1.271 . . . . 2.92 114.431 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.799 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 34.3 Cg_exo -60.46 -42.67 39.01 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.97 1.78 . . . . 1.57 112.542 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -135.62 81.67 1.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.232 0.539 . . . . 4.68 110.197 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.13 86.05 0.6 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.743 -0.662 . . . . 3.12 111.963 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.83 150.62 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 110.173 -0.306 . . . . 3.62 110.173 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.842 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 53.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.735 -0.65 . . . . 2.82 109.649 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.87 -0.419 . . . . 4.8 109.87 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.905 ' HD3' ' HA ' ' B' ' 54' ' ' CYS . 32.5 mmtm -65.98 169.75 6.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 2.48 110.816 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.751 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.7 m -65.19 -49.17 70.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.316 -0.857 . . . . 1.0 110.502 176.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.603 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -88.33 -36.18 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.34 109.635 -178.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.66 78.18 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.387 -0.824 . . . . 0.51 112.284 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG22 ' HB ' ' A' ' 4' ' ' ILE . 29.5 m -119.15 132.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.689 0.757 . . . . 0.23 111.053 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.3 p -114.76 138.89 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.276 -1.329 . . . . 0.17 109.114 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.22 148.97 32.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.069 0.461 . . . . 1.21 110.294 -174.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -112.98 120.28 40.85 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.321 -0.854 . . . . 1.13 108.898 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.636 HG21 HG21 ' B' ' 28' ' ' ILE . 36.3 t -54.7 144.72 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.482 -0.781 . . . . 0.24 111.809 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -80.32 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.842 -1.072 . . . . 1.31 109.917 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' HD11 ' B' ' 30' ' ' ILE . 41.0 mt-10 -153.82 -42.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.931 -1.137 . . . . 1.23 107.931 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.38 -19.01 36.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.462 -1.245 . . . . 0.85 111.472 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 123.89 -3.79 9.19 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.836 -0.697 . . . . 0.17 111.682 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 47.7 mtm180 -67.38 126.45 29.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.361 -0.237 . . . . 3.03 110.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -136.96 179.74 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.191 -0.67 . . . . 0.13 109.191 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.1 p -110.6 118.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.194 0.521 . . . . 0.19 111.094 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.796 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.7 mmt -86.15 151.3 53.99 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.876 -0.602 . . . . 0.84 109.698 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.4 Cg_endo -85.59 156.03 10.51 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.02 1.814 . . . . 0.16 113.157 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.718 HD13 HH21 ' A' ' 23' ' ' ARG . 3.9 tp -51.18 -33.67 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.06 -0.973 . . . . 0.26 109.792 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.55 -29.56 68.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.615 -0.72 . . . . 1.08 111.877 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -80.47 -34.37 35.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.007 -0.738 . . . . 0.2 109.007 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.718 HH21 HD13 ' A' ' 20' ' ' ILE . 62.3 mtm180 -64.84 -29.66 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 1.05 109.812 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.6 mtp180 -84.64 -35.23 22.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.176 -0.92 . . . . 0.71 110.657 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.71 72.34 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.534 -0.757 . . . . 0.26 110.237 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD22 ' H ' ' A' ' 47' ' ' LYS . 97.2 mt -89.45 -89.61 0.15 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.8 -1.091 . . . . 0.52 111.421 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 36.7 t70 168.52 58.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.97 -1.122 . . . . 1.72 107.97 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.0 mp -115.29 134.34 58.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.913 -0.585 . . . . 0.28 110.485 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.13 -59.69 1.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.37 0.605 . . . . 0.3 111.166 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.62 -31.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.466 -0.788 . . . . 0.33 109.59 -176.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.2 mtpt -134.63 -56.34 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.083 -0.71 . . . . 1.46 109.083 174.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.9 -121.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 1.18 113.899 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HB3' HG21 ' B' ' 7' ' ' VAL . 15.6 m -161.4 135.28 6.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.458 0.572 . . . . 0.21 111.236 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -139.88 104.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.28 109.332 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.595 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 40.1 tt0 -102.86 135.05 45.24 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.571 -0.529 . . . . 1.31 109.571 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -112.49 154.33 26.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.02 0.914 . . . . 1.33 113.098 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.564 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 24.9 t80 -131.76 121.91 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.982 -1.463 . . . . 2.22 107.868 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.663 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -92.62 135.32 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.198 -0.601 . . . . 0.27 110.703 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -133.74 102.4 5.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.979 -1.01 . . . . 1.16 109.966 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.5 -82.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.32 112.037 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.75 -20.15 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.34 0.591 . . . . 2.0 109.901 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 5.6 ttpt -93.05 157.97 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.256 -0.884 . . . . 1.05 111.376 -166.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.923 HG13 HD12 ' B' ' 22' ' ' LEU . 16.9 mm -114.78 141.5 31.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.904 -0.589 . . . . 0.18 109.432 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 43.8 mt -122.36 107.2 19.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.607 0.242 . . . . 0.28 110.758 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.772 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.1 mp -94.46 131.29 40.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.442 -0.345 . . . . 0.32 111.265 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HA ' HD21 ' A' ' 26' ' ' LEU . 4.1 ptmt -149.91 148.7 29.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.908 -0.587 . . . . 2.16 111.136 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.813 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.3 tmtp? -72.39 137.3 46.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.52 109.985 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.573 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 63.0 t80 -67.26 -50.06 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.535 -0.757 . . . . 1.25 111.616 -172.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.753 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 25.2 ttpp -47.41 -63.93 1.24 Allowed Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.104 0.779 . . . . 2.86 113.104 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 57.7 Cg_endo -73.89 -46.3 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.364 1.376 . . . . 1.81 112.552 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -117.0 76.76 1.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.344 0.592 . . . . 4.69 110.492 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.61 -53.56 8.36 Favored Glycine 0 CA--C 1.5 -0.851 0 CA-C-N 115.191 -0.913 . . . . 3.14 111.874 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -52.2 147.32 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.38 -0.91 . . . . 3.58 110.817 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.957 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.311 -0.852 . . . . 2.87 111.777 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.72 -0.474 . . . . 4.74 109.72 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.957 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 32.5 mmtm -61.3 169.53 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 2.31 111.643 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.663 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.0 m -68.91 -43.7 74.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.252 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.819 HD12 ' HD2' ' A' ' 36' ' ' PHE . 1.3 mt -96.97 -32.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.32 109.882 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.2 28.61 73.81 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.583 -0.735 . . . . 0.43 112.888 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.474 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -124.52 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.158 0.504 . . . . 0.25 110.609 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -110.63 144.19 19.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.503 -0.771 . . . . 0.16 109.185 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mpt_? -114.56 155.11 27.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.035 0.445 . . . . 1.09 110.631 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 116.98 27.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.258 -1.016 . . . . 1.16 108.258 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 34' ' ' ILE . 9.1 t -52.45 137.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 O-C-N 123.803 0.689 . . . . 0.25 111.226 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.3 t70 -57.19 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.227 -0.897 . . . . 1.22 110.212 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 30' ' ' ILE . 44.3 mt-10 -152.92 -38.11 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.408 -0.96 . . . . 1.22 108.408 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.57 -29.27 25.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.786 -1.097 . . . . 0.9 111.006 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.518 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 133.18 -3.2 4.8 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.663 -0.975 . . . . 0.15 110.663 -172.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.2 mtm180 -63.33 129.47 40.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.356 . . . . 2.91 110.701 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.5 OUTLIER -139.24 179.51 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.901 -0.777 . . . . 0.16 108.901 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -109.26 117.29 54.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.178 0.513 . . . . 0.19 111.263 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 23.8 mmt -81.61 154.6 71.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.235 -0.654 . . . . 0.94 109.235 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.0 Cg_endo -86.47 156.27 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.129 1.886 . . . . 0.19 113.342 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' B' ' 23' ' ' ARG . 4.0 tp -56.47 -30.39 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.832 . . . . 0.22 109.314 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 3.4 mm-40 -58.84 -28.95 66.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.87 . . . . 1.07 110.909 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.923 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.72 -40.22 34.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.987 -0.745 . . . . 0.24 108.987 177.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.635 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 57.0 mtm180 -64.2 -27.69 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.037 -0.983 . . . . 1.3 110.357 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -83.99 -35.19 24.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.165 -0.925 . . . . 0.87 110.018 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -51.33 67.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.849 -1.069 . . . . 0.28 110.878 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.781 HD22 ' H ' ' B' ' 47' ' ' LYS . 70.3 mt -90.83 -85.65 0.22 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.611 -1.177 . . . . 0.57 111.675 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.59 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.3 t0 169.05 55.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.67 -0.863 . . . . 1.54 108.67 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.23 139.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.31 109.908 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.45 -59.58 1.93 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.814 -0.63 . . . . 0.41 111.083 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.47 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -140.85 -33.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.177 -0.465 . . . . 0.34 110.072 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 40.0 mtpt -133.98 -52.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.913 -0.773 . . . . 1.38 108.913 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.8 OUTLIER 36.94 -118.96 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.686 -1.143 . . . . 1.17 114.063 -176.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.572 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 15.9 m -161.43 134.72 6.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.996 0.362 . . . . 0.24 111.337 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.653 HG21 HD23 ' B' ' 45' ' ' LEU . 3.8 mp -141.71 102.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.682 -0.488 . . . . 0.2 109.682 171.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 38.5 tt0 -99.29 136.87 38.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 1.33 109.576 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.731 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -110.43 158.12 18.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.283 1.039 . . . . 1.27 113.268 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.656 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 35.1 t80 -135.39 125.13 25.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.632 -1.622 . . . . 2.1 107.86 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.751 ' H ' ' HB2' ' A' ' 3' ' ' SER . 13.5 p -92.9 135.31 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.87 -0.732 . . . . 0.3 110.111 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -133.64 100.05 4.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.833 -0.621 . . . . 1.18 110.039 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 -80.42 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.42 111.917 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.69 -19.79 3.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.238 0.542 . . . . 1.91 110.008 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -91.82 167.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.489 -0.778 . . . . 0.78 110.796 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 8.4 mm -121.72 139.98 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.554 -0.748 . . . . 0.22 109.149 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.2 mt -118.27 111.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.498 -0.319 . . . . 0.3 110.59 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.85 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -99.61 132.23 45.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.647 0.261 . . . . 0.25 111.478 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HE3' ' A' ' 2' ' ' LYS . 3.1 ptmt -153.76 145.33 23.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.012 -0.54 . . . . 1.85 111.328 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.781 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.9 tmtp? -72.37 135.5 45.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 0.51 109.905 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -62.76 -53.65 51.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.354 -0.839 . . . . 1.17 112.207 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.757 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 26.2 ttpp -49.3 -59.47 6.49 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 113.361 0.874 . . . . 2.92 113.361 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 13.2 Cg_exo -70.93 -44.78 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.931 1.754 . . . . 1.57 112.308 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -122.17 75.67 1.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.212 0.529 . . . . 4.68 110.638 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.22 16.44 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.351 -0.84 . . . . 3.12 111.689 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.85 148.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.007 -1.097 . . . . 3.62 111.027 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.905 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 1.6 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.243 -0.884 . . . . 2.82 111.453 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ptp . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 122.15 0.976 . . . . 4.8 110.315 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.917 ' HG2' ' HB3' ' B' ' 54' ' ' CYS . 55.4 mtmt -75.19 -162.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.065 -1.425 . . . . 2.48 112.035 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.505 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 28.4 m -44.8 -54.59 6.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.38 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -84.82 -34.13 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.297 -1.001 . . . . 0.34 108.297 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' HA2' ' N ' ' A' ' 2' ' ' LYS . . . 73.35 16.09 78.85 Favored Glycine 0 CA--C 1.504 -0.603 0 CA-C-N 114.88 -1.055 . . . . 0.51 112.736 174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 23.4 m -114.7 131.17 67.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.778 0.799 . . . . 0.23 111.475 -175.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.7 p -110.21 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.997 -1.456 . . . . 0.17 108.746 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.7 mpt_? -122.04 164.24 18.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.436 -0.347 . . . . 1.21 110.557 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 34.1 mmtm -115.06 127.59 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.592 -0.892 . . . . 1.13 108.592 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.851 HG23 HD11 ' B' ' 34' ' ' ILE . 18.3 t -58.55 136.64 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.57 -0.53 . . . . 0.24 109.57 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.71 -77.87 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.899 -0.591 . . . . 1.31 109.564 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.3 mt-10 -154.81 -45.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.747 -1.205 . . . . 1.23 107.747 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.13 -34.69 63.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.338 -1.301 . . . . 0.85 110.908 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 141.86 -9.62 2.56 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.21 -0.905 . . . . 0.17 111.12 -172.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 27.9 mtm180 -62.45 131.43 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.262 . . . . 3.03 111.165 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -141.46 179.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.096 -0.705 . . . . 0.13 109.096 174.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -107.91 107.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.346 0.593 . . . . 0.19 110.908 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.62 ' HB3' HD13 ' A' ' 22' ' ' LEU . 77.4 mmm -80.29 152.56 73.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.122 -0.695 . . . . 0.84 109.122 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 95.2 Cg_endo -84.66 157.22 12.12 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.767 1.645 . . . . 0.16 114.119 -171.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.511 HG13 ' HD2' ' A' ' 24' ' ' ARG . 3.1 tp -50.44 -37.81 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.816 -1.084 . . . . 0.26 110.224 170.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.4 mm-40 -59.71 -26.13 65.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 1.08 110.782 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -77.09 -39.21 50.49 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.947 -0.76 . . . . 0.2 108.947 177.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 17.3 mtm180 -64.02 -34.74 78.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.312 -0.858 . . . . 1.05 110.028 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.7 mtp180 -79.62 -35.6 39.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.175 -0.92 . . . . 0.71 110.083 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.43 -51.4 29.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.051 -0.977 . . . . 0.26 110.212 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.5 mt -78.01 -89.87 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.173 -0.921 . . . . 0.52 111.492 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 11.2 t70 175.15 43.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.511 -0.922 . . . . 1.72 108.511 -169.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -115.44 138.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 0.28 111.317 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.94 -51.15 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.013 -0.539 . . . . 0.3 111.513 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -147.18 -29.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.032 -0.359 . . . . 0.33 110.032 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 30' ' ' ILE . 18.4 mtpp -138.98 -52.23 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.265 -0.642 . . . . 1.46 109.265 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 35.08 -110.24 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.49 -1.232 . . . . 1.18 113.946 -177.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 50.4 m -165.34 142.44 5.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.377 0.535 . . . . 0.21 111.168 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.001 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -141.13 108.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 110.26 -0.274 . . . . 0.28 110.26 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.602 ' HG2' ' HE3' ' B' ' 2' ' ' LYS . 40.4 tt0 -105.63 132.17 52.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.987 -0.375 . . . . 1.31 109.987 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.614 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.41 155.97 23.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.404 1.097 . . . . 1.33 113.017 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.941 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 40.9 t80 -125.22 153.38 43.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.331 -1.759 . . . . 2.22 106.454 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.9 p -122.16 133.09 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.788 -0.765 . . . . 0.27 110.175 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.56 96.9 4.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 1.16 110.033 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.89 -82.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.586 -0.733 . . . . 0.32 111.502 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' HD23 ' B' ' 26' ' ' LEU . 14.6 m-20 -125.5 -17.7 5.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.724 -0.238 . . . . 2.0 110.99 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 166.27 12.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 1.05 110.72 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG13 HD12 ' B' ' 22' ' ' LEU . 15.3 mm -120.72 142.96 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.631 -0.507 . . . . 0.18 109.631 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 43.0 mt -124.65 111.24 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.28 110.613 -174.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -94.64 135.78 35.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.24 0.543 . . . . 0.32 111.905 -174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.686 ' HE3' ' HE2' ' B' ' 2' ' ' LYS . 16.4 ttpp -149.68 134.56 17.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.852 -1.067 . . . . 2.16 109.421 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' H ' HD22 ' A' ' 26' ' ' LEU . 1.7 tmtp? -63.86 155.32 30.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.637 -0.875 . . . . 0.52 108.637 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.619 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 25.1 t80 -70.43 -49.33 49.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.067 0.46 . . . . 1.25 111.004 -173.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.576 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 40.4 ttmt -50.87 -55.07 30.34 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 113.807 1.04 . . . . 2.86 113.807 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 36.7 Cg_exo -38.21 136.06 0.6 Allowed 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.523 2.815 . . . . 1.81 113.72 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.76 152.8 40.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.593 -0.73 . . . . 4.69 111.074 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.71 73.93 0.59 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 109.531 -1.427 . . . . 3.14 109.531 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -52.35 137.66 11.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.641 0.734 . . . . 3.58 112.702 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.905 ' HB3' ' HG2' ' B' ' 2' ' ' LYS . 74.6 m . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 114.234 -1.348 . . . . 2.87 108.52 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.757 0.789 . . . . 4.74 110.6 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.941 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 14.5 mttt -75.75 -158.09 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.186 -0.915 . . . . 2.31 112.967 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.1 m -47.25 -58.2 4.36 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.682 -1.144 . . . . 1.0 110.858 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.16 -35.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.528 -1.286 . . . . 0.32 107.528 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.686 ' HA2' ' N ' ' B' ' 2' ' ' LYS . . . 67.11 28.66 73.82 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 114.382 -1.281 . . . . 0.43 112.375 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.8 m -118.66 132.21 69.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.219 0.533 . . . . 0.25 110.603 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -109.44 147.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.16 109.196 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.472 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mpt_? -120.12 167.01 12.65 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.144 -0.48 . . . . 1.09 110.377 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 40.6 mmtm -119.02 122.53 42.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.699 -0.852 . . . . 1.16 108.699 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 1.001 HG23 HD11 ' A' ' 34' ' ' ILE . 4.3 t -56.04 133.31 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.281 -0.637 . . . . 0.25 109.281 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -79.16 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.756 -0.656 . . . . 1.22 109.972 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.521 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.4 mt-10 -152.73 -40.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.085 -1.08 . . . . 1.22 108.085 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.3 OUTLIER -89.74 -15.2 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.067 -1.424 . . . . 0.9 110.493 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 124.21 -4.75 8.91 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.15 111.934 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 53.0 mtm180 -63.45 131.74 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.869 0.067 . . . . 2.91 110.839 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.694 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -142.15 179.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.904 -0.776 . . . . 0.16 108.904 174.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -107.95 109.14 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.007 0.432 . . . . 0.19 110.769 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.6 ' HB3' HD13 ' B' ' 22' ' ' LEU . 77.3 mmm -80.97 152.25 71.41 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.702 -0.851 . . . . 0.94 108.702 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 40.7 Cg_endo -83.16 158.1 15.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.559 1.506 . . . . 0.19 113.583 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.624 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.9 tp -58.62 -29.55 39.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.142 -0.935 . . . . 0.22 109.307 172.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.54 -27.82 67.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 1.07 110.823 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.736 HD12 HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -76.99 -41.42 42.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.723 -0.843 . . . . 0.24 108.723 176.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.765 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 65.1 mtp180 -62.81 -31.25 72.2 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.543 -1.208 . . . . 1.3 110.899 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -81.15 -33.99 32.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.361 -0.836 . . . . 0.87 109.652 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.59 19.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.729 -1.123 . . . . 0.28 111.419 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 74.2 mt -82.06 -81.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.862 -1.063 . . . . 0.57 111.091 -171.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.571 ' C ' HD12 ' B' ' 28' ' ' ILE . 37.6 t70 170.9 49.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 -173.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -115.8 133.93 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.1 0.476 . . . . 0.31 110.336 -173.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.79 -48.47 3.92 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.512 -0.767 . . . . 0.41 111.385 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.662 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -152.9 -29.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.008 0.432 . . . . 0.34 109.97 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.662 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.8 mtpp -138.55 -51.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.944 -0.761 . . . . 1.38 108.944 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.587 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 36.35 -108.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.518 -1.219 . . . . 1.17 114.136 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 21.0 m -167.93 141.27 3.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.884 0.311 . . . . 0.24 110.67 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.851 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -144.23 106.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 110.214 -0.291 . . . . 0.2 110.214 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 tt0 -98.6 142.17 30.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.852 -0.425 . . . . 1.33 109.852 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.589 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -114.45 155.4 26.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.067 0.936 . . . . 1.27 112.911 -175.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.821 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.4 t80 -127.31 151.17 49.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.754 -1.572 . . . . 2.1 106.754 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.505 ' H ' ' HB2' ' A' ' 3' ' ' SER . 4.6 p -118.99 134.62 62.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.665 -0.814 . . . . 0.3 110.604 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 19.8 t70 -129.44 95.81 4.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.222 -0.899 . . . . 1.18 109.827 -175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.59 -82.31 0.39 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.901 -0.666 . . . . 0.42 111.662 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.421 ' O ' HD23 ' A' ' 26' ' ' LEU . 26.6 m-20 -128.46 -13.26 4.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.516 0.198 . . . . 1.91 110.514 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 1.2 ptpp? -100.29 168.94 9.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.389 . . . . 0.78 110.55 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 23.4 mm -124.67 144.81 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.8 -0.637 . . . . 0.22 109.955 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.821 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 39.4 mt -125.93 115.08 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.27 -0.423 . . . . 0.3 110.951 -173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -101.47 134.27 44.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.081 0.467 . . . . 0.25 111.869 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HA ' HD22 ' B' ' 26' ' ' LEU . 24.5 ttpp -147.99 137.6 22.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.191 -0.913 . . . . 1.85 109.257 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -64.68 150.28 47.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.395 -0.965 . . . . 0.51 108.395 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.634 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 0.8 OUTLIER -65.56 -51.93 56.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.77 0.319 . . . . 1.17 110.707 -172.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.679 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 31.6 ttmt -48.81 -57.69 10.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.729 1.011 . . . . 2.92 113.729 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 39.1 Cg_exo -38.99 125.53 1.08 Allowed 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.249 2.633 . . . . 1.57 113.577 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -61.13 154.59 22.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.904 -1.044 . . . . 4.68 111.826 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.3 76.22 0.82 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.693 -1.363 . . . . 3.12 109.693 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.93 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.635 0.731 . . . . 3.62 112.36 -171.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.917 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 73.9 m . . . . . 0 C--O 1.244 0.792 0 CA-C-N 114.487 -1.233 . . . . 2.82 108.159 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.507 -0.183 . . . . 4.8 110.507 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 58.27 -175.33 0.08 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.629 0.728 . . . . 2.48 112.749 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 5.2 m -76.9 -48.37 18.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.244 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' B' ' 37' ' ' PHE . 3.9 mt -97.69 -37.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.34 109.701 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.64 40.54 31.7 Favored Glycine 0 CA--C 1.506 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.51 112.446 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 4' ' ' ILE . 8.1 m -138.12 133.57 44.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.486 0.66 . . . . 0.23 111.309 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -118.89 140.9 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.763 -1.108 . . . . 0.17 109.061 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -116.29 160.05 21.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.82 -0.437 . . . . 1.21 109.82 -174.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 26.3 mmtp -122.15 120.44 34.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.335 -0.987 . . . . 1.13 108.335 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.794 HG23 HD11 ' B' ' 34' ' ' ILE . 18.1 t -52.32 138.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.732 0.645 . . . . 0.24 110.767 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.84 -71.86 0.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.77 -0.65 . . . . 1.31 109.695 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -154.39 -51.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.938 -0.764 . . . . 1.23 108.938 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -82.56 -23.93 34.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.65 -1.159 . . . . 0.85 110.821 -177.136 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 139.75 -9.6 3.12 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.913 -0.661 . . . . 0.17 112.139 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 35.6 mtm180 -62.8 129.82 42.14 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.824 -0.221 . . . . 3.03 110.945 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.18 177.33 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.268 -0.641 . . . . 0.13 109.268 175.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.733 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -106.31 111.61 35.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.301 0.572 . . . . 0.19 111.096 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 2.8 mmt -83.01 155.58 67.47 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.022 -0.733 . . . . 0.84 109.022 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.2 Cg_endo -86.69 153.86 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.033 1.822 . . . . 0.16 113.573 -173.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.3 tp -52.59 -33.0 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.26 109.667 169.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 2.3 mm-40 -62.15 -26.53 68.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.514 -0.766 . . . . 1.08 110.873 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -78.91 -38.9 36.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.73 -0.841 . . . . 0.2 108.73 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.72 ' HD3' HG11 ' B' ' 10' ' ' VAL . 37.3 mtm180 -65.07 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.107 -0.951 . . . . 1.05 110.249 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.3 mtp180 -84.62 -37.52 20.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.164 -0.925 . . . . 0.71 110.529 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.2 -50.18 55.94 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.43 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -80.6 -86.33 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.789 -1.096 . . . . 0.52 111.13 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' H ' HD12 ' A' ' 28' ' ' ILE . 18.4 t0 166.6 61.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.6 -1.259 . . . . 1.72 107.6 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.707 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -123.95 134.27 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.406 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.33 -56.67 2.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.151 0.5 . . . . 0.3 110.825 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -141.48 -30.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.81 -0.632 . . . . 0.33 109.699 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 6.7 mtpp -136.17 -54.15 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.323 -0.621 . . . . 1.46 109.323 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.97 -116.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.423 -1.262 . . . . 1.18 113.706 -175.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 14.0 m -162.0 136.73 7.0 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.409 0.549 . . . . 0.21 111.125 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' B' ' 10' ' ' VAL . 3.8 mp -138.6 103.15 2.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.868 -0.419 . . . . 0.28 109.868 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.6 tt0 -97.95 137.73 36.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.254 -0.647 . . . . 1.31 109.254 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -121.68 151.04 40.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.426 1.108 . . . . 1.33 112.989 -175.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -113.5 165.87 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.311 -1.768 . . . . 2.22 107.034 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' B' ' 3' ' ' SER . 2.9 p -133.19 125.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.49 0.662 . . . . 0.27 109.906 167.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -128.57 104.59 7.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.926 -1.034 . . . . 1.16 109.758 -173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.83 -92.08 0.53 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.156 -0.778 . . . . 0.32 111.156 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD23 ' B' ' 26' ' ' LEU . 28.7 m-20 -126.9 4.57 6.57 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.993 -0.373 . . . . 2.0 109.993 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -109.97 157.24 19.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 1.05 111.437 -168.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HD12 ' B' ' 22' ' ' LEU . 19.8 mm -113.84 142.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.837 -0.431 . . . . 0.18 109.837 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 mt -123.78 115.48 45.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.521 -0.309 . . . . 0.28 110.92 -173.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' B' ' 45' ' ' LEU . 10.5 mp -101.27 129.79 47.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.47 0.652 . . . . 0.32 112.429 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 13.4 ttpt -142.49 141.09 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.579 -1.191 . . . . 2.16 109.749 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 1.5 tmtp? -73.96 148.95 41.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.574 -0.898 . . . . 0.52 108.574 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.636 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 36.6 t80 -66.78 -47.73 71.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.064 0.459 . . . . 1.25 111.235 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.716 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.6 tmtp? -48.56 -56.24 15.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.025 -0.989 . . . . 2.86 113.168 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_exo -52.86 108.36 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.244 1.963 . . . . 1.81 111.948 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -79.07 79.12 5.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.995 -0.548 . . . . 4.69 111.289 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.35 -85.48 1.44 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.336 -1.106 . . . . 3.14 110.336 170.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.1 p -157.85 145.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.857 0.36 . . . . 3.58 110.14 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.427 ' OXT' ' HE3' ' B' ' 2' ' ' LYS . 11.1 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 119.042 -0.504 . . . . 2.87 110.383 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.735 -0.469 . . . . 4.74 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.939 ' HE2' ' HA ' ' B' ' 2' ' ' LYS . 4.3 mmpt? 56.96 179.72 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.918 1.081 . . . . 2.31 113.918 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 19.9 m -68.67 -48.92 62.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.349 -1.296 . . . . 1.0 110.362 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.63 -46.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.481 -0.781 . . . . 0.32 109.398 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.63 35.02 37.59 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.267 -0.879 . . . . 0.43 112.512 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -129.09 132.4 67.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.042 0.448 . . . . 0.25 110.39 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.3 p -112.07 143.15 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.874 -0.787 . . . . 0.16 108.874 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.402 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.4 mpt_? -114.81 162.9 16.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.237 -0.438 . . . . 1.09 110.602 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.59 121.3 38.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.523 -0.918 . . . . 1.16 108.523 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 34' ' ' ILE . 2.9 t -56.32 132.87 20.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 O-C-N 123.358 0.411 . . . . 0.25 110.115 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.17 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.22 109.672 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.55 ' HG2' HD11 ' A' ' 30' ' ' ILE . 40.8 mt-10 -155.13 -39.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 124.272 0.983 . . . . 1.22 108.445 171.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.754 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -92.06 -18.01 24.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.458 -1.246 . . . . 0.9 110.472 -177.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 130.1 -7.49 6.04 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.639 -0.71 . . . . 0.15 112.106 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 39.2 mtm180 -61.45 129.99 43.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.819 -0.224 . . . . 2.91 110.789 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -140.8 176.01 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.298 -0.63 . . . . 0.16 109.298 175.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 1.5 p -105.3 108.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.295 0.569 . . . . 0.19 111.358 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.9 mmt -75.3 156.26 85.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.027 -0.731 . . . . 0.94 109.027 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.1 Cg_endo -87.84 155.58 7.36 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.988 1.792 . . . . 0.19 113.417 -176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.283 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -59.31 -30.03 68.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.401 -0.818 . . . . 1.07 110.804 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.881 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.33 -39.99 58.83 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.24 108.701 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.718 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 33.8 mtm180 -64.47 -30.09 71.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.862 -1.063 . . . . 1.3 110.318 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.414 ' HD2' HG13 ' B' ' 20' ' ' ILE . 74.8 mtp180 -84.64 -24.63 28.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.311 -0.859 . . . . 0.87 110.39 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.12 -53.2 8.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.218 -0.901 . . . . 0.28 110.941 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.785 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 16.2 mt -83.13 -81.39 0.16 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.056 -0.975 . . . . 0.57 110.212 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.593 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.3 t70 165.19 61.24 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.965 -1.124 . . . . 1.54 107.965 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -116.63 133.73 62.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.845 -0.616 . . . . 0.31 109.653 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.58 -56.82 2.21 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.178 -0.464 . . . . 0.41 110.853 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -143.03 -31.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.84 -0.618 . . . . 0.34 109.672 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -134.6 -51.88 0.8 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.354 -0.61 . . . . 1.38 109.354 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.4 OUTLIER 39.77 -113.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.677 -1.147 . . . . 1.17 113.818 -176.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 18.7 m -161.93 135.95 6.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.042 0.214 . . . . 0.24 111.235 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.794 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -139.87 102.07 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 N-CA-C 109.677 -0.49 . . . . 0.2 109.677 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 45.6 tt0 -96.47 135.55 38.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.33 109.388 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.527 ' CE2' ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -121.07 151.29 40.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.603 0.716 . . . . 1.27 112.375 -176.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.563 ' HA ' HG13 ' A' ' 4' ' ' ILE . 2.8 p90 -143.34 139.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.962 -1.017 . . . . 2.1 110.307 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.624 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.2 p -92.9 141.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.383 0.611 . . . . 0.3 110.791 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.98 102.22 5.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.164 -0.926 . . . . 1.18 109.355 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.6 -88.18 0.53 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.104 -0.799 . . . . 0.42 111.104 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.07 -8.13 5.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.412 -0.218 . . . . 1.91 110.412 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -105.78 168.42 9.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.78 111.0 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 22' ' ' LEU . 30.4 mm -119.65 142.5 34.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.861 -0.609 . . . . 0.22 109.491 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 11.8 mt -125.95 125.44 68.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.912 -0.315 . . . . 0.3 110.178 -175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -107.48 128.87 54.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.203 0.525 . . . . 0.25 111.86 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.509 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 10.3 ttpt -142.47 138.68 31.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.831 -1.077 . . . . 1.85 110.158 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.6 tmtp? -70.01 146.67 50.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.822 -0.807 . . . . 0.51 108.822 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.581 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 40.5 t80 -64.89 -50.35 66.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 1.17 111.419 -173.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.713 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -47.96 -57.87 9.2 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.36 -0.836 . . . . 2.92 113.033 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 87.0 Cg_exo -48.69 110.75 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 122.266 1.978 . . . . 1.57 112.149 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -79.17 87.71 4.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.646 -0.706 . . . . 4.68 111.27 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.21 -87.09 1.97 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.311 -1.116 . . . . 3.12 110.311 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.4 142.76 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 3.62 109.907 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 C--O 1.245 0.831 0 CA-C-O 119.28 -0.391 . . . . 2.82 110.313 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.713 0.292 . . . . 4.8 110.874 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.783 ' HD2' ' HB2' ' B' ' 37' ' ' PHE . 54.0 mtmt -89.96 -172.58 3.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.075 0.398 . . . . 2.48 112.075 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 25.0 m -44.94 -57.6 3.69 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.46 0.704 . . . . 1.0 111.998 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.1 mt -82.57 -35.59 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.037 -1.098 . . . . 0.34 108.037 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.53 13.74 74.49 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 114.738 -1.119 . . . . 0.51 112.798 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 29.1 m -105.17 132.44 51.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.502 0.667 . . . . 0.23 110.93 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.8 p -113.52 139.78 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.494 -1.23 . . . . 0.17 109.913 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -114.4 156.65 24.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.893 -0.594 . . . . 1.21 110.435 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -117.71 122.86 44.64 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.877 -0.786 . . . . 1.13 108.877 175.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 28' ' ' ILE . 27.4 t -57.64 146.19 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.24 111.781 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -64.97 -77.55 0.06 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.12 -0.945 . . . . 1.31 110.151 174.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -155.22 -43.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.729 -0.841 . . . . 1.23 108.729 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 -25.88 30.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.647 -1.16 . . . . 0.85 110.936 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 133.93 -6.76 4.79 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.295 -0.866 . . . . 0.17 110.984 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 48.2 mtm180 -62.79 128.18 34.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.423 0.154 . . . . 3.03 110.83 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -139.52 179.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.688 -0.856 . . . . 0.13 108.688 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -106.28 116.18 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.083 0.468 . . . . 0.19 110.907 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.636 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.9 mmt -83.56 150.84 60.77 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.34 -0.615 . . . . 0.84 109.34 174.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.56 154.48 18.22 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.777 1.651 . . . . 0.16 113.098 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.536 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.1 tp -53.41 -32.18 19.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.325 -0.852 . . . . 0.26 109.629 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.1 mm-40 -61.14 -27.78 68.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.08 111.111 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.851 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -40.7 41.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.625 -0.879 . . . . 0.2 108.625 176.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.623 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 42.3 mtm180 -63.66 -30.55 71.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.861 -1.063 . . . . 1.05 110.133 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.0 mtp180 -84.59 -32.12 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.37 -0.832 . . . . 0.71 110.73 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.19 76.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.528 -0.76 . . . . 0.26 109.803 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.773 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.8 mt -96.66 -91.53 0.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.974 -1.012 . . . . 0.52 111.841 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 29.7 t70 172.31 55.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.742 -1.207 . . . . 1.72 107.742 -170.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.623 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.2 mp -116.23 130.38 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.81 -0.632 . . . . 0.28 109.813 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -58.07 2.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.241 0.543 . . . . 0.3 110.915 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.542 ' O ' HG12 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -143.42 -29.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.599 -0.728 . . . . 0.33 109.616 -177.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 30' ' ' ILE . 34.9 mtpt -136.09 -54.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.665 . . . . 1.46 109.458 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 37.38 -124.4 0.21 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.814 1.042 . . . . 1.18 113.814 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 16.4 m -159.88 134.53 7.74 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.426 0.557 . . . . 0.21 111.318 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -139.58 108.42 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 110.155 -0.313 . . . . 0.28 110.155 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 66.9 tt0 -99.68 140.99 33.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.762 -0.458 . . . . 1.31 109.762 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.455 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -119.85 155.2 33.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.417 1.104 . . . . 1.33 113.502 -176.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.923 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 6.6 t80 -121.34 144.81 48.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.418 -1.719 . . . . 2.22 106.481 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' HB2' ' B' ' 3' ' ' SER . 8.8 p -116.47 128.76 73.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.506 -0.878 . . . . 0.27 110.3 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -131.76 102.0 5.7 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.958 -1.019 . . . . 1.16 109.755 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.63 -92.92 0.45 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.334 -0.706 . . . . 0.32 111.334 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.54 -9.99 9.32 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.396 -0.594 . . . . 2.0 109.396 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -97.31 157.72 15.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.779 -0.646 . . . . 1.05 111.397 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.87 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 9.5 mm -116.38 144.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.261 -0.644 . . . . 0.18 109.261 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 47.3 mt -129.52 109.7 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 122.33 0.252 . . . . 0.28 110.782 -173.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.723 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -98.48 142.54 29.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.207 0.447 . . . . 0.32 112.207 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -150.36 158.52 44.25 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.635 -0.711 . . . . 2.16 109.241 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.773 ' H ' HD22 ' A' ' 26' ' ' LEU . 2.8 tmtp? -70.85 149.24 47.0 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.455 -0.943 . . . . 0.52 108.455 174.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.58 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 91.7 t80 -66.75 -54.34 23.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 1.25 110.853 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.851 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 23.5 tptm -45.84 -59.84 4.19 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.028 -0.987 . . . . 2.86 113.333 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.851 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 52.1 Cg_exo -56.09 122.89 12.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.178 1.919 . . . . 1.81 112.459 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -82.67 99.37 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.575 -0.738 . . . . 4.69 109.96 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.88 -120.06 4.45 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.668 -0.777 . . . . 3.14 111.489 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.16 137.46 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.233 0.539 . . . . 3.58 110.474 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.579 -0.737 . . . . 2.87 109.696 -177.075 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.788 0.328 . . . . 4.74 110.749 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.923 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 11.0 mtmt -86.46 -174.66 5.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.659 0.614 . . . . 2.31 112.659 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.4 m -49.01 -53.75 18.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.243 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.416 HD12 ' HD2' ' A' ' 36' ' ' PHE . 3.2 mt -83.19 -35.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.519 -1.289 . . . . 0.32 107.519 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.502 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 63.38 28.02 71.68 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.349 -1.296 . . . . 0.43 112.178 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.5 m -116.62 133.07 64.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.165 0.507 . . . . 0.25 110.272 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.1 p -113.46 140.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.16 109.861 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.462 ' NH1' ' HB ' ' B' ' 6' ' ' VAL . 6.6 mpt_? -114.4 157.35 22.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.993 -0.549 . . . . 1.09 110.667 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.13 119.02 33.47 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.472 -0.936 . . . . 1.16 108.472 177.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.653 HG23 HD11 ' A' ' 34' ' ' ILE . 5.5 t -56.28 141.76 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 123.839 0.712 . . . . 0.25 111.719 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -60.7 -79.56 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.951 -1.022 . . . . 1.22 110.474 175.147 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 30' ' ' ILE . 39.9 mt-10 -156.22 -39.68 0.08 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.228 -1.027 . . . . 1.22 108.228 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.94 -25.03 32.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.686 -1.143 . . . . 0.9 110.457 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 127.66 -3.12 7.04 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.051 -0.977 . . . . 0.15 110.742 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 72.9 mtm180 -62.18 127.02 29.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.275 . . . . 2.91 110.613 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.0 OUTLIER -137.28 179.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.16 108.705 175.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.833 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -107.66 112.71 41.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.151 0.501 . . . . 0.19 111.034 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.666 ' HB3' HD22 ' B' ' 22' ' ' LEU . 29.2 mmt -76.3 154.35 84.19 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.11 -0.7 . . . . 0.94 109.11 173.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 51.5 Cg_endo -85.78 156.29 10.26 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 121.998 1.799 . . . . 0.19 112.707 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -57.67 -29.04 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.381 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.4 -28.48 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.718 -0.674 . . . . 1.07 110.691 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.857 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.77 -40.87 32.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.967 -0.753 . . . . 0.24 108.967 176.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 35.3 mtm180 -62.84 -30.09 71.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.892 -1.049 . . . . 1.3 110.245 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.37 -34.87 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.94 . . . . 0.87 109.973 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.75 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.013 -0.994 . . . . 0.28 109.964 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.654 HD22 ' H ' ' B' ' 47' ' ' LYS . 36.9 mt -94.44 -104.24 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.631 -1.168 . . . . 0.57 110.94 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.495 ' H ' HD12 ' B' ' 28' ' ' ILE . 11.2 m-20 -153.62 16.26 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.812 -0.176 . . . . 1.54 111.461 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.694 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -76.62 129.32 37.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.369 -0.533 . . . . 0.31 110.471 -164.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -57.59 2.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.67 -0.696 . . . . 0.41 110.387 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.573 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -142.48 -31.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.687 -0.688 . . . . 0.34 109.566 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.0 mtpt -134.54 -53.08 0.82 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.773 -0.648 . . . . 1.38 109.359 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.2 OUTLIER 41.05 -119.34 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.886 -1.052 . . . . 1.17 113.51 -177.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 46.5 m -165.43 132.35 2.85 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.475 -0.141 . . . . 0.24 110.866 -173.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -139.71 105.76 2.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.602 0.239 . . . . 0.2 110.609 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 57.9 tt0 -96.32 141.7 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.613 -0.514 . . . . 1.33 109.613 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.712 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.1 OUTLIER -113.83 159.8 19.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 122.121 0.963 . . . . 1.27 112.896 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 14.0 t80 -136.17 126.08 25.86 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 113.776 -1.556 . . . . 2.1 107.656 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 11.0 p -95.81 134.63 32.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.831 -0.748 . . . . 0.3 110.468 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -134.83 101.05 4.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.592 -0.731 . . . . 1.18 110.107 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.01 -93.63 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.005 -0.838 . . . . 0.42 111.005 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.54 -16.48 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.884 -0.413 . . . . 1.91 109.884 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' B' ' 42' ' ' LYS . 3.6 ptpp? -95.62 169.83 9.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.353 0.597 . . . . 0.78 111.109 -167.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.851 HG13 HD12 ' A' ' 22' ' ' LEU . 27.4 mm -125.38 142.34 42.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.172 -0.922 . . . . 0.22 109.447 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.764 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 25.3 mt -124.2 115.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 0.3 111.004 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.87 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -102.86 141.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.125 0.417 . . . . 0.25 112.125 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.426 ' HG2' ' NZ ' ' A' ' 2' ' ' LYS . 18.4 pttp -151.11 158.73 44.39 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.796 -0.816 . . . . 1.85 108.796 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.654 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.4 tmtp? -72.56 153.72 41.16 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.997 -1.112 . . . . 0.51 107.997 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.508 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 69.0 t80 -66.44 -55.49 15.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.821 0.344 . . . . 1.17 111.19 -173.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.639 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 17.7 tptm -56.77 -52.4 74.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.487 0.921 . . . . 2.92 113.487 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 73.1 Cg_exo -53.38 115.27 2.19 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.062 1.841 . . . . 1.57 112.002 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.37 87.4 6.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.652 -0.704 . . . . 4.68 110.636 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.54 -144.48 16.92 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.257 -0.737 . . . . 3.12 111.257 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 143.78 10.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 3.62 110.504 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.249 1.066 0 CA-C-N 115.961 -0.563 . . . . 2.82 109.842 179.152 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.529 0.204 . . . . 4.8 111.072 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.98 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 25.9 mtpp -74.55 -178.5 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.285 -0.166 . . . . 2.48 110.741 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.572 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 54.7 m -48.73 -53.08 20.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.205 0.526 . . . . 1.0 111.888 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' B' ' 36' ' ' PHE . 2.3 mt -81.8 -32.26 11.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.243 -1.021 . . . . 0.34 108.243 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.29 13.12 76.85 Favored Glycine 0 CA--C 1.503 -0.689 0 CA-C-N 114.657 -1.156 . . . . 0.51 112.735 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' B' ' 36' ' ' PHE . 25.5 m -108.98 131.54 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.568 0.699 . . . . 0.23 111.056 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -109.34 140.74 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.553 -1.203 . . . . 0.17 109.284 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.0 mpt_? -114.45 159.71 20.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.166 -0.47 . . . . 1.21 110.344 -175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 30.6 mmtp -122.19 121.76 37.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.326 -0.99 . . . . 1.13 108.326 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HG21 ' B' ' 28' ' ' ILE . 26.9 t -55.25 145.33 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.851 0.719 . . . . 0.24 110.953 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.43 -75.27 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.778 -0.647 . . . . 1.31 109.266 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' HD11 ' B' ' 30' ' ' ILE . 30.5 mt-10 -152.79 -39.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.38 -34.65 28.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.41 -1.268 . . . . 0.85 111.284 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.82 -11.09 2.63 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.942 -0.863 . . . . 0.17 110.942 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 49.7 mtt180 -62.88 131.68 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.517 -0.342 . . . . 3.03 110.869 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -139.85 176.04 6.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.071 -0.715 . . . . 0.13 109.071 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.707 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.3 p -104.64 112.77 39.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.209 0.528 . . . . 0.19 110.873 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 1.2 mmt -82.12 152.43 68.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.686 -0.857 . . . . 0.84 108.686 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 92.4 Cg_endo -83.91 156.54 13.48 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.664 1.576 . . . . 0.16 113.132 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.86 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.7 tp -54.65 -33.33 27.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.176 -0.92 . . . . 0.26 109.538 172.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.13 -26.88 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 1.08 111.01 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.69 -40.98 47.12 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.728 -0.842 . . . . 0.2 108.728 176.447 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 53.3 mtm180 -63.92 -30.18 71.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.097 -0.956 . . . . 1.05 110.165 176.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.86 ' HD2' HG13 ' A' ' 20' ' ' ILE . 37.6 mtp180 -85.15 -30.51 23.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.208 -0.906 . . . . 0.71 110.651 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.31 -45.67 65.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.555 0.693 . . . . 0.26 109.677 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 90.1 mt -88.58 -93.72 0.1 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.862 -1.063 . . . . 0.52 111.508 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 28' ' ' ILE . 37.0 t70 172.71 57.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.096 -1.075 . . . . 1.72 108.096 -172.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.561 HG21 HG21 ' B' ' 10' ' ' VAL . 2.8 mp -113.88 131.27 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.28 110.461 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.31 -54.1 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.122 -0.49 . . . . 0.3 111.404 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.23 -33.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.905 -0.588 . . . . 0.33 109.982 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 30' ' ' ILE . 44.1 mtpt -136.88 -51.26 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.986 -0.746 . . . . 1.46 108.986 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 38.18 -119.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.513 -1.221 . . . . 1.18 113.378 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.404 ' HB3' HG21 ' B' ' 7' ' ' VAL . 17.1 m -163.21 135.29 5.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.482 0.583 . . . . 0.21 111.512 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.662 HD11 HG23 ' B' ' 10' ' ' VAL . 2.6 mp -141.88 105.93 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.96 -0.385 . . . . 0.28 109.96 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 72.0 tt0 -99.66 138.05 37.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.335 -0.617 . . . . 1.31 109.335 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -117.55 152.93 34.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.638 1.209 . . . . 1.33 114.136 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.047 ' HB2' ' HE3' ' B' ' 2' ' ' LYS . 32.1 t80 -114.43 157.78 22.43 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 112.98 -1.918 . . . . 2.22 107.134 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' H ' ' HB2' ' B' ' 3' ' ' SER . 5.5 p -127.55 130.7 70.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.116 -0.634 . . . . 0.27 110.033 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 19.3 t70 -130.63 97.24 4.31 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.471 -0.786 . . . . 1.16 109.744 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.19 -78.85 0.3 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.599 -0.728 . . . . 0.32 111.903 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.57 -30.5 4.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.471 0.653 . . . . 2.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -88.37 165.72 14.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.045 -163.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 22' ' ' LEU . 15.4 mm -121.21 142.94 35.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.426 -0.807 . . . . 0.18 109.053 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.95 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 49.1 mt -128.55 108.45 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.511 -0.313 . . . . 0.28 110.851 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.7 mp -99.82 141.61 32.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.306 0.484 . . . . 0.32 112.306 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.883 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -151.94 156.97 41.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.45 -0.795 . . . . 2.16 110.682 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 3.8 tmtp? -73.32 149.16 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.315 -0.624 . . . . 0.52 109.315 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.64 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 69.7 t80 -74.78 -57.96 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 1.25 111.738 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 41.1 tptt -63.8 -56.71 23.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.256 1.206 . . . . 2.86 114.256 -167.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 80.3 Cg_exo -46.84 -63.5 0.32 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.841 2.361 . . . . 1.81 114.263 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.506 ' HB3' HG12 ' A' ' 53' ' ' VAL . 20.6 m-70 -79.22 -44.82 21.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.914 0.338 . . . . 4.69 111.914 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.84 62.29 6.53 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 120.943 -0.646 . . . . 3.14 112.059 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 51' ' ' HIS . 13.8 p -153.64 153.77 8.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.191 -0.505 . . . . 3.58 109.722 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 55.8 m . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.25 -0.881 . . . . 2.87 110.617 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.385 0.136 . . . . 4.74 111.171 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 1.047 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 26.2 mtpp -78.73 -173.21 3.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.409 0.147 . . . . 2.31 111.108 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 67.0 m -53.85 -54.75 34.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.205 0.526 . . . . 1.0 110.812 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.536 HD12 ' HD2' ' A' ' 36' ' ' PHE . 4.0 mt -80.47 -33.18 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.553 -1.277 . . . . 0.32 107.553 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 65.08 20.12 66.65 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.135 -1.393 . . . . 0.43 112.596 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.8 132.02 59.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.25 110.196 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.7 p -106.5 141.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.597 -0.728 . . . . 0.16 109.041 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.1 mpt_? -113.03 157.4 21.59 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.289 0.566 . . . . 1.09 110.673 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 29.8 mmtp -119.14 119.24 33.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.909 -1.041 . . . . 1.16 108.566 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.662 HG23 HD11 ' A' ' 34' ' ' ILE . 7.4 t -57.25 139.82 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.642 0.589 . . . . 0.25 110.777 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.01 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.486 -0.779 . . . . 1.22 109.805 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -152.63 -42.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.392 -0.966 . . . . 1.22 108.392 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.5 -27.3 37.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.783 -1.098 . . . . 0.9 111.255 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.447 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 130.32 0.03 5.51 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.355 -0.698 . . . . 0.15 111.355 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.707 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 24.6 mtt-85 -66.93 130.84 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.121 -0.326 . . . . 2.91 110.121 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -139.53 175.69 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.413 -0.588 . . . . 0.16 109.413 176.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -105.32 108.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.964 0.412 . . . . 0.19 110.973 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.3 mmt -74.97 154.63 86.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.032 -0.729 . . . . 0.94 109.032 173.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 65.5 Cg_endo -86.85 155.49 8.69 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.999 1.799 . . . . 0.19 113.219 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -55.99 -30.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.22 109.431 171.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.3 -30.59 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 1.07 110.999 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.61 -40.35 56.57 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.78 -0.822 . . . . 0.24 108.78 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 34.4 mtm180 -66.13 -26.52 67.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 1.3 110.626 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' HG13 ' B' ' 20' ' ' ILE . 68.9 mtp180 -84.33 -35.37 23.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.577 -0.738 . . . . 0.87 109.734 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.67 -51.58 66.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.727 -1.124 . . . . 0.28 110.947 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.653 HD22 ' H ' ' B' ' 47' ' ' LYS . 71.0 mt -89.83 -85.6 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.732 -1.122 . . . . 0.57 111.139 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.579 ' C ' HD12 ' B' ' 28' ' ' ILE . 15.9 t0 166.46 61.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.797 -1.186 . . . . 1.54 107.797 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.726 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.56 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.66 -0.7 . . . . 0.31 109.86 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.67 -51.59 2.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.721 -0.672 . . . . 0.41 111.652 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -144.16 -33.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 110.011 -0.366 . . . . 0.34 110.011 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 38.1 mtpt -136.29 -49.05 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 1.38 109.051 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.66 -115.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.384 -1.28 . . . . 1.17 113.832 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 14.2 m -164.08 135.37 4.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.994 0.361 . . . . 0.24 111.347 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.708 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -144.04 102.97 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 110.18 -0.304 . . . . 0.2 110.18 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 65.7 tt0 -96.03 139.32 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.541 -0.54 . . . . 1.33 109.541 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.89 155.62 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.524 1.154 . . . . 1.27 113.889 -175.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.98 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 38.8 t80 -120.14 157.26 29.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.1 -1.864 . . . . 2.1 107.073 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.572 ' H ' ' HB2' ' A' ' 3' ' ' SER . 8.5 p -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 120.093 -0.643 . . . . 0.3 109.955 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.822 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.7 t70 -132.3 95.8 3.73 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 1.18 109.917 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.1 -75.9 0.33 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.685 -0.689 . . . . 0.42 111.654 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.32 -29.04 3.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.484 0.659 . . . . 1.91 109.798 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.822 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.4 OUTLIER -85.81 158.36 20.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.112 -0.949 . . . . 0.78 111.778 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.837 HG13 HD12 ' A' ' 22' ' ' LEU . 17.7 mm -118.27 144.11 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.656 -0.702 . . . . 0.22 109.925 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.894 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.1 mt -128.66 114.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 0.3 110.956 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.1 mp -104.23 141.05 36.96 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.89 0.33 . . . . 0.25 111.89 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -151.71 151.55 31.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.946 -0.57 . . . . 1.85 110.345 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.826 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 2.1 tmtp? -78.1 137.5 38.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.371 -0.603 . . . . 0.51 109.371 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.76 -58.71 5.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.863 -0.608 . . . . 1.17 111.714 -169.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 14.6 tppt? -60.05 -56.29 36.97 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.016 1.487 . . . . 2.92 115.016 -168.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.826 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 11.6 Cg_exo -71.88 15.46 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.704 2.27 . . . . 1.57 114.335 -169.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.12 -53.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.148 -0.316 . . . . 4.68 110.148 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.69 67.63 2.12 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.078 -0.582 . . . . 3.12 112.218 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.31 148.05 3.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.122 -0.539 . . . . 3.62 109.784 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.639 ' OXT' ' HG2' ' A' ' 2' ' ' LYS . 34.2 m . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.854 -0.593 . . . . 2.82 110.442 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HA ' ' HB2' ' B' ' 54' ' ' CYS . 91.9 mtp . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.681 0.277 . . . . 4.8 110.649 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.738 ' HE2' ' HD2' ' B' ' 37' ' ' PHE . 4.4 mmpt? -65.27 172.01 3.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.48 109.834 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.735 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 75.2 m -58.47 -40.77 83.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.276 0.56 . . . . 1.0 110.532 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.607 HD12 ' HB2' ' B' ' 36' ' ' PHE . 2.7 mt -100.04 -45.17 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.785 . . . . 0.34 109.304 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.13 24.03 60.23 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.493 -0.776 . . . . 0.51 112.222 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.4 m -121.22 133.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.648 0.737 . . . . 0.23 111.241 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -108.77 140.49 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.17 109.072 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.6 mpt_? -113.3 157.17 22.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.181 -0.463 . . . . 1.21 110.807 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.22 120.85 36.37 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.455 -0.793 . . . . 1.13 108.971 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG21 ' B' ' 28' ' ' ILE . 42.7 t -55.88 145.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.24 111.026 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -69.31 0.33 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.423 -0.584 . . . . 1.31 109.423 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -155.88 -54.16 0.09 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.126 -0.943 . . . . 1.23 108.734 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.2 mp -77.81 -22.44 50.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.317 -1.311 . . . . 0.85 111.376 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.58 -11.33 4.02 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.821 -0.704 . . . . 0.17 111.886 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.796 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 39.6 mtt180 -60.25 134.51 57.13 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.906 -0.173 . . . . 3.03 110.751 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.43 175.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.515 -0.921 . . . . 0.13 108.515 172.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -106.37 100.69 11.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.347 0.594 . . . . 0.19 110.826 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 16' ' ' ILE . 81.1 mmm -74.94 148.61 84.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.818 -0.808 . . . . 0.84 108.818 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 82.0 Cg_endo -80.25 157.6 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.828 1.685 . . . . 0.16 113.247 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.1 tp -56.04 -31.79 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.333 -0.849 . . . . 0.26 109.405 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.3 mm-40 -61.19 -28.8 69.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 1.08 111.191 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.8 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.64 -39.33 57.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.488 -0.93 . . . . 0.2 108.488 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.642 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 50.6 mtm180 -66.04 -28.56 68.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.84 -1.073 . . . . 1.05 110.28 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.642 ' HD2' HG13 ' A' ' 20' ' ' ILE . 72.4 mtp180 -84.99 -35.0 22.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.435 -0.802 . . . . 0.71 110.522 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.23 55.23 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.275 -0.875 . . . . 0.26 110.136 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.56 HD22 ' H ' ' A' ' 47' ' ' LYS . 87.0 mt -81.49 -88.84 0.08 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.86 -1.064 . . . . 0.52 110.577 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.1 t70 167.17 61.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.634 -1.247 . . . . 1.72 107.634 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.645 HG21 HG21 ' B' ' 10' ' ' VAL . 3.0 mp -113.26 132.23 62.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.657 -0.701 . . . . 0.28 110.102 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.28 -55.74 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 0.3 110.927 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -143.09 -32.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.778 -0.646 . . . . 0.33 109.91 -177.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.62 ' HG3' HG23 ' A' ' 30' ' ' ILE . 31.7 mtpt -136.98 -50.3 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.358 0.599 . . . . 1.46 109.467 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER 36.86 -116.41 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.399 1.259 . . . . 1.18 114.399 -177.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 20.0 m -164.87 134.52 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.416 0.553 . . . . 0.21 111.424 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.768 HD11 HG23 ' B' ' 10' ' ' VAL . 2.8 mp -140.99 106.77 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.369 -0.234 . . . . 0.28 110.369 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 60.0 tt0 -98.76 142.08 30.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.744 -0.465 . . . . 1.31 109.744 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.1 155.03 35.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.231 1.015 . . . . 1.33 113.354 -175.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.781 ' HB2' ' HE3' ' B' ' 2' ' ' LYS . 34.7 t80 -134.47 126.73 30.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.714 -1.585 . . . . 2.22 108.122 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.706 ' H ' ' HB2' ' B' ' 3' ' ' SER . 6.3 p -92.9 129.14 43.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 119.498 -0.881 . . . . 0.27 110.705 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -127.08 109.04 11.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.011 -0.995 . . . . 1.16 108.942 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 -96.49 0.75 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.398 -1.081 . . . . 0.32 110.398 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.28 -8.12 8.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.565 0.221 . . . . 2.0 110.483 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -100.4 166.75 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.687 -0.233 . . . . 1.05 110.88 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.896 HG13 HD12 ' B' ' 22' ' ' LEU . 11.9 mm -116.25 143.42 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.055 -0.35 . . . . 0.18 110.055 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 49.1 mt -122.02 118.79 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.431 -0.349 . . . . 0.28 110.435 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' B' ' 45' ' ' LEU . 11.1 mp -103.37 133.5 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.32 111.63 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 11.4 ttpt -142.19 143.98 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.362 -0.835 . . . . 2.16 110.255 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -75.97 145.94 39.94 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.506 -0.924 . . . . 0.52 108.506 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 84.9 t80 -70.15 -53.55 16.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.418 0.628 . . . . 1.25 110.918 -172.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 16.3 tptp -53.33 -54.78 41.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 114.244 -1.344 . . . . 2.86 114.469 -173.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 36.6 Cg_exo -36.83 -62.96 0.24 Allowed 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.838 3.026 . . . . 1.81 114.633 -174.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -135.68 93.76 2.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.312 -0.996 . . . . 4.69 108.312 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.61 90.3 0.3 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.346 -0.843 . . . . 3.14 113.337 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.8 144.92 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.508 -0.553 . . . . 3.58 109.508 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.605 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 73.5 m . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.375 -0.821 . . . . 2.87 110.404 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.605 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 80.0 mtp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.063 -0.347 . . . . 4.74 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.781 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 9.6 mtpp -72.47 171.58 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.236 -0.653 . . . . 2.31 109.236 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.706 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 75.2 m -57.9 -33.83 69.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.59 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.8 mt -105.72 -46.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.32 108.971 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.7 21.89 73.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.289 -0.868 . . . . 0.43 112.265 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.3 132.53 66.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.269 0.557 . . . . 0.25 110.825 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.5 p -105.0 143.13 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.024 -0.732 . . . . 0.16 109.024 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.478 ' NE ' HG13 ' B' ' 17' ' ' VAL . 2.5 mpt_? -113.17 158.89 19.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.1 0.476 . . . . 1.09 111.084 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.6 mmtp -118.55 121.66 40.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.871 -1.059 . . . . 1.16 109.106 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.768 HG23 HD11 ' A' ' 34' ' ' ILE . 14.5 t -57.66 141.39 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.304 -0.407 . . . . 0.25 110.29 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.16 -74.3 0.12 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 1.22 109.32 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -148.54 -55.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.485 0.66 . . . . 1.22 109.472 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.874 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -76.96 -16.9 59.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.054 -0.976 . . . . 0.9 110.91 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 126.72 -0.85 7.37 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.991 -0.623 . . . . 0.15 111.672 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 6.3 mtm180 -67.01 126.56 29.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.188 -0.301 . . . . 2.91 110.188 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -132.81 172.36 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.811 -0.811 . . . . 0.16 108.811 176.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -104.67 101.58 12.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.301 0.572 . . . . 0.19 110.812 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.51 ' SD ' HD11 ' B' ' 16' ' ' ILE . 84.3 mmm -75.4 151.63 85.46 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.046 -0.724 . . . . 0.94 109.046 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 29.1 Cg_endo -83.36 156.8 14.58 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.628 1.552 . . . . 0.19 113.317 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -55.24 -30.72 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.909 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -62.68 -26.35 68.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.23 -0.441 . . . . 1.07 110.627 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.896 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.46 -40.61 49.92 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.901 -0.778 . . . . 0.24 108.901 175.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.682 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 53.0 mtm180 -65.19 -29.13 69.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.844 -1.071 . . . . 1.3 110.705 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 81.6 mtp180 -83.49 -30.55 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.354 -0.839 . . . . 0.87 109.821 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.83 -53.26 22.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.895 -1.048 . . . . 0.28 110.935 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.791 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 48.4 mt -85.16 -81.39 0.2 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.784 -1.098 . . . . 0.57 110.55 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.575 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.1 t0 163.95 60.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.744 -1.206 . . . . 1.54 107.744 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 10' ' ' VAL . 1.4 mp -116.84 132.89 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.104 -0.498 . . . . 0.31 109.67 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.69 -54.32 2.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.793 -0.64 . . . . 0.41 111.064 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -33.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.15 -0.477 . . . . 0.34 109.801 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 10' ' ' VAL . 21.1 mtpt -133.31 -52.38 0.89 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.328 -0.619 . . . . 1.38 109.328 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 36.25 -118.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.585 -1.189 . . . . 1.17 114.103 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 13.1 m -161.05 135.84 7.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.046 0.384 . . . . 0.24 111.979 -173.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.6 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -143.9 104.39 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 N-CA-C 110.289 -0.263 . . . . 0.2 110.289 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.4 tt0 -96.48 141.05 30.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.767 -0.457 . . . . 1.33 109.767 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.607 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.02 157.79 26.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.014 1.116 . . . . 1.27 114.014 -175.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.738 ' HD2' ' HE2' ' A' ' 2' ' ' LYS . 47.4 t80 -136.83 129.28 30.08 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 113.63 -1.623 . . . . 2.1 108.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.735 ' H ' ' HB2' ' A' ' 3' ' ' SER . 9.6 p -92.37 133.42 33.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 119.816 -0.753 . . . . 0.3 109.746 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -131.9 107.47 8.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.967 -0.753 . . . . 1.18 108.967 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.64 -91.01 0.66 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.051 -0.82 . . . . 0.42 111.051 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -128.77 -9.0 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.748 -0.464 . . . . 1.91 109.748 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -100.93 169.05 9.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.78 110.799 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 22' ' ' LEU . 23.0 mm -118.86 142.93 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 0.22 110.461 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 18.8 mt -119.75 124.89 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.322 -0.399 . . . . 0.3 110.109 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -109.39 132.23 54.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.022 0.439 . . . . 0.25 111.64 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 13.9 ttpt -142.08 145.53 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.85 110.237 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.791 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -80.94 138.85 36.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.028 -0.731 . . . . 0.51 109.028 175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.486 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 37.2 t80 -61.17 -51.22 69.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.17 112.822 -171.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.534 ' HB2' ' HD3' ' B' ' 50' ' ' PRO . 4.8 mptp? -53.42 -61.78 4.54 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.702 1.001 . . . . 2.92 113.702 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.665 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 22.5 Cg_exo -64.81 110.18 1.42 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.745 1.63 . . . . 1.57 111.581 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 66.11 80.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.575 -0.739 . . . . 4.68 109.983 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.17 82.95 1.42 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.27 -0.877 . . . . 3.12 112.816 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.15 142.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 120.964 0.411 . . . . 3.62 110.583 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.667 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 37.6 m . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.51 -0.757 . . . . 2.82 109.35 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.911 0.386 . . . . 4.8 110.387 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.607 ' HG2' ' HA ' ' B' ' 54' ' ' CYS . 48.6 mtmt -103.53 -175.97 2.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.807 -0.357 . . . . 2.48 110.25 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.598 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 31.6 t -49.13 -43.52 41.7 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.675 0.609 . . . . 1.0 111.9 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.7 mt -92.8 -34.0 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.051 -0.722 . . . . 0.34 109.051 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.38 6.18 79.61 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.027 -0.988 . . . . 0.51 112.733 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 31.8 m -102.41 133.38 46.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.605 0.717 . . . . 0.23 111.326 -176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 6.5 p -115.84 140.36 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.413 -1.267 . . . . 0.17 109.68 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.697 ' HG2' ' CZ ' ' B' ' 36' ' ' PHE . 11.6 mmt180 -110.54 165.08 12.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.857 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 28.4 mmtp -124.28 122.36 37.53 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.102 -1.073 . . . . 1.13 108.102 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.665 HG23 HD11 ' B' ' 34' ' ' ILE . 38.4 t -56.5 145.98 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.24 111.726 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.21 -78.04 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 1.31 109.699 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -153.45 -45.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.944 -0.761 . . . . 1.23 108.944 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -81.92 -27.59 33.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.952 -1.022 . . . . 0.85 110.808 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.16 -11.18 2.8 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.623 -0.717 . . . . 0.17 111.582 -174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 46.8 mtp180 -61.21 132.05 52.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.099 0.16 . . . . 3.03 111.0 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -139.07 178.57 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.684 -0.858 . . . . 0.13 108.684 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.82 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -107.41 109.21 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.488 0.661 . . . . 0.19 111.467 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.633 ' HB3' HD22 ' A' ' 22' ' ' LEU . 14.5 mmt -75.74 154.01 85.24 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.503 -0.771 . . . . 0.84 109.315 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.2 Cg_endo -83.26 154.39 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.68 1.587 . . . . 0.16 113.162 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 tp -54.74 -31.7 24.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.562 -0.744 . . . . 0.26 109.568 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.86 -28.21 68.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.45 -0.795 . . . . 1.08 110.768 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.816 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -39.6 44.67 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.787 -0.82 . . . . 0.2 108.787 176.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.1 mtm180 -64.73 -28.91 69.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.142 -0.936 . . . . 1.05 110.394 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -83.68 -38.58 21.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.163 -0.926 . . . . 0.71 110.227 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.67 85.37 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.289 -0.868 . . . . 0.26 110.525 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.555 HD22 ' HB2' ' A' ' 47' ' ' LYS . 93.1 mt -87.8 -93.69 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.06 -0.973 . . . . 0.52 111.587 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 33.0 t70 -179.95 38.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.435 0.636 . . . . 1.72 109.307 -172.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.1 mp -100.06 134.27 40.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.401 -0.363 . . . . 0.28 110.884 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -56.51 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.3 110.684 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.586 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.46 -29.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.954 -0.567 . . . . 0.33 109.724 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 30' ' ' ILE . 37.4 mtpt -136.11 -57.1 0.76 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.474 -0.785 . . . . 1.46 109.028 176.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 37.21 -128.13 0.17 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.097 -0.956 . . . . 1.18 113.036 -175.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 13.1 m -153.29 136.66 15.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.516 0.598 . . . . 0.21 111.589 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.725 HD11 HG23 ' B' ' 10' ' ' VAL . 4.2 mp -139.18 107.79 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.223 -0.288 . . . . 0.28 110.223 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.1 tt0 -105.28 140.67 38.07 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.022 -0.362 . . . . 1.31 110.022 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -123.04 153.62 39.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.533 0.938 . . . . 1.33 113.533 -174.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.064 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 33.8 t80 -125.12 124.31 41.58 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.078 -1.419 . . . . 2.22 108.742 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.1 p -93.65 134.58 30.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 C-N-CA 119.785 -0.766 . . . . 0.27 110.74 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -132.75 105.12 6.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.344 -0.844 . . . . 1.16 109.747 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.54 0.46 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.162 -0.775 . . . . 0.32 111.162 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -128.02 -8.03 5.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.369 0.604 . . . . 2.0 109.528 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.2 ttpt -93.16 156.96 16.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 1.05 111.329 -169.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.93 HG13 HD12 ' B' ' 22' ' ' LEU . 10.0 mm -116.93 142.92 28.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.484 -0.561 . . . . 0.18 109.484 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.622 HD12 ' HD1' ' A' ' 37' ' ' PHE . 47.0 mt -128.98 109.52 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.581 0.229 . . . . 0.28 110.907 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.88 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.4 mp -92.17 137.62 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.291 0.567 . . . . 0.32 112.184 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 12.6 ttpt -145.97 141.59 27.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.794 -1.094 . . . . 2.16 109.527 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 33' ' ' SER . 7.1 tmtt? -76.58 146.32 38.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.098 -0.704 . . . . 0.52 109.098 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -76.47 -51.0 12.62 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.762 -0.375 . . . . 1.25 111.808 -171.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.796 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 87.4 tttt -46.34 -55.67 13.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.832 -0.622 . . . . 2.86 112.616 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 21.6 Cg_exo -67.1 143.48 65.46 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.038 1.825 . . . . 1.81 111.621 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -93.01 152.01 19.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 4.69 109.715 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.68 -142.51 6.81 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.391 -0.909 . . . . 3.14 111.93 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.0 134.41 27.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.493 0.664 . . . . 3.58 111.943 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' B' ' 1' ' ' MET . 84.7 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.726 -1.131 . . . . 2.87 108.556 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.428 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.5 mtt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.029 0.443 . . . . 4.74 110.054 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 1.064 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 48.7 mmtt -88.25 179.22 6.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.781 -0.645 . . . . 2.31 111.067 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.525 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 37.2 t -57.83 -42.82 85.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.751 . . . . 1.0 109.985 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.795 HD12 ' HD2' ' A' ' 36' ' ' PHE . 2.9 mt -88.76 -40.12 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.561 -0.903 . . . . 0.32 108.561 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.28 77.73 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.026 -0.988 . . . . 0.43 112.49 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -114.23 132.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.041 0.448 . . . . 0.25 110.706 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -113.82 139.53 38.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.694 -0.685 . . . . 0.16 109.693 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.726 ' HG2' ' CE1' ' A' ' 36' ' ' PHE . 5.1 mmt180 -106.73 167.0 10.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.063 -0.517 . . . . 1.09 110.623 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HD3' ' O ' ' B' ' 8' ' ' ARG . 30.1 mmtp -125.9 119.03 26.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.113 -1.069 . . . . 1.16 108.113 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.725 HG23 HD11 ' A' ' 34' ' ' ILE . 8.5 t -56.55 142.04 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.43 0.633 . . . . 0.25 111.26 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.75 -76.38 0.06 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 1.22 110.058 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -152.44 -49.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.565 -0.902 . . . . 1.22 108.565 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.83 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.4 OUTLIER -79.93 -19.12 48.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.246 -1.343 . . . . 0.9 110.655 -176.482 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 128.02 -3.3 6.86 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.15 111.489 -176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 52.0 mtm180 -63.99 128.55 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.445 -0.206 . . . . 2.91 110.445 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -136.04 179.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.072 -0.714 . . . . 0.16 109.072 176.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -106.63 108.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.215 0.531 . . . . 0.19 111.04 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.693 ' HB3' HD22 ' B' ' 22' ' ' LEU . 30.4 mmt -74.66 152.95 87.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.65 -0.871 . . . . 0.94 108.65 172.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 43.3 Cg_endo -84.5 154.84 12.16 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.906 1.738 . . . . 0.19 112.943 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 4.1 tp -53.84 -32.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.22 109.571 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -61.12 -26.43 67.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.79 -0.641 . . . . 1.07 110.819 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.93 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.63 -40.94 32.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.926 -0.768 . . . . 0.24 108.926 176.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 38.8 mtm180 -65.65 -27.5 68.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.568 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 72.1 mtp180 -83.96 -30.75 25.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.257 -0.883 . . . . 0.87 110.047 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.99 -52.52 28.0 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.012 -0.994 . . . . 0.28 110.687 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 62.0 mt -85.6 -87.51 0.13 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.734 -1.121 . . . . 0.57 110.8 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.435 ' C ' HD12 ' B' ' 28' ' ' ILE . 38.9 t70 173.89 45.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.754 . . . . 1.54 109.005 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 10' ' ' VAL . 1.2 mp -108.0 129.11 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.31 110.018 -174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.15 4.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.478 -0.783 . . . . 0.41 111.499 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.556 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -150.46 -33.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.742 -0.466 . . . . 0.34 109.742 177.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' B' ' 30' ' ' ILE . 44.1 mtpt -133.55 -50.92 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.316 0.579 . . . . 1.38 109.443 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.536 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.8 -113.56 0.1 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.22 1.192 . . . . 1.17 114.22 -177.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.5 m -164.38 137.39 5.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.189 0.45 . . . . 0.24 111.61 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -141.86 102.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 110.213 -0.292 . . . . 0.2 110.213 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 33.5 tt0 -95.18 142.53 27.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.4 -0.593 . . . . 1.33 109.4 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.697 ' CZ ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -118.99 158.52 25.6 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.183 0.992 . . . . 1.27 113.579 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 18.7 t80 -132.88 125.87 30.93 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 113.675 -1.602 . . . . 2.1 108.011 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.598 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.5 p -93.28 135.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.822 -0.751 . . . . 0.3 110.24 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.074 -0.713 . . . . 1.18 109.074 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.11 -95.17 0.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.977 -0.849 . . . . 0.42 110.977 -171.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.94 -13.58 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 1.91 110.169 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -92.82 167.78 11.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.78 110.834 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.7 mm -121.97 143.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.13 -0.486 . . . . 0.22 109.724 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 17.4 mt -124.5 113.85 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.504 -0.316 . . . . 0.3 110.798 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.836 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -98.02 139.52 33.73 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.265 0.555 . . . . 0.25 112.064 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -152.58 141.07 20.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.799 -1.091 . . . . 1.85 109.188 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tmtt? -72.74 153.4 41.16 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.842 -0.799 . . . . 0.51 108.842 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -77.17 -52.83 8.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.149 0.499 . . . . 1.17 111.358 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.542 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 54.2 tttm -53.65 -46.58 98.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.003 -0.999 . . . . 2.92 113.203 -174.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 16.4 Cg_exo -69.49 130.46 19.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.956 1.77 . . . . 1.57 111.366 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.67 124.3 37.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 4.68 110.899 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.82 -126.49 1.1 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.657 -0.702 . . . . 3.12 111.848 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -78.81 144.93 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.02 0.438 . . . . 3.62 110.854 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.607 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.508 -0.758 . . . . 2.82 110.005 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 111.552 0.204 . . . . 4.8 111.552 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.694 ' HG3' ' HG2' ' B' ' 35' ' ' GLU . 38.3 mmtt 63.21 -175.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.63 0.729 . . . . 2.48 112.45 175.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.626 ' HB2' ' CD1' ' B' ' 37' ' ' PHE . 19.0 t -90.9 -46.2 8.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.681 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.43 -31.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.067 -0.716 . . . . 0.34 109.067 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 75.58 21.43 77.14 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.139 -0.937 . . . . 0.51 112.931 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.57 132.63 68.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.859 0.837 . . . . 0.23 111.748 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -111.1 140.86 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 113.935 -1.484 . . . . 0.17 108.578 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.7 mpt_? -114.78 155.0 27.53 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.017 0.437 . . . . 1.21 110.607 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 121.05 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.584 -0.895 . . . . 1.13 108.584 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.638 HG23 HD11 ' B' ' 34' ' ' ILE . 4.7 t -54.52 141.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.564 0.54 . . . . 0.24 110.312 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.36 -77.86 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.939 -0.763 . . . . 1.31 108.939 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.48 ' HG2' HD11 ' B' ' 30' ' ' ILE . 29.8 mt-10 -151.71 -36.2 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.623 -0.88 . . . . 1.23 108.623 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD12 ' HD2' ' A' ' 15' ' ' ARG . 11.2 mt -86.79 -19.09 29.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.14 -0.936 . . . . 0.85 111.7 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 124.19 -6.43 8.75 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 120.503 -0.856 . . . . 0.17 111.277 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.0 mtp180 -67.25 125.2 25.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.345 -0.242 . . . . 3.03 110.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -131.73 175.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.966 -0.753 . . . . 0.13 108.966 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.7 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -103.27 102.43 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.056 0.455 . . . . 0.19 110.938 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.625 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.2 mmt -74.54 149.99 86.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.4 -0.593 . . . . 0.84 109.4 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.4 Cg_endo -81.19 155.03 19.29 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.781 1.654 . . . . 0.16 113.383 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 4.7 tp -56.2 -31.81 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.178 -0.919 . . . . 0.26 109.059 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 13.0 mm-40 -58.87 -30.93 68.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.211 -0.904 . . . . 1.08 111.253 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.905 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.22 -41.12 58.33 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.457 -0.942 . . . . 0.2 108.457 177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.629 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 32.3 mtm180 -63.92 -29.57 70.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.782 -1.099 . . . . 1.05 110.224 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 73.5 mtp180 -85.26 -35.83 21.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.399 -0.819 . . . . 0.71 110.753 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.28 95.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.598 0.713 . . . . 0.26 109.874 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.565 HD22 ' H ' ' A' ' 47' ' ' LYS . 77.2 mt -92.36 -104.83 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.678 -1.146 . . . . 0.52 110.255 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -174.72 49.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 1.72 109.422 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.629 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -93.18 131.68 39.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.28 109.513 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.58 -57.77 2.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.34 0.59 . . . . 0.3 110.587 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -146.68 -28.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.032 -0.986 . . . . 0.33 109.604 -175.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HG3' HG23 ' A' ' 30' ' ' ILE . 21.2 mtpp -139.88 -52.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 1.46 109.141 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' HB2' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER 37.75 -115.27 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.094 1.146 . . . . 1.18 114.094 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 38.5 m -166.59 137.88 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.436 0.562 . . . . 0.21 111.065 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.751 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -139.0 111.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.701 -0.481 . . . . 0.28 109.701 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.506 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 22.7 tt0 -107.92 130.2 55.04 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.31 0.244 . . . . 1.31 110.552 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.701 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -116.06 153.5 31.61 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.655 0.983 . . . . 1.33 113.655 -170.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' HD1' HD12 ' A' ' 44' ' ' ILE . 25.5 t80 -129.86 132.36 46.41 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 114.112 -1.404 . . . . 2.22 108.478 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.532 ' H ' ' HB3' ' B' ' 3' ' ' SER . 2.8 p -100.29 132.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 119.765 -0.774 . . . . 0.27 111.268 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.9 t70 -125.59 99.89 6.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.67 -1.15 . . . . 1.16 109.534 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.32 -84.31 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.583 -0.735 . . . . 0.32 111.365 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.01 -17.04 5.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.392 0.615 . . . . 2.0 109.64 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' B' ' 44' ' ' ILE . 2.1 ttpt -92.47 158.07 16.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.345 -0.843 . . . . 1.05 111.325 -167.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.968 HG13 HD12 ' B' ' 22' ' ' LEU . 7.0 mm -118.12 139.46 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.887 -0.412 . . . . 0.18 109.887 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.591 HD12 ' HD1' ' A' ' 37' ' ' PHE . 43.6 mt -121.87 111.71 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.444 . . . . 0.28 110.508 -174.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -102.87 138.19 40.08 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.815 0.302 . . . . 0.32 111.815 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 149.89 26.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 2.16 110.081 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 2.9 tmtp? -65.53 147.99 52.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.891 -0.595 . . . . 0.52 110.146 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.634 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 24.3 t80 -60.0 -52.02 67.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 1.25 111.263 -173.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.882 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 36.1 ttmt -55.07 -59.44 10.82 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.464 -0.789 . . . . 2.86 112.485 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.882 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 65.3 Cg_exo -53.98 125.52 19.0 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.277 1.985 . . . . 1.81 112.86 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -83.6 92.09 7.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.881 0.848 . . . . 4.69 110.476 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.3 -118.81 4.51 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.509 -1.036 . . . . 3.14 110.509 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.13 144.59 20.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 110.011 -0.366 . . . . 3.58 110.011 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.146 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 88.5 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.226 -0.892 . . . . 2.87 110.379 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 111.319 0.118 . . . . 4.74 111.319 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 1.146 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 6.5 mmmm 65.48 165.94 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.92 0.867 . . . . 2.31 112.854 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 47.1 t -70.48 -45.99 64.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 1.0 110.723 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HD2' ' A' ' 36' ' ' PHE . 10.5 mt -89.45 -40.73 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.923 -0.769 . . . . 0.32 108.923 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.88 39.65 59.0 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.43 112.538 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 36' ' ' PHE . 15.3 m -131.97 132.21 61.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.023 0.439 . . . . 0.25 110.029 174.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.1 p -108.44 142.66 20.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.819 -0.808 . . . . 0.16 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.701 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 mpt_? -113.79 153.87 28.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.991 0.424 . . . . 1.09 110.764 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 121.45 44.64 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.565 -0.743 . . . . 1.16 109.054 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 34' ' ' ILE . 3.8 t -53.62 137.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 123.837 0.711 . . . . 0.25 110.459 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -55.08 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.631 -0.713 . . . . 1.22 109.998 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.711 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.1 mt-10 -151.64 -32.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.499 -0.926 . . . . 1.22 108.499 173.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.33 -29.96 21.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.304 -1.317 . . . . 0.9 110.858 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 132.06 -8.37 5.42 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.768 -0.933 . . . . 0.15 110.768 -172.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 mtp180 -62.84 124.58 21.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.299 . . . . 2.91 110.508 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -129.58 174.77 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.649 -0.871 . . . . 0.16 108.649 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.723 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.9 p -104.15 104.06 16.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.326 0.584 . . . . 0.19 110.693 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 1.6 mmt -76.29 151.72 83.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 0.94 108.729 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.41 153.84 10.62 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.877 1.718 . . . . 0.19 113.321 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -53.85 -30.25 19.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.413 -0.812 . . . . 0.22 109.985 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.04 -25.67 67.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.206 -0.452 . . . . 1.07 110.88 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.968 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.62 -41.29 39.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.631 -0.877 . . . . 0.24 108.631 174.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 37.4 mtm180 -63.54 -29.83 71.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.887 -1.052 . . . . 1.3 110.683 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.563 ' HD2' HG13 ' B' ' 20' ' ' ILE . 62.0 mtp180 -84.36 -33.93 23.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.271 -0.877 . . . . 0.87 110.048 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -51.03 71.63 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.781 -1.1 . . . . 0.28 110.1 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.575 HD22 ' H ' ' B' ' 47' ' ' LYS . 61.0 mt -92.4 -91.25 0.17 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.462 -1.245 . . . . 0.57 111.637 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.476 ' C ' HD12 ' B' ' 28' ' ' ILE . 16.7 t0 175.5 50.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.637 -0.875 . . . . 1.54 108.637 -170.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -109.34 132.92 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.966 -0.753 . . . . 0.31 108.966 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.36 -51.48 2.91 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.163 0.506 . . . . 0.41 111.852 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.669 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -146.94 -29.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.971 -0.559 . . . . 0.34 109.668 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.669 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.4 mtpp -140.06 -51.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.465 -0.568 . . . . 1.38 109.465 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.452 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.7 OUTLIER 34.91 -115.44 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.802 1.038 . . . . 1.17 113.802 -176.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.0 m -163.4 136.99 5.74 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.155 -0.34 . . . . 0.24 111.37 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.668 HG21 HD23 ' B' ' 45' ' ' LEU . 4.3 mp -142.0 105.22 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.6 -0.519 . . . . 0.2 109.6 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.694 ' HG2' ' HG3' ' A' ' 2' ' ' LYS . 43.1 tt0 -102.73 134.45 46.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.318 -0.253 . . . . 1.33 110.318 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.509 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.79 158.67 23.52 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.214 1.19 . . . . 1.27 114.214 -173.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.692 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 66.4 t80 -126.07 152.71 45.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.199 -1.819 . . . . 2.1 107.177 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.608 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.9 p -117.87 137.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 120.057 -0.657 . . . . 0.3 110.041 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 31.5 t70 -133.65 95.6 3.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.928 -0.578 . . . . 1.18 110.111 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.03 -73.49 1.04 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.572 -0.74 . . . . 0.42 111.684 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -127.71 -30.5 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.462 0.649 . . . . 1.91 109.421 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -89.7 166.22 13.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.096 -0.956 . . . . 0.78 111.341 -163.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.905 HG13 HD12 ' A' ' 22' ' ' LEU . 25.4 mm -121.27 142.99 35.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.46 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 33.5 mt -124.06 109.74 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.409 -0.359 . . . . 0.3 110.69 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 45' ' ' LEU . 10.6 mp -101.69 134.66 44.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.331 0.493 . . . . 0.25 112.331 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.683 ' HE2' ' HE2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -149.08 148.75 30.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.85 109.667 172.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.743 ' HB3' ' HD2' ' B' ' 50' ' ' PRO . 7.1 tttt -64.92 167.05 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.42 -0.585 . . . . 0.51 109.42 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -78.04 -49.66 13.57 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.238 -0.585 . . . . 1.17 110.108 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.774 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 39.9 ttmt -59.45 -58.31 20.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.29 -0.868 . . . . 2.92 112.644 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 50.2 Cg_exo -55.08 125.29 18.69 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.372 2.048 . . . . 1.57 112.695 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.49 81.64 7.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.793 0.806 . . . . 4.68 110.396 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.06 -88.29 1.31 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.562 -0.827 . . . . 3.12 111.506 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.33 143.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 3.62 109.66 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 2' ' ' LYS . 92.0 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.704 -1.141 . . . . 2.82 109.302 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 48.7 m . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.156 0.503 . . . . 1.0 111.289 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -86.02 -33.91 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.647 -0.872 . . . . 0.34000000000000002 108.647 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.52 19.61 76.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.831 -1.077 . . . . 0.51000000000000001 112.548 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 27.9 m -115.92 131.32 68.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.573 0.701 . . . . 0.23000000000000001 111.177 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.8 p -114.63 141.73 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.512 -1.222 . . . . 0.17000000000000001 109.36 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.465 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.74 165.11 13.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.977 0.418 . . . . 1.21 110.607 -176.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 33.4 mmtp -120.22 124.24 45.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.242 -1.021 . . . . 1.1299999999999999 108.242 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.709 HG21 HG21 ' B' ' 28' ' ' ILE . 39.7 t -56.38 141.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.497 0.498 . . . . 0.23999999999999999 109.912 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.85 -75.15 0.07 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.938 -0.574 . . . . 1.3100000000000001 109.676 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.25 -46.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.842 -0.799 . . . . 1.23 108.842 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -77.78 -50.47 12.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.887 -1.051 . . . . 0.84999999999999998 110.734 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.17 -5.49 0.05 OUTLIER Glycine 0 C--O 1.225 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.17000000000000001 111.832 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 56.5 mtm180 -68.99 135.03 50.28 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 122.07 0.148 . . . . 3.0299999999999998 110.868 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -141.12 179.99 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.906 -0.775 . . . . 0.13 108.906 174.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.7 p -107.38 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.171 0.51 . . . . 0.19 110.91 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.653 ' HE1' HD11 ' B' ' 45' ' ' LEU . 78.6 mmm -84.13 148.62 53.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.105 -0.702 . . . . 0.83999999999999997 109.105 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.0 Cg_endo -80.41 157.65 22.45 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.93 1.753 . . . . 0.16 113.679 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.6 tp -52.68 -34.61 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.969 -1.014 . . . . 0.26000000000000001 109.713 171.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.42 -25.67 66.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.344 -0.843 . . . . 1.0800000000000001 110.982 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -78.39 -40.97 34.53 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.83 -0.804 . . . . 0.20000000000000001 108.83 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.65 ' HD2' HG22 ' A' ' 28' ' ' ILE . 21.0 mtm180 -63.78 -30.88 71.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.41 -0.814 . . . . 1.05 109.837 176.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 77.8 mtp180 -83.82 -33.3 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.267 -0.879 . . . . 0.70999999999999996 110.854 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.02 -46.88 73.14 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.806 0.813 . . . . 0.26000000000000001 109.413 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.874 HD22 ' H ' ' A' ' 47' ' ' LYS . 82.8 mt -85.19 -101.52 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.291 -1.322 . . . . 0.52000000000000002 110.372 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' H ' HD12 ' A' ' 28' ' ' ILE . 4.7 p-10 -179.36 50.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.632 -0.713 . . . . 1.72 109.4 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG22 ' HD2' ' A' ' 23' ' ' ARG . 2.4 mp -98.44 136.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.872 -1.058 . . . . 0.28000000000000003 109.932 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.16 -51.59 2.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.802 -0.359 . . . . 0.29999999999999999 111.629 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.881 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -145.31 -32.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.463 -0.335 . . . . 0.33000000000000002 110.221 -177.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 20.3 mtpp -137.83 -50.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.813 -0.81 . . . . 1.46 108.813 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 35.91 -118.84 0.13 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.461 -1.245 . . . . 1.1799999999999999 113.138 -176.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB3' HG21 ' B' ' 7' ' ' VAL . 21.1 m -163.32 138.65 6.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.362 0.528 . . . . 0.20999999999999999 111.198 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.824 HD11 HG23 ' B' ' 10' ' ' VAL . 3.1 mp -139.6 110.23 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.759 -0.46 . . . . 0.28000000000000003 109.759 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 41.3 tt0 -104.15 137.17 42.48 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.501 -0.555 . . . . 1.3100000000000001 109.501 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -110.06 151.37 27.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.964 0.888 . . . . 1.3300000000000001 112.601 -174.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 14.8 t80 -127.25 122.15 33.15 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.11 -1.404 . . . . 2.2200000000000002 107.519 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.464 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -93.28 132.78 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 119.798 -0.761 . . . . 0.27000000000000002 111.131 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -133.92 102.85 5.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.183 -0.917 . . . . 1.1599999999999999 110.343 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.5 -88.44 0.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.815 -0.629 . . . . 0.32000000000000001 112.04 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.67 -8.46 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.598 0.237 . . . . 2.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.68 168.75 9.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.141 0.496 . . . . 1.05 111.09 -168.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.735 HG13 HD12 ' B' ' 22' ' ' LEU . 15.5 mm -122.53 141.65 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.324 -0.853 . . . . 0.17999999999999999 109.249 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 46.4 mt -121.96 111.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.694 0.283 . . . . 0.28000000000000003 110.382 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' B' ' 45' ' ' LEU . 10.6 mp -101.13 132.28 46.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.538 -0.301 . . . . 0.32000000000000001 111.809 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.71 157.34 37.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.139 0.495 . . . . 2.1600000000000001 111.093 172.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.874 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.2 tmtp? -63.15 153.47 34.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.732 . . . . 0.52000000000000002 110.406 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.744 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 61.6 t80 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.496 -0.32 . . . . 1.25 111.245 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 54.2 m . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.145 0.498 . . . . 1.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 36' ' ' PHE . 1.9 mt -84.34 -42.0 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.848 -1.167 . . . . 0.32000000000000001 107.848 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.76 27.02 69.92 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.559 -1.201 . . . . 0.42999999999999999 112.199 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.9 131.9 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.192 0.52 . . . . 0.25 110.345 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.5 p -111.54 141.27 27.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.333 -0.849 . . . . 0.16 109.323 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.717 ' HD2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -114.21 162.39 16.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.009 0.433 . . . . 1.0900000000000001 110.354 -175.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.8 mmtp -118.18 121.57 40.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.449 -0.945 . . . . 1.1599999999999999 108.449 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 34' ' ' ILE . 5.2 t -55.48 135.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.555 -0.535 . . . . 0.25 109.555 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.86 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.999 -0.546 . . . . 1.22 109.535 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.881 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.4 mt-10 -154.7 -34.42 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.302 -0.999 . . . . 1.22 108.302 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.81 -49.23 11.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.098 -1.41 . . . . 0.90000000000000002 110.329 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.511 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 152.21 -6.24 0.5 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.724 -1.125 . . . . 0.14999999999999999 110.711 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 43.0 mtm180 -63.45 131.06 46.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.72 -0.24 . . . . 2.9100000000000001 110.451 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.639 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.8 OUTLIER -138.76 179.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.757 -0.831 . . . . 0.16 108.757 174.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -107.77 113.51 43.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.19 110.885 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.564 ' HB3' HD13 ' B' ' 22' ' ' LEU . 74.8 mmm -84.89 149.0 52.47 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.815 . . . . 0.93999999999999995 108.801 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 39.5 Cg_endo -80.68 158.44 21.75 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.744 1.629 . . . . 0.19 113.63 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.49 -30.92 32.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.229 -0.896 . . . . 0.22 109.707 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -25.76 67.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.223 -0.444 . . . . 1.0700000000000001 110.704 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.735 HD12 HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -78.08 -41.74 34.34 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.826 -0.805 . . . . 0.23999999999999999 108.826 175.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.737 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 32.8 mtp180 -61.79 -33.65 74.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.849 -1.069 . . . . 1.3 110.68 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 55.2 mtp180 -79.66 -37.68 35.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.34 -0.845 . . . . 0.87 109.872 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.42 -50.52 71.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.429 -1.26 . . . . 0.28000000000000003 110.161 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.859 HD22 ' H ' ' B' ' 47' ' ' LYS . 56.5 mt -92.93 -80.44 0.38 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.65 -1.159 . . . . 0.56999999999999995 112.075 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 t0 177.4 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.089 -0.245 . . . . 1.54 111.619 -168.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.737 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.5 mp -88.87 124.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.335 0.588 . . . . 0.31 111.668 -163.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.43 -34.86 9.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.96 . . . . 0.40999999999999998 112.786 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.677 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -166.05 -33.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.502 -0.555 . . . . 0.34000000000000002 109.502 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.677 ' HG3' HG23 ' B' ' 30' ' ' ILE . 18.6 mtpp -136.58 -49.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.787 -0.82 . . . . 1.3799999999999999 108.787 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 35.39 -111.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.467 -1.242 . . . . 1.1699999999999999 113.766 -176.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 27.3 m -166.05 138.35 3.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.343 0.52 . . . . 0.23999999999999999 110.891 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -142.19 107.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.729 -0.471 . . . . 0.20000000000000001 109.729 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 44.7 tt0 -103.62 139.5 38.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.711 -0.477 . . . . 1.3300000000000001 109.711 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.78 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.85 154.73 21.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.015 0.912 . . . . 1.27 112.637 -173.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 22.9 t80 -129.96 126.22 37.3 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 114.091 -1.413 . . . . 2.1000000000000001 107.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 10.2 p -93.04 136.43 25.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.732 -0.787 . . . . 0.29999999999999999 110.339 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 11.8 t70 -134.16 100.91 4.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 1.1799999999999999 109.804 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.34 -90.47 0.19 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.852 -0.69 . . . . 0.41999999999999998 111.721 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -118.31 -13.47 9.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.946 0.403 . . . . 1.9099999999999999 110.704 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' B' ' 39' ' ' ASP . 2.8 ptpt -98.1 169.14 9.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 0.78000000000000003 110.939 -168.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -124.56 140.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.373 -0.831 . . . . 0.22 109.206 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 35.9 mt -119.22 113.75 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.588 -0.278 . . . . 0.29999999999999999 110.546 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 45' ' ' LEU . 11.2 mp -101.13 128.46 47.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.808 0.337 . . . . 0.25 111.575 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.587 ' HA ' HD21 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -152.19 153.53 34.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 1.8500000000000001 110.476 175.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.859 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.6 tmtt? -65.03 166.01 10.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.51000000000000001 109.757 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.038 0.447 . . . . 1.1699999999999999 110.225 -174.114 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 121.415 0.626 . . . . 1.0 109.317 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' B' ' 36' ' ' PHE . 5.3 mt -103.57 -49.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.662 -0.699 . . . . 0.34000000000000002 109.388 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.58 25.32 30.65 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 115.533 -0.758 . . . . 0.51000000000000001 112.567 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.7 133.27 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.0 0.905 . . . . 0.23000000000000001 110.991 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.3 p -112.99 141.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 113.651 -1.613 . . . . 0.17000000000000001 108.727 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 1.2 mpt_? -112.06 156.7 21.78 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.923 0.392 . . . . 1.21 110.462 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -121.25 118.14 28.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.33 -0.989 . . . . 1.1299999999999999 108.33 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG23 HD11 ' B' ' 34' ' ' ILE . 22.5 t -54.22 144.49 5.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 123.948 0.78 . . . . 0.23999999999999999 111.87 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.88 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.95 -1.023 . . . . 1.3100000000000001 110.059 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.606 ' HG2' HD11 ' B' ' 30' ' ' ILE . 40.5 mt-10 -154.3 -43.78 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.627 -1.249 . . . . 1.23 107.627 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.51 -34.96 65.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.259 -1.337 . . . . 0.84999999999999998 111.263 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' B' ' 23' ' ' ARG . . . 137.24 -4.64 3.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.451 -0.795 . . . . 0.17000000000000001 111.152 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.743 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 9.0 mtp180 -68.57 133.57 48.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.644 -0.278 . . . . 3.0299999999999998 110.626 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.2 pt -138.79 -179.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.578 -0.527 . . . . 0.13 109.578 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -109.81 103.11 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.084 0.469 . . . . 0.19 110.802 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 16' ' ' ILE . 83.3 mmm -78.7 149.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.989 -0.745 . . . . 0.83999999999999997 108.989 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -81.48 155.77 18.81 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.871 1.714 . . . . 0.16 113.61 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.7 tp -51.7 -32.36 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.26000000000000001 109.884 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.24 -29.68 68.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.334 -0.848 . . . . 1.0800000000000001 111.487 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.63 35.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.242 -0.651 . . . . 0.20000000000000001 109.242 177.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.679 ' HD3' HG11 ' B' ' 10' ' ' VAL . 33.3 mtm180 -63.98 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.66 -0.7 . . . . 1.05 109.658 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 68.3 mtp180 -83.67 -33.03 25.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.031 -0.986 . . . . 0.70999999999999996 110.663 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.47 -37.85 77.45 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.26000000000000001 110.117 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.67 -88.64 0.23 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.145 -0.934 . . . . 0.52000000000000002 111.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.749 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 22.1 t70 177.27 23.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.024 0.44 . . . . 1.72 109.977 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.6 mp -83.5 129.9 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 O-C-N 122.184 -0.323 . . . . 0.28000000000000003 110.963 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.0 -48.37 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.29999999999999999 111.236 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.653 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.15 -30.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 0.33000000000000002 110.113 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.4 mtpt -137.03 -51.9 0.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.296 -0.631 . . . . 1.46 109.296 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER 36.44 -117.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.517 -1.219 . . . . 1.1799999999999999 113.994 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HG21 ' B' ' 7' ' ' VAL . 13.3 m -162.51 135.51 5.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.274 0.488 . . . . 0.20999999999999999 111.428 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.877 HD11 HG23 ' B' ' 10' ' ' VAL . 3.2 mp -137.38 107.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.28000000000000003 109.775 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 46.2 tt0 -103.1 138.03 40.48 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.287 -0.634 . . . . 1.3100000000000001 109.287 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.993 0.901 . . . . 1.3300000000000001 112.866 -174.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' HD1' HD12 ' A' ' 44' ' ' ILE . 18.4 t80 -127.83 123.43 35.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.126 -1.397 . . . . 2.2200000000000002 108.179 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.516 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.0 p -92.3 132.6 36.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 119.824 -0.75 . . . . 0.27000000000000002 110.492 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -133.59 102.65 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.515 -1.22 . . . . 1.1599999999999999 109.248 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.39 -97.17 0.59 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.706 -0.759 . . . . 0.32000000000000001 111.269 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -117.83 -9.55 10.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.323 0.583 . . . . 2.0 109.697 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.4 ttpt -92.09 157.73 16.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.449 -0.796 . . . . 1.05 111.538 -169.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.878 HG13 HD12 ' B' ' 22' ' ' LEU . 20.2 mm -118.58 139.53 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.179 -0.674 . . . . 0.17999999999999999 109.179 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 44.2 mt -121.99 109.81 25.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.629 -0.26 . . . . 0.28000000000000003 110.676 -173.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' B' ' 45' ' ' LEU . 11.3 mp -96.44 136.15 37.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.003 0.43 . . . . 0.32000000000000001 111.612 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -145.15 170.81 15.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.186 -0.915 . . . . 2.1600000000000001 110.173 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 5.1 tmtt? -87.03 149.23 24.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.307 -0.86 . . . . 0.52000000000000002 109.097 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.8 t80 . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 120.933 0.397 . . . . 1.25 110.936 -175.544 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 24.2 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.527 0.679 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.66 -46.88 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.466 -0.788 . . . . 0.32000000000000001 109.362 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.28 29.12 46.4 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.197 -0.911 . . . . 0.42999999999999999 112.493 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.451 HG23 ' CE2' ' A' ' 36' ' ' PHE . 19.5 m -126.31 131.37 71.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.374 0.607 . . . . 0.25 110.681 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 33' ' ' SER . 15.0 p -107.91 142.89 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.225 -0.898 . . . . 0.16 109.189 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.2 mpt_? -111.56 161.03 16.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.31 -0.405 . . . . 1.0900000000000001 110.535 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.38 116.09 22.71 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.85 . . . . 1.1599999999999999 108.704 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.877 HG23 HD11 ' A' ' 34' ' ' ILE . 7.5 t -53.25 141.86 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.706 0.629 . . . . 0.25 111.196 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.12 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.042 -0.981 . . . . 1.22 109.946 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.653 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.7 mt-10 -149.83 -41.78 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.109 -1.071 . . . . 1.22 108.109 169.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.2 mt -72.88 -36.55 67.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.269 -1.332 . . . . 0.90000000000000002 110.864 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.545 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 134.78 -1.46 3.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.14999999999999999 111.069 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 47.3 mtp85 -64.45 131.27 46.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.685 -0.257 . . . . 2.9100000000000001 110.694 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -138.7 179.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.241 -0.652 . . . . 0.16 109.241 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -108.89 106.28 20.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.185 0.517 . . . . 0.19 110.732 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.509 ' SD ' HD11 ' B' ' 16' ' ' ILE . 81.0 mmm -79.77 146.04 63.62 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.853 -0.795 . . . . 0.93999999999999995 108.853 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.76 158.62 31.61 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.08 1.853 . . . . 0.19 113.316 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -56.81 -31.05 34.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.273 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -59.33 -26.84 65.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.0700000000000001 111.26 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.878 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.36 -39.84 31.64 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.931 -0.766 . . . . 0.23999999999999999 108.931 176.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.581 ' HB2' HD12 ' B' ' 20' ' ' ILE . 42.9 mtm180 -66.45 -26.98 67.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.027 -0.988 . . . . 1.3 110.577 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -83.45 -32.34 26.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.529 -0.76 . . . . 0.87 109.603 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.62 62.35 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.074 -0.966 . . . . 0.28000000000000003 110.494 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 53.0 mt -85.26 -93.9 0.08 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.547 -1.206 . . . . 0.56999999999999995 109.364 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.516 ' OD1' ' HG3' ' B' ' 47' ' ' LYS . 6.7 p30 177.76 40.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.367 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -81.01 125.05 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.31 109.798 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.77 -43.57 10.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.928 -0.578 . . . . 0.40999999999999998 111.138 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -160.4 -30.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 0.34000000000000002 109.388 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.518 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.2 mtpt -133.89 -52.45 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 1.3799999999999999 109.382 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.55 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.4 OUTLIER 39.45 -117.83 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.848 -1.069 . . . . 1.1699999999999999 113.725 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 34.4 m -162.05 134.47 5.77 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.034 0.379 . . . . 0.23999999999999999 111.639 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.689 HD11 HG23 ' A' ' 10' ' ' VAL . 3.7 mp -137.88 103.58 2.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.945 -0.391 . . . . 0.20000000000000001 109.945 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 47.7 tt0 -97.79 137.7 36.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.692 -0.485 . . . . 1.3300000000000001 109.692 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.736 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.31 154.65 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.088 0.947 . . . . 1.27 113.002 -174.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.63 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 27.1 t80 -130.51 123.12 28.93 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 114.031 -1.44 . . . . 2.1000000000000001 108.169 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.5 p -93.11 133.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.566 -0.854 . . . . 0.29999999999999999 110.756 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' B' ' 37' ' ' PHE . 17.3 t70 -132.41 103.78 6.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.3 -0.864 . . . . 1.1799999999999999 109.974 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.53 -84.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.899 -0.591 . . . . 0.41999999999999998 111.719 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.96 -22.49 4.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.7 -0.481 . . . . 1.9099999999999999 109.7 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -91.17 167.96 11.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.569 . . . . 0.78000000000000003 110.866 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 5.3 mm -125.46 139.39 51.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.623 -0.717 . . . . 0.22 109.224 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 15.6 mt -118.23 117.85 56.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.436 -0.347 . . . . 0.29999999999999999 110.559 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' A' ' 45' ' ' LEU . 11.1 mp -104.2 134.68 47.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.955 0.407 . . . . 0.25 111.761 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -147.1 167.96 22.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.284 -0.871 . . . . 1.8500000000000001 109.558 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.7 tmtp? -89.11 149.33 23.24 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.539 -0.912 . . . . 0.51000000000000001 108.539 174.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.518 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 64.8 t80 . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 120.678 0.275 . . . . 1.1699999999999999 111.311 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.751 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.7 m . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.245 0.545 . . . . 1.0 110.502 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.603 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -88.33 -36.18 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.34000000000000002 109.635 -178.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.66 78.18 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.387 -0.824 . . . . 0.51000000000000001 112.284 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.603 HG22 ' HB ' ' A' ' 4' ' ' ILE . 29.5 m -119.15 132.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.689 0.757 . . . . 0.23000000000000001 111.053 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.3 p -114.76 138.89 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.276 -1.329 . . . . 0.17000000000000001 109.114 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.22 148.97 32.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.069 0.461 . . . . 1.21 110.294 -174.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -112.98 120.28 40.85 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.321 -0.854 . . . . 1.1299999999999999 108.898 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.636 HG21 HG21 ' B' ' 28' ' ' ILE . 36.3 t -54.7 144.72 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 111.809 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -80.32 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.842 -1.072 . . . . 1.3100000000000001 109.917 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' HD11 ' B' ' 30' ' ' ILE . 41.0 mt-10 -153.82 -42.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.931 -1.137 . . . . 1.23 107.931 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.38 -19.01 36.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.462 -1.245 . . . . 0.84999999999999998 111.472 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 123.89 -3.79 9.19 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.836 -0.697 . . . . 0.17000000000000001 111.682 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 47.7 mtm180 -67.38 126.45 29.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.361 -0.237 . . . . 3.0299999999999998 110.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -136.96 179.74 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.191 -0.67 . . . . 0.13 109.191 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.1 p -110.6 118.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.194 0.521 . . . . 0.19 111.094 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.796 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.7 mmt -86.15 151.3 53.99 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.876 -0.602 . . . . 0.83999999999999997 109.698 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.4 Cg_endo -85.59 156.03 10.51 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.02 1.814 . . . . 0.16 113.157 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.718 HD13 HH21 ' A' ' 23' ' ' ARG . 3.9 tp -51.18 -33.67 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.06 -0.973 . . . . 0.26000000000000001 109.792 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.55 -29.56 68.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.615 -0.72 . . . . 1.0800000000000001 111.877 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -80.47 -34.37 35.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.007 -0.738 . . . . 0.20000000000000001 109.007 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.718 HH21 HD13 ' A' ' 20' ' ' ILE . 62.3 mtm180 -64.84 -29.66 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 1.05 109.812 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.6 mtp180 -84.64 -35.23 22.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.176 -0.92 . . . . 0.70999999999999996 110.657 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.71 72.34 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.534 -0.757 . . . . 0.26000000000000001 110.237 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.813 HD22 ' H ' ' A' ' 47' ' ' LYS . 97.2 mt -89.45 -89.61 0.15 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.8 -1.091 . . . . 0.52000000000000002 111.421 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 36.7 t70 168.52 58.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.97 -1.122 . . . . 1.72 107.97 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.0 mp -115.29 134.34 58.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.913 -0.585 . . . . 0.28000000000000003 110.485 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.13 -59.69 1.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.37 0.605 . . . . 0.29999999999999999 111.166 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.62 -31.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.466 -0.788 . . . . 0.33000000000000002 109.59 -176.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.2 mtpt -134.63 -56.34 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.083 -0.71 . . . . 1.46 109.083 174.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.9 -121.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 1.1799999999999999 113.899 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.42 ' HB3' HG21 ' B' ' 7' ' ' VAL . 15.6 m -161.4 135.28 6.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.458 0.572 . . . . 0.20999999999999999 111.236 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -139.88 104.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.28000000000000003 109.332 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.1 tt0 -102.86 135.05 45.24 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.571 -0.529 . . . . 1.3100000000000001 109.571 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -112.49 154.33 26.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.02 0.914 . . . . 1.3300000000000001 113.098 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.511 ' HD1' HD12 ' A' ' 44' ' ' ILE . 24.9 t80 -131.76 121.91 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.982 -1.463 . . . . 2.2200000000000002 107.868 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.663 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -92.62 135.32 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.198 -0.601 . . . . 0.27000000000000002 110.703 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -133.74 102.4 5.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.979 -1.01 . . . . 1.1599999999999999 109.966 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.5 -82.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.32000000000000001 112.037 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.75 -20.15 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.34 0.591 . . . . 2.0 109.901 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 5.6 ttpt -93.05 157.97 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.256 -0.884 . . . . 1.05 111.376 -166.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.923 HG13 HD12 ' B' ' 22' ' ' LEU . 16.9 mm -114.78 141.5 31.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.904 -0.589 . . . . 0.17999999999999999 109.432 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 43.8 mt -122.36 107.2 19.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.607 0.242 . . . . 0.28000000000000003 110.758 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.772 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.1 mp -94.46 131.29 40.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 111.265 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HA ' HD21 ' A' ' 26' ' ' LEU . 4.1 ptmt -149.91 148.7 29.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.908 -0.587 . . . . 2.1600000000000001 111.136 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.813 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.3 tmtp? -72.39 137.3 46.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.52000000000000002 109.985 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.573 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 63.0 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.535 -0.757 . . . . 1.25 111.616 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.663 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.0 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.344 0.592 . . . . 1.0 110.252 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.819 HD12 ' HD2' ' A' ' 36' ' ' PHE . 1.3 mt -96.97 -32.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.32000000000000001 109.882 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.2 28.61 73.81 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.583 -0.735 . . . . 0.42999999999999999 112.888 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.474 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -124.52 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.158 0.504 . . . . 0.25 110.609 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -110.63 144.19 19.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.503 -0.771 . . . . 0.16 109.185 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mpt_? -114.56 155.11 27.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.035 0.445 . . . . 1.0900000000000001 110.631 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 116.98 27.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.258 -1.016 . . . . 1.1599999999999999 108.258 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 34' ' ' ILE . 9.1 t -52.45 137.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 O-C-N 123.803 0.689 . . . . 0.25 111.226 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.3 t70 -57.19 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.227 -0.897 . . . . 1.22 110.212 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 30' ' ' ILE . 44.3 mt-10 -152.92 -38.11 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.408 -0.96 . . . . 1.22 108.408 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.57 -29.27 25.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.786 -1.097 . . . . 0.90000000000000002 111.006 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.518 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 133.18 -3.2 4.8 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.663 -0.975 . . . . 0.14999999999999999 110.663 -172.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.2 mtm180 -63.33 129.47 40.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.356 . . . . 2.9100000000000001 110.701 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.5 OUTLIER -139.24 179.51 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.901 -0.777 . . . . 0.16 108.901 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -109.26 117.29 54.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.178 0.513 . . . . 0.19 111.263 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 23.8 mmt -81.61 154.6 71.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.235 -0.654 . . . . 0.93999999999999995 109.235 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.0 Cg_endo -86.47 156.27 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.129 1.886 . . . . 0.19 113.342 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' B' ' 23' ' ' ARG . 4.0 tp -56.47 -30.39 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.832 . . . . 0.22 109.314 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' B' ' 21' ' ' GLU . 3.4 mm-40 -58.84 -28.95 66.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.87 . . . . 1.0700000000000001 110.909 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.923 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.72 -40.22 34.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.987 -0.745 . . . . 0.23999999999999999 108.987 177.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.635 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 57.0 mtm180 -64.2 -27.69 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.037 -0.983 . . . . 1.3 110.357 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -83.99 -35.19 24.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.165 -0.925 . . . . 0.87 110.018 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -51.33 67.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.849 -1.069 . . . . 0.28000000000000003 110.878 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.781 HD22 ' H ' ' B' ' 47' ' ' LYS . 70.3 mt -90.83 -85.65 0.22 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.611 -1.177 . . . . 0.56999999999999995 111.675 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.59 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.3 t0 169.05 55.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.67 -0.863 . . . . 1.54 108.67 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.23 139.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.31 109.908 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.45 -59.58 1.93 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.814 -0.63 . . . . 0.40999999999999998 111.083 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.47 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -140.85 -33.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.177 -0.465 . . . . 0.34000000000000002 110.072 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 40.0 mtpt -133.98 -52.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.913 -0.773 . . . . 1.3799999999999999 108.913 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.8 OUTLIER 36.94 -118.96 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.686 -1.143 . . . . 1.1699999999999999 114.063 -176.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.572 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 15.9 m -161.43 134.72 6.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.996 0.362 . . . . 0.23999999999999999 111.337 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.653 HG21 HD23 ' B' ' 45' ' ' LEU . 3.8 mp -141.71 102.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.682 -0.488 . . . . 0.20000000000000001 109.682 171.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 38.5 tt0 -99.29 136.87 38.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 1.3300000000000001 109.576 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.731 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -110.43 158.12 18.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.283 1.039 . . . . 1.27 113.268 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.656 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 35.1 t80 -135.39 125.13 25.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.632 -1.622 . . . . 2.1000000000000001 107.86 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.751 ' H ' ' HB2' ' A' ' 3' ' ' SER . 13.5 p -92.9 135.31 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.87 -0.732 . . . . 0.29999999999999999 110.111 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -133.64 100.05 4.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.833 -0.621 . . . . 1.1799999999999999 110.039 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 -80.42 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.41999999999999998 111.917 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.69 -19.79 3.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.238 0.542 . . . . 1.9099999999999999 110.008 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -91.82 167.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.489 -0.778 . . . . 0.78000000000000003 110.796 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 8.4 mm -121.72 139.98 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.554 -0.748 . . . . 0.22 109.149 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.2 mt -118.27 111.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.498 -0.319 . . . . 0.29999999999999999 110.59 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.85 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -99.61 132.23 45.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.647 0.261 . . . . 0.25 111.478 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -153.76 145.33 23.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.012 -0.54 . . . . 1.8500000000000001 111.328 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.781 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.9 tmtp? -72.37 135.5 45.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 0.51000000000000001 109.905 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 t80 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.354 -0.839 . . . . 1.1699999999999999 112.207 -171.619 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.505 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.372 0.606 . . . . 1.0 111.38 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -84.82 -34.13 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.297 -1.001 . . . . 0.34000000000000002 108.297 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.35 16.09 78.85 Favored Glycine 0 CA--C 1.504 -0.603 0 CA-C-N 114.88 -1.055 . . . . 0.51000000000000001 112.736 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 23.4 m -114.7 131.17 67.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.778 0.799 . . . . 0.23000000000000001 111.475 -175.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.7 p -110.21 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.997 -1.456 . . . . 0.17000000000000001 108.746 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.7 mpt_? -122.04 164.24 18.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.436 -0.347 . . . . 1.21 110.557 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 34.1 mmtm -115.06 127.59 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.592 -0.892 . . . . 1.1299999999999999 108.592 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.851 HG23 HD11 ' B' ' 34' ' ' ILE . 18.3 t -58.55 136.64 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.57 -0.53 . . . . 0.23999999999999999 109.57 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.71 -77.87 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.899 -0.591 . . . . 1.3100000000000001 109.564 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.3 mt-10 -154.81 -45.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.747 -1.205 . . . . 1.23 107.747 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.13 -34.69 63.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.338 -1.301 . . . . 0.84999999999999998 110.908 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 141.86 -9.62 2.56 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.21 -0.905 . . . . 0.17000000000000001 111.12 -172.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 27.9 mtm180 -62.45 131.43 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.262 . . . . 3.0299999999999998 111.165 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -141.46 179.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.096 -0.705 . . . . 0.13 109.096 174.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -107.91 107.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.346 0.593 . . . . 0.19 110.908 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.62 ' HB3' HD13 ' A' ' 22' ' ' LEU . 77.4 mmm -80.29 152.56 73.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.122 -0.695 . . . . 0.83999999999999997 109.122 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 95.2 Cg_endo -84.66 157.22 12.12 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.767 1.645 . . . . 0.16 114.119 -171.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.511 HG13 ' HD2' ' A' ' 24' ' ' ARG . 3.1 tp -50.44 -37.81 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.816 -1.084 . . . . 0.26000000000000001 110.224 170.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.4 mm-40 -59.71 -26.13 65.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 1.0800000000000001 110.782 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -77.09 -39.21 50.49 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.947 -0.76 . . . . 0.20000000000000001 108.947 177.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 17.3 mtm180 -64.02 -34.74 78.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.312 -0.858 . . . . 1.05 110.028 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.7 mtp180 -79.62 -35.6 39.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.175 -0.92 . . . . 0.70999999999999996 110.083 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.43 -51.4 29.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.051 -0.977 . . . . 0.26000000000000001 110.212 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.5 mt -78.01 -89.87 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.173 -0.921 . . . . 0.52000000000000002 111.492 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 11.2 t70 175.15 43.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.511 -0.922 . . . . 1.72 108.511 -169.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -115.44 138.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 0.28000000000000003 111.317 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.94 -51.15 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.013 -0.539 . . . . 0.29999999999999999 111.513 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -147.18 -29.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.032 -0.359 . . . . 0.33000000000000002 110.032 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 30' ' ' ILE . 18.4 mtpp -138.98 -52.23 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.265 -0.642 . . . . 1.46 109.265 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 35.08 -110.24 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.49 -1.232 . . . . 1.1799999999999999 113.946 -177.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 50.4 m -165.34 142.44 5.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.377 0.535 . . . . 0.20999999999999999 111.168 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.001 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -141.13 108.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 110.26 -0.274 . . . . 0.28000000000000003 110.26 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.4 tt0 -105.63 132.17 52.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.987 -0.375 . . . . 1.3100000000000001 109.987 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.614 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.41 155.97 23.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.404 1.097 . . . . 1.3300000000000001 113.017 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 40.9 t80 -125.22 153.38 43.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.331 -1.759 . . . . 2.2200000000000002 106.454 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.9 p -122.16 133.09 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.788 -0.765 . . . . 0.27000000000000002 110.175 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.56 96.9 4.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 1.1599999999999999 110.033 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.89 -82.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.586 -0.733 . . . . 0.32000000000000001 111.502 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' HD23 ' B' ' 26' ' ' LEU . 14.6 m-20 -125.5 -17.7 5.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.724 -0.238 . . . . 2.0 110.99 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 166.27 12.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 1.05 110.72 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG13 HD12 ' B' ' 22' ' ' LEU . 15.3 mm -120.72 142.96 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.631 -0.507 . . . . 0.17999999999999999 109.631 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 43.0 mt -124.65 111.24 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.28000000000000003 110.613 -174.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -94.64 135.78 35.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.24 0.543 . . . . 0.32000000000000001 111.905 -174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 16.4 ttpp -149.68 134.56 17.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.852 -1.067 . . . . 2.1600000000000001 109.421 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.662 ' H ' HD22 ' A' ' 26' ' ' LEU . 1.7 tmtp? -63.86 155.32 30.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.637 -0.875 . . . . 0.52000000000000002 108.637 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.619 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 25.1 t80 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.067 0.46 . . . . 1.25 111.004 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.1 m . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.248 0.546 . . . . 1.0 110.858 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.16 -35.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.528 -1.286 . . . . 0.32000000000000001 107.528 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.66 73.82 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 114.382 -1.281 . . . . 0.42999999999999999 112.375 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.8 m -118.66 132.21 69.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.219 0.533 . . . . 0.25 110.603 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -109.44 147.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.16 109.196 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.472 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mpt_? -120.12 167.01 12.65 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.144 -0.48 . . . . 1.0900000000000001 110.377 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 40.6 mmtm -119.02 122.53 42.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.699 -0.852 . . . . 1.1599999999999999 108.699 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 1.001 HG23 HD11 ' A' ' 34' ' ' ILE . 4.3 t -56.04 133.31 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.281 -0.637 . . . . 0.25 109.281 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -79.16 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.756 -0.656 . . . . 1.22 109.972 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.521 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.4 mt-10 -152.73 -40.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.085 -1.08 . . . . 1.22 108.085 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.3 OUTLIER -89.74 -15.2 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.067 -1.424 . . . . 0.90000000000000002 110.493 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 124.21 -4.75 8.91 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.14999999999999999 111.934 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 53.0 mtm180 -63.45 131.74 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.869 0.067 . . . . 2.9100000000000001 110.839 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.694 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -142.15 179.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.904 -0.776 . . . . 0.16 108.904 174.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -107.95 109.14 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.007 0.432 . . . . 0.19 110.769 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.6 ' HB3' HD13 ' B' ' 22' ' ' LEU . 77.3 mmm -80.97 152.25 71.41 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.702 -0.851 . . . . 0.93999999999999995 108.702 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 40.7 Cg_endo -83.16 158.1 15.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.559 1.506 . . . . 0.19 113.583 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.624 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.9 tp -58.62 -29.55 39.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.142 -0.935 . . . . 0.22 109.307 172.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.54 -27.82 67.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 1.0700000000000001 110.823 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.736 HD12 HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -76.99 -41.42 42.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.723 -0.843 . . . . 0.23999999999999999 108.723 176.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.765 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 65.1 mtp180 -62.81 -31.25 72.2 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.543 -1.208 . . . . 1.3 110.899 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -81.15 -33.99 32.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.361 -0.836 . . . . 0.87 109.652 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.59 19.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.729 -1.123 . . . . 0.28000000000000003 111.419 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 74.2 mt -82.06 -81.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.862 -1.063 . . . . 0.56999999999999995 111.091 -171.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.571 ' C ' HD12 ' B' ' 28' ' ' ILE . 37.6 t70 170.9 49.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 -173.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -115.8 133.93 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.1 0.476 . . . . 0.31 110.336 -173.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.79 -48.47 3.92 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.512 -0.767 . . . . 0.40999999999999998 111.385 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.662 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -152.9 -29.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.008 0.432 . . . . 0.34000000000000002 109.97 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.662 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.8 mtpp -138.55 -51.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.944 -0.761 . . . . 1.3799999999999999 108.944 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.587 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 36.35 -108.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.518 -1.219 . . . . 1.1699999999999999 114.136 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 21.0 m -167.93 141.27 3.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.884 0.311 . . . . 0.23999999999999999 110.67 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.851 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -144.23 106.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 110.214 -0.291 . . . . 0.20000000000000001 110.214 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 tt0 -98.6 142.17 30.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.852 -0.425 . . . . 1.3300000000000001 109.852 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.589 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -114.45 155.4 26.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.067 0.936 . . . . 1.27 112.911 -175.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.821 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.4 t80 -127.31 151.17 49.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.754 -1.572 . . . . 2.1000000000000001 106.754 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.505 ' H ' ' HB2' ' A' ' 3' ' ' SER . 4.6 p -118.99 134.62 62.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.665 -0.814 . . . . 0.29999999999999999 110.604 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 19.8 t70 -129.44 95.81 4.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.222 -0.899 . . . . 1.1799999999999999 109.827 -175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.59 -82.31 0.39 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.901 -0.666 . . . . 0.41999999999999998 111.662 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.421 ' O ' HD23 ' A' ' 26' ' ' LEU . 26.6 m-20 -128.46 -13.26 4.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.516 0.198 . . . . 1.9099999999999999 110.514 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 1.2 ptpp? -100.29 168.94 9.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.389 . . . . 0.78000000000000003 110.55 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 23.4 mm -124.67 144.81 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.8 -0.637 . . . . 0.22 109.955 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.821 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 39.4 mt -125.93 115.08 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.27 -0.423 . . . . 0.29999999999999999 110.951 -173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -101.47 134.27 44.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.081 0.467 . . . . 0.25 111.869 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HA ' HD22 ' B' ' 26' ' ' LEU . 24.5 ttpp -147.99 137.6 22.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.191 -0.913 . . . . 1.8500000000000001 109.257 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -64.68 150.28 47.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.395 -0.965 . . . . 0.51000000000000001 108.395 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.634 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.77 0.319 . . . . 1.1699999999999999 110.707 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 5.2 m . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 120.985 0.422 . . . . 1.0 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' B' ' 37' ' ' PHE . 3.9 mt -97.69 -37.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.34000000000000002 109.701 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.64 40.54 31.7 Favored Glycine 0 CA--C 1.506 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.51000000000000001 112.446 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 4' ' ' ILE . 8.1 m -138.12 133.57 44.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.486 0.66 . . . . 0.23000000000000001 111.309 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -118.89 140.9 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.763 -1.108 . . . . 0.17000000000000001 109.061 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -116.29 160.05 21.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.82 -0.437 . . . . 1.21 109.82 -174.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 26.3 mmtp -122.15 120.44 34.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.335 -0.987 . . . . 1.1299999999999999 108.335 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.794 HG23 HD11 ' B' ' 34' ' ' ILE . 18.1 t -52.32 138.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.732 0.645 . . . . 0.23999999999999999 110.767 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.84 -71.86 0.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.77 -0.65 . . . . 1.3100000000000001 109.695 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -154.39 -51.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.938 -0.764 . . . . 1.23 108.938 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -82.56 -23.93 34.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.65 -1.159 . . . . 0.84999999999999998 110.821 -177.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 139.75 -9.6 3.12 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.913 -0.661 . . . . 0.17000000000000001 112.139 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 35.6 mtm180 -62.8 129.82 42.14 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.824 -0.221 . . . . 3.0299999999999998 110.945 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.18 177.33 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.268 -0.641 . . . . 0.13 109.268 175.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.733 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -106.31 111.61 35.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.301 0.572 . . . . 0.19 111.096 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 2.8 mmt -83.01 155.58 67.47 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.022 -0.733 . . . . 0.83999999999999997 109.022 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.2 Cg_endo -86.69 153.86 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.033 1.822 . . . . 0.16 113.573 -173.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.3 tp -52.59 -33.0 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.26000000000000001 109.667 169.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 2.3 mm-40 -62.15 -26.53 68.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.514 -0.766 . . . . 1.0800000000000001 110.873 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -78.91 -38.9 36.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.73 -0.841 . . . . 0.20000000000000001 108.73 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.72 ' HD3' HG11 ' B' ' 10' ' ' VAL . 37.3 mtm180 -65.07 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.107 -0.951 . . . . 1.05 110.249 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.3 mtp180 -84.62 -37.52 20.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.164 -0.925 . . . . 0.70999999999999996 110.529 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.2 -50.18 55.94 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.472 -0.785 . . . . 0.26000000000000001 110.43 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -80.6 -86.33 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.789 -1.096 . . . . 0.52000000000000002 111.13 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' H ' HD12 ' A' ' 28' ' ' ILE . 18.4 t0 166.6 61.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.6 -1.259 . . . . 1.72 107.6 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.707 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -123.95 134.27 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.622 -0.717 . . . . 0.28000000000000003 110.406 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.33 -56.67 2.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.151 0.5 . . . . 0.29999999999999999 110.825 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -141.48 -30.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.81 -0.632 . . . . 0.33000000000000002 109.699 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 6.7 mtpp -136.17 -54.15 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.323 -0.621 . . . . 1.46 109.323 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.97 -116.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.423 -1.262 . . . . 1.1799999999999999 113.706 -175.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 14.0 m -162.0 136.73 7.0 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.409 0.549 . . . . 0.20999999999999999 111.125 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' B' ' 10' ' ' VAL . 3.8 mp -138.6 103.15 2.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.868 -0.419 . . . . 0.28000000000000003 109.868 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.6 tt0 -97.95 137.73 36.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.254 -0.647 . . . . 1.3100000000000001 109.254 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -121.68 151.04 40.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.426 1.108 . . . . 1.3300000000000001 112.989 -175.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -113.5 165.87 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.311 -1.768 . . . . 2.2200000000000002 107.034 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' B' ' 3' ' ' SER . 2.9 p -133.19 125.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.49 0.662 . . . . 0.27000000000000002 109.906 167.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -128.57 104.59 7.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.926 -1.034 . . . . 1.1599999999999999 109.758 -173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.83 -92.08 0.53 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.156 -0.778 . . . . 0.32000000000000001 111.156 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD23 ' B' ' 26' ' ' LEU . 28.7 m-20 -126.9 4.57 6.57 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.993 -0.373 . . . . 2.0 109.993 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -109.97 157.24 19.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 1.05 111.437 -168.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HD12 ' B' ' 22' ' ' LEU . 19.8 mm -113.84 142.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.837 -0.431 . . . . 0.17999999999999999 109.837 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 mt -123.78 115.48 45.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.521 -0.309 . . . . 0.28000000000000003 110.92 -173.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' B' ' 45' ' ' LEU . 10.5 mp -101.27 129.79 47.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.47 0.652 . . . . 0.32000000000000001 112.429 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 13.4 ttpt -142.49 141.09 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.579 -1.191 . . . . 2.1600000000000001 109.749 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 1.5 tmtp? -73.96 148.95 41.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.574 -0.898 . . . . 0.52000000000000002 108.574 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.636 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 36.6 t80 . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.064 0.459 . . . . 1.25 111.235 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 19.9 m . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 121.441 0.638 . . . . 1.0 110.362 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.63 -46.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.481 -0.781 . . . . 0.32000000000000001 109.398 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.63 35.02 37.59 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.267 -0.879 . . . . 0.42999999999999999 112.512 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -129.09 132.4 67.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.042 0.448 . . . . 0.25 110.39 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.3 p -112.07 143.15 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.874 -0.787 . . . . 0.16 108.874 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.402 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.4 mpt_? -114.81 162.9 16.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.237 -0.438 . . . . 1.0900000000000001 110.602 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.59 121.3 38.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.523 -0.918 . . . . 1.1599999999999999 108.523 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 34' ' ' ILE . 2.9 t -56.32 132.87 20.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 O-C-N 123.358 0.411 . . . . 0.25 110.115 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.17 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.22 109.672 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.55 ' HG2' HD11 ' A' ' 30' ' ' ILE . 40.8 mt-10 -155.13 -39.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 124.272 0.983 . . . . 1.22 108.445 171.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.754 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -92.06 -18.01 24.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.458 -1.246 . . . . 0.90000000000000002 110.472 -177.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 130.1 -7.49 6.04 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.639 -0.71 . . . . 0.14999999999999999 112.106 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 39.2 mtm180 -61.45 129.99 43.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.819 -0.224 . . . . 2.9100000000000001 110.789 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -140.8 176.01 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.298 -0.63 . . . . 0.16 109.298 175.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 1.5 p -105.3 108.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.295 0.569 . . . . 0.19 111.358 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.9 mmt -75.3 156.26 85.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.027 -0.731 . . . . 0.93999999999999995 109.027 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.1 Cg_endo -87.84 155.58 7.36 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.988 1.792 . . . . 0.19 113.417 -176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.283 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -59.31 -30.03 68.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.401 -0.818 . . . . 1.0700000000000001 110.804 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.881 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.33 -39.99 58.83 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.23999999999999999 108.701 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.718 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 33.8 mtm180 -64.47 -30.09 71.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.862 -1.063 . . . . 1.3 110.318 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.414 ' HD2' HG13 ' B' ' 20' ' ' ILE . 74.8 mtp180 -84.64 -24.63 28.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.311 -0.859 . . . . 0.87 110.39 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.12 -53.2 8.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.218 -0.901 . . . . 0.28000000000000003 110.941 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.785 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 16.2 mt -83.13 -81.39 0.16 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.056 -0.975 . . . . 0.56999999999999995 110.212 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.593 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.3 t70 165.19 61.24 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.965 -1.124 . . . . 1.54 107.965 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -116.63 133.73 62.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.845 -0.616 . . . . 0.31 109.653 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.58 -56.82 2.21 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.178 -0.464 . . . . 0.40999999999999998 110.853 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -143.03 -31.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.84 -0.618 . . . . 0.34000000000000002 109.672 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -134.6 -51.88 0.8 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.354 -0.61 . . . . 1.3799999999999999 109.354 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.4 OUTLIER 39.77 -113.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.677 -1.147 . . . . 1.1699999999999999 113.818 -176.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 18.7 m -161.93 135.95 6.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.042 0.214 . . . . 0.23999999999999999 111.235 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.794 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -139.87 102.07 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 N-CA-C 109.677 -0.49 . . . . 0.20000000000000001 109.677 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 45.6 tt0 -96.47 135.55 38.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.3300000000000001 109.388 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.527 ' CE2' ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -121.07 151.29 40.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.603 0.716 . . . . 1.27 112.375 -176.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.563 ' HA ' HG13 ' A' ' 4' ' ' ILE . 2.8 p90 -143.34 139.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.962 -1.017 . . . . 2.1000000000000001 110.307 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.624 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.2 p -92.9 141.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.383 0.611 . . . . 0.29999999999999999 110.791 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.98 102.22 5.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.164 -0.926 . . . . 1.1799999999999999 109.355 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.6 -88.18 0.53 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.104 -0.799 . . . . 0.41999999999999998 111.104 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.07 -8.13 5.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.412 -0.218 . . . . 1.9099999999999999 110.412 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -105.78 168.42 9.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.78000000000000003 111.0 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 22' ' ' LEU . 30.4 mm -119.65 142.5 34.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.861 -0.609 . . . . 0.22 109.491 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 11.8 mt -125.95 125.44 68.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.912 -0.315 . . . . 0.29999999999999999 110.178 -175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -107.48 128.87 54.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.203 0.525 . . . . 0.25 111.86 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.509 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 10.3 ttpt -142.47 138.68 31.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.831 -1.077 . . . . 1.8500000000000001 110.158 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.6 tmtp? -70.01 146.67 50.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.822 -0.807 . . . . 0.51000000000000001 108.822 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.581 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 40.5 t80 . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 1.1699999999999999 111.419 -173.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 25.0 m . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.0 0.429 . . . . 1.0 111.998 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.1 mt -82.57 -35.59 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.037 -1.098 . . . . 0.34000000000000002 108.037 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.53 13.74 74.49 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 114.738 -1.119 . . . . 0.51000000000000001 112.798 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 29.1 m -105.17 132.44 51.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.502 0.667 . . . . 0.23000000000000001 110.93 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.8 p -113.52 139.78 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.494 -1.23 . . . . 0.17000000000000001 109.913 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -114.4 156.65 24.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.893 -0.594 . . . . 1.21 110.435 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -117.71 122.86 44.64 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.877 -0.786 . . . . 1.1299999999999999 108.877 175.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 28' ' ' ILE . 27.4 t -57.64 146.19 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.23999999999999999 111.781 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -64.97 -77.55 0.06 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.12 -0.945 . . . . 1.3100000000000001 110.151 174.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -155.22 -43.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.729 -0.841 . . . . 1.23 108.729 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 -25.88 30.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.647 -1.16 . . . . 0.84999999999999998 110.936 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 133.93 -6.76 4.79 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.295 -0.866 . . . . 0.17000000000000001 110.984 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 48.2 mtm180 -62.79 128.18 34.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.423 0.154 . . . . 3.0299999999999998 110.83 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -139.52 179.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.688 -0.856 . . . . 0.13 108.688 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -106.28 116.18 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.083 0.468 . . . . 0.19 110.907 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.636 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.9 mmt -83.56 150.84 60.77 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.34 -0.615 . . . . 0.83999999999999997 109.34 174.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.56 154.48 18.22 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.777 1.651 . . . . 0.16 113.098 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.536 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.1 tp -53.41 -32.18 19.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.325 -0.852 . . . . 0.26000000000000001 109.629 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.1 mm-40 -61.14 -27.78 68.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.0800000000000001 111.111 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.851 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -40.7 41.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.625 -0.879 . . . . 0.20000000000000001 108.625 176.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.623 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 42.3 mtm180 -63.66 -30.55 71.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.861 -1.063 . . . . 1.05 110.133 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.0 mtp180 -84.59 -32.12 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.37 -0.832 . . . . 0.70999999999999996 110.73 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.19 76.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.528 -0.76 . . . . 0.26000000000000001 109.803 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.773 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.8 mt -96.66 -91.53 0.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.974 -1.012 . . . . 0.52000000000000002 111.841 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 29.7 t70 172.31 55.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.742 -1.207 . . . . 1.72 107.742 -170.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.623 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.2 mp -116.23 130.38 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.81 -0.632 . . . . 0.28000000000000003 109.813 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -58.07 2.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.241 0.543 . . . . 0.29999999999999999 110.915 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.542 ' O ' HG12 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -143.42 -29.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.599 -0.728 . . . . 0.33000000000000002 109.616 -177.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 30' ' ' ILE . 34.9 mtpt -136.09 -54.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.665 . . . . 1.46 109.458 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 37.38 -124.4 0.21 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.814 1.042 . . . . 1.1799999999999999 113.814 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 16.4 m -159.88 134.53 7.74 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.426 0.557 . . . . 0.20999999999999999 111.318 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -139.58 108.42 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 110.155 -0.313 . . . . 0.28000000000000003 110.155 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 66.9 tt0 -99.68 140.99 33.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.762 -0.458 . . . . 1.3100000000000001 109.762 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.455 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -119.85 155.2 33.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.417 1.104 . . . . 1.3300000000000001 113.502 -176.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.766 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 6.6 t80 -121.34 144.81 48.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.418 -1.719 . . . . 2.2200000000000002 106.481 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' HB2' ' B' ' 3' ' ' SER . 8.8 p -116.47 128.76 73.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.506 -0.878 . . . . 0.27000000000000002 110.3 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -131.76 102.0 5.7 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.958 -1.019 . . . . 1.1599999999999999 109.755 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.63 -92.92 0.45 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.334 -0.706 . . . . 0.32000000000000001 111.334 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.54 -9.99 9.32 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.396 -0.594 . . . . 2.0 109.396 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -97.31 157.72 15.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.779 -0.646 . . . . 1.05 111.397 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.87 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 9.5 mm -116.38 144.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.261 -0.644 . . . . 0.17999999999999999 109.261 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 47.3 mt -129.52 109.7 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 122.33 0.252 . . . . 0.28000000000000003 110.782 -173.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.723 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -98.48 142.54 29.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.207 0.447 . . . . 0.32000000000000001 112.207 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -150.36 158.52 44.25 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.635 -0.711 . . . . 2.1600000000000001 109.241 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.773 ' H ' HD22 ' A' ' 26' ' ' LEU . 2.8 tmtp? -70.85 149.24 47.0 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.455 -0.943 . . . . 0.52000000000000002 108.455 174.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.58 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 91.7 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 1.25 110.853 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.4 m . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.171 0.51 . . . . 1.0 111.243 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.416 HD12 ' HD2' ' A' ' 36' ' ' PHE . 3.2 mt -83.19 -35.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.519 -1.289 . . . . 0.32000000000000001 107.519 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 28.02 71.68 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.349 -1.296 . . . . 0.42999999999999999 112.178 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.5 m -116.62 133.07 64.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.165 0.507 . . . . 0.25 110.272 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.1 p -113.46 140.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.16 109.861 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.462 ' NH1' ' HB ' ' B' ' 6' ' ' VAL . 6.6 mpt_? -114.4 157.35 22.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.993 -0.549 . . . . 1.0900000000000001 110.667 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.13 119.02 33.47 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.472 -0.936 . . . . 1.1599999999999999 108.472 177.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.653 HG23 HD11 ' A' ' 34' ' ' ILE . 5.5 t -56.28 141.76 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 123.839 0.712 . . . . 0.25 111.719 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -60.7 -79.56 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.951 -1.022 . . . . 1.22 110.474 175.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 30' ' ' ILE . 39.9 mt-10 -156.22 -39.68 0.08 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.228 -1.027 . . . . 1.22 108.228 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.94 -25.03 32.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.686 -1.143 . . . . 0.90000000000000002 110.457 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 127.66 -3.12 7.04 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.051 -0.977 . . . . 0.14999999999999999 110.742 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 72.9 mtm180 -62.18 127.02 29.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.275 . . . . 2.9100000000000001 110.613 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.0 OUTLIER -137.28 179.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.16 108.705 175.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.833 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -107.66 112.71 41.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.151 0.501 . . . . 0.19 111.034 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.666 ' HB3' HD22 ' B' ' 22' ' ' LEU . 29.2 mmt -76.3 154.35 84.19 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.11 -0.7 . . . . 0.93999999999999995 109.11 173.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 51.5 Cg_endo -85.78 156.29 10.26 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 121.998 1.799 . . . . 0.19 112.707 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -57.67 -29.04 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.381 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.4 -28.48 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.718 -0.674 . . . . 1.0700000000000001 110.691 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.857 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.77 -40.87 32.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.967 -0.753 . . . . 0.23999999999999999 108.967 176.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 35.3 mtm180 -62.84 -30.09 71.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.892 -1.049 . . . . 1.3 110.245 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.37 -34.87 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.94 . . . . 0.87 109.973 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.75 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.013 -0.994 . . . . 0.28000000000000003 109.964 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.654 HD22 ' H ' ' B' ' 47' ' ' LYS . 36.9 mt -94.44 -104.24 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.631 -1.168 . . . . 0.56999999999999995 110.94 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.495 ' H ' HD12 ' B' ' 28' ' ' ILE . 11.2 m-20 -153.62 16.26 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.812 -0.176 . . . . 1.54 111.461 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.694 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -76.62 129.32 37.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.369 -0.533 . . . . 0.31 110.471 -164.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -57.59 2.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.67 -0.696 . . . . 0.40999999999999998 110.387 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.573 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -142.48 -31.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.687 -0.688 . . . . 0.34000000000000002 109.566 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.0 mtpt -134.54 -53.08 0.82 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.773 -0.648 . . . . 1.3799999999999999 109.359 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.2 OUTLIER 41.05 -119.34 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.886 -1.052 . . . . 1.1699999999999999 113.51 -177.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 46.5 m -165.43 132.35 2.85 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.475 -0.141 . . . . 0.23999999999999999 110.866 -173.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -139.71 105.76 2.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.602 0.239 . . . . 0.20000000000000001 110.609 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 57.9 tt0 -96.32 141.7 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.613 -0.514 . . . . 1.3300000000000001 109.613 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.712 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.1 OUTLIER -113.83 159.8 19.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 122.121 0.963 . . . . 1.27 112.896 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.764 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 14.0 t80 -136.17 126.08 25.86 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 113.776 -1.556 . . . . 2.1000000000000001 107.656 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 11.0 p -95.81 134.63 32.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.831 -0.748 . . . . 0.29999999999999999 110.468 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -134.83 101.05 4.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.592 -0.731 . . . . 1.1799999999999999 110.107 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.01 -93.63 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.005 -0.838 . . . . 0.41999999999999998 111.005 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.54 -16.48 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.884 -0.413 . . . . 1.9099999999999999 109.884 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 3.6 ptpp? -95.62 169.83 9.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.353 0.597 . . . . 0.78000000000000003 111.109 -167.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.851 HG13 HD12 ' A' ' 22' ' ' LEU . 27.4 mm -125.38 142.34 42.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.172 -0.922 . . . . 0.22 109.447 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.764 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 25.3 mt -124.2 115.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 0.29999999999999999 111.004 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.87 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -102.86 141.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.125 0.417 . . . . 0.25 112.125 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -151.11 158.73 44.39 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.796 -0.816 . . . . 1.8500000000000001 108.796 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.654 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.4 tmtp? -72.56 153.72 41.16 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.997 -1.112 . . . . 0.51000000000000001 107.997 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.508 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 69.0 t80 . . . . . 0 C--N 1.322 -0.597 0 CA-C-O 120.821 0.344 . . . . 1.1699999999999999 111.19 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.572 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 54.7 m . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 121.205 0.526 . . . . 1.0 111.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' B' ' 36' ' ' PHE . 2.3 mt -81.8 -32.26 11.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.243 -1.021 . . . . 0.34000000000000002 108.243 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.29 13.12 76.85 Favored Glycine 0 CA--C 1.503 -0.689 0 CA-C-N 114.657 -1.156 . . . . 0.51000000000000001 112.735 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' B' ' 36' ' ' PHE . 25.5 m -108.98 131.54 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.568 0.699 . . . . 0.23000000000000001 111.056 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -109.34 140.74 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.553 -1.203 . . . . 0.17000000000000001 109.284 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.0 mpt_? -114.45 159.71 20.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.166 -0.47 . . . . 1.21 110.344 -175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 30.6 mmtp -122.19 121.76 37.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.326 -0.99 . . . . 1.1299999999999999 108.326 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HG21 ' B' ' 28' ' ' ILE . 26.9 t -55.25 145.33 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.851 0.719 . . . . 0.23999999999999999 110.953 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.43 -75.27 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.778 -0.647 . . . . 1.3100000000000001 109.266 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' HD11 ' B' ' 30' ' ' ILE . 30.5 mt-10 -152.79 -39.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.38 -34.65 28.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.41 -1.268 . . . . 0.84999999999999998 111.284 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.82 -11.09 2.63 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.942 -0.863 . . . . 0.17000000000000001 110.942 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 49.7 mtt180 -62.88 131.68 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.517 -0.342 . . . . 3.0299999999999998 110.869 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -139.85 176.04 6.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.071 -0.715 . . . . 0.13 109.071 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.707 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.3 p -104.64 112.77 39.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.209 0.528 . . . . 0.19 110.873 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 1.2 mmt -82.12 152.43 68.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.686 -0.857 . . . . 0.83999999999999997 108.686 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 92.4 Cg_endo -83.91 156.54 13.48 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.664 1.576 . . . . 0.16 113.132 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.86 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.7 tp -54.65 -33.33 27.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.176 -0.92 . . . . 0.26000000000000001 109.538 172.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.13 -26.88 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 1.0800000000000001 111.01 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.69 -40.98 47.12 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.728 -0.842 . . . . 0.20000000000000001 108.728 176.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 53.3 mtm180 -63.92 -30.18 71.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.097 -0.956 . . . . 1.05 110.165 176.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.86 ' HD2' HG13 ' A' ' 20' ' ' ILE . 37.6 mtp180 -85.15 -30.51 23.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.208 -0.906 . . . . 0.70999999999999996 110.651 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.31 -45.67 65.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.555 0.693 . . . . 0.26000000000000001 109.677 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 90.1 mt -88.58 -93.72 0.1 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.862 -1.063 . . . . 0.52000000000000002 111.508 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 28' ' ' ILE . 37.0 t70 172.71 57.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.096 -1.075 . . . . 1.72 108.096 -172.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.561 HG21 HG21 ' B' ' 10' ' ' VAL . 2.8 mp -113.88 131.27 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.28000000000000003 110.461 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.31 -54.1 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.122 -0.49 . . . . 0.29999999999999999 111.404 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.23 -33.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.905 -0.588 . . . . 0.33000000000000002 109.982 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 30' ' ' ILE . 44.1 mtpt -136.88 -51.26 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.986 -0.746 . . . . 1.46 108.986 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 38.18 -119.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.513 -1.221 . . . . 1.1799999999999999 113.378 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.404 ' HB3' HG21 ' B' ' 7' ' ' VAL . 17.1 m -163.21 135.29 5.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.482 0.583 . . . . 0.20999999999999999 111.512 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.662 HD11 HG23 ' B' ' 10' ' ' VAL . 2.6 mp -141.88 105.93 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.96 -0.385 . . . . 0.28000000000000003 109.96 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 72.0 tt0 -99.66 138.05 37.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.335 -0.617 . . . . 1.3100000000000001 109.335 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -117.55 152.93 34.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.638 1.209 . . . . 1.3300000000000001 114.136 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.95 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 32.1 t80 -114.43 157.78 22.43 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 112.98 -1.918 . . . . 2.2200000000000002 107.134 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' H ' ' HB2' ' B' ' 3' ' ' SER . 5.5 p -127.55 130.7 70.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.116 -0.634 . . . . 0.27000000000000002 110.033 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 19.3 t70 -130.63 97.24 4.31 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.471 -0.786 . . . . 1.1599999999999999 109.744 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.19 -78.85 0.3 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.599 -0.728 . . . . 0.32000000000000001 111.903 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.57 -30.5 4.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.471 0.653 . . . . 2.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -88.37 165.72 14.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.045 -163.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 22' ' ' LEU . 15.4 mm -121.21 142.94 35.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.426 -0.807 . . . . 0.17999999999999999 109.053 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.95 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 49.1 mt -128.55 108.45 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.511 -0.313 . . . . 0.28000000000000003 110.851 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.7 mp -99.82 141.61 32.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.306 0.484 . . . . 0.32000000000000001 112.306 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 156.97 41.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.45 -0.795 . . . . 2.1600000000000001 110.682 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 3.8 tmtp? -73.32 149.16 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.315 -0.624 . . . . 0.52000000000000002 109.315 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.64 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 69.7 t80 . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 1.25 111.738 -173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 67.0 m . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 121.205 0.526 . . . . 1.0 110.812 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.536 HD12 ' HD2' ' A' ' 36' ' ' PHE . 4.0 mt -80.47 -33.18 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.553 -1.277 . . . . 0.32000000000000001 107.553 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 20.12 66.65 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.135 -1.393 . . . . 0.42999999999999999 112.596 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.8 132.02 59.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.25 110.196 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.7 p -106.5 141.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.597 -0.728 . . . . 0.16 109.041 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.1 mpt_? -113.03 157.4 21.59 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.289 0.566 . . . . 1.0900000000000001 110.673 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 29.8 mmtp -119.14 119.24 33.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.909 -1.041 . . . . 1.1599999999999999 108.566 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.662 HG23 HD11 ' A' ' 34' ' ' ILE . 7.4 t -57.25 139.82 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.642 0.589 . . . . 0.25 110.777 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.01 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.486 -0.779 . . . . 1.22 109.805 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -152.63 -42.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.392 -0.966 . . . . 1.22 108.392 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.5 -27.3 37.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.783 -1.098 . . . . 0.90000000000000002 111.255 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.447 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 130.32 0.03 5.51 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.355 -0.698 . . . . 0.14999999999999999 111.355 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.707 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 24.6 mtt-85 -66.93 130.84 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.121 -0.326 . . . . 2.9100000000000001 110.121 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -139.53 175.69 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.413 -0.588 . . . . 0.16 109.413 176.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -105.32 108.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.964 0.412 . . . . 0.19 110.973 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.3 mmt -74.97 154.63 86.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.032 -0.729 . . . . 0.93999999999999995 109.032 173.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 65.5 Cg_endo -86.85 155.49 8.69 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.999 1.799 . . . . 0.19 113.219 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -55.99 -30.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.22 109.431 171.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.3 -30.59 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 1.0700000000000001 110.999 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.61 -40.35 56.57 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.78 -0.822 . . . . 0.23999999999999999 108.78 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 34.4 mtm180 -66.13 -26.52 67.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 1.3 110.626 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' HG13 ' B' ' 20' ' ' ILE . 68.9 mtp180 -84.33 -35.37 23.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.577 -0.738 . . . . 0.87 109.734 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.67 -51.58 66.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.727 -1.124 . . . . 0.28000000000000003 110.947 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.653 HD22 ' H ' ' B' ' 47' ' ' LYS . 71.0 mt -89.83 -85.6 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.732 -1.122 . . . . 0.56999999999999995 111.139 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.579 ' C ' HD12 ' B' ' 28' ' ' ILE . 15.9 t0 166.46 61.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.797 -1.186 . . . . 1.54 107.797 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.726 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.56 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.66 -0.7 . . . . 0.31 109.86 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.67 -51.59 2.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.721 -0.672 . . . . 0.40999999999999998 111.652 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -144.16 -33.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 110.011 -0.366 . . . . 0.34000000000000002 110.011 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 38.1 mtpt -136.29 -49.05 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 1.3799999999999999 109.051 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.66 -115.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.384 -1.28 . . . . 1.1699999999999999 113.832 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 14.2 m -164.08 135.37 4.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.994 0.361 . . . . 0.23999999999999999 111.347 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.708 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -144.04 102.97 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 110.18 -0.304 . . . . 0.20000000000000001 110.18 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 65.7 tt0 -96.03 139.32 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.541 -0.54 . . . . 1.3300000000000001 109.541 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.89 155.62 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.524 1.154 . . . . 1.27 113.889 -175.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.894 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -120.14 157.26 29.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.1 -1.864 . . . . 2.1000000000000001 107.073 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.572 ' H ' ' HB2' ' A' ' 3' ' ' SER . 8.5 p -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 120.093 -0.643 . . . . 0.29999999999999999 109.955 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.822 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.7 t70 -132.3 95.8 3.73 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 1.1799999999999999 109.917 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.1 -75.9 0.33 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.685 -0.689 . . . . 0.41999999999999998 111.654 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.32 -29.04 3.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.484 0.659 . . . . 1.9099999999999999 109.798 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.822 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.4 OUTLIER -85.81 158.36 20.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.112 -0.949 . . . . 0.78000000000000003 111.778 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.837 HG13 HD12 ' A' ' 22' ' ' LEU . 17.7 mm -118.27 144.11 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.656 -0.702 . . . . 0.22 109.925 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.894 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.1 mt -128.66 114.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 0.29999999999999999 110.956 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.1 mp -104.23 141.05 36.96 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.89 0.33 . . . . 0.25 111.89 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -151.71 151.55 31.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.946 -0.57 . . . . 1.8500000000000001 110.345 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.653 ' H ' HD22 ' B' ' 26' ' ' LEU . 2.1 tmtp? -78.1 137.5 38.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.371 -0.603 . . . . 0.51000000000000001 109.371 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.863 -0.608 . . . . 1.1699999999999999 111.714 -169.574 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.735 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 75.2 m . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.276 0.56 . . . . 1.0 110.532 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.607 HD12 ' HB2' ' B' ' 36' ' ' PHE . 2.7 mt -100.04 -45.17 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.785 . . . . 0.34000000000000002 109.304 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.13 24.03 60.23 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.493 -0.776 . . . . 0.51000000000000001 112.222 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.4 m -121.22 133.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.648 0.737 . . . . 0.23000000000000001 111.241 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -108.77 140.49 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.17000000000000001 109.072 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.6 mpt_? -113.3 157.17 22.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.181 -0.463 . . . . 1.21 110.807 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.22 120.85 36.37 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.455 -0.793 . . . . 1.1299999999999999 108.971 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG21 ' B' ' 28' ' ' ILE . 42.7 t -55.88 145.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.23999999999999999 111.026 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -69.31 0.33 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.423 -0.584 . . . . 1.3100000000000001 109.423 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -155.88 -54.16 0.09 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.126 -0.943 . . . . 1.23 108.734 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.2 mp -77.81 -22.44 50.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.317 -1.311 . . . . 0.84999999999999998 111.376 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.58 -11.33 4.02 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.821 -0.704 . . . . 0.17000000000000001 111.886 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.796 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 39.6 mtt180 -60.25 134.51 57.13 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.906 -0.173 . . . . 3.0299999999999998 110.751 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.43 175.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.515 -0.921 . . . . 0.13 108.515 172.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -106.37 100.69 11.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.347 0.594 . . . . 0.19 110.826 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 16' ' ' ILE . 81.1 mmm -74.94 148.61 84.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.818 -0.808 . . . . 0.83999999999999997 108.818 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 82.0 Cg_endo -80.25 157.6 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.828 1.685 . . . . 0.16 113.247 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.1 tp -56.04 -31.79 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.333 -0.849 . . . . 0.26000000000000001 109.405 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.3 mm-40 -61.19 -28.8 69.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 1.0800000000000001 111.191 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.8 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.64 -39.33 57.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.488 -0.93 . . . . 0.20000000000000001 108.488 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.642 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 50.6 mtm180 -66.04 -28.56 68.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.84 -1.073 . . . . 1.05 110.28 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.642 ' HD2' HG13 ' A' ' 20' ' ' ILE . 72.4 mtp180 -84.99 -35.0 22.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.435 -0.802 . . . . 0.70999999999999996 110.522 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.23 55.23 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.275 -0.875 . . . . 0.26000000000000001 110.136 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.56 HD22 ' H ' ' A' ' 47' ' ' LYS . 87.0 mt -81.49 -88.84 0.08 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.86 -1.064 . . . . 0.52000000000000002 110.577 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.1 t70 167.17 61.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.634 -1.247 . . . . 1.72 107.634 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.645 HG21 HG21 ' B' ' 10' ' ' VAL . 3.0 mp -113.26 132.23 62.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.657 -0.701 . . . . 0.28000000000000003 110.102 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.28 -55.74 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 0.29999999999999999 110.927 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -143.09 -32.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.778 -0.646 . . . . 0.33000000000000002 109.91 -177.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.62 ' HG3' HG23 ' A' ' 30' ' ' ILE . 31.7 mtpt -136.98 -50.3 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.358 0.599 . . . . 1.46 109.467 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER 36.86 -116.41 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.399 1.259 . . . . 1.1799999999999999 114.399 -177.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 20.0 m -164.87 134.52 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.416 0.553 . . . . 0.20999999999999999 111.424 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.768 HD11 HG23 ' B' ' 10' ' ' VAL . 2.8 mp -140.99 106.77 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.369 -0.234 . . . . 0.28000000000000003 110.369 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 60.0 tt0 -98.76 142.08 30.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.744 -0.465 . . . . 1.3100000000000001 109.744 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.1 155.03 35.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.231 1.015 . . . . 1.3300000000000001 113.354 -175.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' A' ' 44' ' ' ILE . 34.7 t80 -134.47 126.73 30.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.714 -1.585 . . . . 2.2200000000000002 108.122 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.706 ' H ' ' HB2' ' B' ' 3' ' ' SER . 6.3 p -92.9 129.14 43.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 119.498 -0.881 . . . . 0.27000000000000002 110.705 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -127.08 109.04 11.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.011 -0.995 . . . . 1.1599999999999999 108.942 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 -96.49 0.75 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.398 -1.081 . . . . 0.32000000000000001 110.398 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.28 -8.12 8.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.565 0.221 . . . . 2.0 110.483 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -100.4 166.75 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.687 -0.233 . . . . 1.05 110.88 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.896 HG13 HD12 ' B' ' 22' ' ' LEU . 11.9 mm -116.25 143.42 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.055 -0.35 . . . . 0.17999999999999999 110.055 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 49.1 mt -122.02 118.79 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.431 -0.349 . . . . 0.28000000000000003 110.435 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' B' ' 45' ' ' LEU . 11.1 mp -103.37 133.5 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.32000000000000001 111.63 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 11.4 ttpt -142.19 143.98 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.362 -0.835 . . . . 2.1600000000000001 110.255 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -75.97 145.94 39.94 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.506 -0.924 . . . . 0.52000000000000002 108.506 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 84.9 t80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.418 0.628 . . . . 1.25 110.918 -172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.706 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 75.2 m . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.063 0.459 . . . . 1.0 111.59 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.8 mt -105.72 -46.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.32000000000000001 108.971 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.7 21.89 73.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.289 -0.868 . . . . 0.42999999999999999 112.265 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.3 132.53 66.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.269 0.557 . . . . 0.25 110.825 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.5 p -105.0 143.13 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.024 -0.732 . . . . 0.16 109.024 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.478 ' NE ' HG13 ' B' ' 17' ' ' VAL . 2.5 mpt_? -113.17 158.89 19.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.1 0.476 . . . . 1.0900000000000001 111.084 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.6 mmtp -118.55 121.66 40.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.871 -1.059 . . . . 1.1599999999999999 109.106 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.768 HG23 HD11 ' A' ' 34' ' ' ILE . 14.5 t -57.66 141.39 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.304 -0.407 . . . . 0.25 110.29 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.16 -74.3 0.12 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 1.22 109.32 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -148.54 -55.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.485 0.66 . . . . 1.22 109.472 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.874 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -76.96 -16.9 59.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.054 -0.976 . . . . 0.90000000000000002 110.91 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 126.72 -0.85 7.37 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.991 -0.623 . . . . 0.14999999999999999 111.672 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 6.3 mtm180 -67.01 126.56 29.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.188 -0.301 . . . . 2.9100000000000001 110.188 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -132.81 172.36 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.811 -0.811 . . . . 0.16 108.811 176.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -104.67 101.58 12.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.301 0.572 . . . . 0.19 110.812 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.51 ' SD ' HD11 ' B' ' 16' ' ' ILE . 84.3 mmm -75.4 151.63 85.46 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.046 -0.724 . . . . 0.93999999999999995 109.046 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 29.1 Cg_endo -83.36 156.8 14.58 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.628 1.552 . . . . 0.19 113.317 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -55.24 -30.72 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.909 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -62.68 -26.35 68.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.23 -0.441 . . . . 1.0700000000000001 110.627 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.896 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.46 -40.61 49.92 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.901 -0.778 . . . . 0.23999999999999999 108.901 175.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.682 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 53.0 mtm180 -65.19 -29.13 69.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.844 -1.071 . . . . 1.3 110.705 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 81.6 mtp180 -83.49 -30.55 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.354 -0.839 . . . . 0.87 109.821 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.83 -53.26 22.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.895 -1.048 . . . . 0.28000000000000003 110.935 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.791 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 48.4 mt -85.16 -81.39 0.2 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.784 -1.098 . . . . 0.56999999999999995 110.55 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.575 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.1 t0 163.95 60.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.744 -1.206 . . . . 1.54 107.744 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 10' ' ' VAL . 1.4 mp -116.84 132.89 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.104 -0.498 . . . . 0.31 109.67 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.69 -54.32 2.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.793 -0.64 . . . . 0.40999999999999998 111.064 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -33.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.15 -0.477 . . . . 0.34000000000000002 109.801 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 10' ' ' VAL . 21.1 mtpt -133.31 -52.38 0.89 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.328 -0.619 . . . . 1.3799999999999999 109.328 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 36.25 -118.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.585 -1.189 . . . . 1.1699999999999999 114.103 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 13.1 m -161.05 135.84 7.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.046 0.384 . . . . 0.23999999999999999 111.979 -173.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.6 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -143.9 104.39 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 N-CA-C 110.289 -0.263 . . . . 0.20000000000000001 110.289 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.4 tt0 -96.48 141.05 30.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.767 -0.457 . . . . 1.3300000000000001 109.767 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.607 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.02 157.79 26.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.014 1.116 . . . . 1.27 114.014 -175.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.454 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 47.4 t80 -136.83 129.28 30.08 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 113.63 -1.623 . . . . 2.1000000000000001 108.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.735 ' H ' ' HB2' ' A' ' 3' ' ' SER . 9.6 p -92.37 133.42 33.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 119.816 -0.753 . . . . 0.29999999999999999 109.746 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -131.9 107.47 8.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.967 -0.753 . . . . 1.1799999999999999 108.967 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.64 -91.01 0.66 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.051 -0.82 . . . . 0.41999999999999998 111.051 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -128.77 -9.0 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.748 -0.464 . . . . 1.9099999999999999 109.748 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -100.93 169.05 9.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.78000000000000003 110.799 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 22' ' ' LEU . 23.0 mm -118.86 142.93 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 0.22 110.461 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 18.8 mt -119.75 124.89 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.322 -0.399 . . . . 0.29999999999999999 110.109 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -109.39 132.23 54.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.022 0.439 . . . . 0.25 111.64 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 13.9 ttpt -142.08 145.53 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.8500000000000001 110.237 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.791 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -80.94 138.85 36.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.028 -0.731 . . . . 0.51000000000000001 109.028 175.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.486 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 37.2 t80 . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.1699999999999999 112.822 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.598 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 31.6 t . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 121.015 0.436 . . . . 1.0 111.9 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.7 mt -92.8 -34.0 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.051 -0.722 . . . . 0.34000000000000002 109.051 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.38 6.18 79.61 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.027 -0.988 . . . . 0.51000000000000001 112.733 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 31.8 m -102.41 133.38 46.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.605 0.717 . . . . 0.23000000000000001 111.326 -176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 6.5 p -115.84 140.36 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.413 -1.267 . . . . 0.17000000000000001 109.68 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.697 ' HG2' ' CZ ' ' B' ' 36' ' ' PHE . 11.6 mmt180 -110.54 165.08 12.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.857 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 28.4 mmtp -124.28 122.36 37.53 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.102 -1.073 . . . . 1.1299999999999999 108.102 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.665 HG23 HD11 ' B' ' 34' ' ' ILE . 38.4 t -56.5 145.98 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.23999999999999999 111.726 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.21 -78.04 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 1.3100000000000001 109.699 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -153.45 -45.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.944 -0.761 . . . . 1.23 108.944 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -81.92 -27.59 33.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.952 -1.022 . . . . 0.84999999999999998 110.808 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.16 -11.18 2.8 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.623 -0.717 . . . . 0.17000000000000001 111.582 -174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 46.8 mtp180 -61.21 132.05 52.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.099 0.16 . . . . 3.0299999999999998 111.0 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -139.07 178.57 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.684 -0.858 . . . . 0.13 108.684 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.82 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -107.41 109.21 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.488 0.661 . . . . 0.19 111.467 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.633 ' HB3' HD22 ' A' ' 22' ' ' LEU . 14.5 mmt -75.74 154.01 85.24 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.503 -0.771 . . . . 0.83999999999999997 109.315 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.2 Cg_endo -83.26 154.39 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.68 1.587 . . . . 0.16 113.162 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 tp -54.74 -31.7 24.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.562 -0.744 . . . . 0.26000000000000001 109.568 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.86 -28.21 68.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.45 -0.795 . . . . 1.0800000000000001 110.768 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.816 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -39.6 44.67 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.787 -0.82 . . . . 0.20000000000000001 108.787 176.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.1 mtm180 -64.73 -28.91 69.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.142 -0.936 . . . . 1.05 110.394 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -83.68 -38.58 21.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.163 -0.926 . . . . 0.70999999999999996 110.227 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.67 85.37 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.289 -0.868 . . . . 0.26000000000000001 110.525 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.555 HD22 ' HB2' ' A' ' 47' ' ' LYS . 93.1 mt -87.8 -93.69 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.06 -0.973 . . . . 0.52000000000000002 111.587 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 33.0 t70 -179.95 38.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.435 0.636 . . . . 1.72 109.307 -172.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.1 mp -100.06 134.27 40.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.401 -0.363 . . . . 0.28000000000000003 110.884 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -56.51 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.29999999999999999 110.684 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.586 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.46 -29.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.954 -0.567 . . . . 0.33000000000000002 109.724 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 30' ' ' ILE . 37.4 mtpt -136.11 -57.1 0.76 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.474 -0.785 . . . . 1.46 109.028 176.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 37.21 -128.13 0.17 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.097 -0.956 . . . . 1.1799999999999999 113.036 -175.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 13.1 m -153.29 136.66 15.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.516 0.598 . . . . 0.20999999999999999 111.589 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.725 HD11 HG23 ' B' ' 10' ' ' VAL . 4.2 mp -139.18 107.79 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.223 -0.288 . . . . 0.28000000000000003 110.223 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.1 tt0 -105.28 140.67 38.07 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.022 -0.362 . . . . 1.3100000000000001 110.022 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -123.04 153.62 39.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.533 0.938 . . . . 1.3300000000000001 113.533 -174.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' HD1' HD12 ' A' ' 44' ' ' ILE . 33.8 t80 -125.12 124.31 41.58 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.078 -1.419 . . . . 2.2200000000000002 108.742 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.1 p -93.65 134.58 30.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 C-N-CA 119.785 -0.766 . . . . 0.27000000000000002 110.74 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -132.75 105.12 6.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.344 -0.844 . . . . 1.1599999999999999 109.747 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.54 0.46 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.162 -0.775 . . . . 0.32000000000000001 111.162 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -128.02 -8.03 5.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.369 0.604 . . . . 2.0 109.528 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.2 ttpt -93.16 156.96 16.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 1.05 111.329 -169.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.93 HG13 HD12 ' B' ' 22' ' ' LEU . 10.0 mm -116.93 142.92 28.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.484 -0.561 . . . . 0.17999999999999999 109.484 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.622 HD12 ' HD1' ' A' ' 37' ' ' PHE . 47.0 mt -128.98 109.52 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.581 0.229 . . . . 0.28000000000000003 110.907 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.88 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.4 mp -92.17 137.62 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.291 0.567 . . . . 0.32000000000000001 112.184 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 12.6 ttpt -145.97 141.59 27.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.794 -1.094 . . . . 2.1600000000000001 109.527 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 33' ' ' SER . 7.1 tmtt? -76.58 146.32 38.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.098 -0.704 . . . . 0.52000000000000002 109.098 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 t80 . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 120.762 -0.375 . . . . 1.25 111.808 -171.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.525 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 37.2 t . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.338 0.589 . . . . 1.0 109.985 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.795 HD12 ' HD2' ' A' ' 36' ' ' PHE . 2.9 mt -88.76 -40.12 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.561 -0.903 . . . . 0.32000000000000001 108.561 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.28 77.73 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.026 -0.988 . . . . 0.42999999999999999 112.49 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -114.23 132.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.041 0.448 . . . . 0.25 110.706 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -113.82 139.53 38.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.694 -0.685 . . . . 0.16 109.693 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.726 ' HG2' ' CE1' ' A' ' 36' ' ' PHE . 5.1 mmt180 -106.73 167.0 10.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 110.623 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HD3' ' O ' ' B' ' 8' ' ' ARG . 30.1 mmtp -125.9 119.03 26.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.113 -1.069 . . . . 1.1599999999999999 108.113 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.725 HG23 HD11 ' A' ' 34' ' ' ILE . 8.5 t -56.55 142.04 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.43 0.633 . . . . 0.25 111.26 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.75 -76.38 0.06 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 1.22 110.058 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -152.44 -49.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.565 -0.902 . . . . 1.22 108.565 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.83 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.4 OUTLIER -79.93 -19.12 48.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.246 -1.343 . . . . 0.90000000000000002 110.655 -176.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 128.02 -3.3 6.86 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.14999999999999999 111.489 -176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 52.0 mtm180 -63.99 128.55 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.445 -0.206 . . . . 2.9100000000000001 110.445 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -136.04 179.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.072 -0.714 . . . . 0.16 109.072 176.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -106.63 108.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.215 0.531 . . . . 0.19 111.04 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.693 ' HB3' HD22 ' B' ' 22' ' ' LEU . 30.4 mmt -74.66 152.95 87.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.65 -0.871 . . . . 0.93999999999999995 108.65 172.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 43.3 Cg_endo -84.5 154.84 12.16 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.906 1.738 . . . . 0.19 112.943 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 4.1 tp -53.84 -32.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.22 109.571 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -61.12 -26.43 67.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.79 -0.641 . . . . 1.0700000000000001 110.819 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.93 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.63 -40.94 32.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.926 -0.768 . . . . 0.23999999999999999 108.926 176.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 38.8 mtm180 -65.65 -27.5 68.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.568 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 72.1 mtp180 -83.96 -30.75 25.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.257 -0.883 . . . . 0.87 110.047 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.99 -52.52 28.0 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.012 -0.994 . . . . 0.28000000000000003 110.687 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 62.0 mt -85.6 -87.51 0.13 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.734 -1.121 . . . . 0.56999999999999995 110.8 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.435 ' C ' HD12 ' B' ' 28' ' ' ILE . 38.9 t70 173.89 45.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.754 . . . . 1.54 109.005 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 10' ' ' VAL . 1.2 mp -108.0 129.11 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.31 110.018 -174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.15 4.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.478 -0.783 . . . . 0.40999999999999998 111.499 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.556 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -150.46 -33.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.742 -0.466 . . . . 0.34000000000000002 109.742 177.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' B' ' 30' ' ' ILE . 44.1 mtpt -133.55 -50.92 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.316 0.579 . . . . 1.3799999999999999 109.443 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.536 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.8 -113.56 0.1 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.22 1.192 . . . . 1.1699999999999999 114.22 -177.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.5 m -164.38 137.39 5.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.189 0.45 . . . . 0.23999999999999999 111.61 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -141.86 102.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 110.213 -0.292 . . . . 0.20000000000000001 110.213 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 33.5 tt0 -95.18 142.53 27.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.4 -0.593 . . . . 1.3300000000000001 109.4 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.697 ' CZ ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -118.99 158.52 25.6 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.183 0.992 . . . . 1.27 113.579 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 18.7 t80 -132.88 125.87 30.93 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 113.675 -1.602 . . . . 2.1000000000000001 108.011 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.598 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.5 p -93.28 135.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.822 -0.751 . . . . 0.29999999999999999 110.24 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.074 -0.713 . . . . 1.1799999999999999 109.074 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.11 -95.17 0.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.977 -0.849 . . . . 0.41999999999999998 110.977 -171.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.94 -13.58 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 1.9099999999999999 110.169 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -92.82 167.78 11.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.78000000000000003 110.834 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.7 mm -121.97 143.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.13 -0.486 . . . . 0.22 109.724 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 17.4 mt -124.5 113.85 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.504 -0.316 . . . . 0.29999999999999999 110.798 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.836 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -98.02 139.52 33.73 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.265 0.555 . . . . 0.25 112.064 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -152.58 141.07 20.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.799 -1.091 . . . . 1.8500000000000001 109.188 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tmtt? -72.74 153.4 41.16 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.842 -0.799 . . . . 0.51000000000000001 108.842 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 75.9 t80 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.149 0.499 . . . . 1.1699999999999999 111.358 -172.08 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.626 ' HB2' ' CD1' ' B' ' 37' ' ' PHE . 19.0 t . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.161 0.505 . . . . 1.0 109.681 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.43 -31.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.067 -0.716 . . . . 0.34000000000000002 109.067 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.58 21.43 77.14 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.139 -0.937 . . . . 0.51000000000000001 112.931 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.57 132.63 68.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.859 0.837 . . . . 0.23000000000000001 111.748 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -111.1 140.86 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 113.935 -1.484 . . . . 0.17000000000000001 108.578 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.7 mpt_? -114.78 155.0 27.53 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.017 0.437 . . . . 1.21 110.607 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 121.05 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.584 -0.895 . . . . 1.1299999999999999 108.584 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.638 HG23 HD11 ' B' ' 34' ' ' ILE . 4.7 t -54.52 141.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.564 0.54 . . . . 0.23999999999999999 110.312 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.36 -77.86 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.939 -0.763 . . . . 1.3100000000000001 108.939 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.48 ' HG2' HD11 ' B' ' 30' ' ' ILE . 29.8 mt-10 -151.71 -36.2 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.623 -0.88 . . . . 1.23 108.623 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD12 ' HD2' ' A' ' 15' ' ' ARG . 11.2 mt -86.79 -19.09 29.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.14 -0.936 . . . . 0.84999999999999998 111.7 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 124.19 -6.43 8.75 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 120.503 -0.856 . . . . 0.17000000000000001 111.277 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.0 mtp180 -67.25 125.2 25.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.345 -0.242 . . . . 3.0299999999999998 110.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -131.73 175.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.966 -0.753 . . . . 0.13 108.966 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.7 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -103.27 102.43 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.056 0.455 . . . . 0.19 110.938 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.625 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.2 mmt -74.54 149.99 86.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.4 -0.593 . . . . 0.83999999999999997 109.4 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.4 Cg_endo -81.19 155.03 19.29 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.781 1.654 . . . . 0.16 113.383 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 4.7 tp -56.2 -31.81 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.178 -0.919 . . . . 0.26000000000000001 109.059 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 13.0 mm-40 -58.87 -30.93 68.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.211 -0.904 . . . . 1.0800000000000001 111.253 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.905 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.22 -41.12 58.33 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.457 -0.942 . . . . 0.20000000000000001 108.457 177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.629 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 32.3 mtm180 -63.92 -29.57 70.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.782 -1.099 . . . . 1.05 110.224 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 73.5 mtp180 -85.26 -35.83 21.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.399 -0.819 . . . . 0.70999999999999996 110.753 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.28 95.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.598 0.713 . . . . 0.26000000000000001 109.874 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.565 HD22 ' H ' ' A' ' 47' ' ' LYS . 77.2 mt -92.36 -104.83 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.678 -1.146 . . . . 0.52000000000000002 110.255 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -174.72 49.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 1.72 109.422 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.629 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -93.18 131.68 39.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.28000000000000003 109.513 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.58 -57.77 2.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.34 0.59 . . . . 0.29999999999999999 110.587 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -146.68 -28.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.032 -0.986 . . . . 0.33000000000000002 109.604 -175.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HG3' HG23 ' A' ' 30' ' ' ILE . 21.2 mtpp -139.88 -52.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 1.46 109.141 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' HB2' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER 37.75 -115.27 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.094 1.146 . . . . 1.1799999999999999 114.094 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 38.5 m -166.59 137.88 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.436 0.562 . . . . 0.20999999999999999 111.065 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.751 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -139.0 111.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.701 -0.481 . . . . 0.28000000000000003 109.701 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 22.7 tt0 -107.92 130.2 55.04 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.31 0.244 . . . . 1.3100000000000001 110.552 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.701 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -116.06 153.5 31.61 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.655 0.983 . . . . 1.3300000000000001 113.655 -170.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' HD1' HD12 ' A' ' 44' ' ' ILE . 25.5 t80 -129.86 132.36 46.41 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 114.112 -1.404 . . . . 2.2200000000000002 108.478 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.532 ' H ' ' HB3' ' B' ' 3' ' ' SER . 2.8 p -100.29 132.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 119.765 -0.774 . . . . 0.27000000000000002 111.268 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.9 t70 -125.59 99.89 6.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.67 -1.15 . . . . 1.1599999999999999 109.534 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.32 -84.31 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.583 -0.735 . . . . 0.32000000000000001 111.365 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.01 -17.04 5.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.392 0.615 . . . . 2.0 109.64 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' B' ' 44' ' ' ILE . 2.1 ttpt -92.47 158.07 16.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.345 -0.843 . . . . 1.05 111.325 -167.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.968 HG13 HD12 ' B' ' 22' ' ' LEU . 7.0 mm -118.12 139.46 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.887 -0.412 . . . . 0.17999999999999999 109.887 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.591 HD12 ' HD1' ' A' ' 37' ' ' PHE . 43.6 mt -121.87 111.71 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.444 . . . . 0.28000000000000003 110.508 -174.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -102.87 138.19 40.08 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.815 0.302 . . . . 0.32000000000000001 111.815 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 149.89 26.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 2.1600000000000001 110.081 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -65.53 147.99 52.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.891 -0.595 . . . . 0.52000000000000002 110.146 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.634 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 24.3 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 1.25 111.263 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 47.1 t . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.081 0.467 . . . . 1.0 110.723 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HD2' ' A' ' 36' ' ' PHE . 10.5 mt -89.45 -40.73 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.923 -0.769 . . . . 0.32000000000000001 108.923 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.88 39.65 59.0 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.42999999999999999 112.538 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 36' ' ' PHE . 15.3 m -131.97 132.21 61.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.023 0.439 . . . . 0.25 110.029 174.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.1 p -108.44 142.66 20.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.819 -0.808 . . . . 0.16 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.701 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 mpt_? -113.79 153.87 28.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.991 0.424 . . . . 1.0900000000000001 110.764 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 121.45 44.64 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.565 -0.743 . . . . 1.1599999999999999 109.054 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 34' ' ' ILE . 3.8 t -53.62 137.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 123.837 0.711 . . . . 0.25 110.459 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -55.08 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.631 -0.713 . . . . 1.22 109.998 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.711 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.1 mt-10 -151.64 -32.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.499 -0.926 . . . . 1.22 108.499 173.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.33 -29.96 21.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.304 -1.317 . . . . 0.90000000000000002 110.858 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 132.06 -8.37 5.42 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.768 -0.933 . . . . 0.14999999999999999 110.768 -172.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 mtp180 -62.84 124.58 21.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.299 . . . . 2.9100000000000001 110.508 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -129.58 174.77 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.649 -0.871 . . . . 0.16 108.649 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.723 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.9 p -104.15 104.06 16.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.326 0.584 . . . . 0.19 110.693 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 1.6 mmt -76.29 151.72 83.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 0.93999999999999995 108.729 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.41 153.84 10.62 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.877 1.718 . . . . 0.19 113.321 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -53.85 -30.25 19.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.413 -0.812 . . . . 0.22 109.985 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.04 -25.67 67.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.206 -0.452 . . . . 1.0700000000000001 110.88 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.968 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.62 -41.29 39.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.631 -0.877 . . . . 0.23999999999999999 108.631 174.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 37.4 mtm180 -63.54 -29.83 71.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.887 -1.052 . . . . 1.3 110.683 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.563 ' HD2' HG13 ' B' ' 20' ' ' ILE . 62.0 mtp180 -84.36 -33.93 23.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.271 -0.877 . . . . 0.87 110.048 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -51.03 71.63 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.781 -1.1 . . . . 0.28000000000000003 110.1 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.575 HD22 ' H ' ' B' ' 47' ' ' LYS . 61.0 mt -92.4 -91.25 0.17 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.462 -1.245 . . . . 0.56999999999999995 111.637 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.476 ' C ' HD12 ' B' ' 28' ' ' ILE . 16.7 t0 175.5 50.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.637 -0.875 . . . . 1.54 108.637 -170.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -109.34 132.92 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.966 -0.753 . . . . 0.31 108.966 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.36 -51.48 2.91 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.163 0.506 . . . . 0.40999999999999998 111.852 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.669 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -146.94 -29.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.971 -0.559 . . . . 0.34000000000000002 109.668 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.669 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.4 mtpp -140.06 -51.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.465 -0.568 . . . . 1.3799999999999999 109.465 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.452 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.7 OUTLIER 34.91 -115.44 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.802 1.038 . . . . 1.1699999999999999 113.802 -176.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.0 m -163.4 136.99 5.74 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.155 -0.34 . . . . 0.23999999999999999 111.37 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.668 HG21 HD23 ' B' ' 45' ' ' LEU . 4.3 mp -142.0 105.22 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.6 -0.519 . . . . 0.20000000000000001 109.6 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.1 tt0 -102.73 134.45 46.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.318 -0.253 . . . . 1.3300000000000001 110.318 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.509 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.79 158.67 23.52 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.214 1.19 . . . . 1.27 114.214 -173.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.692 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 66.4 t80 -126.07 152.71 45.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.199 -1.819 . . . . 2.1000000000000001 107.177 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.608 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.9 p -117.87 137.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 120.057 -0.657 . . . . 0.29999999999999999 110.041 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 31.5 t70 -133.65 95.6 3.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 110.111 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.03 -73.49 1.04 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.572 -0.74 . . . . 0.41999999999999998 111.684 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -127.71 -30.5 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.462 0.649 . . . . 1.9099999999999999 109.421 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -89.7 166.22 13.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.096 -0.956 . . . . 0.78000000000000003 111.341 -163.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.905 HG13 HD12 ' A' ' 22' ' ' LEU . 25.4 mm -121.27 142.99 35.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.46 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 33.5 mt -124.06 109.74 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.409 -0.359 . . . . 0.29999999999999999 110.69 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 45' ' ' LEU . 10.6 mp -101.69 134.66 44.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.331 0.493 . . . . 0.25 112.331 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.3 OUTLIER -149.08 148.75 30.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.8500000000000001 109.667 172.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.575 ' H ' HD22 ' B' ' 26' ' ' LEU . 7.1 tttt -64.92 167.05 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.238 -0.585 . . . . 1.1699999999999999 110.108 -171.494 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.863 0.363 . . . . 4.7999999999999998 110.066 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.857 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 32.3 mtmm -140.76 -160.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.812 -0.631 . . . . 2.48 109.92 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 48.7 m -48.56 -52.8 20.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.156 0.503 . . . . 1.0 111.289 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -86.02 -33.91 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.647 -0.872 . . . . 0.34000000000000002 108.647 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.857 ' HA2' ' H ' ' A' ' 2' ' ' LYS . . . 70.52 19.61 76.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.831 -1.077 . . . . 0.51000000000000001 112.548 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 27.9 m -115.92 131.32 68.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.573 0.701 . . . . 0.23000000000000001 111.177 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.8 p -114.63 141.73 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.512 -1.222 . . . . 0.17000000000000001 109.36 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.465 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.74 165.11 13.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.977 0.418 . . . . 1.21 110.607 -176.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 33.4 mmtp -120.22 124.24 45.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.242 -1.021 . . . . 1.1299999999999999 108.242 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.709 HG21 HG21 ' B' ' 28' ' ' ILE . 39.7 t -56.38 141.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.497 0.498 . . . . 0.23999999999999999 109.912 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.85 -75.15 0.07 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.938 -0.574 . . . . 1.3100000000000001 109.676 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.25 -46.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.842 -0.799 . . . . 1.23 108.842 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -77.78 -50.47 12.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.887 -1.051 . . . . 0.84999999999999998 110.734 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.17 -5.49 0.05 OUTLIER Glycine 0 C--O 1.225 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.17000000000000001 111.832 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 56.5 mtm180 -68.99 135.03 50.28 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 122.07 0.148 . . . . 3.0299999999999998 110.868 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -141.12 179.99 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.906 -0.775 . . . . 0.13 108.906 174.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.7 p -107.38 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.171 0.51 . . . . 0.19 110.91 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.653 ' HE1' HD11 ' B' ' 45' ' ' LEU . 78.6 mmm -84.13 148.62 53.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.105 -0.702 . . . . 0.83999999999999997 109.105 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.0 Cg_endo -80.41 157.65 22.45 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.93 1.753 . . . . 0.16 113.679 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.6 tp -52.68 -34.61 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.969 -1.014 . . . . 0.26000000000000001 109.713 171.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.42 -25.67 66.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.344 -0.843 . . . . 1.0800000000000001 110.982 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -78.39 -40.97 34.53 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.83 -0.804 . . . . 0.20000000000000001 108.83 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.65 ' HD2' HG22 ' A' ' 28' ' ' ILE . 21.0 mtm180 -63.78 -30.88 71.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.41 -0.814 . . . . 1.05 109.837 176.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 77.8 mtp180 -83.82 -33.3 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.267 -0.879 . . . . 0.70999999999999996 110.854 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.02 -46.88 73.14 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.806 0.813 . . . . 0.26000000000000001 109.413 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.874 HD22 ' H ' ' A' ' 47' ' ' LYS . 82.8 mt -85.19 -101.52 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.291 -1.322 . . . . 0.52000000000000002 110.372 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' H ' HD12 ' A' ' 28' ' ' ILE . 4.7 p-10 -179.36 50.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.632 -0.713 . . . . 1.72 109.4 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG22 ' HD2' ' A' ' 23' ' ' ARG . 2.4 mp -98.44 136.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.872 -1.058 . . . . 0.28000000000000003 109.932 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.16 -51.59 2.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.802 -0.359 . . . . 0.29999999999999999 111.629 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.881 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -145.31 -32.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.463 -0.335 . . . . 0.33000000000000002 110.221 -177.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 20.3 mtpp -137.83 -50.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.813 -0.81 . . . . 1.46 108.813 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 35.91 -118.84 0.13 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.461 -1.245 . . . . 1.1799999999999999 113.138 -176.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB3' HG21 ' B' ' 7' ' ' VAL . 21.1 m -163.32 138.65 6.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.362 0.528 . . . . 0.20999999999999999 111.198 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD11 HG23 ' B' ' 10' ' ' VAL . 3.1 mp -139.6 110.23 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.759 -0.46 . . . . 0.28000000000000003 109.759 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 41.3 tt0 -104.15 137.17 42.48 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.501 -0.555 . . . . 1.3100000000000001 109.501 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -110.06 151.37 27.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.964 0.888 . . . . 1.3300000000000001 112.601 -174.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 14.8 t80 -127.25 122.15 33.15 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.11 -1.404 . . . . 2.2200000000000002 107.519 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.464 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -93.28 132.78 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 119.798 -0.761 . . . . 0.27000000000000002 111.131 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -133.92 102.85 5.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.183 -0.917 . . . . 1.1599999999999999 110.343 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.5 -88.44 0.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.815 -0.629 . . . . 0.32000000000000001 112.04 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.67 -8.46 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.598 0.237 . . . . 2.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.68 168.75 9.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.141 0.496 . . . . 1.05 111.09 -168.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.735 HG13 HD12 ' B' ' 22' ' ' LEU . 15.5 mm -122.53 141.65 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.324 -0.853 . . . . 0.17999999999999999 109.249 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 46.4 mt -121.96 111.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.694 0.283 . . . . 0.28000000000000003 110.382 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' B' ' 45' ' ' LEU . 10.6 mp -101.13 132.28 46.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.538 -0.301 . . . . 0.32000000000000001 111.809 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.71 157.34 37.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.139 0.495 . . . . 2.1600000000000001 111.093 172.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.874 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.2 tmtp? -63.15 153.47 34.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.732 . . . . 0.52000000000000002 110.406 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.744 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 61.6 t80 -71.28 -51.26 25.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.496 -0.32 . . . . 1.25 111.245 -175.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 24.1 ttmm -46.4 -59.73 4.6 Favored Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 123.85 0.719 . . . . 2.8599999999999999 112.827 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 15.2 Cg_exo -68.95 108.97 2.04 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.742 1.628 . . . . 1.8100000000000001 111.112 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -84.87 95.56 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 4.6900000000000004 110.707 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.53 -153.79 30.0 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.827 -0.909 . . . . 3.1400000000000001 110.827 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.35 137.18 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 3.5800000000000001 110.709 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.723 -0.671 . . . . 2.8700000000000001 109.607 -176.429 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.716 0.293 . . . . 4.7400000000000002 110.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.818 ' H ' ' HA2' ' B' ' 5' ' ' GLY . 28.4 mttm -146.26 -162.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 2.3100000000000001 110.293 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 54.2 m -52.11 -50.42 61.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.312 172.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 36' ' ' PHE . 1.9 mt -84.34 -42.0 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.848 -1.167 . . . . 0.32000000000000001 107.848 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.818 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 72.76 27.02 69.92 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.559 -1.201 . . . . 0.42999999999999999 112.199 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.9 131.9 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.192 0.52 . . . . 0.25 110.345 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.5 p -111.54 141.27 27.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.333 -0.849 . . . . 0.16 109.323 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.717 ' HD2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -114.21 162.39 16.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.009 0.433 . . . . 1.0900000000000001 110.354 -175.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.8 mmtp -118.18 121.57 40.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.449 -0.945 . . . . 1.1599999999999999 108.449 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 34' ' ' ILE . 5.2 t -55.48 135.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.555 -0.535 . . . . 0.25 109.555 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.86 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.999 -0.546 . . . . 1.22 109.535 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.881 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.4 mt-10 -154.7 -34.42 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.302 -0.999 . . . . 1.22 108.302 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.81 -49.23 11.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.098 -1.41 . . . . 0.90000000000000002 110.329 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.511 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 152.21 -6.24 0.5 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.724 -1.125 . . . . 0.14999999999999999 110.711 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 43.0 mtm180 -63.45 131.06 46.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.72 -0.24 . . . . 2.9100000000000001 110.451 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.639 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.8 OUTLIER -138.76 179.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.757 -0.831 . . . . 0.16 108.757 174.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -107.77 113.51 43.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.19 110.885 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.564 ' HB3' HD13 ' B' ' 22' ' ' LEU . 74.8 mmm -84.89 149.0 52.47 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.815 . . . . 0.93999999999999995 108.801 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 39.5 Cg_endo -80.68 158.44 21.75 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.744 1.629 . . . . 0.19 113.63 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.49 -30.92 32.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.229 -0.896 . . . . 0.22 109.707 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -25.76 67.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.223 -0.444 . . . . 1.0700000000000001 110.704 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.735 HD12 HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -78.08 -41.74 34.34 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.826 -0.805 . . . . 0.23999999999999999 108.826 175.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.737 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 32.8 mtp180 -61.79 -33.65 74.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.849 -1.069 . . . . 1.3 110.68 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 55.2 mtp180 -79.66 -37.68 35.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.34 -0.845 . . . . 0.87 109.872 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.42 -50.52 71.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.429 -1.26 . . . . 0.28000000000000003 110.161 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.859 HD22 ' H ' ' B' ' 47' ' ' LYS . 56.5 mt -92.93 -80.44 0.38 Allowed 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.65 -1.159 . . . . 0.56999999999999995 112.075 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 t0 177.4 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.089 -0.245 . . . . 1.54 111.619 -168.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.737 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.5 mp -88.87 124.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.335 0.588 . . . . 0.31 111.668 -163.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.43 -34.86 9.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.96 . . . . 0.40999999999999998 112.786 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.677 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -166.05 -33.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.502 -0.555 . . . . 0.34000000000000002 109.502 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.677 ' HG3' HG23 ' B' ' 30' ' ' ILE . 18.6 mtpp -136.58 -49.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.787 -0.82 . . . . 1.3799999999999999 108.787 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 35.39 -111.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.467 -1.242 . . . . 1.1699999999999999 113.766 -176.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 27.3 m -166.05 138.35 3.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.343 0.52 . . . . 0.23999999999999999 110.891 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -142.19 107.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.729 -0.471 . . . . 0.20000000000000001 109.729 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 44.7 tt0 -103.62 139.5 38.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.711 -0.477 . . . . 1.3300000000000001 109.711 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.78 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.85 154.73 21.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.015 0.912 . . . . 1.27 112.637 -173.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.725 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 22.9 t80 -129.96 126.22 37.3 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 114.091 -1.413 . . . . 2.1000000000000001 107.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 10.2 p -93.04 136.43 25.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.732 -0.787 . . . . 0.29999999999999999 110.339 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 11.8 t70 -134.16 100.91 4.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 1.1799999999999999 109.804 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.34 -90.47 0.19 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.852 -0.69 . . . . 0.41999999999999998 111.721 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -118.31 -13.47 9.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.946 0.403 . . . . 1.9099999999999999 110.704 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' B' ' 39' ' ' ASP . 2.8 ptpt -98.1 169.14 9.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 0.78000000000000003 110.939 -168.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -124.56 140.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.373 -0.831 . . . . 0.22 109.206 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 35.9 mt -119.22 113.75 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.588 -0.278 . . . . 0.29999999999999999 110.546 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 45' ' ' LEU . 11.2 mp -101.13 128.46 47.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.808 0.337 . . . . 0.25 111.575 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.587 ' HA ' HD21 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -152.19 153.53 34.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 1.8500000000000001 110.476 175.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.859 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.6 tmtt? -65.03 166.01 10.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.51000000000000001 109.757 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -86.87 -49.29 7.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.038 0.447 . . . . 1.1699999999999999 110.225 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.777 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 24.2 ttmm -49.76 -56.38 17.49 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.926 -1.034 . . . . 2.9199999999999999 112.577 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 13.2 Cg_exo -70.15 94.84 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.891 1.727 . . . . 1.5700000000000001 111.642 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -63.73 114.85 4.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.099 -0.955 . . . . 4.6799999999999997 111.021 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.1 -149.9 9.12 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.419 -1.072 . . . . 3.1200000000000001 110.419 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.0 134.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.141 0.495 . . . . 3.6200000000000001 110.286 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.243 0.758 0 CA-C-O 118.579 -0.724 . . . . 2.8199999999999998 109.358 -175.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.173 -0.306 . . . . 4.7999999999999998 110.173 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.842 ' HE3' ' HA ' ' B' ' 54' ' ' CYS . 1.9 mmpt? 55.0 -170.44 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.824 0.821 . . . . 2.48 113.173 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 22.8 t -80.01 -35.68 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.036 -0.984 . . . . 1.0 109.317 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' B' ' 36' ' ' PHE . 5.3 mt -103.57 -49.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.662 -0.699 . . . . 0.34000000000000002 109.388 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.58 25.32 30.65 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 115.533 -0.758 . . . . 0.51000000000000001 112.567 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.7 133.27 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.0 0.905 . . . . 0.23000000000000001 110.991 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.3 p -112.99 141.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 113.651 -1.613 . . . . 0.17000000000000001 108.727 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 1.2 mpt_? -112.06 156.7 21.78 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.923 0.392 . . . . 1.21 110.462 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -121.25 118.14 28.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.33 -0.989 . . . . 1.1299999999999999 108.33 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG23 HD11 ' B' ' 34' ' ' ILE . 22.5 t -54.22 144.49 5.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 123.948 0.78 . . . . 0.23999999999999999 111.87 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -60.88 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.95 -1.023 . . . . 1.3100000000000001 110.059 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.606 ' HG2' HD11 ' B' ' 30' ' ' ILE . 40.5 mt-10 -154.3 -43.78 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.627 -1.249 . . . . 1.23 107.627 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.51 -34.96 65.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.259 -1.337 . . . . 0.84999999999999998 111.263 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' B' ' 23' ' ' ARG . . . 137.24 -4.64 3.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.451 -0.795 . . . . 0.17000000000000001 111.152 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.743 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 9.0 mtp180 -68.57 133.57 48.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.644 -0.278 . . . . 3.0299999999999998 110.626 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.2 pt -138.79 -179.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.578 -0.527 . . . . 0.13 109.578 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -109.81 103.11 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.084 0.469 . . . . 0.19 110.802 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 16' ' ' ILE . 83.3 mmm -78.7 149.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.989 -0.745 . . . . 0.83999999999999997 108.989 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -81.48 155.77 18.81 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.871 1.714 . . . . 0.16 113.61 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.7 tp -51.7 -32.36 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.26000000000000001 109.884 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.24 -29.68 68.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.334 -0.848 . . . . 1.0800000000000001 111.487 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' B' ' 43' ' ' ILE . 0.0 OUTLIER -80.47 -34.63 35.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.242 -0.651 . . . . 0.20000000000000001 109.242 177.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.679 ' HD3' HG11 ' B' ' 10' ' ' VAL . 33.3 mtm180 -63.98 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.66 -0.7 . . . . 1.05 109.658 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 68.3 mtp180 -83.67 -33.03 25.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.031 -0.986 . . . . 0.70999999999999996 110.663 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.47 -37.85 77.45 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.26000000000000001 110.117 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.67 -88.64 0.23 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.145 -0.934 . . . . 0.52000000000000002 111.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.749 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 22.1 t70 177.27 23.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.024 0.44 . . . . 1.72 109.977 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.6 mp -83.5 129.9 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 O-C-N 122.184 -0.323 . . . . 0.28000000000000003 110.963 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.0 -48.37 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.29999999999999999 111.236 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.653 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.15 -30.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 0.33000000000000002 110.113 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.4 mtpt -137.03 -51.9 0.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.296 -0.631 . . . . 1.46 109.296 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER 36.44 -117.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.517 -1.219 . . . . 1.1799999999999999 113.994 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HG21 ' B' ' 7' ' ' VAL . 13.3 m -162.51 135.51 5.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.274 0.488 . . . . 0.20999999999999999 111.428 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.877 HD11 HG23 ' B' ' 10' ' ' VAL . 3.2 mp -137.38 107.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.28000000000000003 109.775 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 46.2 tt0 -103.1 138.03 40.48 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.287 -0.634 . . . . 1.3100000000000001 109.287 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.993 0.901 . . . . 1.3300000000000001 112.866 -174.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.753 ' HD2' ' HE2' ' B' ' 2' ' ' LYS . 18.4 t80 -127.83 123.43 35.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.126 -1.397 . . . . 2.2200000000000002 108.179 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.0 p -92.3 132.6 36.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 119.824 -0.75 . . . . 0.27000000000000002 110.492 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -133.59 102.65 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.515 -1.22 . . . . 1.1599999999999999 109.248 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.39 -97.17 0.59 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.706 -0.759 . . . . 0.32000000000000001 111.269 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -117.83 -9.55 10.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.323 0.583 . . . . 2.0 109.697 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.4 ttpt -92.09 157.73 16.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.449 -0.796 . . . . 1.05 111.538 -169.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.878 HG13 HD12 ' B' ' 22' ' ' LEU . 20.2 mm -118.58 139.53 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.179 -0.674 . . . . 0.17999999999999999 109.179 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 44.2 mt -121.99 109.81 25.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.629 -0.26 . . . . 0.28000000000000003 110.676 -173.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' B' ' 45' ' ' LEU . 11.3 mp -96.44 136.15 37.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.003 0.43 . . . . 0.32000000000000001 111.612 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 18.5 pttp -145.15 170.81 15.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.186 -0.915 . . . . 2.1600000000000001 110.173 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 5.1 tmtt? -87.03 149.23 24.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.307 -0.86 . . . . 0.52000000000000002 109.097 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -77.95 -56.19 4.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.933 0.397 . . . . 1.25 110.936 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.642 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 24.0 tptm -56.03 -60.77 7.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 113.92 1.081 . . . . 2.8599999999999999 113.92 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 61.3 Cg_endo -73.39 -2.47 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.026 1.817 . . . . 1.8100000000000001 113.89 -170.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -166.54 78.87 0.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 4.6900000000000004 110.422 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.77 85.95 0.57 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.969 -0.634 . . . . 3.1400000000000001 112.125 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.92 148.24 13.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.061 -0.348 . . . . 3.5800000000000001 110.061 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.021 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 47.8 t . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.368 -0.825 . . . . 2.8700000000000001 109.889 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.36 -0.237 . . . . 4.7400000000000002 110.36 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 1.021 ' HE3' ' HA ' ' A' ' 54' ' ' CYS . 5.2 mmpt? 53.1 -161.81 0.11 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.686 0.624 . . . . 2.3100000000000001 112.686 173.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 24.2 t -87.4 -36.78 17.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.66 -46.88 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.466 -0.788 . . . . 0.32000000000000001 109.362 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.28 29.12 46.4 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.197 -0.911 . . . . 0.42999999999999999 112.493 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.451 HG23 ' CE2' ' A' ' 36' ' ' PHE . 19.5 m -126.31 131.37 71.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.374 0.607 . . . . 0.25 110.681 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 33' ' ' SER . 15.0 p -107.91 142.89 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.225 -0.898 . . . . 0.16 109.189 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.2 mpt_? -111.56 161.03 16.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.31 -0.405 . . . . 1.0900000000000001 110.535 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.38 116.09 22.71 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.85 . . . . 1.1599999999999999 108.704 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.877 HG23 HD11 ' A' ' 34' ' ' ILE . 7.5 t -53.25 141.86 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.706 0.629 . . . . 0.25 111.196 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.12 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.042 -0.981 . . . . 1.22 109.946 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.653 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.7 mt-10 -149.83 -41.78 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.109 -1.071 . . . . 1.22 108.109 169.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.2 mt -72.88 -36.55 67.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.269 -1.332 . . . . 0.90000000000000002 110.864 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.545 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 134.78 -1.46 3.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.14999999999999999 111.069 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 47.3 mtp85 -64.45 131.27 46.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.685 -0.257 . . . . 2.9100000000000001 110.694 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -138.7 179.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.241 -0.652 . . . . 0.16 109.241 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -108.89 106.28 20.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.185 0.517 . . . . 0.19 110.732 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.509 ' SD ' HD11 ' B' ' 16' ' ' ILE . 81.0 mmm -79.77 146.04 63.62 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.853 -0.795 . . . . 0.93999999999999995 108.853 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.76 158.62 31.61 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.08 1.853 . . . . 0.19 113.316 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -56.81 -31.05 34.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.273 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -59.33 -26.84 65.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.0700000000000001 111.26 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.878 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.36 -39.84 31.64 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.931 -0.766 . . . . 0.23999999999999999 108.931 176.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.581 ' HB2' HD12 ' B' ' 20' ' ' ILE . 42.9 mtm180 -66.45 -26.98 67.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.027 -0.988 . . . . 1.3 110.577 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -83.45 -32.34 26.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.529 -0.76 . . . . 0.87 109.603 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.62 62.35 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.074 -0.966 . . . . 0.28000000000000003 110.494 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 53.0 mt -85.26 -93.9 0.08 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.547 -1.206 . . . . 0.56999999999999995 109.364 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.516 ' OD1' ' HG3' ' B' ' 47' ' ' LYS . 6.7 p30 177.76 40.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.367 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -81.01 125.05 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.31 109.798 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.77 -43.57 10.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.928 -0.578 . . . . 0.40999999999999998 111.138 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -160.4 -30.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 0.34000000000000002 109.388 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.518 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.2 mtpt -133.89 -52.45 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 1.3799999999999999 109.382 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.55 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.4 OUTLIER 39.45 -117.83 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.848 -1.069 . . . . 1.1699999999999999 113.725 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 34.4 m -162.05 134.47 5.77 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.034 0.379 . . . . 0.23999999999999999 111.639 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.689 HD11 HG23 ' A' ' 10' ' ' VAL . 3.7 mp -137.88 103.58 2.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.945 -0.391 . . . . 0.20000000000000001 109.945 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 47.7 tt0 -97.79 137.7 36.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.692 -0.485 . . . . 1.3300000000000001 109.692 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.736 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.31 154.65 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.088 0.947 . . . . 1.27 113.002 -174.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.63 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 27.1 t80 -130.51 123.12 28.93 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 114.031 -1.44 . . . . 2.1000000000000001 108.169 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.5 p -93.11 133.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.566 -0.854 . . . . 0.29999999999999999 110.756 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' B' ' 37' ' ' PHE . 17.3 t70 -132.41 103.78 6.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.3 -0.864 . . . . 1.1799999999999999 109.974 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.53 -84.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.899 -0.591 . . . . 0.41999999999999998 111.719 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.96 -22.49 4.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.7 -0.481 . . . . 1.9099999999999999 109.7 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -91.17 167.96 11.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.569 . . . . 0.78000000000000003 110.866 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 5.3 mm -125.46 139.39 51.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.623 -0.717 . . . . 0.22 109.224 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 15.6 mt -118.23 117.85 56.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.436 -0.347 . . . . 0.29999999999999999 110.559 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.853 HD13 HD13 ' A' ' 45' ' ' LEU . 11.1 mp -104.2 134.68 47.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.955 0.407 . . . . 0.25 111.761 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.443 ' HE3' ' HD2' ' A' ' 2' ' ' LYS . 19.2 pttp -147.1 167.96 22.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.284 -0.871 . . . . 1.8500000000000001 109.558 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.799 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -89.11 149.33 23.24 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.539 -0.912 . . . . 0.51000000000000001 108.539 174.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.518 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 64.8 t80 -72.78 -57.69 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.678 0.275 . . . . 1.1699999999999999 111.311 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.714 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 22.9 tptm -50.6 -60.66 4.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 114.431 1.271 . . . . 2.9199999999999999 114.431 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.799 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 34.3 Cg_exo -60.46 -42.67 39.01 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.97 1.78 . . . . 1.5700000000000001 112.542 -172.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -135.62 81.67 1.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.232 0.539 . . . . 4.6799999999999997 110.197 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.13 86.05 0.6 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.743 -0.662 . . . . 3.1200000000000001 111.963 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.83 150.62 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 110.173 -0.306 . . . . 3.6200000000000001 110.173 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.842 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 53.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.735 -0.65 . . . . 2.8199999999999998 109.649 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.87 -0.419 . . . . 4.7999999999999998 109.87 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.905 ' HD3' ' HA ' ' B' ' 54' ' ' CYS . 32.5 mmtm -65.98 169.75 6.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 2.48 110.816 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.751 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.7 m -65.19 -49.17 70.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.316 -0.857 . . . . 1.0 110.502 176.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.603 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -88.33 -36.18 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.34000000000000002 109.635 -178.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.66 78.18 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.387 -0.824 . . . . 0.51000000000000001 112.284 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG22 ' HB ' ' A' ' 4' ' ' ILE . 29.5 m -119.15 132.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.689 0.757 . . . . 0.23000000000000001 111.053 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.3 p -114.76 138.89 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.276 -1.329 . . . . 0.17000000000000001 109.114 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.22 148.97 32.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.069 0.461 . . . . 1.21 110.294 -174.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -112.98 120.28 40.85 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.321 -0.854 . . . . 1.1299999999999999 108.898 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.636 HG21 HG21 ' B' ' 28' ' ' ILE . 36.3 t -54.7 144.72 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 111.809 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -80.32 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.842 -1.072 . . . . 1.3100000000000001 109.917 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' HD11 ' B' ' 30' ' ' ILE . 41.0 mt-10 -153.82 -42.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.931 -1.137 . . . . 1.23 107.931 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.38 -19.01 36.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.462 -1.245 . . . . 0.84999999999999998 111.472 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 123.89 -3.79 9.19 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.836 -0.697 . . . . 0.17000000000000001 111.682 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 47.7 mtm180 -67.38 126.45 29.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.361 -0.237 . . . . 3.0299999999999998 110.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -136.96 179.74 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.191 -0.67 . . . . 0.13 109.191 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.1 p -110.6 118.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.194 0.521 . . . . 0.19 111.094 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.796 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.7 mmt -86.15 151.3 53.99 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.876 -0.602 . . . . 0.83999999999999997 109.698 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.4 Cg_endo -85.59 156.03 10.51 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.02 1.814 . . . . 0.16 113.157 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.718 HD13 HH21 ' A' ' 23' ' ' ARG . 3.9 tp -51.18 -33.67 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.06 -0.973 . . . . 0.26000000000000001 109.792 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.55 -29.56 68.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.615 -0.72 . . . . 1.0800000000000001 111.877 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -80.47 -34.37 35.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.007 -0.738 . . . . 0.20000000000000001 109.007 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.718 HH21 HD13 ' A' ' 20' ' ' ILE . 62.3 mtm180 -64.84 -29.66 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 1.05 109.812 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.6 mtp180 -84.64 -35.23 22.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.176 -0.92 . . . . 0.70999999999999996 110.657 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.71 72.34 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.534 -0.757 . . . . 0.26000000000000001 110.237 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD22 ' H ' ' A' ' 47' ' ' LYS . 97.2 mt -89.45 -89.61 0.15 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.8 -1.091 . . . . 0.52000000000000002 111.421 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 36.7 t70 168.52 58.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.97 -1.122 . . . . 1.72 107.97 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.0 mp -115.29 134.34 58.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.913 -0.585 . . . . 0.28000000000000003 110.485 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.13 -59.69 1.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.37 0.605 . . . . 0.29999999999999999 111.166 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.62 -31.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.466 -0.788 . . . . 0.33000000000000002 109.59 -176.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.2 mtpt -134.63 -56.34 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.083 -0.71 . . . . 1.46 109.083 174.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.9 -121.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 1.1799999999999999 113.899 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HB3' HG21 ' B' ' 7' ' ' VAL . 15.6 m -161.4 135.28 6.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.458 0.572 . . . . 0.20999999999999999 111.236 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -139.88 104.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.28000000000000003 109.332 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.595 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 40.1 tt0 -102.86 135.05 45.24 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.571 -0.529 . . . . 1.3100000000000001 109.571 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -112.49 154.33 26.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.02 0.914 . . . . 1.3300000000000001 113.098 -172.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.564 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 24.9 t80 -131.76 121.91 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.982 -1.463 . . . . 2.2200000000000002 107.868 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.663 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.3 p -92.62 135.32 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.198 -0.601 . . . . 0.27000000000000002 110.703 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -133.74 102.4 5.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.979 -1.01 . . . . 1.1599999999999999 109.966 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.5 -82.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.32000000000000001 112.037 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.75 -20.15 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.34 0.591 . . . . 2.0 109.901 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 5.6 ttpt -93.05 157.97 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.256 -0.884 . . . . 1.05 111.376 -166.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.923 HG13 HD12 ' B' ' 22' ' ' LEU . 16.9 mm -114.78 141.5 31.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.904 -0.589 . . . . 0.17999999999999999 109.432 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 43.8 mt -122.36 107.2 19.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.607 0.242 . . . . 0.28000000000000003 110.758 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.772 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.1 mp -94.46 131.29 40.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 111.265 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HA ' HD21 ' A' ' 26' ' ' LEU . 4.1 ptmt -149.91 148.7 29.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.908 -0.587 . . . . 2.1600000000000001 111.136 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.813 ' H ' HD22 ' A' ' 26' ' ' LEU . 3.3 tmtp? -72.39 137.3 46.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.52000000000000002 109.985 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.573 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 63.0 t80 -67.26 -50.06 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.535 -0.757 . . . . 1.25 111.616 -172.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.753 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 25.2 ttpp -47.41 -63.93 1.24 Allowed Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.104 0.779 . . . . 2.8599999999999999 113.104 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 57.7 Cg_endo -73.89 -46.3 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.364 1.376 . . . . 1.8100000000000001 112.552 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -117.0 76.76 1.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.344 0.592 . . . . 4.6900000000000004 110.492 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.61 -53.56 8.36 Favored Glycine 0 CA--C 1.5 -0.851 0 CA-C-N 115.191 -0.913 . . . . 3.1400000000000001 111.874 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -52.2 147.32 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.38 -0.91 . . . . 3.5800000000000001 110.817 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.957 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.311 -0.852 . . . . 2.8700000000000001 111.777 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.72 -0.474 . . . . 4.7400000000000002 109.72 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.957 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 32.5 mmtm -61.3 169.53 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 2.3100000000000001 111.643 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.663 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.0 m -68.91 -43.7 74.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.252 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.819 HD12 ' HD2' ' A' ' 36' ' ' PHE . 1.3 mt -96.97 -32.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.32000000000000001 109.882 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.2 28.61 73.81 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.583 -0.735 . . . . 0.42999999999999999 112.888 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.474 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -124.52 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.158 0.504 . . . . 0.25 110.609 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -110.63 144.19 19.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.503 -0.771 . . . . 0.16 109.185 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mpt_? -114.56 155.11 27.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.035 0.445 . . . . 1.0900000000000001 110.631 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.42 116.98 27.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.258 -1.016 . . . . 1.1599999999999999 108.258 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 34' ' ' ILE . 9.1 t -52.45 137.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 O-C-N 123.803 0.689 . . . . 0.25 111.226 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.3 t70 -57.19 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.227 -0.897 . . . . 1.22 110.212 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 30' ' ' ILE . 44.3 mt-10 -152.92 -38.11 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.408 -0.96 . . . . 1.22 108.408 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.57 -29.27 25.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.786 -1.097 . . . . 0.90000000000000002 111.006 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.518 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 133.18 -3.2 4.8 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.663 -0.975 . . . . 0.14999999999999999 110.663 -172.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.2 mtm180 -63.33 129.47 40.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.356 . . . . 2.9100000000000001 110.701 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.5 OUTLIER -139.24 179.51 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.901 -0.777 . . . . 0.16 108.901 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -109.26 117.29 54.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.178 0.513 . . . . 0.19 111.263 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 23.8 mmt -81.61 154.6 71.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.235 -0.654 . . . . 0.93999999999999995 109.235 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.0 Cg_endo -86.47 156.27 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.129 1.886 . . . . 0.19 113.342 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' B' ' 23' ' ' ARG . 4.0 tp -56.47 -30.39 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.832 . . . . 0.22 109.314 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' B' ' 21' ' ' GLU . 3.4 mm-40 -58.84 -28.95 66.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.87 . . . . 1.0700000000000001 110.909 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.923 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.72 -40.22 34.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.987 -0.745 . . . . 0.23999999999999999 108.987 177.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.635 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 57.0 mtm180 -64.2 -27.69 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.037 -0.983 . . . . 1.3 110.357 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -83.99 -35.19 24.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.165 -0.925 . . . . 0.87 110.018 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -51.33 67.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.849 -1.069 . . . . 0.28000000000000003 110.878 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.781 HD22 ' H ' ' B' ' 47' ' ' LYS . 70.3 mt -90.83 -85.65 0.22 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.611 -1.177 . . . . 0.56999999999999995 111.675 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.59 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.3 t0 169.05 55.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.67 -0.863 . . . . 1.54 108.67 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.23 139.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.31 109.908 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.45 -59.58 1.93 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.814 -0.63 . . . . 0.40999999999999998 111.083 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.47 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -140.85 -33.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.177 -0.465 . . . . 0.34000000000000002 110.072 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 40.0 mtpt -133.98 -52.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.913 -0.773 . . . . 1.3799999999999999 108.913 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.8 OUTLIER 36.94 -118.96 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.686 -1.143 . . . . 1.1699999999999999 114.063 -176.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.572 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 15.9 m -161.43 134.72 6.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.996 0.362 . . . . 0.23999999999999999 111.337 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.653 HG21 HD23 ' B' ' 45' ' ' LEU . 3.8 mp -141.71 102.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.682 -0.488 . . . . 0.20000000000000001 109.682 171.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 38.5 tt0 -99.29 136.87 38.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 1.3300000000000001 109.576 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.731 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -110.43 158.12 18.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.283 1.039 . . . . 1.27 113.268 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.656 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 35.1 t80 -135.39 125.13 25.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.632 -1.622 . . . . 2.1000000000000001 107.86 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.751 ' H ' ' HB2' ' A' ' 3' ' ' SER . 13.5 p -92.9 135.31 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.87 -0.732 . . . . 0.29999999999999999 110.111 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -133.64 100.05 4.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.833 -0.621 . . . . 1.1799999999999999 110.039 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 -80.42 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.41999999999999998 111.917 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.69 -19.79 3.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.238 0.542 . . . . 1.9099999999999999 110.008 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -91.82 167.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.489 -0.778 . . . . 0.78000000000000003 110.796 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 8.4 mm -121.72 139.98 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.554 -0.748 . . . . 0.22 109.149 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.2 mt -118.27 111.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.498 -0.319 . . . . 0.29999999999999999 110.59 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.85 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -99.61 132.23 45.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.647 0.261 . . . . 0.25 111.478 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HE3' ' A' ' 2' ' ' LYS . 3.1 ptmt -153.76 145.33 23.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.012 -0.54 . . . . 1.8500000000000001 111.328 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.781 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.9 tmtp? -72.37 135.5 45.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 0.51000000000000001 109.905 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -62.76 -53.65 51.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.354 -0.839 . . . . 1.1699999999999999 112.207 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.757 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 26.2 ttpp -49.3 -59.47 6.49 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 113.361 0.874 . . . . 2.9199999999999999 113.361 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 13.2 Cg_exo -70.93 -44.78 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.931 1.754 . . . . 1.5700000000000001 112.308 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -122.17 75.67 1.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.212 0.529 . . . . 4.6799999999999997 110.638 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.22 16.44 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.351 -0.84 . . . . 3.1200000000000001 111.689 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.85 148.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.007 -1.097 . . . . 3.6200000000000001 111.027 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.905 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 1.6 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.243 -0.884 . . . . 2.8199999999999998 111.453 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ptp . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 122.15 0.976 . . . . 4.7999999999999998 110.315 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.917 ' HG2' ' HB3' ' B' ' 54' ' ' CYS . 55.4 mtmt -75.19 -162.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.065 -1.425 . . . . 2.48 112.035 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.505 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 28.4 m -44.8 -54.59 6.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.38 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.4 mt -84.82 -34.13 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.297 -1.001 . . . . 0.34000000000000002 108.297 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' HA2' ' N ' ' A' ' 2' ' ' LYS . . . 73.35 16.09 78.85 Favored Glycine 0 CA--C 1.504 -0.603 0 CA-C-N 114.88 -1.055 . . . . 0.51000000000000001 112.736 174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' B' ' 35' ' ' GLU . 23.4 m -114.7 131.17 67.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.778 0.799 . . . . 0.23000000000000001 111.475 -175.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.7 p -110.21 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 113.997 -1.456 . . . . 0.17000000000000001 108.746 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.7 mpt_? -122.04 164.24 18.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.436 -0.347 . . . . 1.21 110.557 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 34.1 mmtm -115.06 127.59 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.592 -0.892 . . . . 1.1299999999999999 108.592 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.851 HG23 HD11 ' B' ' 34' ' ' ILE . 18.3 t -58.55 136.64 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.57 -0.53 . . . . 0.23999999999999999 109.57 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.71 -77.87 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.899 -0.591 . . . . 1.3100000000000001 109.564 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.3 mt-10 -154.81 -45.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.747 -1.205 . . . . 1.23 107.747 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.13 -34.69 63.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.338 -1.301 . . . . 0.84999999999999998 110.908 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 141.86 -9.62 2.56 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.21 -0.905 . . . . 0.17000000000000001 111.12 -172.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 27.9 mtm180 -62.45 131.43 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.262 . . . . 3.0299999999999998 111.165 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -141.46 179.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.096 -0.705 . . . . 0.13 109.096 174.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -107.91 107.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.346 0.593 . . . . 0.19 110.908 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.62 ' HB3' HD13 ' A' ' 22' ' ' LEU . 77.4 mmm -80.29 152.56 73.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.122 -0.695 . . . . 0.83999999999999997 109.122 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 95.2 Cg_endo -84.66 157.22 12.12 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.767 1.645 . . . . 0.16 114.119 -171.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.511 HG13 ' HD2' ' A' ' 24' ' ' ARG . 3.1 tp -50.44 -37.81 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.816 -1.084 . . . . 0.26000000000000001 110.224 170.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.4 mm-40 -59.71 -26.13 65.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 1.0800000000000001 110.782 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -77.09 -39.21 50.49 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.947 -0.76 . . . . 0.20000000000000001 108.947 177.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 17.3 mtm180 -64.02 -34.74 78.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.312 -0.858 . . . . 1.05 110.028 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.7 mtp180 -79.62 -35.6 39.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.175 -0.92 . . . . 0.70999999999999996 110.083 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.43 -51.4 29.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.051 -0.977 . . . . 0.26000000000000001 110.212 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.5 mt -78.01 -89.87 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.173 -0.921 . . . . 0.52000000000000002 111.492 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 11.2 t70 175.15 43.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.511 -0.922 . . . . 1.72 108.511 -169.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -115.44 138.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 0.28000000000000003 111.317 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.94 -51.15 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.013 -0.539 . . . . 0.29999999999999999 111.513 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -147.18 -29.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.032 -0.359 . . . . 0.33000000000000002 110.032 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 30' ' ' ILE . 18.4 mtpp -138.98 -52.23 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.265 -0.642 . . . . 1.46 109.265 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 35.08 -110.24 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.49 -1.232 . . . . 1.1799999999999999 113.946 -177.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 50.4 m -165.34 142.44 5.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.377 0.535 . . . . 0.20999999999999999 111.168 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.001 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -141.13 108.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 110.26 -0.274 . . . . 0.28000000000000003 110.26 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.602 ' HG2' ' HE3' ' B' ' 2' ' ' LYS . 40.4 tt0 -105.63 132.17 52.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.987 -0.375 . . . . 1.3100000000000001 109.987 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.614 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.41 155.97 23.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.404 1.097 . . . . 1.3300000000000001 113.017 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.941 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 40.9 t80 -125.22 153.38 43.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.331 -1.759 . . . . 2.2200000000000002 106.454 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.9 p -122.16 133.09 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.788 -0.765 . . . . 0.27000000000000002 110.175 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.56 96.9 4.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 1.1599999999999999 110.033 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.89 -82.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.586 -0.733 . . . . 0.32000000000000001 111.502 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' HD23 ' B' ' 26' ' ' LEU . 14.6 m-20 -125.5 -17.7 5.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.724 -0.238 . . . . 2.0 110.99 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 166.27 12.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 1.05 110.72 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG13 HD12 ' B' ' 22' ' ' LEU . 15.3 mm -120.72 142.96 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.631 -0.507 . . . . 0.17999999999999999 109.631 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 43.0 mt -124.65 111.24 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.28000000000000003 110.613 -174.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -94.64 135.78 35.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.24 0.543 . . . . 0.32000000000000001 111.905 -174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.686 ' HE3' ' HE2' ' B' ' 2' ' ' LYS . 16.4 ttpp -149.68 134.56 17.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.852 -1.067 . . . . 2.1600000000000001 109.421 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' H ' HD22 ' A' ' 26' ' ' LEU . 1.7 tmtp? -63.86 155.32 30.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.637 -0.875 . . . . 0.52000000000000002 108.637 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.619 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 25.1 t80 -70.43 -49.33 49.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.067 0.46 . . . . 1.25 111.004 -173.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.576 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 40.4 ttmt -50.87 -55.07 30.34 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 113.807 1.04 . . . . 2.8599999999999999 113.807 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 36.7 Cg_exo -38.21 136.06 0.6 Allowed 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.523 2.815 . . . . 1.8100000000000001 113.72 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.76 152.8 40.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.593 -0.73 . . . . 4.6900000000000004 111.074 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.71 73.93 0.59 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 109.531 -1.427 . . . . 3.1400000000000001 109.531 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -52.35 137.66 11.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.641 0.734 . . . . 3.5800000000000001 112.702 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.905 ' HB3' ' HG2' ' B' ' 2' ' ' LYS . 74.6 m . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 114.234 -1.348 . . . . 2.8700000000000001 108.52 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.757 0.789 . . . . 4.7400000000000002 110.6 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.941 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 14.5 mttt -75.75 -158.09 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.186 -0.915 . . . . 2.3100000000000001 112.967 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.1 m -47.25 -58.2 4.36 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.682 -1.144 . . . . 1.0 110.858 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.16 -35.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.528 -1.286 . . . . 0.32000000000000001 107.528 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.686 ' HA2' ' N ' ' B' ' 2' ' ' LYS . . . 67.11 28.66 73.82 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 114.382 -1.281 . . . . 0.42999999999999999 112.375 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.8 m -118.66 132.21 69.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.219 0.533 . . . . 0.25 110.603 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.3 p -109.44 147.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.16 109.196 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.472 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 5.2 mpt_? -120.12 167.01 12.65 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.144 -0.48 . . . . 1.0900000000000001 110.377 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 40.6 mmtm -119.02 122.53 42.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.699 -0.852 . . . . 1.1599999999999999 108.699 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 1.001 HG23 HD11 ' A' ' 34' ' ' ILE . 4.3 t -56.04 133.31 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.281 -0.637 . . . . 0.25 109.281 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -79.16 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.756 -0.656 . . . . 1.22 109.972 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.521 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.4 mt-10 -152.73 -40.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.085 -1.08 . . . . 1.22 108.085 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.3 OUTLIER -89.74 -15.2 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.067 -1.424 . . . . 0.90000000000000002 110.493 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' B' ' 10' ' ' VAL . . . 124.21 -4.75 8.91 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.14999999999999999 111.934 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 53.0 mtm180 -63.45 131.74 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.869 0.067 . . . . 2.9100000000000001 110.839 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.694 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -142.15 179.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.904 -0.776 . . . . 0.16 108.904 174.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -107.95 109.14 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.007 0.432 . . . . 0.19 110.769 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.6 ' HB3' HD13 ' B' ' 22' ' ' LEU . 77.3 mmm -80.97 152.25 71.41 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.702 -0.851 . . . . 0.93999999999999995 108.702 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' B' ' 22' ' ' LEU . 40.7 Cg_endo -83.16 158.1 15.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.559 1.506 . . . . 0.19 113.583 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.624 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.9 tp -58.62 -29.55 39.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.142 -0.935 . . . . 0.22 109.307 172.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.54 -27.82 67.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 1.0700000000000001 110.823 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.736 HD12 HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -76.99 -41.42 42.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.723 -0.843 . . . . 0.23999999999999999 108.723 176.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.765 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 65.1 mtp180 -62.81 -31.25 72.2 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.543 -1.208 . . . . 1.3 110.899 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -81.15 -33.99 32.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.361 -0.836 . . . . 0.87 109.652 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.59 19.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.729 -1.123 . . . . 0.28000000000000003 111.419 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 74.2 mt -82.06 -81.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.862 -1.063 . . . . 0.56999999999999995 111.091 -171.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.571 ' C ' HD12 ' B' ' 28' ' ' ILE . 37.6 t70 170.9 49.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 -173.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -115.8 133.93 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.1 0.476 . . . . 0.31 110.336 -173.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.79 -48.47 3.92 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.512 -0.767 . . . . 0.40999999999999998 111.385 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.662 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -152.9 -29.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.008 0.432 . . . . 0.34000000000000002 109.97 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.662 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.8 mtpp -138.55 -51.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.944 -0.761 . . . . 1.3799999999999999 108.944 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.587 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 36.35 -108.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.518 -1.219 . . . . 1.1699999999999999 114.136 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 21.0 m -167.93 141.27 3.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.884 0.311 . . . . 0.23999999999999999 110.67 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.851 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -144.23 106.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 110.214 -0.291 . . . . 0.20000000000000001 110.214 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 tt0 -98.6 142.17 30.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.852 -0.425 . . . . 1.3300000000000001 109.852 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.589 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -114.45 155.4 26.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.067 0.936 . . . . 1.27 112.911 -175.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.821 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.4 t80 -127.31 151.17 49.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.754 -1.572 . . . . 2.1000000000000001 106.754 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.505 ' H ' ' HB2' ' A' ' 3' ' ' SER . 4.6 p -118.99 134.62 62.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.665 -0.814 . . . . 0.29999999999999999 110.604 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' B' ' 42' ' ' LYS . 19.8 t70 -129.44 95.81 4.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.222 -0.899 . . . . 1.1799999999999999 109.827 -175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.59 -82.31 0.39 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.901 -0.666 . . . . 0.41999999999999998 111.662 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.421 ' O ' HD23 ' A' ' 26' ' ' LEU . 26.6 m-20 -128.46 -13.26 4.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.516 0.198 . . . . 1.9099999999999999 110.514 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 1.2 ptpp? -100.29 168.94 9.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.389 . . . . 0.78000000000000003 110.55 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 23.4 mm -124.67 144.81 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.8 -0.637 . . . . 0.22 109.955 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.821 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 39.4 mt -125.93 115.08 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.27 -0.423 . . . . 0.29999999999999999 110.951 -173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -101.47 134.27 44.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.081 0.467 . . . . 0.25 111.869 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HA ' HD22 ' B' ' 26' ' ' LEU . 24.5 ttpp -147.99 137.6 22.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.191 -0.913 . . . . 1.8500000000000001 109.257 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -64.68 150.28 47.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.395 -0.965 . . . . 0.51000000000000001 108.395 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.634 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 0.8 OUTLIER -65.56 -51.93 56.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.77 0.319 . . . . 1.1699999999999999 110.707 -172.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.679 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 31.6 ttmt -48.81 -57.69 10.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.729 1.011 . . . . 2.9199999999999999 113.729 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 39.1 Cg_exo -38.99 125.53 1.08 Allowed 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.249 2.633 . . . . 1.5700000000000001 113.577 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -61.13 154.59 22.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.904 -1.044 . . . . 4.6799999999999997 111.826 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.3 76.22 0.82 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.693 -1.363 . . . . 3.1200000000000001 109.693 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.93 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.635 0.731 . . . . 3.6200000000000001 112.36 -171.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.917 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 73.9 m . . . . . 0 C--O 1.244 0.792 0 CA-C-N 114.487 -1.233 . . . . 2.8199999999999998 108.159 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.507 -0.183 . . . . 4.7999999999999998 110.507 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 58.27 -175.33 0.08 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.629 0.728 . . . . 2.48 112.749 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 5.2 m -76.9 -48.37 18.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.244 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' B' ' 37' ' ' PHE . 3.9 mt -97.69 -37.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.34000000000000002 109.701 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.64 40.54 31.7 Favored Glycine 0 CA--C 1.506 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.51000000000000001 112.446 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 4' ' ' ILE . 8.1 m -138.12 133.57 44.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.486 0.66 . . . . 0.23000000000000001 111.309 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -118.89 140.9 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.763 -1.108 . . . . 0.17000000000000001 109.061 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -116.29 160.05 21.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.82 -0.437 . . . . 1.21 109.82 -174.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HD2' ' O ' ' B' ' 32' ' ' ASP . 26.3 mmtp -122.15 120.44 34.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.335 -0.987 . . . . 1.1299999999999999 108.335 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.794 HG23 HD11 ' B' ' 34' ' ' ILE . 18.1 t -52.32 138.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.732 0.645 . . . . 0.23999999999999999 110.767 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.84 -71.86 0.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.77 -0.65 . . . . 1.3100000000000001 109.695 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -154.39 -51.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.938 -0.764 . . . . 1.23 108.938 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -82.56 -23.93 34.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.65 -1.159 . . . . 0.84999999999999998 110.821 -177.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 139.75 -9.6 3.12 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.913 -0.661 . . . . 0.17000000000000001 112.139 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 35.6 mtm180 -62.8 129.82 42.14 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.824 -0.221 . . . . 3.0299999999999998 110.945 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.18 177.33 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.268 -0.641 . . . . 0.13 109.268 175.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.733 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -106.31 111.61 35.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.301 0.572 . . . . 0.19 111.096 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 2.8 mmt -83.01 155.58 67.47 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.022 -0.733 . . . . 0.83999999999999997 109.022 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 94.2 Cg_endo -86.69 153.86 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.033 1.822 . . . . 0.16 113.573 -173.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 3.3 tp -52.59 -33.0 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.26000000000000001 109.667 169.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 2.3 mm-40 -62.15 -26.53 68.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.514 -0.766 . . . . 1.0800000000000001 110.873 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -78.91 -38.9 36.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.73 -0.841 . . . . 0.20000000000000001 108.73 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.72 ' HD3' HG11 ' B' ' 10' ' ' VAL . 37.3 mtm180 -65.07 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.107 -0.951 . . . . 1.05 110.249 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 80.3 mtp180 -84.62 -37.52 20.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.164 -0.925 . . . . 0.70999999999999996 110.529 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.2 -50.18 55.94 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.472 -0.785 . . . . 0.26000000000000001 110.43 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 87.0 mt -80.6 -86.33 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.789 -1.096 . . . . 0.52000000000000002 111.13 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' H ' HD12 ' A' ' 28' ' ' ILE . 18.4 t0 166.6 61.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.6 -1.259 . . . . 1.72 107.6 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.707 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.8 mp -123.95 134.27 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.622 -0.717 . . . . 0.28000000000000003 110.406 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.33 -56.67 2.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.151 0.5 . . . . 0.29999999999999999 110.825 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -141.48 -30.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.81 -0.632 . . . . 0.33000000000000002 109.699 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' B' ' 10' ' ' VAL . 6.7 mtpp -136.17 -54.15 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.323 -0.621 . . . . 1.46 109.323 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER 38.97 -116.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.423 -1.262 . . . . 1.1799999999999999 113.706 -175.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.629 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 14.0 m -162.0 136.73 7.0 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.409 0.549 . . . . 0.20999999999999999 111.125 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' B' ' 10' ' ' VAL . 3.8 mp -138.6 103.15 2.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.868 -0.419 . . . . 0.28000000000000003 109.868 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 43.6 tt0 -97.95 137.73 36.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.254 -0.647 . . . . 1.3100000000000001 109.254 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -121.68 151.04 40.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.426 1.108 . . . . 1.3300000000000001 112.989 -175.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -113.5 165.87 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.311 -1.768 . . . . 2.2200000000000002 107.034 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' B' ' 3' ' ' SER . 2.9 p -133.19 125.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.49 0.662 . . . . 0.27000000000000002 109.906 167.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -128.57 104.59 7.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.926 -1.034 . . . . 1.1599999999999999 109.758 -173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.83 -92.08 0.53 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.156 -0.778 . . . . 0.32000000000000001 111.156 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD23 ' B' ' 26' ' ' LEU . 28.7 m-20 -126.9 4.57 6.57 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.993 -0.373 . . . . 2.0 109.993 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -109.97 157.24 19.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 1.05 111.437 -168.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HD12 ' B' ' 22' ' ' LEU . 19.8 mm -113.84 142.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.837 -0.431 . . . . 0.17999999999999999 109.837 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 mt -123.78 115.48 45.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.521 -0.309 . . . . 0.28000000000000003 110.92 -173.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' B' ' 45' ' ' LEU . 10.5 mp -101.27 129.79 47.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.47 0.652 . . . . 0.32000000000000001 112.429 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 13.4 ttpt -142.49 141.09 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.579 -1.191 . . . . 2.1600000000000001 109.749 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 1.5 tmtp? -73.96 148.95 41.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.574 -0.898 . . . . 0.52000000000000002 108.574 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.636 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 36.6 t80 -66.78 -47.73 71.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.064 0.459 . . . . 1.25 111.235 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.716 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.6 tmtp? -48.56 -56.24 15.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.025 -0.989 . . . . 2.8599999999999999 113.168 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_exo -52.86 108.36 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.244 1.963 . . . . 1.8100000000000001 111.948 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -79.07 79.12 5.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.995 -0.548 . . . . 4.6900000000000004 111.289 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.35 -85.48 1.44 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.336 -1.106 . . . . 3.1400000000000001 110.336 170.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.1 p -157.85 145.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.857 0.36 . . . . 3.5800000000000001 110.14 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.427 ' OXT' ' HE3' ' B' ' 2' ' ' LYS . 11.1 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 119.042 -0.504 . . . . 2.8700000000000001 110.383 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.735 -0.469 . . . . 4.7400000000000002 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.939 ' HE2' ' HA ' ' B' ' 2' ' ' LYS . 4.3 mmpt? 56.96 179.72 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.918 1.081 . . . . 2.3100000000000001 113.918 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 19.9 m -68.67 -48.92 62.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.349 -1.296 . . . . 1.0 110.362 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.63 -46.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.481 -0.781 . . . . 0.32000000000000001 109.398 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.63 35.02 37.59 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.267 -0.879 . . . . 0.42999999999999999 112.512 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -129.09 132.4 67.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.042 0.448 . . . . 0.25 110.39 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.3 p -112.07 143.15 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.874 -0.787 . . . . 0.16 108.874 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.402 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.4 mpt_? -114.81 162.9 16.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.237 -0.438 . . . . 1.0900000000000001 110.602 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.59 121.3 38.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.523 -0.918 . . . . 1.1599999999999999 108.523 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 34' ' ' ILE . 2.9 t -56.32 132.87 20.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 O-C-N 123.358 0.411 . . . . 0.25 110.115 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.17 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.22 109.672 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.55 ' HG2' HD11 ' A' ' 30' ' ' ILE . 40.8 mt-10 -155.13 -39.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 124.272 0.983 . . . . 1.22 108.445 171.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.754 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -92.06 -18.01 24.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.458 -1.246 . . . . 0.90000000000000002 110.472 -177.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 130.1 -7.49 6.04 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.639 -0.71 . . . . 0.14999999999999999 112.106 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 39.2 mtm180 -61.45 129.99 43.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.819 -0.224 . . . . 2.9100000000000001 110.789 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -140.8 176.01 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.298 -0.63 . . . . 0.16 109.298 175.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 1.5 p -105.3 108.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.295 0.569 . . . . 0.19 111.358 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.9 mmt -75.3 156.26 85.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.027 -0.731 . . . . 0.93999999999999995 109.027 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 58.1 Cg_endo -87.84 155.58 7.36 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.988 1.792 . . . . 0.19 113.417 -176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.5 tp -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.283 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -59.31 -30.03 68.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.401 -0.818 . . . . 1.0700000000000001 110.804 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.881 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.33 -39.99 58.83 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.23999999999999999 108.701 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.718 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 33.8 mtm180 -64.47 -30.09 71.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.862 -1.063 . . . . 1.3 110.318 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.414 ' HD2' HG13 ' B' ' 20' ' ' ILE . 74.8 mtp180 -84.64 -24.63 28.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.311 -0.859 . . . . 0.87 110.39 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.12 -53.2 8.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.218 -0.901 . . . . 0.28000000000000003 110.941 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.785 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 16.2 mt -83.13 -81.39 0.16 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.056 -0.975 . . . . 0.56999999999999995 110.212 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.593 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.3 t70 165.19 61.24 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.965 -1.124 . . . . 1.54 107.965 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -116.63 133.73 62.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.845 -0.616 . . . . 0.31 109.653 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.58 -56.82 2.21 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.178 -0.464 . . . . 0.40999999999999998 110.853 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -143.03 -31.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.84 -0.618 . . . . 0.34000000000000002 109.672 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -134.6 -51.88 0.8 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.354 -0.61 . . . . 1.3799999999999999 109.354 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.4 OUTLIER 39.77 -113.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.677 -1.147 . . . . 1.1699999999999999 113.818 -176.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 18.7 m -161.93 135.95 6.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.042 0.214 . . . . 0.23999999999999999 111.235 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.794 HD11 HG23 ' A' ' 10' ' ' VAL . 4.2 mp -139.87 102.07 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 N-CA-C 109.677 -0.49 . . . . 0.20000000000000001 109.677 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 45.6 tt0 -96.47 135.55 38.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.3300000000000001 109.388 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.527 ' CE2' ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -121.07 151.29 40.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.603 0.716 . . . . 1.27 112.375 -176.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.563 ' HA ' HG13 ' A' ' 4' ' ' ILE . 2.8 p90 -143.34 139.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.962 -1.017 . . . . 2.1000000000000001 110.307 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.624 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.2 p -92.9 141.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.383 0.611 . . . . 0.29999999999999999 110.791 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.98 102.22 5.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.164 -0.926 . . . . 1.1799999999999999 109.355 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.6 -88.18 0.53 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.104 -0.799 . . . . 0.41999999999999998 111.104 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.07 -8.13 5.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.412 -0.218 . . . . 1.9099999999999999 110.412 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -105.78 168.42 9.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.78000000000000003 111.0 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 22' ' ' LEU . 30.4 mm -119.65 142.5 34.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.861 -0.609 . . . . 0.22 109.491 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 11.8 mt -125.95 125.44 68.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.912 -0.315 . . . . 0.29999999999999999 110.178 -175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -107.48 128.87 54.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.203 0.525 . . . . 0.25 111.86 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.509 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 10.3 ttpt -142.47 138.68 31.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.831 -1.077 . . . . 1.8500000000000001 110.158 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.6 tmtp? -70.01 146.67 50.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.822 -0.807 . . . . 0.51000000000000001 108.822 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.581 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 40.5 t80 -64.89 -50.35 66.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 1.1699999999999999 111.419 -173.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.713 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -47.96 -57.87 9.2 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.36 -0.836 . . . . 2.9199999999999999 113.033 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 87.0 Cg_exo -48.69 110.75 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 122.266 1.978 . . . . 1.5700000000000001 112.149 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -79.17 87.71 4.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.646 -0.706 . . . . 4.6799999999999997 111.27 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.21 -87.09 1.97 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.311 -1.116 . . . . 3.1200000000000001 110.311 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.4 142.76 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 3.6200000000000001 109.907 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 C--O 1.245 0.831 0 CA-C-O 119.28 -0.391 . . . . 2.8199999999999998 110.313 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.713 0.292 . . . . 4.7999999999999998 110.874 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.783 ' HD2' ' HB2' ' B' ' 37' ' ' PHE . 54.0 mtmt -89.96 -172.58 3.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.075 0.398 . . . . 2.48 112.075 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 25.0 m -44.94 -57.6 3.69 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.46 0.704 . . . . 1.0 111.998 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.1 mt -82.57 -35.59 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.037 -1.098 . . . . 0.34000000000000002 108.037 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.53 13.74 74.49 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 114.738 -1.119 . . . . 0.51000000000000001 112.798 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 29.1 m -105.17 132.44 51.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.502 0.667 . . . . 0.23000000000000001 110.93 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 8.8 p -113.52 139.78 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.494 -1.23 . . . . 0.17000000000000001 109.913 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -114.4 156.65 24.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.893 -0.594 . . . . 1.21 110.435 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -117.71 122.86 44.64 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.877 -0.786 . . . . 1.1299999999999999 108.877 175.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 28' ' ' ILE . 27.4 t -57.64 146.19 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.23999999999999999 111.781 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -64.97 -77.55 0.06 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.12 -0.945 . . . . 1.3100000000000001 110.151 174.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -155.22 -43.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.729 -0.841 . . . . 1.23 108.729 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 -25.88 30.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.647 -1.16 . . . . 0.84999999999999998 110.936 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 133.93 -6.76 4.79 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.295 -0.866 . . . . 0.17000000000000001 110.984 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 48.2 mtm180 -62.79 128.18 34.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.423 0.154 . . . . 3.0299999999999998 110.83 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -139.52 179.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.688 -0.856 . . . . 0.13 108.688 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -106.28 116.18 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.083 0.468 . . . . 0.19 110.907 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.636 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.9 mmt -83.56 150.84 60.77 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.34 -0.615 . . . . 0.83999999999999997 109.34 174.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.56 154.48 18.22 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.777 1.651 . . . . 0.16 113.098 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.536 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.1 tp -53.41 -32.18 19.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.325 -0.852 . . . . 0.26000000000000001 109.629 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.1 mm-40 -61.14 -27.78 68.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.0800000000000001 111.111 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.851 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -40.7 41.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.625 -0.879 . . . . 0.20000000000000001 108.625 176.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.623 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 42.3 mtm180 -63.66 -30.55 71.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.861 -1.063 . . . . 1.05 110.133 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' A' ' 20' ' ' ILE . 80.0 mtp180 -84.59 -32.12 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.37 -0.832 . . . . 0.70999999999999996 110.73 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.19 76.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.528 -0.76 . . . . 0.26000000000000001 109.803 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.773 HD22 ' H ' ' A' ' 47' ' ' LYS . 86.8 mt -96.66 -91.53 0.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.974 -1.012 . . . . 0.52000000000000002 111.841 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 29.7 t70 172.31 55.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.742 -1.207 . . . . 1.72 107.742 -170.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.623 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.2 mp -116.23 130.38 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.81 -0.632 . . . . 0.28000000000000003 109.813 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -58.07 2.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.241 0.543 . . . . 0.29999999999999999 110.915 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.542 ' O ' HG12 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -143.42 -29.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.599 -0.728 . . . . 0.33000000000000002 109.616 -177.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 30' ' ' ILE . 34.9 mtpt -136.09 -54.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.665 . . . . 1.46 109.458 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER 37.38 -124.4 0.21 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.814 1.042 . . . . 1.1799999999999999 113.814 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 16.4 m -159.88 134.53 7.74 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.426 0.557 . . . . 0.20999999999999999 111.318 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -139.58 108.42 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 110.155 -0.313 . . . . 0.28000000000000003 110.155 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 66.9 tt0 -99.68 140.99 33.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.762 -0.458 . . . . 1.3100000000000001 109.762 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.455 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -119.85 155.2 33.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.417 1.104 . . . . 1.3300000000000001 113.502 -176.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.923 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 6.6 t80 -121.34 144.81 48.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.418 -1.719 . . . . 2.2200000000000002 106.481 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' HB2' ' B' ' 3' ' ' SER . 8.8 p -116.47 128.76 73.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.506 -0.878 . . . . 0.27000000000000002 110.3 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -131.76 102.0 5.7 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.958 -1.019 . . . . 1.1599999999999999 109.755 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.63 -92.92 0.45 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.334 -0.706 . . . . 0.32000000000000001 111.334 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.54 -9.99 9.32 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.396 -0.594 . . . . 2.0 109.396 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -97.31 157.72 15.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.779 -0.646 . . . . 1.05 111.397 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.87 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 9.5 mm -116.38 144.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.261 -0.644 . . . . 0.17999999999999999 109.261 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 47.3 mt -129.52 109.7 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 122.33 0.252 . . . . 0.28000000000000003 110.782 -173.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.723 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -98.48 142.54 29.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.207 0.447 . . . . 0.32000000000000001 112.207 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -150.36 158.52 44.25 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.635 -0.711 . . . . 2.1600000000000001 109.241 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.773 ' H ' HD22 ' A' ' 26' ' ' LEU . 2.8 tmtp? -70.85 149.24 47.0 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.455 -0.943 . . . . 0.52000000000000002 108.455 174.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.58 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 91.7 t80 -66.75 -54.34 23.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 1.25 110.853 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.851 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 23.5 tptm -45.84 -59.84 4.19 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.028 -0.987 . . . . 2.8599999999999999 113.333 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.851 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 52.1 Cg_exo -56.09 122.89 12.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.178 1.919 . . . . 1.8100000000000001 112.459 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -82.67 99.37 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.575 -0.738 . . . . 4.6900000000000004 109.96 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.88 -120.06 4.45 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.668 -0.777 . . . . 3.1400000000000001 111.489 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.16 137.46 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.233 0.539 . . . . 3.5800000000000001 110.474 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.579 -0.737 . . . . 2.8700000000000001 109.696 -177.075 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.788 0.328 . . . . 4.7400000000000002 110.749 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.923 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 11.0 mtmt -86.46 -174.66 5.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.659 0.614 . . . . 2.3100000000000001 112.659 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 68.4 m -49.01 -53.75 18.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.243 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.416 HD12 ' HD2' ' A' ' 36' ' ' PHE . 3.2 mt -83.19 -35.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.519 -1.289 . . . . 0.32000000000000001 107.519 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.502 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 63.38 28.02 71.68 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.349 -1.296 . . . . 0.42999999999999999 112.178 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.5 m -116.62 133.07 64.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.165 0.507 . . . . 0.25 110.272 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.1 p -113.46 140.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.16 109.861 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.462 ' NH1' ' HB ' ' B' ' 6' ' ' VAL . 6.6 mpt_? -114.4 157.35 22.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.993 -0.549 . . . . 1.0900000000000001 110.667 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.13 119.02 33.47 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.472 -0.936 . . . . 1.1599999999999999 108.472 177.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.653 HG23 HD11 ' A' ' 34' ' ' ILE . 5.5 t -56.28 141.76 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 123.839 0.712 . . . . 0.25 111.719 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -60.7 -79.56 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.951 -1.022 . . . . 1.22 110.474 175.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 30' ' ' ILE . 39.9 mt-10 -156.22 -39.68 0.08 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.228 -1.027 . . . . 1.22 108.228 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.94 -25.03 32.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.686 -1.143 . . . . 0.90000000000000002 110.457 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 127.66 -3.12 7.04 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.051 -0.977 . . . . 0.14999999999999999 110.742 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.806 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 72.9 mtm180 -62.18 127.02 29.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.275 . . . . 2.9100000000000001 110.613 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.0 OUTLIER -137.28 179.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.16 108.705 175.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.833 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -107.66 112.71 41.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.151 0.501 . . . . 0.19 111.034 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.666 ' HB3' HD22 ' B' ' 22' ' ' LEU . 29.2 mmt -76.3 154.35 84.19 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.11 -0.7 . . . . 0.93999999999999995 109.11 173.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 51.5 Cg_endo -85.78 156.29 10.26 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 121.998 1.799 . . . . 0.19 112.707 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -57.67 -29.04 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.381 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.4 -28.48 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.718 -0.674 . . . . 1.0700000000000001 110.691 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.857 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.77 -40.87 32.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.967 -0.753 . . . . 0.23999999999999999 108.967 176.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 35.3 mtm180 -62.84 -30.09 71.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.892 -1.049 . . . . 1.3 110.245 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.37 -34.87 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.94 . . . . 0.87 109.973 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.75 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.013 -0.994 . . . . 0.28000000000000003 109.964 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.654 HD22 ' H ' ' B' ' 47' ' ' LYS . 36.9 mt -94.44 -104.24 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.631 -1.168 . . . . 0.56999999999999995 110.94 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.495 ' H ' HD12 ' B' ' 28' ' ' ILE . 11.2 m-20 -153.62 16.26 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.812 -0.176 . . . . 1.54 111.461 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.694 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -76.62 129.32 37.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.369 -0.533 . . . . 0.31 110.471 -164.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -57.59 2.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.67 -0.696 . . . . 0.40999999999999998 110.387 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.573 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -142.48 -31.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.687 -0.688 . . . . 0.34000000000000002 109.566 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' B' ' 30' ' ' ILE . 36.0 mtpt -134.54 -53.08 0.82 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.773 -0.648 . . . . 1.3799999999999999 109.359 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.2 OUTLIER 41.05 -119.34 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.886 -1.052 . . . . 1.1699999999999999 113.51 -177.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 46.5 m -165.43 132.35 2.85 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.475 -0.141 . . . . 0.23999999999999999 110.866 -173.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 10' ' ' VAL . 3.8 mp -139.71 105.76 2.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.602 0.239 . . . . 0.20000000000000001 110.609 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 57.9 tt0 -96.32 141.7 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.613 -0.514 . . . . 1.3300000000000001 109.613 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.712 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.1 OUTLIER -113.83 159.8 19.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 122.121 0.963 . . . . 1.27 112.896 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 14.0 t80 -136.17 126.08 25.86 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 113.776 -1.556 . . . . 2.1000000000000001 107.656 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 3' ' ' SER . 11.0 p -95.81 134.63 32.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.831 -0.748 . . . . 0.29999999999999999 110.468 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -134.83 101.05 4.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.592 -0.731 . . . . 1.1799999999999999 110.107 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.01 -93.63 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.005 -0.838 . . . . 0.41999999999999998 111.005 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.54 -16.48 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.884 -0.413 . . . . 1.9099999999999999 109.884 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 3.6 ptpp? -95.62 169.83 9.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.353 0.597 . . . . 0.78000000000000003 111.109 -167.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.851 HG13 HD12 ' A' ' 22' ' ' LEU . 27.4 mm -125.38 142.34 42.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.172 -0.922 . . . . 0.22 109.447 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.764 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 25.3 mt -124.2 115.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 0.29999999999999999 111.004 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.87 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.9 mp -102.86 141.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.125 0.417 . . . . 0.25 112.125 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.426 ' HG2' ' NZ ' ' A' ' 2' ' ' LYS . 18.4 pttp -151.11 158.73 44.39 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.796 -0.816 . . . . 1.8500000000000001 108.796 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.654 ' H ' HD22 ' B' ' 26' ' ' LEU . 1.4 tmtp? -72.56 153.72 41.16 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.997 -1.112 . . . . 0.51000000000000001 107.997 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.508 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 69.0 t80 -66.44 -55.49 15.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.821 0.344 . . . . 1.1699999999999999 111.19 -173.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.639 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 17.7 tptm -56.77 -52.4 74.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.487 0.921 . . . . 2.9199999999999999 113.487 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 73.1 Cg_exo -53.38 115.27 2.19 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.062 1.841 . . . . 1.5700000000000001 112.002 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.37 87.4 6.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.652 -0.704 . . . . 4.6799999999999997 110.636 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.54 -144.48 16.92 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.257 -0.737 . . . . 3.1200000000000001 111.257 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 143.78 10.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 3.6200000000000001 110.504 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.249 1.066 0 CA-C-N 115.961 -0.563 . . . . 2.8199999999999998 109.842 179.152 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.529 0.204 . . . . 4.7999999999999998 111.072 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.98 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 25.9 mtpp -74.55 -178.5 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.285 -0.166 . . . . 2.48 110.741 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.572 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 54.7 m -48.73 -53.08 20.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.205 0.526 . . . . 1.0 111.888 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' B' ' 36' ' ' PHE . 2.3 mt -81.8 -32.26 11.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.243 -1.021 . . . . 0.34000000000000002 108.243 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.29 13.12 76.85 Favored Glycine 0 CA--C 1.503 -0.689 0 CA-C-N 114.657 -1.156 . . . . 0.51000000000000001 112.735 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' B' ' 36' ' ' PHE . 25.5 m -108.98 131.54 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.568 0.699 . . . . 0.23000000000000001 111.056 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -109.34 140.74 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.553 -1.203 . . . . 0.17000000000000001 109.284 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.0 mpt_? -114.45 159.71 20.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.166 -0.47 . . . . 1.21 110.344 -175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 30.6 mmtp -122.19 121.76 37.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.326 -0.99 . . . . 1.1299999999999999 108.326 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HG21 ' B' ' 28' ' ' ILE . 26.9 t -55.25 145.33 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.851 0.719 . . . . 0.23999999999999999 110.953 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.43 -75.27 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.778 -0.647 . . . . 1.3100000000000001 109.266 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' HD11 ' B' ' 30' ' ' ILE . 30.5 mt-10 -152.79 -39.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.38 -34.65 28.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.41 -1.268 . . . . 0.84999999999999998 111.284 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.82 -11.09 2.63 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.942 -0.863 . . . . 0.17000000000000001 110.942 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 49.7 mtt180 -62.88 131.68 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.517 -0.342 . . . . 3.0299999999999998 110.869 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -139.85 176.04 6.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.071 -0.715 . . . . 0.13 109.071 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.707 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.3 p -104.64 112.77 39.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.209 0.528 . . . . 0.19 110.873 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' B' ' 14' ' ' GLY . 1.2 mmt -82.12 152.43 68.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.686 -0.857 . . . . 0.83999999999999997 108.686 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 92.4 Cg_endo -83.91 156.54 13.48 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.664 1.576 . . . . 0.16 113.132 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.86 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.7 tp -54.65 -33.33 27.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.176 -0.92 . . . . 0.26000000000000001 109.538 172.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.13 -26.88 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 1.0800000000000001 111.01 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.69 -40.98 47.12 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.728 -0.842 . . . . 0.20000000000000001 108.728 176.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 53.3 mtm180 -63.92 -30.18 71.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.097 -0.956 . . . . 1.05 110.165 176.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.86 ' HD2' HG13 ' A' ' 20' ' ' ILE . 37.6 mtp180 -85.15 -30.51 23.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.208 -0.906 . . . . 0.70999999999999996 110.651 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.31 -45.67 65.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.555 0.693 . . . . 0.26000000000000001 109.677 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 90.1 mt -88.58 -93.72 0.1 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.862 -1.063 . . . . 0.52000000000000002 111.508 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 28' ' ' ILE . 37.0 t70 172.71 57.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.096 -1.075 . . . . 1.72 108.096 -172.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.561 HG21 HG21 ' B' ' 10' ' ' VAL . 2.8 mp -113.88 131.27 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.28000000000000003 110.461 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.31 -54.1 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.122 -0.49 . . . . 0.29999999999999999 111.404 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.23 -33.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.905 -0.588 . . . . 0.33000000000000002 109.982 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 30' ' ' ILE . 44.1 mtpt -136.88 -51.26 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.986 -0.746 . . . . 1.46 108.986 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.7 OUTLIER 38.18 -119.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.513 -1.221 . . . . 1.1799999999999999 113.378 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.404 ' HB3' HG21 ' B' ' 7' ' ' VAL . 17.1 m -163.21 135.29 5.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.482 0.583 . . . . 0.20999999999999999 111.512 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.662 HD11 HG23 ' B' ' 10' ' ' VAL . 2.6 mp -141.88 105.93 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.96 -0.385 . . . . 0.28000000000000003 109.96 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 72.0 tt0 -99.66 138.05 37.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.335 -0.617 . . . . 1.3100000000000001 109.335 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -117.55 152.93 34.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.638 1.209 . . . . 1.3300000000000001 114.136 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.047 ' HB2' ' HE3' ' B' ' 2' ' ' LYS . 32.1 t80 -114.43 157.78 22.43 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 112.98 -1.918 . . . . 2.2200000000000002 107.134 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' H ' ' HB2' ' B' ' 3' ' ' SER . 5.5 p -127.55 130.7 70.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.116 -0.634 . . . . 0.27000000000000002 110.033 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 19.3 t70 -130.63 97.24 4.31 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.471 -0.786 . . . . 1.1599999999999999 109.744 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.19 -78.85 0.3 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.599 -0.728 . . . . 0.32000000000000001 111.903 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.57 -30.5 4.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.471 0.653 . . . . 2.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -88.37 165.72 14.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.045 -163.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 22' ' ' LEU . 15.4 mm -121.21 142.94 35.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.426 -0.807 . . . . 0.17999999999999999 109.053 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.95 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 49.1 mt -128.55 108.45 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.511 -0.313 . . . . 0.28000000000000003 110.851 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.7 mp -99.82 141.61 32.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.306 0.484 . . . . 0.32000000000000001 112.306 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.883 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -151.94 156.97 41.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.45 -0.795 . . . . 2.1600000000000001 110.682 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 48' ' ' TYR . 3.8 tmtp? -73.32 149.16 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.315 -0.624 . . . . 0.52000000000000002 109.315 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.64 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 69.7 t80 -74.78 -57.96 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 1.25 111.738 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 41.1 tptt -63.8 -56.71 23.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.256 1.206 . . . . 2.8599999999999999 114.256 -167.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 80.3 Cg_exo -46.84 -63.5 0.32 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.841 2.361 . . . . 1.8100000000000001 114.263 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.506 ' HB3' HG12 ' A' ' 53' ' ' VAL . 20.6 m-70 -79.22 -44.82 21.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.914 0.338 . . . . 4.6900000000000004 111.914 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.84 62.29 6.53 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 120.943 -0.646 . . . . 3.1400000000000001 112.059 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 51' ' ' HIS . 13.8 p -153.64 153.77 8.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.191 -0.505 . . . . 3.5800000000000001 109.722 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 55.8 m . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.25 -0.881 . . . . 2.8700000000000001 110.617 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.385 0.136 . . . . 4.7400000000000002 111.171 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 1.047 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 26.2 mtpp -78.73 -173.21 3.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.409 0.147 . . . . 2.3100000000000001 111.108 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 67.0 m -53.85 -54.75 34.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.205 0.526 . . . . 1.0 110.812 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.536 HD12 ' HD2' ' A' ' 36' ' ' PHE . 4.0 mt -80.47 -33.18 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.553 -1.277 . . . . 0.32000000000000001 107.553 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 65.08 20.12 66.65 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.135 -1.393 . . . . 0.42999999999999999 112.596 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.8 132.02 59.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.25 110.196 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.7 p -106.5 141.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.597 -0.728 . . . . 0.16 109.041 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 4.1 mpt_? -113.03 157.4 21.59 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.289 0.566 . . . . 1.0900000000000001 110.673 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 29.8 mmtp -119.14 119.24 33.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.909 -1.041 . . . . 1.1599999999999999 108.566 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.662 HG23 HD11 ' A' ' 34' ' ' ILE . 7.4 t -57.25 139.82 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.642 0.589 . . . . 0.25 110.777 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.01 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.486 -0.779 . . . . 1.22 109.805 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -152.63 -42.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.392 -0.966 . . . . 1.22 108.392 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.5 -27.3 37.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.783 -1.098 . . . . 0.90000000000000002 111.255 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.447 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 130.32 0.03 5.51 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.355 -0.698 . . . . 0.14999999999999999 111.355 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.707 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 24.6 mtt-85 -66.93 130.84 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.121 -0.326 . . . . 2.9100000000000001 110.121 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.4 OUTLIER -139.53 175.69 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.413 -0.588 . . . . 0.16 109.413 176.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -105.32 108.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.964 0.412 . . . . 0.19 110.973 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 28.3 mmt -74.97 154.63 86.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.032 -0.729 . . . . 0.93999999999999995 109.032 173.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 65.5 Cg_endo -86.85 155.49 8.69 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.999 1.799 . . . . 0.19 113.219 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.8 tp -55.99 -30.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.22 109.431 171.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.3 -30.59 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 1.0700000000000001 110.999 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.61 -40.35 56.57 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.78 -0.822 . . . . 0.23999999999999999 108.78 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 34.4 mtm180 -66.13 -26.52 67.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 1.3 110.626 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' HG13 ' B' ' 20' ' ' ILE . 68.9 mtp180 -84.33 -35.37 23.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.577 -0.738 . . . . 0.87 109.734 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.67 -51.58 66.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.727 -1.124 . . . . 0.28000000000000003 110.947 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.653 HD22 ' H ' ' B' ' 47' ' ' LYS . 71.0 mt -89.83 -85.6 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.732 -1.122 . . . . 0.56999999999999995 111.139 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.579 ' C ' HD12 ' B' ' 28' ' ' ILE . 15.9 t0 166.46 61.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.797 -1.186 . . . . 1.54 107.797 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.726 HG21 HG21 ' A' ' 10' ' ' VAL . 1.3 mp -116.56 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.66 -0.7 . . . . 0.31 109.86 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.67 -51.59 2.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.721 -0.672 . . . . 0.40999999999999998 111.652 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -144.16 -33.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 110.011 -0.366 . . . . 0.34000000000000002 110.011 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 38.1 mtpt -136.29 -49.05 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 1.3799999999999999 109.051 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.66 -115.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.384 -1.28 . . . . 1.1699999999999999 113.832 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 14.2 m -164.08 135.37 4.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.994 0.361 . . . . 0.23999999999999999 111.347 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.708 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -144.04 102.97 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 110.18 -0.304 . . . . 0.20000000000000001 110.18 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 65.7 tt0 -96.03 139.32 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.541 -0.54 . . . . 1.3300000000000001 109.541 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.89 155.62 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.524 1.154 . . . . 1.27 113.889 -175.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.98 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 38.8 t80 -120.14 157.26 29.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.1 -1.864 . . . . 2.1000000000000001 107.073 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.572 ' H ' ' HB2' ' A' ' 3' ' ' SER . 8.5 p -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 120.093 -0.643 . . . . 0.29999999999999999 109.955 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.822 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.7 t70 -132.3 95.8 3.73 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 1.1799999999999999 109.917 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.1 -75.9 0.33 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.685 -0.689 . . . . 0.41999999999999998 111.654 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.32 -29.04 3.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.484 0.659 . . . . 1.9099999999999999 109.798 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.822 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.4 OUTLIER -85.81 158.36 20.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.112 -0.949 . . . . 0.78000000000000003 111.778 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.837 HG13 HD12 ' A' ' 22' ' ' LEU . 17.7 mm -118.27 144.11 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.656 -0.702 . . . . 0.22 109.925 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.894 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.1 mt -128.66 114.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 0.29999999999999999 110.956 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.1 mp -104.23 141.05 36.96 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.89 0.33 . . . . 0.25 111.89 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -151.71 151.55 31.59 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.946 -0.57 . . . . 1.8500000000000001 110.345 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.826 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 2.1 tmtp? -78.1 137.5 38.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.371 -0.603 . . . . 0.51000000000000001 109.371 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.76 -58.71 5.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.863 -0.608 . . . . 1.1699999999999999 111.714 -169.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 14.6 tppt? -60.05 -56.29 36.97 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.016 1.487 . . . . 2.9199999999999999 115.016 -168.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.826 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 11.6 Cg_exo -71.88 15.46 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.704 2.27 . . . . 1.5700000000000001 114.335 -169.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.12 -53.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.148 -0.316 . . . . 4.6799999999999997 110.148 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.69 67.63 2.12 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.078 -0.582 . . . . 3.1200000000000001 112.218 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.31 148.05 3.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.122 -0.539 . . . . 3.6200000000000001 109.784 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.639 ' OXT' ' HG2' ' A' ' 2' ' ' LYS . 34.2 m . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.854 -0.593 . . . . 2.8199999999999998 110.442 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HA ' ' HB2' ' B' ' 54' ' ' CYS . 91.9 mtp . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.681 0.277 . . . . 4.7999999999999998 110.649 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.738 ' HE2' ' HD2' ' B' ' 37' ' ' PHE . 4.4 mmpt? -65.27 172.01 3.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.48 109.834 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.735 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 75.2 m -58.47 -40.77 83.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.276 0.56 . . . . 1.0 110.532 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.607 HD12 ' HB2' ' B' ' 36' ' ' PHE . 2.7 mt -100.04 -45.17 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.785 . . . . 0.34000000000000002 109.304 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.13 24.03 60.23 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.493 -0.776 . . . . 0.51000000000000001 112.222 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.4 m -121.22 133.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.648 0.737 . . . . 0.23000000000000001 111.241 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 7.2 p -108.77 140.49 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.17000000000000001 109.072 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' NE ' HG13 ' A' ' 17' ' ' VAL . 2.6 mpt_? -113.3 157.17 22.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.181 -0.463 . . . . 1.21 110.807 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.22 120.85 36.37 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.455 -0.793 . . . . 1.1299999999999999 108.971 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG21 ' B' ' 28' ' ' ILE . 42.7 t -55.88 145.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.23999999999999999 111.026 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -69.31 0.33 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.423 -0.584 . . . . 1.3100000000000001 109.423 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -155.88 -54.16 0.09 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.126 -0.943 . . . . 1.23 108.734 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.2 mp -77.81 -22.44 50.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.317 -1.311 . . . . 0.84999999999999998 111.376 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.58 -11.33 4.02 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.821 -0.704 . . . . 0.17000000000000001 111.886 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.796 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 39.6 mtt180 -60.25 134.51 57.13 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.906 -0.173 . . . . 3.0299999999999998 110.751 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.43 175.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.515 -0.921 . . . . 0.13 108.515 172.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -106.37 100.69 11.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.347 0.594 . . . . 0.19 110.826 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 16' ' ' ILE . 81.1 mmm -74.94 148.61 84.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.818 -0.808 . . . . 0.83999999999999997 108.818 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 82.0 Cg_endo -80.25 157.6 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.828 1.685 . . . . 0.16 113.247 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 24' ' ' ARG . 4.1 tp -56.04 -31.79 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.333 -0.849 . . . . 0.26000000000000001 109.405 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 5.3 mm-40 -61.19 -28.8 69.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 1.0800000000000001 111.191 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.8 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.64 -39.33 57.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.488 -0.93 . . . . 0.20000000000000001 108.488 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.642 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 50.6 mtm180 -66.04 -28.56 68.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.84 -1.073 . . . . 1.05 110.28 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.642 ' HD2' HG13 ' A' ' 20' ' ' ILE . 72.4 mtp180 -84.99 -35.0 22.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.435 -0.802 . . . . 0.70999999999999996 110.522 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.23 55.23 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.275 -0.875 . . . . 0.26000000000000001 110.136 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.56 HD22 ' H ' ' A' ' 47' ' ' LYS . 87.0 mt -81.49 -88.84 0.08 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.86 -1.064 . . . . 0.52000000000000002 110.577 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.1 t70 167.17 61.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.634 -1.247 . . . . 1.72 107.634 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.645 HG21 HG21 ' B' ' 10' ' ' VAL . 3.0 mp -113.26 132.23 62.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.657 -0.701 . . . . 0.28000000000000003 110.102 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.28 -55.74 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 0.29999999999999999 110.927 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -143.09 -32.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.778 -0.646 . . . . 0.33000000000000002 109.91 -177.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.62 ' HG3' HG23 ' A' ' 30' ' ' ILE . 31.7 mtpt -136.98 -50.3 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.358 0.599 . . . . 1.46 109.467 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CB ' ' HA ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER 36.86 -116.41 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.399 1.259 . . . . 1.1799999999999999 114.399 -177.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 20.0 m -164.87 134.52 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.416 0.553 . . . . 0.20999999999999999 111.424 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.768 HD11 HG23 ' B' ' 10' ' ' VAL . 2.8 mp -140.99 106.77 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.369 -0.234 . . . . 0.28000000000000003 110.369 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 60.0 tt0 -98.76 142.08 30.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.744 -0.465 . . . . 1.3100000000000001 109.744 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.1 155.03 35.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.231 1.015 . . . . 1.3300000000000001 113.354 -175.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.781 ' HB2' ' HE3' ' B' ' 2' ' ' LYS . 34.7 t80 -134.47 126.73 30.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.714 -1.585 . . . . 2.2200000000000002 108.122 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.706 ' H ' ' HB2' ' B' ' 3' ' ' SER . 6.3 p -92.9 129.14 43.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 119.498 -0.881 . . . . 0.27000000000000002 110.705 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -127.08 109.04 11.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.011 -0.995 . . . . 1.1599999999999999 108.942 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 -96.49 0.75 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.398 -1.081 . . . . 0.32000000000000001 110.398 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.28 -8.12 8.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.565 0.221 . . . . 2.0 110.483 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -100.4 166.75 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.687 -0.233 . . . . 1.05 110.88 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.896 HG13 HD12 ' B' ' 22' ' ' LEU . 11.9 mm -116.25 143.42 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.055 -0.35 . . . . 0.17999999999999999 110.055 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 49.1 mt -122.02 118.79 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.431 -0.349 . . . . 0.28000000000000003 110.435 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' B' ' 45' ' ' LEU . 11.1 mp -103.37 133.5 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.32000000000000001 111.63 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 11.4 ttpt -142.19 143.98 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.362 -0.835 . . . . 2.1600000000000001 110.255 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.9 tmtp? -75.97 145.94 39.94 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.506 -0.924 . . . . 0.52000000000000002 108.506 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 84.9 t80 -70.15 -53.55 16.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.418 0.628 . . . . 1.25 110.918 -172.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 16.3 tptp -53.33 -54.78 41.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 114.244 -1.344 . . . . 2.8599999999999999 114.469 -173.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 36.6 Cg_exo -36.83 -62.96 0.24 Allowed 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.838 3.026 . . . . 1.8100000000000001 114.633 -174.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -135.68 93.76 2.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.312 -0.996 . . . . 4.6900000000000004 108.312 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.61 90.3 0.3 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.346 -0.843 . . . . 3.1400000000000001 113.337 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.8 144.92 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.508 -0.553 . . . . 3.5800000000000001 109.508 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.605 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 73.5 m . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.375 -0.821 . . . . 2.8700000000000001 110.404 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.605 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 80.0 mtp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.063 -0.347 . . . . 4.7400000000000002 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.781 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 9.6 mtpp -72.47 171.58 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.236 -0.653 . . . . 2.3100000000000001 109.236 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.706 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 75.2 m -57.9 -33.83 69.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.59 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.8 mt -105.72 -46.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.32000000000000001 108.971 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.7 21.89 73.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.289 -0.868 . . . . 0.42999999999999999 112.265 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.3 132.53 66.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.269 0.557 . . . . 0.25 110.825 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.5 p -105.0 143.13 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.024 -0.732 . . . . 0.16 109.024 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.478 ' NE ' HG13 ' B' ' 17' ' ' VAL . 2.5 mpt_? -113.17 158.89 19.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.1 0.476 . . . . 1.0900000000000001 111.084 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 33.6 mmtp -118.55 121.66 40.76 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.871 -1.059 . . . . 1.1599999999999999 109.106 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.768 HG23 HD11 ' A' ' 34' ' ' ILE . 14.5 t -57.66 141.39 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.304 -0.407 . . . . 0.25 110.29 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.16 -74.3 0.12 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 1.22 109.32 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -148.54 -55.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.485 0.66 . . . . 1.22 109.472 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.874 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.2 OUTLIER -76.96 -16.9 59.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.054 -0.976 . . . . 0.90000000000000002 110.91 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 126.72 -0.85 7.37 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.991 -0.623 . . . . 0.14999999999999999 111.672 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 6.3 mtm180 -67.01 126.56 29.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.188 -0.301 . . . . 2.9100000000000001 110.188 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -132.81 172.36 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.811 -0.811 . . . . 0.16 108.811 176.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -104.67 101.58 12.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.301 0.572 . . . . 0.19 110.812 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.51 ' SD ' HD11 ' B' ' 16' ' ' ILE . 84.3 mmm -75.4 151.63 85.46 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.046 -0.724 . . . . 0.93999999999999995 109.046 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 29.1 Cg_endo -83.36 156.8 14.58 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.628 1.552 . . . . 0.19 113.317 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -55.24 -30.72 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.22 109.909 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -62.68 -26.35 68.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.23 -0.441 . . . . 1.0700000000000001 110.627 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.896 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.46 -40.61 49.92 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.901 -0.778 . . . . 0.23999999999999999 108.901 175.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.682 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 53.0 mtm180 -65.19 -29.13 69.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.844 -1.071 . . . . 1.3 110.705 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 81.6 mtp180 -83.49 -30.55 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.354 -0.839 . . . . 0.87 109.821 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.83 -53.26 22.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.895 -1.048 . . . . 0.28000000000000003 110.935 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.791 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 48.4 mt -85.16 -81.39 0.2 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.784 -1.098 . . . . 0.56999999999999995 110.55 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.575 ' C ' HD12 ' B' ' 28' ' ' ILE . 20.1 t0 163.95 60.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.744 -1.206 . . . . 1.54 107.744 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 10' ' ' VAL . 1.4 mp -116.84 132.89 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.104 -0.498 . . . . 0.31 109.67 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.69 -54.32 2.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.793 -0.64 . . . . 0.40999999999999998 111.064 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -33.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.15 -0.477 . . . . 0.34000000000000002 109.801 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 10' ' ' VAL . 21.1 mtpt -133.31 -52.38 0.89 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.328 -0.619 . . . . 1.3799999999999999 109.328 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 0.7 OUTLIER 36.25 -118.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.585 -1.189 . . . . 1.1699999999999999 114.103 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 13.1 m -161.05 135.84 7.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.046 0.384 . . . . 0.23999999999999999 111.979 -173.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.6 HG21 HD23 ' B' ' 45' ' ' LEU . 3.6 mp -143.9 104.39 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 N-CA-C 110.289 -0.263 . . . . 0.20000000000000001 110.289 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.4 tt0 -96.48 141.05 30.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.767 -0.457 . . . . 1.3300000000000001 109.767 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.607 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.02 157.79 26.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.014 1.116 . . . . 1.27 114.014 -175.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.738 ' HD2' ' HE2' ' A' ' 2' ' ' LYS . 47.4 t80 -136.83 129.28 30.08 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 113.63 -1.623 . . . . 2.1000000000000001 108.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.735 ' H ' ' HB2' ' A' ' 3' ' ' SER . 9.6 p -92.37 133.42 33.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 119.816 -0.753 . . . . 0.29999999999999999 109.746 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -131.9 107.47 8.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.967 -0.753 . . . . 1.1799999999999999 108.967 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.64 -91.01 0.66 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.051 -0.82 . . . . 0.41999999999999998 111.051 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -128.77 -9.0 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.748 -0.464 . . . . 1.9099999999999999 109.748 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -100.93 169.05 9.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.78000000000000003 110.799 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 22' ' ' LEU . 23.0 mm -118.86 142.93 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 0.22 110.461 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 18.8 mt -119.75 124.89 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.322 -0.399 . . . . 0.29999999999999999 110.109 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.868 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -109.39 132.23 54.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.022 0.439 . . . . 0.25 111.64 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 13.9 ttpt -142.08 145.53 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.8500000000000001 110.237 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.791 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.1 tmtp? -80.94 138.85 36.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.028 -0.731 . . . . 0.51000000000000001 109.028 175.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.486 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 37.2 t80 -61.17 -51.22 69.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.1699999999999999 112.822 -171.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.534 ' HB2' ' HD3' ' B' ' 50' ' ' PRO . 4.8 mptp? -53.42 -61.78 4.54 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.702 1.001 . . . . 2.9199999999999999 113.702 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.665 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 22.5 Cg_exo -64.81 110.18 1.42 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.745 1.63 . . . . 1.5700000000000001 111.581 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 66.11 80.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.575 -0.739 . . . . 4.6799999999999997 109.983 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.17 82.95 1.42 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.27 -0.877 . . . . 3.1200000000000001 112.816 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.15 142.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 120.964 0.411 . . . . 3.6200000000000001 110.583 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.667 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 37.6 m . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.51 -0.757 . . . . 2.8199999999999998 109.35 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.911 0.386 . . . . 4.7999999999999998 110.387 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.607 ' HG2' ' HA ' ' B' ' 54' ' ' CYS . 48.6 mtmt -103.53 -175.97 2.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.807 -0.357 . . . . 2.48 110.25 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.598 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 31.6 t -49.13 -43.52 41.7 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.675 0.609 . . . . 1.0 111.9 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.7 mt -92.8 -34.0 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.051 -0.722 . . . . 0.34000000000000002 109.051 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.38 6.18 79.61 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.027 -0.988 . . . . 0.51000000000000001 112.733 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 31.8 m -102.41 133.38 46.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.605 0.717 . . . . 0.23000000000000001 111.326 -176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 6.5 p -115.84 140.36 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.413 -1.267 . . . . 0.17000000000000001 109.68 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.697 ' HG2' ' CZ ' ' B' ' 36' ' ' PHE . 11.6 mmt180 -110.54 165.08 12.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.857 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 28.4 mmtp -124.28 122.36 37.53 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.102 -1.073 . . . . 1.1299999999999999 108.102 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.665 HG23 HD11 ' B' ' 34' ' ' ILE . 38.4 t -56.5 145.98 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.23999999999999999 111.726 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.21 -78.04 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 1.3100000000000001 109.699 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -153.45 -45.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.944 -0.761 . . . . 1.23 108.944 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -81.92 -27.59 33.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.952 -1.022 . . . . 0.84999999999999998 110.808 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 141.16 -11.18 2.8 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.623 -0.717 . . . . 0.17000000000000001 111.582 -174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 46.8 mtp180 -61.21 132.05 52.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.099 0.16 . . . . 3.0299999999999998 111.0 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -139.07 178.57 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.684 -0.858 . . . . 0.13 108.684 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.82 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -107.41 109.21 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.488 0.661 . . . . 0.19 111.467 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.633 ' HB3' HD22 ' A' ' 22' ' ' LEU . 14.5 mmt -75.74 154.01 85.24 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.503 -0.771 . . . . 0.83999999999999997 109.315 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.2 Cg_endo -83.26 154.39 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.68 1.587 . . . . 0.16 113.162 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 tp -54.74 -31.7 24.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.562 -0.744 . . . . 0.26000000000000001 109.568 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.86 -28.21 68.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.45 -0.795 . . . . 1.0800000000000001 110.768 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.816 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -77.63 -39.6 44.67 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.787 -0.82 . . . . 0.20000000000000001 108.787 176.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.1 mtm180 -64.73 -28.91 69.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.142 -0.936 . . . . 1.05 110.394 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -83.68 -38.58 21.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.163 -0.926 . . . . 0.70999999999999996 110.227 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.67 85.37 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.289 -0.868 . . . . 0.26000000000000001 110.525 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.555 HD22 ' HB2' ' A' ' 47' ' ' LYS . 93.1 mt -87.8 -93.69 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.06 -0.973 . . . . 0.52000000000000002 111.587 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' H ' HD12 ' A' ' 28' ' ' ILE . 33.0 t70 -179.95 38.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.435 0.636 . . . . 1.72 109.307 -172.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 3.1 mp -100.06 134.27 40.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.401 -0.363 . . . . 0.28000000000000003 110.884 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.51 -56.51 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.29999999999999999 110.684 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.586 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.46 -29.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.954 -0.567 . . . . 0.33000000000000002 109.724 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 30' ' ' ILE . 37.4 mtpt -136.11 -57.1 0.76 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.474 -0.785 . . . . 1.46 109.028 176.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER 37.21 -128.13 0.17 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.097 -0.956 . . . . 1.1799999999999999 113.036 -175.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 13.1 m -153.29 136.66 15.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.516 0.598 . . . . 0.20999999999999999 111.589 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.725 HD11 HG23 ' B' ' 10' ' ' VAL . 4.2 mp -139.18 107.79 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.223 -0.288 . . . . 0.28000000000000003 110.223 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.1 tt0 -105.28 140.67 38.07 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.022 -0.362 . . . . 1.3100000000000001 110.022 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HD2' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -123.04 153.62 39.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.533 0.938 . . . . 1.3300000000000001 113.533 -174.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.064 ' HB2' ' HD2' ' B' ' 2' ' ' LYS . 33.8 t80 -125.12 124.31 41.58 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.078 -1.419 . . . . 2.2200000000000002 108.742 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' H ' ' HB3' ' B' ' 3' ' ' SER . 4.1 p -93.65 134.58 30.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 C-N-CA 119.785 -0.766 . . . . 0.27000000000000002 110.74 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -132.75 105.12 6.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.344 -0.844 . . . . 1.1599999999999999 109.747 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.54 0.46 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.162 -0.775 . . . . 0.32000000000000001 111.162 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -128.02 -8.03 5.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.369 0.604 . . . . 2.0 109.528 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.2 ttpt -93.16 156.96 16.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 1.05 111.329 -169.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.93 HG13 HD12 ' B' ' 22' ' ' LEU . 10.0 mm -116.93 142.92 28.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.484 -0.561 . . . . 0.17999999999999999 109.484 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.622 HD12 ' HD1' ' A' ' 37' ' ' PHE . 47.0 mt -128.98 109.52 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.581 0.229 . . . . 0.28000000000000003 110.907 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.88 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.4 mp -92.17 137.62 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.291 0.567 . . . . 0.32000000000000001 112.184 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 12.6 ttpt -145.97 141.59 27.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.794 -1.094 . . . . 2.1600000000000001 109.527 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 33' ' ' SER . 7.1 tmtt? -76.58 146.32 38.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.098 -0.704 . . . . 0.52000000000000002 109.098 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -76.47 -51.0 12.62 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.762 -0.375 . . . . 1.25 111.808 -171.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.796 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 87.4 tttt -46.34 -55.67 13.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.832 -0.622 . . . . 2.8599999999999999 112.616 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 21.6 Cg_exo -67.1 143.48 65.46 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.038 1.825 . . . . 1.8100000000000001 111.621 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -93.01 152.01 19.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 4.6900000000000004 109.715 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.68 -142.51 6.81 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.391 -0.909 . . . . 3.1400000000000001 111.93 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.0 134.41 27.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.493 0.664 . . . . 3.5800000000000001 111.943 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' B' ' 1' ' ' MET . 84.7 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.726 -1.131 . . . . 2.8700000000000001 108.556 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.428 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.5 mtt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.029 0.443 . . . . 4.7400000000000002 110.054 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 1.064 ' HD2' ' HB2' ' A' ' 37' ' ' PHE . 48.7 mmtt -88.25 179.22 6.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.781 -0.645 . . . . 2.3100000000000001 111.067 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.525 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 37.2 t -57.83 -42.82 85.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.751 . . . . 1.0 109.985 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.795 HD12 ' HD2' ' A' ' 36' ' ' PHE . 2.9 mt -88.76 -40.12 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.561 -0.903 . . . . 0.32000000000000001 108.561 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.28 77.73 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.026 -0.988 . . . . 0.42999999999999999 112.49 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.6 m -114.23 132.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.041 0.448 . . . . 0.25 110.706 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -113.82 139.53 38.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.694 -0.685 . . . . 0.16 109.693 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.726 ' HG2' ' CE1' ' A' ' 36' ' ' PHE . 5.1 mmt180 -106.73 167.0 10.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 110.623 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HD3' ' O ' ' B' ' 8' ' ' ARG . 30.1 mmtp -125.9 119.03 26.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.113 -1.069 . . . . 1.1599999999999999 108.113 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.725 HG23 HD11 ' A' ' 34' ' ' ILE . 8.5 t -56.55 142.04 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.43 0.633 . . . . 0.25 111.26 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.75 -76.38 0.06 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 1.22 110.058 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -152.44 -49.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.565 -0.902 . . . . 1.22 108.565 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.83 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.4 OUTLIER -79.93 -19.12 48.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.246 -1.343 . . . . 0.90000000000000002 110.655 -176.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 128.02 -3.3 6.86 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.14999999999999999 111.489 -176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 52.0 mtm180 -63.99 128.55 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.445 -0.206 . . . . 2.9100000000000001 110.445 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.7 OUTLIER -136.04 179.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.072 -0.714 . . . . 0.16 109.072 176.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -106.63 108.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.215 0.531 . . . . 0.19 111.04 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.693 ' HB3' HD22 ' B' ' 22' ' ' LEU . 30.4 mmt -74.66 152.95 87.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.65 -0.871 . . . . 0.93999999999999995 108.65 172.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 43.3 Cg_endo -84.5 154.84 12.16 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.906 1.738 . . . . 0.19 112.943 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 4.1 tp -53.84 -32.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.22 109.571 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -61.12 -26.43 67.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.79 -0.641 . . . . 1.0700000000000001 110.819 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.93 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.63 -40.94 32.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.926 -0.768 . . . . 0.23999999999999999 108.926 176.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 38.8 mtm180 -65.65 -27.5 68.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.568 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 72.1 mtp180 -83.96 -30.75 25.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.257 -0.883 . . . . 0.87 110.047 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.99 -52.52 28.0 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.012 -0.994 . . . . 0.28000000000000003 110.687 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 62.0 mt -85.6 -87.51 0.13 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.734 -1.121 . . . . 0.56999999999999995 110.8 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.435 ' C ' HD12 ' B' ' 28' ' ' ILE . 38.9 t70 173.89 45.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.754 . . . . 1.54 109.005 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 10' ' ' VAL . 1.2 mp -108.0 129.11 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.31 110.018 -174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.15 4.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.478 -0.783 . . . . 0.40999999999999998 111.499 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.556 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -150.46 -33.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.742 -0.466 . . . . 0.34000000000000002 109.742 177.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' B' ' 30' ' ' ILE . 44.1 mtpt -133.55 -50.92 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.316 0.579 . . . . 1.3799999999999999 109.443 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.536 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.6 OUTLIER 36.8 -113.56 0.1 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.22 1.192 . . . . 1.1699999999999999 114.22 -177.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.5 m -164.38 137.39 5.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.189 0.45 . . . . 0.23999999999999999 111.61 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -141.86 102.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 110.213 -0.292 . . . . 0.20000000000000001 110.213 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 33.5 tt0 -95.18 142.53 27.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.4 -0.593 . . . . 1.3300000000000001 109.4 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.697 ' CZ ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -118.99 158.52 25.6 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.183 0.992 . . . . 1.27 113.579 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 18.7 t80 -132.88 125.87 30.93 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 113.675 -1.602 . . . . 2.1000000000000001 108.011 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.598 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.5 p -93.28 135.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.822 -0.751 . . . . 0.29999999999999999 110.24 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.074 -0.713 . . . . 1.1799999999999999 109.074 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.11 -95.17 0.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.977 -0.849 . . . . 0.41999999999999998 110.977 -171.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.94 -13.58 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 1.9099999999999999 110.169 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -92.82 167.78 11.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.78000000000000003 110.834 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.7 mm -121.97 143.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.13 -0.486 . . . . 0.22 109.724 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 17.4 mt -124.5 113.85 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.504 -0.316 . . . . 0.29999999999999999 110.798 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.836 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -98.02 139.52 33.73 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.265 0.555 . . . . 0.25 112.064 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -152.58 141.07 20.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.799 -1.091 . . . . 1.8500000000000001 109.188 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.729 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 7.1 tmtt? -72.74 153.4 41.16 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.842 -0.799 . . . . 0.51000000000000001 108.842 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -77.17 -52.83 8.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.149 0.499 . . . . 1.1699999999999999 111.358 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.542 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 54.2 tttm -53.65 -46.58 98.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.003 -0.999 . . . . 2.9199999999999999 113.203 -174.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 16.4 Cg_exo -69.49 130.46 19.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.956 1.77 . . . . 1.5700000000000001 111.366 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.67 124.3 37.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 4.6799999999999997 110.899 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.82 -126.49 1.1 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.657 -0.702 . . . . 3.1200000000000001 111.848 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -78.81 144.93 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.02 0.438 . . . . 3.6200000000000001 110.854 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.607 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.508 -0.758 . . . . 2.8199999999999998 110.005 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 111.552 0.204 . . . . 4.7999999999999998 111.552 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.694 ' HG3' ' HG2' ' B' ' 35' ' ' GLU . 38.3 mmtt 63.21 -175.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.63 0.729 . . . . 2.48 112.45 175.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.626 ' HB2' ' CD1' ' B' ' 37' ' ' PHE . 19.0 t -90.9 -46.2 8.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.681 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.43 -31.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.067 -0.716 . . . . 0.34000000000000002 109.067 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 75.58 21.43 77.14 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.139 -0.937 . . . . 0.51000000000000001 112.931 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.57 132.63 68.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.859 0.837 . . . . 0.23000000000000001 111.748 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 12.2 p -111.1 140.86 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 113.935 -1.484 . . . . 0.17000000000000001 108.578 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' NE ' HG13 ' A' ' 17' ' ' VAL . 3.7 mpt_? -114.78 155.0 27.53 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.017 0.437 . . . . 1.21 110.607 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 121.05 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.584 -0.895 . . . . 1.1299999999999999 108.584 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.638 HG23 HD11 ' B' ' 34' ' ' ILE . 4.7 t -54.52 141.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.564 0.54 . . . . 0.23999999999999999 110.312 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.36 -77.86 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.939 -0.763 . . . . 1.3100000000000001 108.939 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.48 ' HG2' HD11 ' B' ' 30' ' ' ILE . 29.8 mt-10 -151.71 -36.2 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.623 -0.88 . . . . 1.23 108.623 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD12 ' HD2' ' A' ' 15' ' ' ARG . 11.2 mt -86.79 -19.09 29.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.14 -0.936 . . . . 0.84999999999999998 111.7 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 124.19 -6.43 8.75 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 120.503 -0.856 . . . . 0.17000000000000001 111.277 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.0 mtp180 -67.25 125.2 25.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.345 -0.242 . . . . 3.0299999999999998 110.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -131.73 175.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.966 -0.753 . . . . 0.13 108.966 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.7 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.9 p -103.27 102.43 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.056 0.455 . . . . 0.19 110.938 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.625 ' HB3' HD22 ' A' ' 22' ' ' LEU . 13.2 mmt -74.54 149.99 86.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.4 -0.593 . . . . 0.83999999999999997 109.4 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 72.4 Cg_endo -81.19 155.03 19.29 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.781 1.654 . . . . 0.16 113.383 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 4.7 tp -56.2 -31.81 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.178 -0.919 . . . . 0.26000000000000001 109.059 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 13.0 mm-40 -58.87 -30.93 68.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.211 -0.904 . . . . 1.0800000000000001 111.253 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.905 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -75.22 -41.12 58.33 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.457 -0.942 . . . . 0.20000000000000001 108.457 177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.629 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 32.3 mtm180 -63.92 -29.57 70.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.782 -1.099 . . . . 1.05 110.224 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 73.5 mtp180 -85.26 -35.83 21.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.399 -0.819 . . . . 0.70999999999999996 110.753 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.28 95.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.598 0.713 . . . . 0.26000000000000001 109.874 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.565 HD22 ' H ' ' A' ' 47' ' ' LYS . 77.2 mt -92.36 -104.83 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.678 -1.146 . . . . 0.52000000000000002 110.255 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -174.72 49.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 1.72 109.422 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.629 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -93.18 131.68 39.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.28000000000000003 109.513 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.58 -57.77 2.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.34 0.59 . . . . 0.29999999999999999 110.587 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -146.68 -28.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.032 -0.986 . . . . 0.33000000000000002 109.604 -175.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HG3' HG23 ' A' ' 30' ' ' ILE . 21.2 mtpp -139.88 -52.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 1.46 109.141 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' HB2' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER 37.75 -115.27 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.094 1.146 . . . . 1.1799999999999999 114.094 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 38.5 m -166.59 137.88 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.436 0.562 . . . . 0.20999999999999999 111.065 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.751 HD11 HG23 ' B' ' 10' ' ' VAL . 3.7 mp -139.0 111.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.701 -0.481 . . . . 0.28000000000000003 109.701 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.506 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 22.7 tt0 -107.92 130.2 55.04 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.31 0.244 . . . . 1.3100000000000001 110.552 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.701 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -116.06 153.5 31.61 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.655 0.983 . . . . 1.3300000000000001 113.655 -170.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' HD1' HD12 ' A' ' 44' ' ' ILE . 25.5 t80 -129.86 132.36 46.41 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 114.112 -1.404 . . . . 2.2200000000000002 108.478 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.532 ' H ' ' HB3' ' B' ' 3' ' ' SER . 2.8 p -100.29 132.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 119.765 -0.774 . . . . 0.27000000000000002 111.268 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 23.9 t70 -125.59 99.89 6.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.67 -1.15 . . . . 1.1599999999999999 109.534 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.32 -84.31 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.583 -0.735 . . . . 0.32000000000000001 111.365 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.01 -17.04 5.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.392 0.615 . . . . 2.0 109.64 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' B' ' 44' ' ' ILE . 2.1 ttpt -92.47 158.07 16.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.345 -0.843 . . . . 1.05 111.325 -167.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.968 HG13 HD12 ' B' ' 22' ' ' LEU . 7.0 mm -118.12 139.46 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.887 -0.412 . . . . 0.17999999999999999 109.887 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.591 HD12 ' HD1' ' A' ' 37' ' ' PHE . 43.6 mt -121.87 111.71 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.444 . . . . 0.28000000000000003 110.508 -174.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -102.87 138.19 40.08 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.815 0.302 . . . . 0.32000000000000001 111.815 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 149.89 26.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 2.1600000000000001 110.081 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 2.9 tmtp? -65.53 147.99 52.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.891 -0.595 . . . . 0.52000000000000002 110.146 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.634 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 24.3 t80 -60.0 -52.02 67.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 1.25 111.263 -173.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.882 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 36.1 ttmt -55.07 -59.44 10.82 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.464 -0.789 . . . . 2.8599999999999999 112.485 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.882 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 65.3 Cg_exo -53.98 125.52 19.0 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.277 1.985 . . . . 1.8100000000000001 112.86 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -83.6 92.09 7.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.881 0.848 . . . . 4.6900000000000004 110.476 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.3 -118.81 4.51 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.509 -1.036 . . . . 3.1400000000000001 110.509 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.13 144.59 20.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 110.011 -0.366 . . . . 3.5800000000000001 110.011 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.146 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 88.5 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.226 -0.892 . . . . 2.8700000000000001 110.379 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 111.319 0.118 . . . . 4.7400000000000002 111.319 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 1.146 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 6.5 mmmm 65.48 165.94 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.92 0.867 . . . . 2.3100000000000001 112.854 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 47.1 t -70.48 -45.99 64.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 1.0 110.723 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.451 HD12 ' HD2' ' A' ' 36' ' ' PHE . 10.5 mt -89.45 -40.73 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.923 -0.769 . . . . 0.32000000000000001 108.923 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.88 39.65 59.0 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.42999999999999999 112.538 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 36' ' ' PHE . 15.3 m -131.97 132.21 61.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.023 0.439 . . . . 0.25 110.029 174.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 33' ' ' SER . 12.1 p -108.44 142.66 20.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.819 -0.808 . . . . 0.16 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.701 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 mpt_? -113.79 153.87 28.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.991 0.424 . . . . 1.0900000000000001 110.764 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 121.45 44.64 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.565 -0.743 . . . . 1.1599999999999999 109.054 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 34' ' ' ILE . 3.8 t -53.62 137.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 123.837 0.711 . . . . 0.25 110.459 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -55.08 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.631 -0.713 . . . . 1.22 109.998 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.711 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.1 mt-10 -151.64 -32.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.499 -0.926 . . . . 1.22 108.499 173.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.33 -29.96 21.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.304 -1.317 . . . . 0.90000000000000002 110.858 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 18' ' ' MET . . . 132.06 -8.37 5.42 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.768 -0.933 . . . . 0.14999999999999999 110.768 -172.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 mtp180 -62.84 124.58 21.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.299 . . . . 2.9100000000000001 110.508 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -129.58 174.77 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.649 -0.871 . . . . 0.16 108.649 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.723 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.9 p -104.15 104.06 16.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.326 0.584 . . . . 0.19 110.693 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 1.6 mmt -76.29 151.72 83.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 0.93999999999999995 108.729 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.41 153.84 10.62 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.877 1.718 . . . . 0.19 113.321 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' B' ' 23' ' ' ARG . 3.7 tp -53.85 -30.25 19.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.413 -0.812 . . . . 0.22 109.985 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.04 -25.67 67.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.206 -0.452 . . . . 1.0700000000000001 110.88 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.968 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.62 -41.29 39.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.631 -0.877 . . . . 0.23999999999999999 108.631 174.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 37.4 mtm180 -63.54 -29.83 71.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.887 -1.052 . . . . 1.3 110.683 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.563 ' HD2' HG13 ' B' ' 20' ' ' ILE . 62.0 mtp180 -84.36 -33.93 23.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.271 -0.877 . . . . 0.87 110.048 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -51.03 71.63 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.781 -1.1 . . . . 0.28000000000000003 110.1 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.575 HD22 ' H ' ' B' ' 47' ' ' LYS . 61.0 mt -92.4 -91.25 0.17 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.462 -1.245 . . . . 0.56999999999999995 111.637 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.476 ' C ' HD12 ' B' ' 28' ' ' ILE . 16.7 t0 175.5 50.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.637 -0.875 . . . . 1.54 108.637 -170.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -109.34 132.92 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.966 -0.753 . . . . 0.31 108.966 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.36 -51.48 2.91 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.163 0.506 . . . . 0.40999999999999998 111.852 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.669 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -146.94 -29.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.971 -0.559 . . . . 0.34000000000000002 109.668 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.669 ' HG3' HG23 ' B' ' 30' ' ' ILE . 20.4 mtpp -140.06 -51.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.465 -0.568 . . . . 1.3799999999999999 109.465 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.452 ' HB2' HG23 ' B' ' 28' ' ' ILE . 0.7 OUTLIER 34.91 -115.44 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.802 1.038 . . . . 1.1699999999999999 113.802 -176.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 25.0 m -163.4 136.99 5.74 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.155 -0.34 . . . . 0.23999999999999999 111.37 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.668 HG21 HD23 ' B' ' 45' ' ' LEU . 4.3 mp -142.0 105.22 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.6 -0.519 . . . . 0.20000000000000001 109.6 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.694 ' HG2' ' HG3' ' A' ' 2' ' ' LYS . 43.1 tt0 -102.73 134.45 46.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.318 -0.253 . . . . 1.3300000000000001 110.318 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.509 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.79 158.67 23.52 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.214 1.19 . . . . 1.27 114.214 -173.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.692 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 66.4 t80 -126.07 152.71 45.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.199 -1.819 . . . . 2.1000000000000001 107.177 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.608 ' H ' ' HB3' ' A' ' 3' ' ' SER . 13.9 p -117.87 137.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 120.057 -0.657 . . . . 0.29999999999999999 110.041 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 31.5 t70 -133.65 95.6 3.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 110.111 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.03 -73.49 1.04 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.572 -0.74 . . . . 0.41999999999999998 111.684 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -127.71 -30.5 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.462 0.649 . . . . 1.9099999999999999 109.421 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -89.7 166.22 13.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.096 -0.956 . . . . 0.78000000000000003 111.341 -163.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.905 HG13 HD12 ' A' ' 22' ' ' LEU . 25.4 mm -121.27 142.99 35.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.618 -0.719 . . . . 0.22 109.46 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 33.5 mt -124.06 109.74 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.409 -0.359 . . . . 0.29999999999999999 110.69 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 45' ' ' LEU . 10.6 mp -101.69 134.66 44.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.331 0.493 . . . . 0.25 112.331 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.683 ' HE2' ' HE2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -149.08 148.75 30.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.8500000000000001 109.667 172.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.743 ' HB3' ' HD2' ' B' ' 50' ' ' PRO . 7.1 tttt -64.92 167.05 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -78.04 -49.66 13.57 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.238 -0.585 . . . . 1.1699999999999999 110.108 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.774 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 39.9 ttmt -59.45 -58.31 20.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.29 -0.868 . . . . 2.9199999999999999 112.644 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 50.2 Cg_exo -55.08 125.29 18.69 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.372 2.048 . . . . 1.5700000000000001 112.695 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.49 81.64 7.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.793 0.806 . . . . 4.6799999999999997 110.396 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.06 -88.29 1.31 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.562 -0.827 . . . . 3.1200000000000001 111.506 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.33 143.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 3.6200000000000001 109.66 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 2' ' ' LYS . 92.0 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.704 -1.141 . . . . 2.8199999999999998 109.302 174.815 . . . . . . . . 1 1 . 1 stop_ save_